| Level/ Type |
Code |
Display Name |
Code System |
| 0‑L |
5
|
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
6
|
3-methylcrotonyl-CoA carboxylase deficiency
|
ORPHAnet |
| 0‑L |
7
|
3C syndrome
|
ORPHAnet |
| 0‑L |
8
|
47,XYY syndrome
|
ORPHAnet |
| 0‑L |
9
|
Tetrasomy X
|
ORPHAnet |
| 0‑L |
10
|
48,XXYY syndrome
|
ORPHAnet |
| 0‑L |
11
|
Pentasomy X
|
ORPHAnet |
| 0‑L |
13
|
6-pyruvoyl-tetrahydropterin synthase deficiency
|
ORPHAnet |
| 0‑L |
14
|
Abetalipoproteinemia
|
ORPHAnet |
| 0‑L |
15
|
Achondroplasia
|
ORPHAnet |
| 0‑L |
16
|
Blue cone monochromatism
|
ORPHAnet |
| 0‑L |
17
|
Fatal infantile lactic acidosis with methylmalonic aciduria
|
ORPHAnet |
| 0‑L |
18
|
Distal renal tubular acidosis
|
ORPHAnet |
| 0‑L |
20
|
3-hydroxy-3-methylglutaric aciduria
|
ORPHAnet |
| 0‑L |
22
|
Succinic semialdehyde dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
23
|
Argininosuccinic aciduria
|
ORPHAnet |
| 0‑L |
24
|
Fumaric aciduria
|
ORPHAnet |
| 0‑L |
25
|
Glutaryl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
26
|
Methylmalonic acidemia with homocystinuria
|
ORPHAnet |
| 0‑L |
27
|
Vitamin B12-unresponsive methylmalonic acidemia
|
ORPHAnet |
| 0‑L |
28
|
Vitamin B12-responsive methylmalonic acidemia
|
ORPHAnet |
| 0‑L |
29
|
Mevalonic aciduria
|
ORPHAnet |
| 0‑L |
30
|
Hereditary orotic aciduria
|
ORPHAnet |
| 0‑L |
31
|
Oxoglutaric aciduria
|
ORPHAnet |
| 0‑L |
32
|
Glutathione synthetase deficiency
|
ORPHAnet |
| 0‑L |
33
|
Isovaleric acidemia
|
ORPHAnet |
| 0‑L |
35
|
Propionic acidemia
|
ORPHAnet |
| 0‑L |
36
|
Acrocallosal syndrome
|
ORPHAnet |
| 0‑L |
37
|
Acrodermatitis enteropathica
|
ORPHAnet |
| 0‑L |
38
|
Acrokeratoelastoidosis of Costa
|
ORPHAnet |
| 0‑L |
39
|
Acromelanosis
|
ORPHAnet |
| 0‑L |
40
|
Acromesomelic dysplasia, Maroteaux type
|
ORPHAnet |
| 0‑L |
41
|
Dyschromatosis symmetrica hereditaria
|
ORPHAnet |
| 0‑L |
42
|
Medium chain acyl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
43
|
X-linked adrenoleukodystrophy
|
ORPHAnet |
| 0‑L |
44
|
Neonatal adrenoleukodystrophy
|
ORPHAnet |
| 0‑L |
45
|
Adenosine monophosphate deaminase deficiency
|
ORPHAnet |
| 0‑L |
46
|
Adenylosuccinate lyase deficiency
|
ORPHAnet |
| 0‑L |
47
|
X-linked agammaglobulinemia
|
ORPHAnet |
| 0‑L |
48
|
Congenital bilateral absence of vas deferens
|
ORPHAnet |
| 0‑L |
49
|
Penile agenesis
|
ORPHAnet |
| 0‑L |
50
|
Aicardi syndrome
|
ORPHAnet |
| 0‑L |
51
|
Aicardi-Goutières syndrome
|
ORPHAnet |
| 0‑L |
52
|
Alagille syndrome
|
ORPHAnet |
| 0‑L |
53
|
Albers-Schönberg osteopetrosis
|
ORPHAnet |
| 0‑L |
54
|
X-linked recessive ocular albinism
|
ORPHAnet |
| 0‑L |
56
|
Alkaptonuria
|
ORPHAnet |
| 0‑L |
57
|
Glycogen storage disease due to aldolase A deficiency
|
ORPHAnet |
| 0‑L |
58
|
Alexander disease
|
ORPHAnet |
| 0‑L |
59
|
Allan-Herndon-Dudley syndrome
|
ORPHAnet |
| 0‑L |
60
|
Alpha-1-antitrypsin deficiency
|
ORPHAnet |
| 0‑L |
61
|
Alpha-mannosidosis
|
ORPHAnet |
| 0‑L |
62
|
Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3
|
ORPHAnet |
| 0‑L |
63
|
Alport syndrome
|
ORPHAnet |
| 0‑L |
64
|
Alström syndrome
|
ORPHAnet |
| 0‑L |
65
|
Leber congenital amaurosis
|
ORPHAnet |
| 0‑L |
67
|
Amoebiasis due to Entamoeba histolytica
|
ORPHAnet |
| 0‑L |
68
|
Amoebiasis due to free-living amoebae
|
ORPHAnet |
| 0‑L |
70
|
Proximal spinal muscular atrophy
|
ORPHAnet |
| 0‑L |
71
|
Chylomicron retention disease
|
ORPHAnet |
| 0‑L |
72
|
Angelman syndrome
|
ORPHAnet |
| 0‑L |
73
|
Gorham-Stout disease
|
ORPHAnet |
| 0‑L |
74
|
Angiostrongyliasis
|
ORPHAnet |
| 0‑L |
76
|
Strongyloidiasis
|
ORPHAnet |
| 0‑L |
78
|
Ankylostomiasis
|
ORPHAnet |
| 0‑L |
79
|
Congenital alpha2-antiplasmin deficiency
|
ORPHAnet |
| 0‑L |
80
|
Antiphospholipid syndrome
|
ORPHAnet |
| 0‑L |
81
|
Antisynthetase syndrome
|
ORPHAnet |
| 0‑L |
82
|
Hereditary thrombophilia due to congenital antithrombin deficiency
|
ORPHAnet |
| 0‑L |
83
|
Antley-Bixler syndrome
|
ORPHAnet |
| 0‑L |
84
|
Fanconi anemia
|
ORPHAnet |
| 0‑L |
86
|
Familial abdominal aortic aneurysm
|
ORPHAnet |
| 0‑L |
87
|
Apert syndrome
|
ORPHAnet |
| 0‑L |
88
|
Idiopathic aplastic anemia
|
ORPHAnet |
| 0‑L |
90
|
Argininemia
|
ORPHAnet |
| 0‑L |
91
|
Aromatase deficiency
|
ORPHAnet |
| 0‑L |
93
|
Aspartylglucosaminuria
|
ORPHAnet |
| 0‑L |
95
|
Friedreich ataxia
|
ORPHAnet |
| 0‑L |
96
|
Ataxia with vitamin E deficiency
|
ORPHAnet |
| 0‑L |
97
|
Familial paroxysmal ataxia
|
ORPHAnet |
| 0‑L |
98
|
Autosomal recessive spastic ataxia of Charlevoix-Saguenay
|
ORPHAnet |
| 0‑L |
100
|
Ataxia-telangiectasia
|
ORPHAnet |
| 0‑L |
101
|
Dentatorubral pallidoluysian atrophy
|
ORPHAnet |
| 0‑L |
102
|
Multiple system atrophy
|
ORPHAnet |
| 0‑L |
104
|
Leber hereditary optic neuropathy
|
ORPHAnet |
| 0‑L |
105
|
Atresia of urethra
|
ORPHAnet |
| 0‑L |
107
|
BOR syndrome
|
ORPHAnet |
| 0‑L |
108
|
Babesiosis
|
ORPHAnet |
| 0‑L |
109
|
Bannayan-Riley-Ruvalcaba syndrome
|
ORPHAnet |
| 0‑L |
110
|
Bardet-Biedl syndrome
|
ORPHAnet |
| 0‑L |
111
|
Barth syndrome
|
ORPHAnet |
| 0‑L |
112
|
Bartter syndrome
|
ORPHAnet |
| 0‑L |
113
|
Bazex-Dupré-Christol syndrome
|
ORPHAnet |
| 0‑L |
114
|
Auriculoosteodysplasia
|
ORPHAnet |
| 0‑L |
115
|
Congenital contractural arachnodactyly
|
ORPHAnet |
| 0‑L |
116
|
Beckwith-Wiedemann syndrome
|
ORPHAnet |
| 0‑L |
117
|
Behçet disease
|
ORPHAnet |
| 0‑L |
118
|
Beta-mannosidosis
|
ORPHAnet |
| 0‑L |
119
|
Beta-sarcoglycan-related limb-girdle muscular dystrophy R4
|
ORPHAnet |
| 0‑L |
122
|
Birt-Hogg-Dubé syndrome
|
ORPHAnet |
| 0‑L |
123
|
Björnstad syndrome
|
ORPHAnet |
| 0‑L |
124
|
Blackfan-Diamond anemia
|
ORPHAnet |
| 0‑L |
125
|
Bloom syndrome
|
ORPHAnet |
| 0‑L |
126
|
Blepharophimosis-ptosis-epicanthus inversus syndrome
|
ORPHAnet |
| 0‑L |
127
|
Borjeson-Forssman-Lehmann syndrome
|
ORPHAnet |
| 0‑L |
128
|
Diphyllobothriasis
|
ORPHAnet |
| 0‑L |
129
|
Pseudopelade of Brocq
|
ORPHAnet |
| 0‑L |
130
|
Brugada syndrome
|
ORPHAnet |
| 0‑L |
131
|
Budd-Chiari syndrome
|
ORPHAnet |
| 0‑L |
132
|
Butyrylcholinesterase deficiency
|
ORPHAnet |
| 0‑L |
133
|
Chronic beryllium disease
|
ORPHAnet |
| 0‑L |
134
|
Beta-ketothiolase deficiency
|
ORPHAnet |
| 0‑L |
135
|
CACH syndrome
|
ORPHAnet |
| 0‑L |
136
|
Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy
|
ORPHAnet |
| 0‑L |
138
|
CHARGE syndrome
|
ORPHAnet |
| 0‑L |
139
|
CHILD syndrome
|
ORPHAnet |
| 0‑L |
140
|
Campomelic dysplasia
|
ORPHAnet |
| 0‑L |
141
|
Canavan disease
|
ORPHAnet |
| 0‑L |
142
|
Anaplastic thyroid carcinoma
|
ORPHAnet |
| 0‑L |
143
|
Parathyroid carcinoma
|
ORPHAnet |
| 0‑L |
144
|
Lynch syndrome
|
ORPHAnet |
| 0‑L |
145
|
Hereditary breast and ovarian cancer syndrome
|
ORPHAnet |
| 0‑L |
146
|
Differentiated thyroid carcinoma
|
ORPHAnet |
| 0‑L |
147
|
Carbamoyl-phosphate synthetase 1 deficiency
|
ORPHAnet |
| 0‑L |
150
|
Nasopharyngeal carcinoma
|
ORPHAnet |
| 0‑L |
154
|
Familial isolated dilated cardiomyopathy
|
ORPHAnet |
| 0‑L |
156
|
Carnitine palmitoyl transferase 1A deficiency
|
ORPHAnet |
| 0‑L |
157
|
Carnitine palmitoyltransferase II deficiency
|
ORPHAnet |
| 0‑L |
158
|
Systemic primary carnitine deficiency
|
ORPHAnet |
| 0‑L |
159
|
Carnitine-acylcarnitine translocase deficiency
|
ORPHAnet |
| 0‑L |
160
|
Castleman disease
|
ORPHAnet |
| 0‑L |
162
|
Cataract-glaucoma syndrome
|
ORPHAnet |
| 0‑L |
163
|
Hereditary hyperferritinemia-cataract syndrome
|
ORPHAnet |
| 0‑L |
167
|
Chédiak-Higashi syndrome
|
ORPHAnet |
| 0‑L |
168
|
Loose anagen syndrome
|
ORPHAnet |
| 0‑L |
169
|
Ringed hair disease
|
ORPHAnet |
| 0‑L |
170
|
Woolly hair
|
ORPHAnet |
| 0‑L |
171
|
Primary sclerosing cholangitis
|
ORPHAnet |
| 0‑L |
172
|
Progressive familial intrahepatic cholestasis
|
ORPHAnet |
| 0‑L |
173
|
Cholera
|
ORPHAnet |
| 0‑L |
174
|
Metaphyseal chondrodysplasia, Schmid type
|
ORPHAnet |
| 0‑L |
175
|
Cartilage-hair hypoplasia
|
ORPHAnet |
| 0‑L |
177
|
Rhizomelic chondrodysplasia punctata
|
ORPHAnet |
| 0‑L |
178
|
Chordoma
|
ORPHAnet |
| 0‑L |
179
|
Birdshot chorioretinopathy
|
ORPHAnet |
| 0‑L |
180
|
Choroideremia
|
ORPHAnet |
| 0‑L |
181
|
X-linked hypohidrotic ectodermal dysplasia
|
ORPHAnet |
| 0‑L |
182
|
Chromomycosis
|
ORPHAnet |
| 0‑L |
183
|
Eosinophilic granulomatosis with polyangiitis
|
ORPHAnet |
| 0‑L |
184
|
Cherubism
|
ORPHAnet |
| 0‑L |
185
|
Scimitar syndrome
|
ORPHAnet |
| 0‑L |
186
|
Primary biliary cholangitis
|
ORPHAnet |
| 0‑L |
188
|
Systemic capillary leak syndrome
|
ORPHAnet |
| 0‑L |
189
|
Hidrotic ectodermal dysplasia
|
ORPHAnet |
| 0‑L |
190
|
Coats disease
|
ORPHAnet |
| 0‑L |
191
|
Cockayne syndrome
|
ORPHAnet |
| 0‑L |
192
|
Coffin-Lowry syndrome
|
ORPHAnet |
| 0‑L |
193
|
Cohen syndrome
|
ORPHAnet |
| 0‑L |
195
|
Cat-eye syndrome
|
ORPHAnet |
| 0‑L |
198
|
Occipital horn syndrome
|
ORPHAnet |
| 0‑L |
199
|
Cornelia de Lange syndrome
|
ORPHAnet |
| 0‑L |
200
|
Isolated corpus callosum agenesis
|
ORPHAnet |
| 0‑L |
201
|
Cowden syndrome
|
ORPHAnet |
| 0‑L |
202
|
Crandall syndrome
|
ORPHAnet |
| 0‑L |
204
|
Sporadic Creutzfeldt-Jakob disease
|
ORPHAnet |
| 0‑L |
205
|
Crigler-Najjar syndrome
|
ORPHAnet |
| 0‑L |
207
|
Crouzon syndrome
|
ORPHAnet |
| 0‑L |
210
|
Cyclosporosis
|
ORPHAnet |
| 0‑L |
211
|
Familial cylindromatosis
|
ORPHAnet |
| 0‑L |
212
|
Cystathioninuria
|
ORPHAnet |
| 0‑L |
213
|
Cystinosis
|
ORPHAnet |
| 0‑L |
214
|
Cystinuria
|
ORPHAnet |
| 0‑L |
215
|
Congenital stationary night blindness
|
ORPHAnet |
| 0‑L |
217
|
Isolated Dandy-Walker malformation
|
ORPHAnet |
| 0‑L |
218
|
Darier disease
|
ORPHAnet |
| 0‑L |
219
|
Delta-sarcoglycan-related limb-girdle muscular dystrophy R6
|
ORPHAnet |
| 0‑L |
220
|
Denys-Drash syndrome
|
ORPHAnet |
| 0‑L |
221
|
Dermatomyositis
|
ORPHAnet |
| 0‑L |
222
|
Erosive pustular dermatosis of the scalp
|
ORPHAnet |
| 0‑L |
223
|
Nephrogenic diabetes insipidus
|
ORPHAnet |
| 0‑L |
225
|
Maternally-inherited diabetes and deafness
|
ORPHAnet |
| 0‑L |
226
|
Dihydropteridine reductase deficiency
|
ORPHAnet |
| 0‑L |
227
|
Diphallia
|
ORPHAnet |
| 0‑L |
229
|
Familial aortic dissection
|
ORPHAnet |
| 0‑L |
230
|
Dopamine beta-hydroxylase deficiency
|
ORPHAnet |
| 0‑L |
231
|
Dracunculiasis
|
ORPHAnet |
| 0‑L |
232
|
Sickle cell anemia
|
ORPHAnet |
| 0‑L |
233
|
Duane retraction syndrome
|
ORPHAnet |
| 0‑L |
234
|
Dubin-Johnson syndrome
|
ORPHAnet |
| 0‑L |
235
|
Dubowitz syndrome
|
ORPHAnet |
| 0‑L |
236
|
Trisomy 9p
|
ORPHAnet |
| 0‑L |
237
|
Duplication of urethra
|
ORPHAnet |
| 0‑L |
238
|
Digestive duplication
|
ORPHAnet |
| 0‑L |
239
|
Dyggve-Melchior-Clausen disease
|
ORPHAnet |
| 0‑L |
240
|
Léri-Weill dyschondrosteosis
|
ORPHAnet |
| 0‑L |
241
|
Dyschromatosis universalis hereditaria
|
ORPHAnet |
| 0‑L |
242
|
46,XY complete gonadal dysgenesis
|
ORPHAnet |
| 0‑L |
243
|
46,XX gonadal dysgenesis
|
ORPHAnet |
| 0‑L |
244
|
Primary ciliary dyskinesia
|
ORPHAnet |
| 0‑L |
245
|
Nager syndrome
|
ORPHAnet |
| 0‑L |
246
|
Postaxial acrofacial dysostosis
|
ORPHAnet |
| 0‑L |
248
|
Autosomal recessive hypohidrotic ectodermal dysplasia
|
ORPHAnet |
| 0‑L |
249
|
Fibrous dysplasia of bone
|
ORPHAnet |
| 0‑L |
256
|
Early-onset generalized limb-onset dystonia
|
ORPHAnet |
| 0‑L |
257
|
Epidermolysis bullosa simplex with muscular dystrophy
|
ORPHAnet |
| 0‑L |
258
|
Laminin subunit alpha 2-related congenital muscular dystrophy
|
ORPHAnet |
| 0‑L |
261
|
Emery-Dreifuss muscular dystrophy
|
ORPHAnet |
| 0‑L |
266
|
Autosomal dominant limb-girdle muscular dystrophy type 1A
|
ORPHAnet |
| 0‑L |
267
|
Calpain-3-related limb-girdle muscular dystrophy R1
|
ORPHAnet |
| 0‑L |
268
|
Dysferlin-related limb-girdle muscular dystrophy R2
|
ORPHAnet |
| 0‑L |
269
|
Facioscapulohumeral dystrophy
|
ORPHAnet |
| 0‑L |
270
|
Oculopharyngeal muscular dystrophy
|
ORPHAnet |
| 0‑L |
272
|
Congenital muscular dystrophy, Fukuyama type
|
ORPHAnet |
| 0‑L |
273
|
Steinert myotonic dystrophy
|
ORPHAnet |
| 0‑L |
274
|
Bernard-Soulier syndrome
|
ORPHAnet |
| 0‑L |
275
|
Severe combined immunodeficiency due to DCLRE1C deficiency
|
ORPHAnet |
| 0‑L |
276
|
T-B+ severe combined immunodeficiency due to gamma chain deficiency
|
ORPHAnet |
| 0‑L |
277
|
Severe combined immunodeficiency due to adenosine deaminase deficiency
|
ORPHAnet |
| 0‑L |
280
|
Wolf-Hirschhorn syndrome
|
ORPHAnet |
| 0‑L |
281
|
Monosomy 5p
|
ORPHAnet |
| 0‑L |
283
|
Demodicidosis
|
ORPHAnet |
| 0‑L |
284
|
Alveolar echinococcosis
|
ORPHAnet |
| 0‑L |
285
|
Hypermobile Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
286
|
Vascular Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
287
|
Classical Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
288
|
Hereditary elliptocytosis
|
ORPHAnet |
| 0‑L |
289
|
Ellis Van Creveld syndrome
|
ORPHAnet |
| 0‑L |
290
|
Congenital rubella syndrome
|
ORPHAnet |
| 0‑L |
291
|
Congenital varicella syndrome
|
ORPHAnet |
| 0‑L |
292
|
Congenital enterovirus infection
|
ORPHAnet |
| 0‑L |
293
|
Congenital herpes simplex virus infection
|
ORPHAnet |
| 0‑L |
294
|
Fetal cytomegalovirus syndrome
|
ORPHAnet |
| 0‑L |
295
|
Fetal parvovirus syndrome
|
ORPHAnet |
| 0‑L |
296
|
Ollier disease
|
ORPHAnet |
| 0‑L |
297
|
Tick-borne encephalitis
|
ORPHAnet |
| 0‑L |
298
|
Mitochondrial neurogastrointestinal encephalomyopathy
|
ORPHAnet |
| 0‑L |
300
|
Bifunctional enzyme deficiency
|
ORPHAnet |
| 0‑L |
302
|
Epidermodysplasia verruciformis
|
ORPHAnet |
| 0‑L |
306
|
Benign familial infantile epilepsy
|
ORPHAnet |
| 0‑L |
307
|
Juvenile myoclonic epilepsy
|
ORPHAnet |
| 0‑L |
308
|
Progressive myoclonic epilepsy type 1
|
ORPHAnet |
| 0‑L |
312
|
Autosomal dominant epidermolytic ichthyosis
|
ORPHAnet |
| 0‑L |
313
|
Lamellar ichthyosis
|
ORPHAnet |
| 0‑L |
314
|
Erythroderma desquamativum
|
ORPHAnet |
| 0‑L |
315
|
Erythrokeratoderma ''en cocardes''
|
ORPHAnet |
| 0‑L |
316
|
Progressive symmetric erythrokeratodermia
|
ORPHAnet |
| 0‑L |
317
|
Erythrokeratodermia variabilis
|
ORPHAnet |
| 0‑L |
318
|
Acute erythroid leukemia
|
ORPHAnet |
| 0‑L |
319
|
Skeletal Ewing sarcoma
|
ORPHAnet |
| 0‑L |
320
|
Apparent mineralocorticoid excess
|
ORPHAnet |
| 0‑L |
321
|
Multiple osteochondromas
|
ORPHAnet |
| 0‑L |
322
|
Exstrophy-epispadias complex
|
ORPHAnet |
| 0‑L |
324
|
Fabry disease
|
ORPHAnet |
| 0‑L |
325
|
Congenital factor II deficiency
|
ORPHAnet |
| 0‑L |
326
|
Congenital factor V deficiency
|
ORPHAnet |
| 0‑L |
327
|
Congenital factor VII deficiency
|
ORPHAnet |
| 0‑L |
328
|
Congenital factor X deficiency
|
ORPHAnet |
| 0‑L |
329
|
Congenital factor XI deficiency
|
ORPHAnet |
| 0‑L |
330
|
Congenital factor XII deficiency
|
ORPHAnet |
| 0‑L |
331
|
Congenital factor XIII deficiency
|
ORPHAnet |
| 0‑L |
332
|
Congenital intrinsic factor deficiency
|
ORPHAnet |
| 0‑L |
333
|
Farber disease
|
ORPHAnet |
| 0‑L |
334
|
Familial atrial fibrillation
|
ORPHAnet |
| 0‑L |
335
|
Congenital fibrinogen deficiency
|
ORPHAnet |
| 0‑L |
337
|
Fibrodysplasia ossificans progressiva
|
ORPHAnet |
| 0‑L |
340
|
Hemorrhagic fever-renal syndrome
|
ORPHAnet |
| 0‑L |
342
|
Familial Mediterranean fever
|
ORPHAnet |
| 0‑L |
343
|
Hyperimmunoglobulinemia D with periodic fever
|
ORPHAnet |
| 0‑L |
345
|
Dissecting cellulitis of the scalp
|
ORPHAnet |
| 0‑L |
346
|
Quinquaud folliculitis decalvans
|
ORPHAnet |
| 0‑L |
347
|
Frasier syndrome
|
ORPHAnet |
| 0‑L |
348
|
Fructose-1,6-bisphosphatase deficiency
|
ORPHAnet |
| 0‑L |
349
|
Fucosidosis
|
ORPHAnet |
| 0‑L |
351
|
Galactosialidosis
|
ORPHAnet |
| 0‑L |
353
|
Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5
|
ORPHAnet |
| 0‑L |
354
|
GM1 gangliosidosis
|
ORPHAnet |
| 0‑L |
355
|
Gaucher disease
|
ORPHAnet |
| 0‑L |
356
|
Gerstmann-Straussler-Scheinker syndrome
|
ORPHAnet |
| 0‑L |
358
|
Gitelman syndrome
|
ORPHAnet |
| 0‑L |
360
|
Glioblastoma
|
ORPHAnet |
| 0‑L |
361
|
Familial glucocorticoid deficiency
|
ORPHAnet |
| 0‑L |
364
|
Glycogen storage disease due to glucose-6-phosphatase deficiency
|
ORPHAnet |
| 0‑L |
365
|
Glycogen storage disease due to acid maltase deficiency
|
ORPHAnet |
| 0‑L |
366
|
Glycogen storage disease due to glycogen debranching enzyme deficiency
|
ORPHAnet |
| 0‑L |
367
|
Glycogen storage disease due to glycogen branching enzyme deficiency
|
ORPHAnet |
| 0‑L |
368
|
Glycogen storage disease due to muscle glycogen phosphorylase deficiency
|
ORPHAnet |
| 0‑L |
369
|
Glycogen storage disease due to liver glycogen phosphorylase deficiency
|
ORPHAnet |
| 0‑L |
371
|
Glycogen storage disease due to muscle phosphofructokinase deficiency
|
ORPHAnet |
| 0‑L |
373
|
Simpson-Golabi-Behmel syndrome
|
ORPHAnet |
| 0‑L |
375
|
Anti-glomerular basement membrane disease
|
ORPHAnet |
| 0‑L |
376
|
Gordon syndrome
|
ORPHAnet |
| 0‑L |
377
|
Gorlin syndrome
|
ORPHAnet |
| 0‑L |
379
|
Chronic granulomatous disease
|
ORPHAnet |
| 0‑L |
380
|
Greig cephalopolysyndactyly syndrome
|
ORPHAnet |
| 0‑L |
381
|
Griscelli syndrome
|
ORPHAnet |
| 0‑L |
382
|
Guanidinoacetate methyltransferase deficiency
|
ORPHAnet |
| 0‑L |
384
|
Huriez syndrome
|
ORPHAnet |
| 0‑L |
386
|
Hepatic cystic hamartoma
|
ORPHAnet |
| 0‑L |
388
|
Hirschsprung disease
|
ORPHAnet |
| 0‑L |
389
|
Langerhans cell histiocytosis
|
ORPHAnet |
| 0‑L |
390
|
Histoplasmosis
|
ORPHAnet |
| 0‑L |
391
|
Classic Hodgkin lymphoma
|
ORPHAnet |
| 0‑L |
392
|
Holt-Oram syndrome
|
ORPHAnet |
| 0‑L |
393
|
46,XX testicular disorder of sex development
|
ORPHAnet |
| 0‑L |
394
|
Classic homocystinuria
|
ORPHAnet |
| 0‑L |
395
|
Homocystinuria due to methylene tetrahydrofolate reductase deficiency
|
ORPHAnet |
| 0‑L |
396
|
Chronic hiccup
|
ORPHAnet |
| 0‑L |
397
|
Giant cell arteritis
|
ORPHAnet |
| 0‑L |
399
|
Huntington disease
|
ORPHAnet |
| 0‑L |
400
|
Cystic echinococcosis
|
ORPHAnet |
| 0‑L |
401
|
Hymenolepiasis
|
ORPHAnet |
| 0‑L |
403
|
Familial hyperaldosteronism type I
|
ORPHAnet |
| 0‑L |
404
|
Familial hyperaldosteronism type II
|
ORPHAnet |
| 0‑L |
405
|
Familial hypocalciuric hypercalcemia
|
ORPHAnet |
| 0‑L |
407
|
Glycine encephalopathy
|
ORPHAnet |
| 0‑L |
408
|
Isolated glycerol kinase deficiency
|
ORPHAnet |
| 0‑L |
409
|
Hyperkeratosis lenticularis perstans
|
ORPHAnet |
| 0‑L |
412
|
Dysbetalipoproteinemia
|
ORPHAnet |
| 0‑L |
414
|
Gyrate atrophy of choroid and retina
|
ORPHAnet |
| 0‑L |
415
|
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
ORPHAnet |
| 0‑L |
416
|
Primary hyperoxaluria
|
ORPHAnet |
| 0‑L |
417
|
Neonatal severe primary hyperparathyroidism
|
ORPHAnet |
| 0‑L |
419
|
Hyperprolinemia type 1
|
ORPHAnet |
| 0‑L |
422
|
Idiopathic/heritable pulmonary arterial hypertension
|
ORPHAnet |
| 0‑L |
423
|
Malignant hyperthermia of anesthesia
|
ORPHAnet |
| 0‑L |
424
|
Familial hyperthyroidism due to mutations in TSH receptor
|
ORPHAnet |
| 0‑L |
425
|
Apolipoprotein A-I deficiency
|
ORPHAnet |
| 0‑L |
427
|
Familial hypoaldosteronism
|
ORPHAnet |
| 0‑L |
428
|
Autosomal dominant hypocalcemia
|
ORPHAnet |
| 0‑L |
429
|
Hypochondroplasia
|
ORPHAnet |
| 0‑L |
432
|
Normosmic congenital hypogonadotropic hypogonadism
|
ORPHAnet |
| 0‑L |
436
|
Hypophosphatasia
|
ORPHAnet |
| 0‑L |
439
|
Isolated right ventricular hypoplasia
|
ORPHAnet |
| 0‑L |
441
|
Pure autonomic failure
|
ORPHAnet |
| 0‑L |
444
|
Marie Unna hereditary hypotrichosis
|
ORPHAnet |
| 0‑L |
446
|
Neonatal hemochromatosis
|
ORPHAnet |
| 0‑L |
447
|
Paroxysmal nocturnal hemoglobinuria
|
ORPHAnet |
| 0‑L |
449
|
Hepatoblastoma
|
ORPHAnet |
| 0‑L |
452
|
X-linked lissencephaly with abnormal genitalia
|
ORPHAnet |
| 0‑L |
454
|
Acquired ichthyosis
|
ORPHAnet |
| 0‑L |
455
|
Superficial epidermolytic ichthyosis
|
ORPHAnet |
| 0‑L |
457
|
Harlequin ichthyosis
|
ORPHAnet |
| 0‑L |
461
|
Recessive X-linked ichthyosis
|
ORPHAnet |
| 0‑L |
464
|
Incontinentia pigmenti
|
ORPHAnet |
| 0‑L |
465
|
Congenital plasminogen activator inhibitor type 1 deficiency
|
ORPHAnet |
| 0‑L |
466
|
Fatal familial insomnia
|
ORPHAnet |
| 0‑L |
469
|
Hereditary fructose intolerance
|
ORPHAnet |
| 0‑L |
470
|
Lysinuric protein intolerance
|
ORPHAnet |
| 0‑L |
472
|
Isosporiasis
|
ORPHAnet |
| 0‑L |
474
|
Jeune syndrome
|
ORPHAnet |
| 0‑L |
475
|
Joubert syndrome
|
ORPHAnet |
| 0‑L |
477
|
KID syndrome
|
ORPHAnet |
| 0‑L |
478
|
Kallmann syndrome
|
ORPHAnet |
| 0‑L |
480
|
Kearns-Sayre syndrome
|
ORPHAnet |
| 0‑L |
481
|
Kennedy disease
|
ORPHAnet |
| 0‑L |
482
|
Kimura disease
|
ORPHAnet |
| 0‑L |
483
|
Congenital high-molecular-weight kininogen deficiency
|
ORPHAnet |
| 0‑L |
485
|
Kniest dysplasia
|
ORPHAnet |
| 0‑L |
486
|
Autosomal dominant severe congenital neutropenia
|
ORPHAnet |
| 0‑L |
487
|
Krabbe disease
|
ORPHAnet |
| 0‑L |
488
|
Urachal cyst
|
ORPHAnet |
| 0‑L |
490
|
Omphalomesenteric cyst
|
ORPHAnet |
| 0‑L |
492
|
Proliferating trichilemmal cyst
|
ORPHAnet |
| 0‑L |
493
|
Familial keratoacanthoma
|
ORPHAnet |
| 0‑L |
494
|
Keratoderma hereditarium mutilans
|
ORPHAnet |
| 0‑L |
495
|
Transgrediens et progrediens palmoplantar keratoderma
|
ORPHAnet |
| 0‑L |
499
|
Kerion celsi
|
ORPHAnet |
| 0‑L |
500
|
Noonan syndrome with multiple lentigines
|
ORPHAnet |
| 0‑L |
501
|
Lafora disease
|
ORPHAnet |
| 0‑L |
502
|
Trichorhinophalangeal syndrome type 2
|
ORPHAnet |
| 0‑L |
503
|
Larsen syndrome
|
ORPHAnet |
| 0‑L |
504
|
Creeping myiasis
|
ORPHAnet |
| 0‑L |
505
|
Graham Little-Piccardi-Lassueur syndrome
|
ORPHAnet |
| 0‑L |
507
|
Leishmaniasis
|
ORPHAnet |
| 0‑L |
508
|
Leprechaunism
|
ORPHAnet |
| 0‑L |
509
|
Leptospirosis
|
ORPHAnet |
| 0‑L |
510
|
Lesch-Nyhan syndrome
|
ORPHAnet |
| 0‑L |
511
|
Maple syrup urine disease
|
ORPHAnet |
| 0‑L |
512
|
Metachromatic leukodystrophy
|
ORPHAnet |
| 0‑L |
514
|
Acute monoblastic/monocytic leukemia
|
ORPHAnet |
| 0‑L |
517
|
Acute myelomonocytic leukemia
|
ORPHAnet |
| 0‑L |
518
|
Acute megakaryoblastic leukemia
|
ORPHAnet |
| 0‑L |
520
|
Acute promyelocytic leukemia
|
ORPHAnet |
| 0‑L |
521
|
Chronic myeloid leukemia
|
ORPHAnet |
| 0‑L |
523
|
Hereditary leiomyomatosis and renal cell cancer
|
ORPHAnet |
| 0‑L |
524
|
Li-Fraumeni syndrome
|
ORPHAnet |
| 0‑L |
525
|
Lichen planopilaris
|
ORPHAnet |
| 0‑L |
526
|
Liddle syndrome
|
ORPHAnet |
| 0‑L |
528
|
Congenital generalized lipodystrophy
|
ORPHAnet |
| 0‑L |
529
|
Roch-Leri mesosomatous lipomatosis
|
ORPHAnet |
| 0‑L |
530
|
Lipoid proteinosis
|
ORPHAnet |
| 0‑L |
531
|
Miller-Dieker syndrome
|
ORPHAnet |
| 0‑L |
533
|
Listeriosis
|
ORPHAnet |
| 0‑L |
534
|
Oculocerebrorenal syndrome of Lowe
|
ORPHAnet |
| 0‑L |
536
|
Systemic lupus erythematosus
|
ORPHAnet |
| 0‑L |
537
|
Toxic epidermal necrolysis
|
ORPHAnet |
| 0‑L |
538
|
Lymphangioleiomyomatosis
|
ORPHAnet |
| 0‑L |
540
|
Familial hemophagocytic lymphohistiocytosis
|
ORPHAnet |
| 0‑L |
543
|
Burkitt lymphoma
|
ORPHAnet |
| 0‑L |
545
|
Follicular lymphoma
|
ORPHAnet |
| 0‑L |
548
|
Leprosy
|
ORPHAnet |
| 0‑L |
549
|
Legionnaires disease
|
ORPHAnet |
| 0‑L |
550
|
MELAS
|
ORPHAnet |
| 0‑L |
551
|
MERRF
|
ORPHAnet |
| 0‑L |
552
|
MODY
|
ORPHAnet |
| 0‑L |
556
|
Malakoplakia
|
ORPHAnet |
| 0‑L |
558
|
Marfan syndrome
|
ORPHAnet |
| 0‑L |
559
|
Marinesco-Sjögren syndrome
|
ORPHAnet |
| 0‑L |
560
|
Marshall syndrome
|
ORPHAnet |
| 0‑L |
561
|
Marshall-Smith syndrome
|
ORPHAnet |
| 0‑L |
562
|
McCune-Albright syndrome
|
ORPHAnet |
| 0‑L |
563
|
Peripartum cardiomyopathy
|
ORPHAnet |
| 0‑L |
564
|
Meckel syndrome
|
ORPHAnet |
| 0‑L |
565
|
Menkes disease
|
ORPHAnet |
| 0‑L |
566
|
Congenital microcoria
|
ORPHAnet |
| 0‑L |
567
|
22q11.2 deletion syndrome
|
ORPHAnet |
| 0‑L |
568
|
Microphthalmia, Lenz type
|
ORPHAnet |
| 0‑L |
569
|
Familial or sporadic hemiplegic migraine
|
ORPHAnet |
| 0‑L |
570
|
Moebius syndrome
|
ORPHAnet |
| 0‑L |
572
|
Immunodeficiency by defective expression of MHC class II
|
ORPHAnet |
| 0‑L |
573
|
Monilethrix
|
ORPHAnet |
| 0‑L |
574
|
Monosomy 21
|
ORPHAnet |
| 0‑L |
575
|
Muckle-Wells syndrome
|
ORPHAnet |
| 0‑L |
576
|
Mucolipidosis type II
|
ORPHAnet |
| 0‑L |
577
|
Mucolipidosis type III
|
ORPHAnet |
| 0‑L |
578
|
Mucolipidosis type IV
|
ORPHAnet |
| 0‑L |
579
|
Mucopolysaccharidosis type 1
|
ORPHAnet |
| 0‑L |
580
|
Mucopolysaccharidosis type 2
|
ORPHAnet |
| 0‑L |
581
|
Mucopolysaccharidosis type 3
|
ORPHAnet |
| 0‑L |
582
|
Mucopolysaccharidosis type 4
|
ORPHAnet |
| 0‑L |
583
|
Mucopolysaccharidosis type 6
|
ORPHAnet |
| 0‑L |
584
|
Mucopolysaccharidosis type 7
|
ORPHAnet |
| 0‑L |
585
|
Multiple sulfatase deficiency
|
ORPHAnet |
| 0‑L |
586
|
Cystic fibrosis
|
ORPHAnet |
| 0‑L |
587
|
Muir-Torre syndrome
|
ORPHAnet |
| 0‑L |
588
|
Muscle-eye-brain disease
|
ORPHAnet |
| 0‑L |
589
|
Myasthenia gravis
|
ORPHAnet |
| 0‑L |
590
|
Congenital myasthenic syndrome
|
ORPHAnet |
| 0‑L |
591
|
Furuncular myiasis
|
ORPHAnet |
| 0‑L |
592
|
Macrophagic myofasciitis
|
ORPHAnet |
| 0‑L |
596
|
X-linked centronuclear myopathy
|
ORPHAnet |
| 0‑L |
597
|
Central core disease
|
ORPHAnet |
| 0‑L |
598
|
Multiminicore myopathy
|
ORPHAnet |
| 0‑L |
600
|
Vocal cord and pharyngeal distal myopathy
|
ORPHAnet |
| 0‑L |
602
|
GNE myopathy
|
ORPHAnet |
| 0‑L |
603
|
Distal myopathy, Welander type
|
ORPHAnet |
| 0‑L |
606
|
Proximal myotonic myopathy
|
ORPHAnet |
| 0‑L |
609
|
Tibial muscular dystrophy
|
ORPHAnet |
| 0‑L |
610
|
Bethlem myopathy
|
ORPHAnet |
| 0‑L |
611
|
Inclusion body myositis
|
ORPHAnet |
| 0‑L |
614
|
Thomsen and Becker disease
|
ORPHAnet |
| 0‑L |
615
|
Familial atrial myxoma
|
ORPHAnet |
| 0‑L |
616
|
Medulloblastoma
|
ORPHAnet |
| 0‑L |
617
|
Congenital primary megaureter
|
ORPHAnet |
| 0‑L |
618
|
Familial melanoma
|
ORPHAnet |
| 0‑L |
621
|
Hereditary methemoglobinemia
|
ORPHAnet |
| 0‑L |
622
|
Homocystinuria without methylmalonic aciduria
|
ORPHAnet |
| 0‑L |
624
|
Familial multiple nevi flammei
|
ORPHAnet |
| 0‑L |
626
|
Large congenital melanocytic nevus
|
ORPHAnet |
| 0‑L |
627
|
Nance-Horan syndrome
|
ORPHAnet |
| 0‑L |
628
|
Diastrophic dysplasia
|
ORPHAnet |
| 0‑L |
629
|
Short stature due to growth hormone qualitative anomaly
|
ORPHAnet |
| 0‑L |
631
|
Non-acquired isolated growth hormone deficiency
|
ORPHAnet |
| 0‑L |
632
|
Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia
|
ORPHAnet |
| 0‑L |
633
|
Laron syndrome
|
ORPHAnet |
| 0‑L |
634
|
Netherton syndrome
|
ORPHAnet |
| 0‑L |
635
|
Neuroblastoma
|
ORPHAnet |
| 0‑L |
636
|
Neurofibromatosis type 1
|
ORPHAnet |
| 0‑L |
637
|
Neurofibromatosis type 2
|
ORPHAnet |
| 0‑L |
638
|
Neurofibromatosis-Noonan syndrome
|
ORPHAnet |
| 0‑L |
639
|
Polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG
|
ORPHAnet |
| 0‑L |
640
|
Hereditary neuropathy with liability to pressure palsies
|
ORPHAnet |
| 0‑L |
641
|
Multifocal motor neuropathy
|
ORPHAnet |
| 0‑L |
642
|
Hereditary sensory and autonomic neuropathy type 4
|
ORPHAnet |
| 0‑L |
643
|
Giant axonal neuropathy
|
ORPHAnet |
| 0‑L |
644
|
NARP syndrome
|
ORPHAnet |
| 0‑L |
646
|
Niemann-Pick disease type C
|
ORPHAnet |
| 0‑L |
647
|
Nijmegen breakage syndrome
|
ORPHAnet |
| 0‑L |
648
|
Noonan syndrome
|
ORPHAnet |
| 0‑L |
649
|
Norrie disease
|
ORPHAnet |
| 0‑L |
650
|
LCAT deficiency
|
ORPHAnet |
| 0‑L |
652
|
Multiple endocrine neoplasia type 1
|
ORPHAnet |
| 0‑L |
653
|
Multiple endocrine neoplasia type 2
|
ORPHAnet |
| 0‑L |
654
|
Nephroblastoma
|
ORPHAnet |
| 0‑L |
655
|
Nephronophthisis
|
ORPHAnet |
| 0‑L |
656
|
Genetic steroid-resistant nephrotic syndrome
|
ORPHAnet |
| 0‑L |
659
|
Mutilating palmoplantar keratoderma with periorificial keratotic plaques
|
ORPHAnet |
| 0‑L |
660
|
Omphalocele
|
ORPHAnet |
| 0‑L |
661
|
Congenital central hypoventilation syndrome
|
ORPHAnet |
| 0‑L |
662
|
Yellow nail syndrome
|
ORPHAnet |
| 0‑L |
663
|
Mitochondrial DNA-related progressive external ophthalmoplegia
|
ORPHAnet |
| 0‑L |
664
|
Ornithine transcarbamylase deficiency
|
ORPHAnet |
| 0‑L |
666
|
Osteogenesis imperfecta
|
ORPHAnet |
| 0‑L |
667
|
Autosomal recessive malignant osteopetrosis
|
ORPHAnet |
| 0‑L |
668
|
Osteosarcoma
|
ORPHAnet |
| 0‑L |
672
|
Pallister-Hall syndrome
|
ORPHAnet |
| 0‑L |
673
|
Malaria
|
ORPHAnet |
| 0‑L |
674
|
Accessory pancreas
|
ORPHAnet |
| 0‑L |
675
|
Annular pancreas
|
ORPHAnet |
| 0‑L |
676
|
Hereditary chronic pancreatitis
|
ORPHAnet |
| 0‑L |
677
|
Pancreatoblastoma
|
ORPHAnet |
| 0‑L |
678
|
Papillon-Lefèvre syndrome
|
ORPHAnet |
| 0‑L |
679
|
Malignant atrophic papulosis
|
ORPHAnet |
| 0‑L |
681
|
Hypokalemic periodic paralysis
|
ORPHAnet |
| 0‑L |
682
|
Hyperkalemic periodic paralysis
|
ORPHAnet |
| 0‑L |
683
|
Progressive supranuclear palsy
|
ORPHAnet |
| 0‑L |
684
|
Paramyotonia congenita of Von Eulenburg
|
ORPHAnet |
| 0‑L |
699
|
Pearson syndrome
|
ORPHAnet |
| 0‑L |
700
|
Alopecia totalis
|
ORPHAnet |
| 0‑L |
701
|
Alopecia universalis
|
ORPHAnet |
| 0‑L |
702
|
Pelizaeus-Merzbacher disease
|
ORPHAnet |
| 0‑L |
703
|
Bullous pemphigoid
|
ORPHAnet |
| 0‑L |
704
|
Pemphigus vulgaris
|
ORPHAnet |
| 0‑L |
705
|
Pendred syndrome
|
ORPHAnet |
| 0‑L |
707
|
Plague
|
ORPHAnet |
| 0‑L |
708
|
Peters anomaly
|
ORPHAnet |
| 0‑L |
709
|
Peters plus syndrome
|
ORPHAnet |
| 0‑L |
710
|
Pfeiffer syndrome
|
ORPHAnet |
| 0‑L |
712
|
Hemolytic anemia due to glucophosphate isomerase deficiency
|
ORPHAnet |
| 0‑L |
713
|
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency
|
ORPHAnet |
| 0‑L |
714
|
Hemolytic anemia due to diphosphoglycerate mutase deficiency
|
ORPHAnet |
| 0‑L |
715
|
Glycogen storage disease due to muscle phosphorylase kinase deficiency
|
ORPHAnet |
| 0‑L |
716
|
Phenylketonuria
|
ORPHAnet |
| 0‑L |
718
|
Isolated Pierre Robin syndrome
|
ORPHAnet |
| 0‑L |
720
|
Pili bifurcati
|
ORPHAnet |
| 0‑L |
721
|
Gray platelet syndrome
|
ORPHAnet |
| 0‑L |
722
|
Hypoplasminogenemia
|
ORPHAnet |
| 0‑L |
723
|
Pneumocystosis
|
ORPHAnet |
| 0‑L |
724
|
Idiopathic acute eosinophilic pneumonia
|
ORPHAnet |
| 0‑L |
725
|
Continuous spikes and waves during sleep
|
ORPHAnet |
| 0‑L |
726
|
Alpers-Huttenlocher syndrome
|
ORPHAnet |
| 0‑L |
727
|
Microscopic polyangiitis
|
ORPHAnet |
| 0‑L |
728
|
Relapsing polychondritis
|
ORPHAnet |
| 0‑L |
729
|
Polycythemia vera
|
ORPHAnet |
| 0‑L |
730
|
Autosomal dominant polycystic kidney disease
|
ORPHAnet |
| 0‑L |
731
|
Autosomal recessive polycystic kidney disease
|
ORPHAnet |
| 0‑L |
732
|
Polymyositis
|
ORPHAnet |
| 0‑L |
733
|
Familial adenomatous polyposis
|
ORPHAnet |
| 0‑L |
734
|
Alpha delta granule deficiency
|
ORPHAnet |
| 0‑L |
735
|
Porokeratosis of Mibelli
|
ORPHAnet |
| 0‑L |
737
|
Porokeratosis plantaris palmaris et disseminata
|
ORPHAnet |
| 0‑L |
739
|
Prader-Willi syndrome
|
ORPHAnet |
| 0‑L |
740
|
Hutchinson-Gilford progeria syndrome
|
ORPHAnet |
| 0‑L |
741
|
Familial mitral valve prolapse
|
ORPHAnet |
| 0‑L |
742
|
Prolidase deficiency
|
ORPHAnet |
| 0‑L |
743
|
Severe hereditary thrombophilia due to congenital protein S deficiency
|
ORPHAnet |
| 0‑L |
744
|
Proteus syndrome
|
ORPHAnet |
| 0‑L |
745
|
Severe hereditary thrombophilia due to congenital protein C deficiency
|
ORPHAnet |
| 0‑L |
746
|
Mitochondrial trifunctional protein deficiency
|
ORPHAnet |
| 0‑L |
747
|
Autoimmune pulmonary alveolar proteinosis
|
ORPHAnet |
| 0‑L |
749
|
Congenital prekallikrein deficiency
|
ORPHAnet |
| 0‑L |
750
|
Pseudoachondroplasia
|
ORPHAnet |
| 0‑L |
752
|
46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
|
ORPHAnet |
| 0‑L |
753
|
46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency
|
ORPHAnet |
| 0‑L |
755
|
Leydig cell hypoplasia
|
ORPHAnet |
| 0‑L |
756
|
Pseudohypoaldosteronism type 1
|
ORPHAnet |
| 0‑L |
757
|
Pseudohypoaldosteronism type 2
|
ORPHAnet |
| 0‑L |
758
|
Pseudoxanthoma elasticum
|
ORPHAnet |
| 0‑L |
759
|
Central precocious puberty
|
ORPHAnet |
| 0‑L |
760
|
Purine nucleoside phosphorylase deficiency
|
ORPHAnet |
| 0‑L |
761
|
Immunoglobulin A vasculitis
|
ORPHAnet |
| 0‑L |
763
|
Pycnodysostosis
|
ORPHAnet |
| 0‑L |
764
|
Pyomyositis
|
ORPHAnet |
| 0‑L |
765
|
Pyruvate dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
766
|
Hemolytic anemia due to red cell pyruvate kinase deficiency
|
ORPHAnet |
| 0‑L |
767
|
Polyarteritis nodosa
|
ORPHAnet |
| 0‑L |
769
|
Rabson-Mendenhall syndrome
|
ORPHAnet |
| 0‑L |
770
|
Rabies
|
ORPHAnet |
| 0‑L |
772
|
Infantile Refsum disease
|
ORPHAnet |
| 0‑L |
773
|
Refsum disease
|
ORPHAnet |
| 0‑L |
774
|
Hereditary hemorrhagic telangiectasia
|
ORPHAnet |
| 0‑L |
776
|
Lujan-Fryns syndrome
|
ORPHAnet |
| 0‑L |
777
|
X-linked non-syndromic intellectual disability
|
ORPHAnet |
| 0‑L |
778
|
Rett syndrome
|
ORPHAnet |
| 0‑L |
779
|
Reynolds syndrome
|
ORPHAnet |
| 0‑L |
780
|
Rhabdomyosarcoma
|
ORPHAnet |
| 0‑L |
781
|
Q fever
|
ORPHAnet |
| 0‑L |
782
|
Axenfeld-Rieger syndrome
|
ORPHAnet |
| 0‑L |
783
|
Rubinstein-Taybi syndrome
|
ORPHAnet |
| 0‑L |
785
|
Estrogen resistance syndrome
|
ORPHAnet |
| 0‑L |
786
|
Generalized glucocorticoid resistance syndrome
|
ORPHAnet |
| 0‑L |
790
|
Retinoblastoma
|
ORPHAnet |
| 0‑L |
791
|
Retinitis pigmentosa
|
ORPHAnet |
| 0‑L |
792
|
X-linked retinoschisis
|
ORPHAnet |
| 0‑L |
793
|
SAPHO syndrome
|
ORPHAnet |
| 0‑L |
794
|
Saethre-Chotzen syndrome
|
ORPHAnet |
| 0‑L |
796
|
Sandhoff disease
|
ORPHAnet |
| 0‑L |
797
|
Sarcoidosis
|
ORPHAnet |
| 0‑L |
798
|
Schinzel-Giedion syndrome
|
ORPHAnet |
| 0‑L |
799
|
Schizencephaly
|
ORPHAnet |
| 0‑L |
800
|
Schwartz-Jampel syndrome
|
ORPHAnet |
| 0‑L |
803
|
Amyotrophic lateral sclerosis
|
ORPHAnet |
| 0‑L |
805
|
Tuberous sclerosis complex
|
ORPHAnet |
| 0‑L |
806
|
Scott syndrome
|
ORPHAnet |
| 0‑L |
808
|
Seckel syndrome
|
ORPHAnet |
| 0‑L |
809
|
Mixed connective tissue disease
|
ORPHAnet |
| 0‑L |
810
|
Shigellosis
|
ORPHAnet |
| 0‑L |
811
|
Shwachman-Diamond syndrome
|
ORPHAnet |
| 0‑L |
812
|
Sialidosis type 1
|
ORPHAnet |
| 0‑L |
813
|
Silver-Russell syndrome
|
ORPHAnet |
| 0‑L |
816
|
Sjögren-Larsson syndrome
|
ORPHAnet |
| 0‑L |
818
|
Smith-Lemli-Opitz syndrome
|
ORPHAnet |
| 0‑L |
819
|
Smith-Magenis syndrome
|
ORPHAnet |
| 0‑L |
820
|
Sneddon syndrome
|
ORPHAnet |
| 0‑L |
821
|
Sotos syndrome
|
ORPHAnet |
| 0‑L |
822
|
Hereditary spherocytosis
|
ORPHAnet |
| 0‑L |
824
|
Primary myelofibrosis
|
ORPHAnet |
| 0‑L |
826
|
Sporotrichosis
|
ORPHAnet |
| 0‑L |
827
|
Stargardt disease
|
ORPHAnet |
| 0‑L |
828
|
Stickler syndrome
|
ORPHAnet |
| 0‑L |
829
|
Adult-onset Still disease
|
ORPHAnet |
| 0‑L |
831
|
Congenital cervical spinal stenosis
|
ORPHAnet |
| 0‑L |
832
|
Succinyl-CoA:3-oxoacid CoA transferase deficiency
|
ORPHAnet |
| 0‑L |
833
|
Encephalopathy due to sulfite oxidase deficiency
|
ORPHAnet |
| 0‑L |
834
|
Free sialic acid storage disease
|
ORPHAnet |
| 0‑L |
838
|
Susac syndrome
|
ORPHAnet |
| 0‑L |
839
|
Congenital nephrotic syndrome, Finnish type
|
ORPHAnet |
| 0‑L |
840
|
Syringocystadenoma papilliferum
|
ORPHAnet |
| 0‑L |
841
|
Sebocystomatosis
|
ORPHAnet |
| 0‑L |
842
|
Testicular seminomatous germ cell tumor
|
ORPHAnet |
| 0‑L |
844
|
Lown-Ganong-Levine syndrome
|
ORPHAnet |
| 0‑L |
845
|
Tay-Sachs disease
|
ORPHAnet |
| 0‑L |
846
|
Alpha-thalassemia
|
ORPHAnet |
| 0‑L |
847
|
Alpha-thalassemia-X-linked intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
848
|
Beta-thalassemia
|
ORPHAnet |
| 0‑L |
849
|
Glanzmann thrombasthenia
|
ORPHAnet |
| 0‑L |
851
|
Paris-Trousseau thrombocytopenia
|
ORPHAnet |
| 0‑L |
852
|
X-linked thrombocytopenia with normal platelets
|
ORPHAnet |
| 0‑L |
853
|
Fetal and neonatal alloimmune thrombocytopenia
|
ORPHAnet |
| 0‑L |
854
|
Primitive portal vein thrombosis
|
ORPHAnet |
| 0‑L |
857
|
Townes-Brocks syndrome
|
ORPHAnet |
| 0‑L |
858
|
Congenital toxoplasmosis
|
ORPHAnet |
| 0‑L |
859
|
Transcobalamin deficiency
|
ORPHAnet |
| 0‑L |
860
|
Congenitally uncorrected transposition of the great arteries
|
ORPHAnet |
| 0‑L |
861
|
Treacher-Collins syndrome
|
ORPHAnet |
| 0‑L |
863
|
Trichinellosis
|
ORPHAnet |
| 0‑L |
864
|
Trichofolliculoma
|
ORPHAnet |
| 0‑L |
867
|
Familial multiple trichoepithelioma
|
ORPHAnet |
| 0‑L |
868
|
Triose phosphate-isomerase deficiency
|
ORPHAnet |
| 0‑L |
869
|
Triple A syndrome
|
ORPHAnet |
| 0‑L |
870
|
Down syndrome
|
ORPHAnet |
| 0‑L |
871
|
Familial progressive cardiac conduction defect
|
ORPHAnet |
| 0‑L |
873
|
Desmoid tumor
|
ORPHAnet |
| 0‑L |
874
|
Primary adult heart tumor
|
ORPHAnet |
| 0‑L |
875
|
Primary pediatric heart tumor
|
ORPHAnet |
| 0‑L |
876
|
Yolk sac tumor
|
ORPHAnet |
| 0‑L |
879
|
Tungiasis
|
ORPHAnet |
| 0‑L |
881
|
Turner syndrome
|
ORPHAnet |
| 0‑L |
882
|
Tyrosinemia type 1
|
ORPHAnet |
| 0‑L |
883
|
Extragonadal teratoma
|
ORPHAnet |
| 0‑L |
884
|
Tetrasomy 12p
|
ORPHAnet |
| 0‑L |
886
|
Usher syndrome
|
ORPHAnet |
| 0‑L |
887
|
VACTERL/VATER association
|
ORPHAnet |
| 0‑L |
888
|
Van der Woude syndrome
|
ORPHAnet |
| 0‑L |
889
|
Cutaneous small vessel vasculitis
|
ORPHAnet |
| 0‑L |
890
|
Hepatic veno-occlusive disease
|
ORPHAnet |
| 0‑L |
891
|
Familial exudative vitreoretinopathy
|
ORPHAnet |
| 0‑L |
892
|
Von Hippel-Lindau disease
|
ORPHAnet |
| 0‑L |
893
|
WAGR syndrome
|
ORPHAnet |
| 0‑L |
894
|
Waardenburg syndrome type 1
|
ORPHAnet |
| 0‑L |
895
|
Waardenburg syndrome type 2
|
ORPHAnet |
| 0‑L |
896
|
Waardenburg syndrome type 3
|
ORPHAnet |
| 0‑L |
897
|
Waardenburg-Shah syndrome
|
ORPHAnet |
| 0‑L |
898
|
Wagner disease
|
ORPHAnet |
| 0‑L |
899
|
Walker-Warburg syndrome
|
ORPHAnet |
| 0‑L |
900
|
Granulomatosis with polyangiitis
|
ORPHAnet |
| 0‑L |
901
|
Wells syndrome
|
ORPHAnet |
| 0‑L |
902
|
Werner syndrome
|
ORPHAnet |
| 0‑L |
903
|
Von Willebrand disease
|
ORPHAnet |
| 0‑L |
904
|
Williams syndrome
|
ORPHAnet |
| 0‑L |
905
|
Wilson disease
|
ORPHAnet |
| 0‑L |
906
|
Wiskott-Aldrich syndrome
|
ORPHAnet |
| 0‑L |
908
|
Fragile X syndrome
|
ORPHAnet |
| 0‑L |
909
|
Cerebrotendinous xanthomatosis
|
ORPHAnet |
| 0‑L |
910
|
Xeroderma pigmentosum
|
ORPHAnet |
| 0‑L |
911
|
Combined immunodeficiency due to ZAP70 deficiency
|
ORPHAnet |
| 0‑L |
912
|
Zellweger syndrome
|
ORPHAnet |
| 0‑L |
913
|
Zollinger-Ellison syndrome
|
ORPHAnet |
| 0‑L |
915
|
Aarskog-Scott syndrome
|
ORPHAnet |
| 0‑L |
916
|
Aase-Smith syndrome
|
ORPHAnet |
| 0‑L |
920
|
Ablepharon macrostomia syndrome
|
ORPHAnet |
| 0‑L |
921
|
Abruzzo-Erickson syndrome
|
ORPHAnet |
| 0‑L |
922
|
Familial nasal acilia
|
ORPHAnet |
| 0‑L |
926
|
Acatalasemia
|
ORPHAnet |
| 0‑L |
927
|
Hyperammonemia due to N-acetylglutamate synthase deficiency
|
ORPHAnet |
| 0‑L |
929
|
Achalasia-microcephaly syndrome
|
ORPHAnet |
| 0‑L |
930
|
Idiopathic achalasia
|
ORPHAnet |
| 0‑L |
931
|
Acheiropodia
|
ORPHAnet |
| 0‑L |
932
|
Achondrogenesis
|
ORPHAnet |
| 0‑L |
935
|
Short-limb skeletal dysplasia with severe combined immunodeficiency
|
ORPHAnet |
| 0‑L |
939
|
3-hydroxyisobutyric aciduria
|
ORPHAnet |
| 0‑L |
941
|
D-glyceric aciduria
|
ORPHAnet |
| 0‑L |
943
|
Malonic aciduria
|
ORPHAnet |
| 0‑L |
945
|
Acalvaria
|
ORPHAnet |
| 0‑L |
949
|
Acrocraniofacial dysostosis
|
ORPHAnet |
| 0‑L |
950
|
Acrodysostosis
|
ORPHAnet |
| 0‑L |
952
|
Acrofacial dysostosis, Weyers type
|
ORPHAnet |
| 0‑L |
955
|
Hajdu-Cheney syndrome
|
ORPHAnet |
| 0‑L |
957
|
Acropectorovertebral dysplasia
|
ORPHAnet |
| 0‑L |
958
|
Acro-renal-mandibular syndrome
|
ORPHAnet |
| 0‑L |
959
|
Acro-renal-ocular syndrome
|
ORPHAnet |
| 0‑L |
963
|
Acromegaly
|
ORPHAnet |
| 0‑L |
968
|
Acromesomelic dysplasia, Hunter-Thompson type
|
ORPHAnet |
| 0‑L |
969
|
Acromicric dysplasia
|
ORPHAnet |
| 0‑L |
970
|
Hereditary sensory and autonomic neuropathy type 2
|
ORPHAnet |
| 0‑L |
971
|
Acrorenal syndrome
|
ORPHAnet |
| 0‑L |
972
|
Hereditary continuous muscle fiber activity
|
ORPHAnet |
| 0‑L |
973
|
Congenital absence/hypoplasia of fingers excluding thumb, unilateral
|
ORPHAnet |
| 0‑L |
974
|
Adams-Oliver syndrome
|
ORPHAnet |
| 0‑L |
976
|
Adenine phosphoribosyltransferase deficiency
|
ORPHAnet |
| 0‑L |
977
|
Adrenomyodystrophy
|
ORPHAnet |
| 0‑L |
978
|
ADULT syndrome
|
ORPHAnet |
| 0‑L |
980
|
Absence of the pulmonary artery
|
ORPHAnet |
| 0‑L |
981
|
Internal carotid absence
|
ORPHAnet |
| 0‑L |
983
|
Testicular regression syndrome
|
ORPHAnet |
| 0‑L |
984
|
Pulmonary agenesis
|
ORPHAnet |
| 0‑L |
988
|
Tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome
|
ORPHAnet |
| 0‑L |
989
|
Hypoglossia-hypodactyly syndrome
|
ORPHAnet |
| 0‑L |
990
|
Agnathia-holoprosencephaly-situs inversus syndrome
|
ORPHAnet |
| 0‑L |
991
|
PAGOD syndrome
|
ORPHAnet |
| 0‑L |
994
|
Fetal akinesia deformation sequence
|
ORPHAnet |
| 0‑L |
998
|
Albinism-deafness syndrome
|
ORPHAnet |
| 0‑L |
999
|
Ermine phenotype
|
ORPHAnet |
| 0‑L |
1000
|
Ocular albinism with late-onset sensorineural deafness
|
ORPHAnet |
| 0‑L |
1001
|
2q37 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
1003
|
Scalp defects-postaxial polydactyly syndrome
|
ORPHAnet |
| 0‑L |
1005
|
Alopecia-contractures-dwarfism-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1006
|
Alopecia antibody deficiency
|
ORPHAnet |
| 0‑L |
1008
|
Alopecia-epilepsy-pyorrhea-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1010
|
Autosomal dominant palmoplantar keratoderma and congenital alopecia
|
ORPHAnet |
| 0‑L |
1014
|
Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
1018
|
X-linked Alport syndrome-diffuse leiomyomatosis
|
ORPHAnet |
| 0‑L |
1020
|
Early-onset autosomal dominant Alzheimer disease
|
ORPHAnet |
| 0‑L |
1021
|
Amaurosis-hypertrichosis syndrome
|
ORPHAnet |
| 0‑L |
1023
|
Congenital generalized hypertrichosis, Ambras type
|
ORPHAnet |
| 0‑L |
1027
|
Autosomal recessive amelia
|
ORPHAnet |
| 0‑L |
1028
|
Amelo-onycho-hypohidrotic syndrome
|
ORPHAnet |
| 0‑L |
1031
|
Enamel-renal syndrome
|
ORPHAnet |
| 0‑L |
1035
|
Beta-mercaptolactate cysteine disulfiduria
|
ORPHAnet |
| 0‑L |
1040
|
Metaphyseal anadysplasia
|
ORPHAnet |
| 0‑L |
1041
|
Hydrops fetalis
|
ORPHAnet |
| 0‑L |
1046
|
Lethal hemolytic anemia-genital anomalies syndrome
|
ORPHAnet |
| 0‑L |
1048
|
Isolated anencephaly/exencephaly
|
ORPHAnet |
| 0‑L |
1051
|
Ramos-Arroyo syndrome
|
ORPHAnet |
| 0‑L |
1052
|
Mosaic variegated aneuploidy syndrome
|
ORPHAnet |
| 0‑L |
1053
|
Vein of Galen aneurysmal malformation
|
ORPHAnet |
| 0‑L |
1054
|
Aneurysm of sinus of Valsalva
|
ORPHAnet |
| 0‑L |
1055
|
Congenital left ventricular aneurysm
|
ORPHAnet |
| 0‑L |
1059
|
Blue rubber bleb nevus
|
ORPHAnet |
| 0‑L |
1062
|
Hereditary neurocutaneous malformation
|
ORPHAnet |
| 0‑L |
1063
|
Tufted angioma
|
ORPHAnet |
| 0‑L |
1064
|
Aniridia-renal agenesis-psychomotor retardation syndrome
|
ORPHAnet |
| 0‑L |
1065
|
Aniridia-cerebellar ataxia-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1067
|
Aniridia-ptosis-intellectual disability-familial obesity syndrome
|
ORPHAnet |
| 0‑L |
1068
|
Aniridia-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1069
|
Aniridia-absent patella syndrome
|
ORPHAnet |
| 0‑L |
1070
|
Anisakiasis
|
ORPHAnet |
| 0‑L |
1071
|
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
|
ORPHAnet |
| 0‑L |
1072
|
Ankyloblepharon filiforme adnatum-cleft palate syndrome
|
ORPHAnet |
| 0‑L |
1074
|
Ankyloblepharon filiforme adnatum-imperforate anus syndrome
|
ORPHAnet |
| 0‑L |
1077
|
Dental ankylosis
|
ORPHAnet |
| 0‑L |
1078
|
Thumb stiffness-brachydactyly-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1083
|
Microlissencephaly
|
ORPHAnet |
| 0‑L |
1084
|
Isolated lissencephaly type 1 without known genetic defects
|
ORPHAnet |
| 0‑L |
1094
|
Anonychia-microcephaly syndrome
|
ORPHAnet |
| 0‑L |
1101
|
Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome
|
ORPHAnet |
| 0‑L |
1104
|
Anophthalmia plus syndrome
|
ORPHAnet |
| 0‑L |
1106
|
Microphthalmia with limb anomalies
|
ORPHAnet |
| 0‑L |
1110
|
Aortic arch anomaly-facial dysmorphism-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1112
|
Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome
|
ORPHAnet |
| 0‑L |
1113
|
Aphalangy-syndactyly-microcephaly syndrome
|
ORPHAnet |
| 0‑L |
1114
|
Aplasia cutis congenita
|
ORPHAnet |
| 0‑L |
1116
|
Aplasia cutis congenita-intestinal lymphangiectasia syndrome
|
ORPHAnet |
| 0‑L |
1117
|
Aplasia cutis-myopia syndrome
|
ORPHAnet |
| 0‑L |
1118
|
Fibular aplasia-ectrodactyly syndrome
|
ORPHAnet |
| 0‑L |
1120
|
Lung agenesis-heart defect-thumb anomalies syndrome
|
ORPHAnet |
| 0‑L |
1121
|
Radial deficiency-tibial hypoplasia syndrome
|
ORPHAnet |
| 0‑L |
1122
|
Ulnar hypoplasia-split foot syndrome
|
ORPHAnet |
| 0‑L |
1123
|
Caudal appendage-deafness syndrome
|
ORPHAnet |
| 0‑L |
1125
|
Ocular motor apraxia, Cogan type
|
ORPHAnet |
| 0‑L |
1126
|
Aprosencephaly cerebellar dysgenesis
|
ORPHAnet |
| 0‑L |
1129
|
Arachnodactyly-abnormal ossification-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1130
|
Arachnodactyly-intellectual disability-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
1131
|
X-linked mandibulofacial dysostosis
|
ORPHAnet |
| 0‑L |
1133
|
AREDYLD syndrome
|
ORPHAnet |
| 0‑L |
1134
|
Isolated arrhinia
|
ORPHAnet |
| 0‑L |
1135
|
Arrhinia-choanal atresia-microphthalmia syndrome
|
ORPHAnet |
| 0‑L |
1136
|
Arnold-Chiari malformation type II
|
ORPHAnet |
| 0‑L |
1143
|
Neurogenic arthrogryposis multiplex congenita
|
ORPHAnet |
| 0‑L |
1144
|
Arthrogryposis-like hand anomaly-sensorineural deafness syndrome
|
ORPHAnet |
| 0‑L |
1145
|
Infantile-onset X-linked spinal muscular atrophy
|
ORPHAnet |
| 0‑L |
1146
|
Distal arthrogryposis type 1
|
ORPHAnet |
| 0‑L |
1147
|
Sheldon-Hall syndrome
|
ORPHAnet |
| 0‑L |
1149
|
Kuskokwim syndrome
|
ORPHAnet |
| 0‑L |
1150
|
Arthrogryposis multiplex congenita-whistling face syndrome
|
ORPHAnet |
| 0‑L |
1154
|
Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome
|
ORPHAnet |
| 0‑L |
1159
|
Progressive pseudorheumatoid arthropathy of childhood
|
ORPHAnet |
| 0‑L |
1160
|
Chylous ascites
|
ORPHAnet |
| 0‑L |
1163
|
Aspergillosis
|
ORPHAnet |
| 0‑L |
1164
|
Allergic bronchopulmonary aspergillosis
|
ORPHAnet |
| 0‑L |
1166
|
Congenital unilateral hypoplasia of depressor anguli oris
|
ORPHAnet |
| 0‑L |
1168
|
Ataxia-oculomotor apraxia type 1
|
ORPHAnet |
| 0‑L |
1170
|
Autosomal recessive cerebelloparenchymal disorder type 3
|
ORPHAnet |
| 0‑L |
1171
|
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
|
ORPHAnet |
| 0‑L |
1173
|
Cerebellar ataxia-hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
1174
|
Cerebellar ataxia-ectodermal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
1175
|
X-linked progressive cerebellar ataxia
|
ORPHAnet |
| 0‑L |
1177
|
Early-onset cerebellar ataxia with retained tendon reflexes
|
ORPHAnet |
| 0‑L |
1178
|
Ataxia-tapetoretinal degeneration syndrome
|
ORPHAnet |
| 0‑L |
1179
|
Benign paroxysmal tonic upgaze of childhood with ataxia
|
ORPHAnet |
| 0‑L |
1180
|
Ataxia-hypogonadism-choroidal dystrophy syndrome
|
ORPHAnet |
| 0‑L |
1182
|
Spastic ataxia with congenital miosis
|
ORPHAnet |
| 0‑L |
1183
|
Opsoclonus-myoclonus syndrome
|
ORPHAnet |
| 0‑L |
1184
|
Ataxia-photosensitivity-short stature syndrome
|
ORPHAnet |
| 0‑L |
1185
|
Spinocerebellar ataxia-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
1186
|
Infantile-onset spinocerebellar ataxia
|
ORPHAnet |
| 0‑L |
1187
|
Lethal ataxia with deafness and optic atrophy
|
ORPHAnet |
| 0‑L |
1188
|
Ataxia-deafness-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1190
|
Atelosteogenesis type I
|
ORPHAnet |
| 0‑L |
1192
|
Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome
|
ORPHAnet |
| 0‑L |
1193
|
Atkin-Flaitz syndrome
|
ORPHAnet |
| 0‑L |
1194
|
TMEM70-related mitochondrial encephalo-cardio-myopathy
|
ORPHAnet |
| 0‑L |
1195
|
Congenital atransferrinemia
|
ORPHAnet |
| 0‑L |
1198
|
Colonic atresia
|
ORPHAnet |
| 0‑L |
1199
|
Esophageal atresia
|
ORPHAnet |
| 0‑L |
1200
|
Burn-McKeown syndrome
|
ORPHAnet |
| 0‑L |
1201
|
Atresia of small intestine
|
ORPHAnet |
| 0‑L |
1202
|
Larynx atresia
|
ORPHAnet |
| 0‑L |
1203
|
Duodenal atresia
|
ORPHAnet |
| 0‑L |
1205
|
Mitral atresia
|
ORPHAnet |
| 0‑L |
1207
|
Pulmonary atresia with ventricular septal defect
|
ORPHAnet |
| 0‑L |
1208
|
Pulmonary atresia-intact ventricular septum syndrome
|
ORPHAnet |
| 0‑L |
1209
|
Tricuspid atresia
|
ORPHAnet |
| 0‑L |
1214
|
Progressive hemifacial atrophy
|
ORPHAnet |
| 0‑L |
1215
|
Autosomal dominant optic atrophy plus syndrome
|
ORPHAnet |
| 0‑L |
1216
|
Autosomal dominant congenital benign spinal muscular atrophy
|
ORPHAnet |
| 0‑L |
1217
|
Spinal atrophy-ophthalmoplegia-pyramidal syndrome
|
ORPHAnet |
| 0‑L |
1221
|
Cheilitis glandularis
|
ORPHAnet |
| 0‑L |
1223
|
Balantidiasis
|
ORPHAnet |
| 0‑L |
1225
|
Baller-Gerold syndrome
|
ORPHAnet |
| 0‑L |
1226
|
Bamforth-Lazarus syndrome
|
ORPHAnet |
| 0‑L |
1227
|
Bangstad syndrome
|
ORPHAnet |
| 0‑L |
1228
|
Banki syndrome
|
ORPHAnet |
| 0‑L |
1229
|
Congenital intrauterine infection-like syndrome
|
ORPHAnet |
| 0‑L |
1231
|
Barber-Say syndrome
|
ORPHAnet |
| 0‑L |
1234
|
Bartsocas-Papas syndrome
|
ORPHAnet |
| 0‑L |
1236
|
Severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome
|
ORPHAnet |
| 0‑L |
1237
|
Beemer-Ertbruggen syndrome
|
ORPHAnet |
| 0‑L |
1240
|
Metaphyseal acroscyphodysplasia
|
ORPHAnet |
| 0‑L |
1241
|
Bencze syndrome
|
ORPHAnet |
| 0‑L |
1243
|
Best vitelliform macular dystrophy
|
ORPHAnet |
| 0‑L |
1246
|
Brachydactyly-nystagmus-cerebellar ataxia syndrome
|
ORPHAnet |
| 0‑L |
1247
|
Schistosomiasis
|
ORPHAnet |
| 0‑L |
1248
|
Maxillonasal dysplasia
|
ORPHAnet |
| 0‑L |
1252
|
Blepharonasofacial malformation syndrome
|
ORPHAnet |
| 0‑L |
1253
|
Ascher syndrome
|
ORPHAnet |
| 0‑L |
1259
|
Blepharoptosis-myopia-ectopia lentis syndrome
|
ORPHAnet |
| 0‑L |
1261
|
Bonnemann-Meinecke-Reich syndrome
|
ORPHAnet |
| 0‑L |
1262
|
Böök syndrome
|
ORPHAnet |
| 0‑L |
1263
|
Boomerang dysplasia
|
ORPHAnet |
| 0‑L |
1264
|
Tricho-retino-dento-digital syndrome
|
ORPHAnet |
| 0‑L |
1267
|
Botulism
|
ORPHAnet |
| 0‑L |
1270
|
Bowen-Conradi syndrome
|
ORPHAnet |
| 0‑L |
1272
|
Aymé-Gripp syndrome
|
ORPHAnet |
| 0‑L |
1275
|
Brachydactyly-elbow wrist dysplasia syndrome
|
ORPHAnet |
| 0‑L |
1276
|
Brachydactyly-arterial hypertension syndrome
|
ORPHAnet |
| 0‑L |
1277
|
Brachydactyly-mesomelia-intellectual disability-heart defects syndrome
|
ORPHAnet |
| 0‑L |
1278
|
Brachydactyly-preaxial hallux varus syndrome
|
ORPHAnet |
| 0‑L |
1292
|
Brachymorphism-onychodysplasia-dysphalangism syndrome
|
ORPHAnet |
| 0‑L |
1295
|
Brachytelephalangy-dysmorphism-Kallmann syndrome
|
ORPHAnet |
| 0‑L |
1296
|
Lambert syndrome
|
ORPHAnet |
| 0‑L |
1297
|
Branchio-oculo-facial syndrome
|
ORPHAnet |
| 0‑L |
1299
|
Branchioskeletogenital syndrome
|
ORPHAnet |
| 0‑L |
1300
|
Autosomal dominant popliteal pterygium syndrome
|
ORPHAnet |
| 0‑L |
1302
|
Cryptogenic organizing pneumonia
|
ORPHAnet |
| 0‑L |
1303
|
Bronchiolitis obliterans with obstructive pulmonary disease
|
ORPHAnet |
| 0‑L |
1304
|
Brucellosis
|
ORPHAnet |
| 0‑L |
1305
|
Feingold syndrome
|
ORPHAnet |
| 0‑L |
1306
|
Buschke-Ollendorff syndrome
|
ORPHAnet |
| 0‑L |
1307
|
Distal limb deficiencies-micrognathia syndrome
|
ORPHAnet |
| 0‑L |
1308
|
C syndrome
|
ORPHAnet |
| 0‑L |
1309
|
Medullary sponge kidney
|
ORPHAnet |
| 0‑L |
1310
|
Caffey disease
|
ORPHAnet |
| 0‑L |
1313
|
Infantile choroidocerebral calcification syndrome
|
ORPHAnet |
| 0‑L |
1314
|
Symmetrical thalamic calcifications
|
ORPHAnet |
| 0‑L |
1318
|
Campomelia, Cumming type
|
ORPHAnet |
| 0‑L |
1319
|
Camptobrachydactyly
|
ORPHAnet |
| 0‑L |
1320
|
Idiopathic camptocormia
|
ORPHAnet |
| 0‑L |
1321
|
Camptodactyly-fibrous tissue hyperplasia-skeletal anomalies syndrome
|
ORPHAnet |
| 0‑L |
1323
|
Camptodactyly-joint contractures-facial skeletal defects syndrome
|
ORPHAnet |
| 0‑L |
1325
|
Camptodactyly-taurinuria syndrome
|
ORPHAnet |
| 0‑L |
1326
|
Camptodactyly syndrome, Guadalajara type 2
|
ORPHAnet |
| 0‑L |
1327
|
Camptodactyly syndrome, Guadalajara type 1
|
ORPHAnet |
| 0‑L |
1328
|
Camurati-Engelmann disease
|
ORPHAnet |
| 0‑L |
1329
|
Complete atrioventricular septal defect
|
ORPHAnet |
| 0‑L |
1330
|
Partial atrioventricular septal defect
|
ORPHAnet |
| 0‑L |
1331
|
Familial prostate cancer
|
ORPHAnet |
| 0‑L |
1332
|
Medullary thyroid carcinoma
|
ORPHAnet |
| 0‑L |
1333
|
Familial pancreatic carcinoma
|
ORPHAnet |
| 0‑L |
1334
|
Chronic mucocutaneous candidiasis
|
ORPHAnet |
| 0‑L |
1335
|
Pentalogy of Cantrell
|
ORPHAnet |
| 0‑L |
1336
|
Hyperkeratosis-hyperpigmentation syndrome
|
ORPHAnet |
| 0‑L |
1338
|
Heart defect-tongue hamartoma-polysyndactyly syndrome
|
ORPHAnet |
| 0‑L |
1340
|
Cardiofaciocutaneous syndrome
|
ORPHAnet |
| 0‑L |
1342
|
Heart-hand syndrome type 3
|
ORPHAnet |
| 0‑L |
1344
|
Atrial standstill
|
ORPHAnet |
| 0‑L |
1345
|
Cardiomyopathy-cataract-hip spine disease syndrome
|
ORPHAnet |
| 0‑L |
1349
|
Mitochondrial DNA-related cardiomyopathy and hearing loss
|
ORPHAnet |
| 0‑L |
1350
|
Heart-hand syndrome type 2
|
ORPHAnet |
| 0‑L |
1352
|
Atrioventricular defect-blepharophimosis-radial and anal defect syndrome
|
ORPHAnet |
| 0‑L |
1354
|
Heart defects-limb shortening syndrome
|
ORPHAnet |
| 0‑L |
1355
|
Congenital heart defect-round face-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
1358
|
Carey-Fineman-Ziter syndrome
|
ORPHAnet |
| 0‑L |
1359
|
Carney complex
|
ORPHAnet |
| 0‑L |
1361
|
Carnosinase deficiency
|
ORPHAnet |
| 0‑L |
1366
|
Autosomal recessive palmoplantar keratoderma and congenital alopecia
|
ORPHAnet |
| 0‑L |
1368
|
Cataract-ataxia-deafness syndrome
|
ORPHAnet |
| 0‑L |
1369
|
Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome
|
ORPHAnet |
| 0‑L |
1373
|
Cataract-aberrant oral frenula-growth delay syndrome
|
ORPHAnet |
| 0‑L |
1375
|
Cataract-hypertrichosis-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1377
|
Cataract-microcornea syndrome
|
ORPHAnet |
| 0‑L |
1380
|
Cataract-nephropathy-encephalopathy syndrome
|
ORPHAnet |
| 0‑L |
1381
|
Cataract-intellectual disability-anal atresia-urinary defects syndrome
|
ORPHAnet |
| 0‑L |
1383
|
Cataract-deafness-hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
1387
|
Cataract-intellectual disability-hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
1388
|
Catel-Manzke syndrome
|
ORPHAnet |
| 0‑L |
1389
|
Cortical blindness-intellectual disability-polydactyly syndrome
|
ORPHAnet |
| 0‑L |
1390
|
Night blindness-skeletal anomalies-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
1393
|
Cerebrocostomandibular syndrome
|
ORPHAnet |
| 0‑L |
1394
|
Cerebrofaciothoracic dysplasia
|
ORPHAnet |
| 0‑L |
1397
|
Hydrocephaly-cerebellar agenesis syndrome
|
ORPHAnet |
| 0‑L |
1398
|
Isolated cerebellar agenesis
|
ORPHAnet |
| 0‑L |
1399
|
Richards-Rundle syndrome
|
ORPHAnet |
| 0‑L |
1401
|
CHAND syndrome
|
ORPHAnet |
| 0‑L |
1406
|
Charlie M syndrome
|
ORPHAnet |
| 0‑L |
1410
|
Uncombable hair syndrome
|
ORPHAnet |
| 0‑L |
1412
|
Tarsal-carpal coalition syndrome
|
ORPHAnet |
| 0‑L |
1414
|
Cholestasis-lymphedema syndrome
|
ORPHAnet |
| 0‑L |
1415
|
Cholestasis-pigmentary retinopathy-cleft palate syndrome
|
ORPHAnet |
| 0‑L |
1416
|
Familial calcium pyrophosphate deposition
|
ORPHAnet |
| 0‑L |
1422
|
Chondrodysplasia-disorder of sex development syndrome
|
ORPHAnet |
| 0‑L |
1423
|
Lethal recessive chondrodysplasia
|
ORPHAnet |
| 0‑L |
1425
|
Desbuquois syndrome
|
ORPHAnet |
| 0‑L |
1426
|
Greenberg dysplasia
|
ORPHAnet |
| 0‑L |
1427
|
Otospondylomegaepiphyseal dysplasia
|
ORPHAnet |
| 0‑L |
1429
|
Benign hereditary chorea
|
ORPHAnet |
| 0‑L |
1433
|
Choroidal atrophy-alopecia syndrome
|
ORPHAnet |
| 0‑L |
1435
|
Xq21 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
1436
|
X-linked skeletal dysplasia-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1437
|
Ring chromosome 1 syndrome
|
ORPHAnet |
| 0‑L |
1438
|
Ring chromosome 10 syndrome
|
ORPHAnet |
| 0‑L |
1439
|
Ring chromosome 12 syndrome
|
ORPHAnet |
| 0‑L |
1440
|
Ring chromosome 14 syndrome
|
ORPHAnet |
| 0‑L |
1441
|
Ring chromosome 17 syndrome
|
ORPHAnet |
| 0‑L |
1442
|
Ring chromosome 18 syndrome
|
ORPHAnet |
| 0‑L |
1443
|
Ring chromosome 19 syndrome
|
ORPHAnet |
| 0‑L |
1444
|
Ring chromosome 20 syndrome
|
ORPHAnet |
| 0‑L |
1445
|
Ring chromosome 21 syndrome
|
ORPHAnet |
| 0‑L |
1446
|
Ring chromosome 22 syndrome
|
ORPHAnet |
| 0‑L |
1447
|
Ring chromosome 4 syndrome
|
ORPHAnet |
| 0‑L |
1448
|
Ring chromosome 6 syndrome
|
ORPHAnet |
| 0‑L |
1449
|
Ring chromosome 7 syndrome
|
ORPHAnet |
| 0‑L |
1450
|
Ring chromosome 8 syndrome
|
ORPHAnet |
| 0‑L |
1451
|
CINCA syndrome
|
ORPHAnet |
| 0‑L |
1452
|
Cleidocranial dysplasia
|
ORPHAnet |
| 0‑L |
1453
|
Cleidorhizomelic syndrome
|
ORPHAnet |
| 0‑L |
1454
|
Joubert syndrome with hepatic defect
|
ORPHAnet |
| 0‑L |
1455
|
Autosomal dominant coarctation of aorta
|
ORPHAnet |
| 0‑L |
1456
|
Atypical coarctation of aorta
|
ORPHAnet |
| 0‑L |
1457
|
Aorta coarctation
|
ORPHAnet |
| 0‑L |
1458
|
CODAS syndrome
|
ORPHAnet |
| 0‑L |
1459
|
Celiac disease-epilepsy-cerebral calcification syndrome
|
ORPHAnet |
| 0‑L |
1460
|
Isolated complex III deficiency
|
ORPHAnet |
| 0‑L |
1461
|
Criss-cross heart
|
ORPHAnet |
| 0‑L |
1464
|
Univentricular heart
|
ORPHAnet |
| 0‑L |
1465
|
Coffin-Siris syndrome
|
ORPHAnet |
| 0‑L |
1466
|
COFS syndrome
|
ORPHAnet |
| 0‑L |
1467
|
Cogan syndrome
|
ORPHAnet |
| 0‑L |
1471
|
Coloboma of macula-brachydactyly type B syndrome
|
ORPHAnet |
| 0‑L |
1473
|
Uveal coloboma-cleft lip and palate-intellectual disability
|
ORPHAnet |
| 0‑L |
1475
|
Renal coloboma syndrome
|
ORPHAnet |
| 0‑L |
1478
|
Interatrial communication
|
ORPHAnet |
| 0‑L |
1479
|
Atrial septal defect-atrioventricular conduction defects syndrome
|
ORPHAnet |
| 0‑L |
1482
|
Gonococcal conjunctivitis
|
ORPHAnet |
| 0‑L |
1484
|
Contractures-ectodermal dysplasia-cleft lip/palate syndrome
|
ORPHAnet |
| 0‑L |
1485
|
Arthrogryposis-hyperkeratosis syndrome, lethal form
|
ORPHAnet |
| 0‑L |
1486
|
Lethal congenital contracture syndrome type 1
|
ORPHAnet |
| 0‑L |
1487
|
Cooks syndrome
|
ORPHAnet |
| 0‑L |
1488
|
Cooper-Jabs syndrome
|
ORPHAnet |
| 0‑L |
1489
|
Whooping cough
|
ORPHAnet |
| 0‑L |
1490
|
Corneal dystrophy-perceptive deafness syndrome
|
ORPHAnet |
| 0‑L |
1493
|
Vici syndrome
|
ORPHAnet |
| 0‑L |
1495
|
Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome
|
ORPHAnet |
| 0‑L |
1496
|
Corpus callosum agenesis-neuronopathy syndrome
|
ORPHAnet |
| 0‑L |
1497
|
X-linked complicated corpus callosum dysgenesis
|
ORPHAnet |
| 0‑L |
1501
|
Adrenocortical carcinoma
|
ORPHAnet |
| 0‑L |
1506
|
Thin ribs-tubular bones-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
1507
|
Autosomal recessive Robinow syndrome
|
ORPHAnet |
| 0‑L |
1508
|
Coxoauricular syndrome
|
ORPHAnet |
| 0‑L |
1509
|
Coxopodopatellar syndrome
|
ORPHAnet |
| 0‑L |
1512
|
Crane-Heise syndrome
|
ORPHAnet |
| 0‑L |
1513
|
Craniodiaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
1514
|
Craniodigital-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1515
|
Cranioectodermal dysplasia
|
ORPHAnet |
| 0‑L |
1516
|
Non-syndromic bilambdoid and sagittal craniosynostosis
|
ORPHAnet |
| 0‑L |
1517
|
Cantú syndrome
|
ORPHAnet |
| 0‑L |
1519
|
SPECC1L-related hypertelorism syndrome
|
ORPHAnet |
| 0‑L |
1520
|
Craniofrontonasal dysplasia
|
ORPHAnet |
| 0‑L |
1521
|
Craniofrontonasal dysplasia-Poland anomaly syndrome
|
ORPHAnet |
| 0‑L |
1522
|
Craniometaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
1524
|
Craniomicromelic syndrome
|
ORPHAnet |
| 0‑L |
1525
|
Cranio-osteoarthropathy
|
ORPHAnet |
| 0‑L |
1527
|
Craniosynostosis, Philadelphia type
|
ORPHAnet |
| 0‑L |
1528
|
Craniotelencephalic dysplasia
|
ORPHAnet |
| 0‑L |
1529
|
Craniofacial-deafness-hand syndrome
|
ORPHAnet |
| 0‑L |
1532
|
Gómez-López-Hernández syndrome
|
ORPHAnet |
| 0‑L |
1538
|
Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome
|
ORPHAnet |
| 0‑L |
1540
|
Jackson-Weiss syndrome
|
ORPHAnet |
| 0‑L |
1541
|
Craniosynostosis, Boston type
|
ORPHAnet |
| 0‑L |
1544
|
Benign focal seizures of adolescence
|
ORPHAnet |
| 0‑L |
1545
|
Crisponi syndrome
|
ORPHAnet |
| 0‑L |
1546
|
Cryptococcosis
|
ORPHAnet |
| 0‑L |
1547
|
Cryptomicrotia-brachydactyly-excess fingertip arch syndrome
|
ORPHAnet |
| 0‑L |
1548
|
Cryptorchidism-arachnodactyly-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
1551
|
Familial benign copper deficiency
|
ORPHAnet |
| 0‑L |
1552
|
Currarino syndrome
|
ORPHAnet |
| 0‑L |
1553
|
Curry-Jones syndrome
|
ORPHAnet |
| 0‑L |
1555
|
Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome
|
ORPHAnet |
| 0‑L |
1556
|
Cutis marmorata telangiectatica congenita
|
ORPHAnet |
| 0‑L |
1560
|
Cysticercosis
|
ORPHAnet |
| 0‑L |
1561
|
Fatal infantile cytochrome C oxidase deficiency
|
ORPHAnet |
| 0‑L |
1562
|
Dacryocystitis-osteopoikilosis syndrome
|
ORPHAnet |
| 0‑L |
1563
|
Dahlberg-Borer-Newcomer syndrome
|
ORPHAnet |
| 0‑L |
1566
|
Dandy-Walker malformation-postaxial polydactyly syndrome
|
ORPHAnet |
| 0‑L |
1568
|
X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures
syndrome
|
ORPHAnet |
| 0‑L |
1570
|
Symbrachydactyly of hands and feet
|
ORPHAnet |
| 0‑L |
1571
|
Knobloch syndrome
|
ORPHAnet |
| 0‑L |
1572
|
Common variable immunodeficiency
|
ORPHAnet |
| 0‑L |
1573
|
Hypotrichosis with juvenile macular degeneration
|
ORPHAnet |
| 0‑L |
1574
|
Retinal degeneration-nanophthalmos-glaucoma syndrome
|
ORPHAnet |
| 0‑L |
1578
|
Pterin-4 alpha-carbinolamine dehydratase deficiency
|
ORPHAnet |
| 0‑L |
1580
|
Distal monosomy 10p
|
ORPHAnet |
| 0‑L |
1581
|
Non-distal monosomy 10q
|
ORPHAnet |
| 0‑L |
1587
|
Monosomy 13q14
|
ORPHAnet |
| 0‑L |
1590
|
Distal monosomy 13q
|
ORPHAnet |
| 0‑L |
1596
|
Distal monosomy 15q
|
ORPHAnet |
| 0‑L |
1597
|
Distal monosomy 17q
|
ORPHAnet |
| 0‑L |
1598
|
Monosomy 18p
|
ORPHAnet |
| 0‑L |
1600
|
Monosomy 18q
|
ORPHAnet |
| 0‑L |
1606
|
1p36 deletion syndrome
|
ORPHAnet |
| 0‑L |
1617
|
2q24 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
1620
|
Distal monosomy 3p
|
ORPHAnet |
| 0‑L |
1621
|
3q13 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
1627
|
Deletion 5q35
|
ORPHAnet |
| 0‑L |
1636
|
Distal monosomy 7q36
|
ORPHAnet |
| 0‑L |
1642
|
Distal monosomy 9p
|
ORPHAnet |
| 0‑L |
1643
|
Xp22.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
1646
|
Partial chromosome Y deletion
|
ORPHAnet |
| 0‑L |
1647
|
Oculocerebrocutaneous syndrome
|
ORPHAnet |
| 0‑L |
1652
|
Dent disease
|
ORPHAnet |
| 0‑L |
1653
|
Dentin dysplasia
|
ORPHAnet |
| 0‑L |
1655
|
Müllerian derivatives-lymphangiectasia-polydactyly syndrome
|
ORPHAnet |
| 0‑L |
1656
|
Dermatitis herpetiformis
|
ORPHAnet |
| 0‑L |
1657
|
Dermatoosteolysis, Kirghizian type
|
ORPHAnet |
| 0‑L |
1658
|
Absence of fingerprints-congenital milia syndrome
|
ORPHAnet |
| 0‑L |
1659
|
Dermatoleukodystrophy
|
ORPHAnet |
| 0‑L |
1660
|
Dermoodontodysplasia
|
ORPHAnet |
| 0‑L |
1661
|
X-linked corneal dermoid
|
ORPHAnet |
| 0‑L |
1662
|
Restrictive dermopathy
|
ORPHAnet |
| 0‑L |
1665
|
Sporadic fetal brain disruption sequence
|
ORPHAnet |
| 0‑L |
1666
|
Dextrocardia
|
ORPHAnet |
| 0‑L |
1667
|
Wolcott-Rallison syndrome
|
ORPHAnet |
| 0‑L |
1670
|
Chronic diarrhea with villous atrophy
|
ORPHAnet |
| 0‑L |
1671
|
Split cord malformation type I
|
ORPHAnet |
| 0‑L |
1672
|
Diencephalic syndrome
|
ORPHAnet |
| 0‑L |
1675
|
Dihydropyrimidine dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
1676
|
Idiopathic pulmonary artery dilatation
|
ORPHAnet |
| 0‑L |
1677
|
Familial idiopathic dilatation of the right atrium
|
ORPHAnet |
| 0‑L |
1679
|
Diphtheria
|
ORPHAnet |
| 0‑L |
1681
|
Diprosopus
|
ORPHAnet |
| 0‑L |
1682
|
Arterial dissection-lentiginosis syndrome
|
ORPHAnet |
| 0‑L |
1685
|
Distomatosis
|
ORPHAnet |
| 0‑L |
1686
|
Cardiac diverticulum
|
ORPHAnet |
| 0‑L |
1692
|
Mosaic trisomy 1
|
ORPHAnet |
| 0‑L |
1695
|
Non-distal trisomy 10q
|
ORPHAnet |
| 0‑L |
1698
|
Mosaic trisomy 12
|
ORPHAnet |
| 0‑L |
1699
|
Trisomy 12p
|
ORPHAnet |
| 0‑L |
1702
|
Non-distal trisomy 13q
|
ORPHAnet |
| 0‑L |
1703
|
Mosaic trisomy 14
|
ORPHAnet |
| 0‑L |
1705
|
Distal trisomy 14q
|
ORPHAnet |
| 0‑L |
1706
|
Mosaic trisomy 15
|
ORPHAnet |
| 0‑L |
1707
|
Distal trisomy 15q
|
ORPHAnet |
| 0‑L |
1708
|
Mosaic trisomy 16
|
ORPHAnet |
| 0‑L |
1711
|
Mosaic trisomy 17
|
ORPHAnet |
| 0‑L |
1713
|
17p11.2 microduplication syndrome
|
ORPHAnet |
| 0‑L |
1715
|
Trisomy 18p
|
ORPHAnet |
| 0‑L |
1716
|
Distal trisomy 18q
|
ORPHAnet |
| 0‑L |
1717
|
Distal trisomy 19q
|
ORPHAnet |
| 0‑L |
1723
|
Mosaic trisomy 2
|
ORPHAnet |
| 0‑L |
1724
|
Mosaic trisomy 20
|
ORPHAnet |
| 0‑L |
1727
|
22q11.2 duplication syndrome
|
ORPHAnet |
| 0‑L |
1738
|
Trisomy 4p
|
ORPHAnet |
| 0‑L |
1742
|
Trisomy 5p
|
ORPHAnet |
| 0‑L |
1745
|
Distal trisomy 6p
|
ORPHAnet |
| 0‑L |
1747
|
Mosaic trisomy 7
|
ORPHAnet |
| 0‑L |
1752
|
Trisomy 8q
|
ORPHAnet |
| 0‑L |
1756
|
Caudal duplication
|
ORPHAnet |
| 0‑L |
1757
|
Fibular dimelia-diplopodia syndrome
|
ORPHAnet |
| 0‑L |
1759
|
Thoraco-abdominal enteric duplication
|
ORPHAnet |
| 0‑L |
1762
|
Proximal Xq28 duplication syndrome
|
ORPHAnet |
| 0‑L |
1764
|
Familial dysautonomia
|
ORPHAnet |
| 0‑L |
1765
|
Dyschondrosteosis-nephritis syndrome
|
ORPHAnet |
| 0‑L |
1766
|
Dysequilibrium syndrome
|
ORPHAnet |
| 0‑L |
1768
|
Familial caudal dysgenesis
|
ORPHAnet |
| 0‑L |
1770
|
XY type gonadal dysgenesis-associated anomalies syndrome
|
ORPHAnet |
| 0‑L |
1772
|
45,X/46,XY mixed gonadal dysgenesis
|
ORPHAnet |
| 0‑L |
1775
|
Dyskeratosis congenita
|
ORPHAnet |
| 0‑L |
1777
|
Temtamy syndrome
|
ORPHAnet |
| 0‑L |
1778
|
Facial dysmorphism-shawl scrotum-joint laxity syndrome
|
ORPHAnet |
| 0‑L |
1779
|
Dysmorphism-cleft palate-loose skin syndrome
|
ORPHAnet |
| 0‑L |
1780
|
Thakker-Donnai syndrome
|
ORPHAnet |
| 0‑L |
1782
|
Dysosteosclerosis
|
ORPHAnet |
| 0‑L |
1784
|
Acrofrontofacionasal dysostosis
|
ORPHAnet |
| 0‑L |
1786
|
Acrofacial dysostosis, Catania type
|
ORPHAnet |
| 0‑L |
1787
|
Acrofacial dysostosis, Palagonia type
|
ORPHAnet |
| 0‑L |
1788
|
Acrofacial dysostosis, Rodríguez type
|
ORPHAnet |
| 0‑L |
1790
|
Hypomandibular faciocranial dysostosis
|
ORPHAnet |
| 0‑L |
1791
|
Frontofacionasal dysplasia
|
ORPHAnet |
| 0‑L |
1794
|
Oculomaxillofacial dysostosis
|
ORPHAnet |
| 0‑L |
1795
|
Peripheral dysostosis
|
ORPHAnet |
| 0‑L |
1797
|
Autosomal dominant spondylocostal dysostosis
|
ORPHAnet |
| 0‑L |
1798
|
Dysostosis, Stanescu type
|
ORPHAnet |
| 0‑L |
1799
|
Familial developmental dysphasia
|
ORPHAnet |
| 0‑L |
1801
|
Kyphomelic dysplasia
|
ORPHAnet |
| 0‑L |
1802
|
Ghosal hematodiaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
1803
|
Thoracomelic dysplasia
|
ORPHAnet |
| 0‑L |
1806
|
Ectodermal dysplasia-blindness syndrome
|
ORPHAnet |
| 0‑L |
1807
|
Focal facial dermal dysplasia type III
|
ORPHAnet |
| 0‑L |
1808
|
Hidrotic ectodermal dysplasia, Christianson-Fourie type
|
ORPHAnet |
| 0‑L |
1809
|
Hidrotic ectodermal dysplasia, Halal type
|
ORPHAnet |
| 0‑L |
1810
|
Autosomal dominant hypohidrotic ectodermal dysplasia
|
ORPHAnet |
| 0‑L |
1811
|
Odontomicronychial dysplasia
|
ORPHAnet |
| 0‑L |
1812
|
Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome
|
ORPHAnet |
| 0‑L |
1816
|
Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome
|
ORPHAnet |
| 0‑L |
1818
|
Ectodermal dysplasia, trichoodontoonychial type
|
ORPHAnet |
| 0‑L |
1822
|
Dysplasia epiphysealis hemimelica
|
ORPHAnet |
| 0‑L |
1824
|
Lowry-Wood syndrome
|
ORPHAnet |
| 0‑L |
1825
|
Epiphyseal dysplasia-hearing loss-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
1826
|
Frontometaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
1827
|
Acromelic frontonasal dysplasia
|
ORPHAnet |
| 0‑L |
1830
|
Schimke immuno-osseous dysplasia
|
ORPHAnet |
| 0‑L |
1832
|
Lethal osteosclerotic bone dysplasia
|
ORPHAnet |
| 0‑L |
1834
|
Axial mesodermal dysplasia spectrum
|
ORPHAnet |
| 0‑L |
1836
|
Mesomelic dysplasia, Kantaputra type
|
ORPHAnet |
| 0‑L |
1837
|
Ulna metaphyseal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
1839
|
Hereditary mucoepithelial dysplasia
|
ORPHAnet |
| 0‑L |
1842
|
Bone dysplasia, lethal Holmgren type
|
ORPHAnet |
| 0‑L |
1848
|
Renal agenesis, bilateral
|
ORPHAnet |
| 0‑L |
1851
|
Multicystic dysplastic kidney
|
ORPHAnet |
| 0‑L |
1852
|
X-linked retinal dysplasia
|
ORPHAnet |
| 0‑L |
1855
|
Spondyloenchondrodysplasia
|
ORPHAnet |
| 0‑L |
1856
|
Spondyloperipheral dysplasia-short ulna syndrome
|
ORPHAnet |
| 0‑L |
1858
|
Skeletal dysplasia-epilepsy-short stature syndrome
|
ORPHAnet |
| 0‑L |
1860
|
Thanatophoric dysplasia type 1
|
ORPHAnet |
| 0‑L |
1861
|
Thoracic dysplasia-hydrocephalus syndrome
|
ORPHAnet |
| 0‑L |
1865
|
Dyssegmental dysplasia, Silverman-Handmaker type
|
ORPHAnet |
| 0‑L |
1867
|
Hereditary bullous dystrophy, macular type
|
ORPHAnet |
| 0‑L |
1871
|
Progressive cone dystrophy
|
ORPHAnet |
| 0‑L |
1872
|
Cone rod dystrophy
|
ORPHAnet |
| 0‑L |
1873
|
Jalili syndrome
|
ORPHAnet |
| 0‑L |
1875
|
Congenital muscular dystrophy-infantile cataract-hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
1876
|
Oculogastrointestinal muscular dystrophy
|
ORPHAnet |
| 0‑L |
1878
|
TRIM32-related limb-girdle muscular dystrophy R8
|
ORPHAnet |
| 0‑L |
1879
|
Melorheostosis with osteopoikilosis
|
ORPHAnet |
| 0‑L |
1880
|
Ebstein malformation of the tricuspid valve
|
ORPHAnet |
| 0‑L |
1882
|
Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome
|
ORPHAnet |
| 0‑L |
1883
|
Ectodermal dysplasia-sensorineural deafness syndrome
|
ORPHAnet |
| 0‑L |
1884
|
Ectopia lentis-chorioretinal dystrophy-myopia syndrome
|
ORPHAnet |
| 0‑L |
1885
|
Isolated ectopia lentis
|
ORPHAnet |
| 0‑L |
1891
|
Intellectual disability-spasticity-ectrodactyly syndrome
|
ORPHAnet |
| 0‑L |
1892
|
Ectrodactyly-polydactyly syndrome
|
ORPHAnet |
| 0‑L |
1895
|
Edinburgh malformation syndrome
|
ORPHAnet |
| 0‑L |
1896
|
EEC syndrome
|
ORPHAnet |
| 0‑L |
1897
|
EEM syndrome
|
ORPHAnet |
| 0‑L |
1899
|
Arthrochalasia Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
1900
|
Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency
|
ORPHAnet |
| 0‑L |
1901
|
Dermatosparaxis Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
1902
|
Ehrlichiosis
|
ORPHAnet |
| 0‑L |
1906
|
Fetal valproate spectrum disorder
|
ORPHAnet |
| 0‑L |
1908
|
Aminopterin/methotrexate embryofetopathy
|
ORPHAnet |
| 0‑L |
1909
|
Indomethacin embryofetopathy
|
ORPHAnet |
| 0‑L |
1910
|
Fetal iodine syndrome
|
ORPHAnet |
| 0‑L |
1911
|
Cocaine embryofetopathy
|
ORPHAnet |
| 0‑L |
1912
|
Fetal hydantoin syndrome
|
ORPHAnet |
| 0‑L |
1913
|
Fetal trimethadione syndrome
|
ORPHAnet |
| 0‑L |
1914
|
Vitamin K antagonist embryofetopathy
|
ORPHAnet |
| 0‑L |
1915
|
Fetal alcohol syndrome
|
ORPHAnet |
| 0‑L |
1916
|
Diethylstilbestrol syndrome
|
ORPHAnet |
| 0‑L |
1917
|
Fetal methylmercury syndrome
|
ORPHAnet |
| 0‑L |
1918
|
Fetal minoxidil syndrome
|
ORPHAnet |
| 0‑L |
1919
|
Phenobarbital embryopathy
|
ORPHAnet |
| 0‑L |
1920
|
Toluene embryopathy
|
ORPHAnet |
| 0‑L |
1923
|
Methimazole embryofetopathy
|
ORPHAnet |
| 0‑L |
1926
|
Diabetic embryopathy
|
ORPHAnet |
| 0‑L |
1927
|
Emery-Nelson syndrome
|
ORPHAnet |
| 0‑L |
1928
|
Congenital lobar emphysema
|
ORPHAnet |
| 0‑L |
1929
|
Rasmussen subacute encephalitis
|
ORPHAnet |
| 0‑L |
1930
|
Herpes simplex virus encephalitis
|
ORPHAnet |
| 0‑L |
1931
|
Frontal encephalocele
|
ORPHAnet |
| 0‑L |
1933
|
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
|
ORPHAnet |
| 0‑L |
1934
|
Early infantile epileptic encephalopathy
|
ORPHAnet |
| 0‑L |
1935
|
Early myoclonic encephalopathy
|
ORPHAnet |
| 0‑L |
1937
|
Eng-Strom syndrome
|
ORPHAnet |
| 0‑L |
1941
|
Juvenile absence epilepsy
|
ORPHAnet |
| 0‑L |
1942
|
Myoclonic-astatic epilepsy
|
ORPHAnet |
| 0‑L |
1943
|
Early-onset progressive encephalopathy with migrant continuous myoclonus
|
ORPHAnet |
| 0‑L |
1945
|
Rolandic epilepsy
|
ORPHAnet |
| 0‑L |
1946
|
Amelocerebrohypohidrotic syndrome
|
ORPHAnet |
| 0‑L |
1947
|
Progressive epilepsy-intellectual disability syndrome, Finnish type
|
ORPHAnet |
| 0‑L |
1948
|
Epilepsy-microcephaly-skeletal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
1949
|
Benign familial neonatal epilepsy
|
ORPHAnet |
| 0‑L |
1951
|
Epilepsy-telangiectasia syndrome
|
ORPHAnet |
| 0‑L |
1952
|
Epiphyseal stippling-osteoclastic hyperplasia syndrome
|
ORPHAnet |
| 0‑L |
1954
|
Congenital lethal erythroderma
|
ORPHAnet |
| 0‑L |
1955
|
Spinocerebellar ataxia type 34
|
ORPHAnet |
| 0‑L |
1957
|
Esthesioneuroblastoma
|
ORPHAnet |
| 0‑L |
1959
|
Evans syndrome
|
ORPHAnet |
| 0‑L |
1962
|
Exostoses-anetodermia-brachydactyly type E syndrome
|
ORPHAnet |
| 0‑L |
1964
|
Extrasystoles-short stature-hyperpigmentation-microcephaly syndrome
|
ORPHAnet |
| 0‑L |
1968
|
Flat face-microstomia-ear anomaly syndrome
|
ORPHAnet |
| 0‑L |
1969
|
Facial dysmorphism-anorexia-cachexia-eye and skin anomalies syndrome
|
ORPHAnet |
| 0‑L |
1970
|
Facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome
|
ORPHAnet |
| 0‑L |
1972
|
Lethal faciocardiomelic dysplasia
|
ORPHAnet |
| 0‑L |
1973
|
Faciocardiorenal syndrome
|
ORPHAnet |
| 0‑L |
1974
|
Autosomal recessive faciodigitogenital syndrome
|
ORPHAnet |
| 0‑L |
1979
|
Lipodystrophy due to peptidic growth factors deficiency
|
ORPHAnet |
| 0‑L |
1980
|
Bilateral striopallidodentate calcinosis
|
ORPHAnet |
| 0‑L |
1986
|
Gollop-Wolfgang complex
|
ORPHAnet |
| 0‑L |
1987
|
Femoral agenesis/hypoplasia
|
ORPHAnet |
| 0‑L |
1988
|
Femoral-facial syndrome
|
ORPHAnet |
| 0‑L |
1993
|
Pai syndrome
|
ORPHAnet |
| 0‑L |
1995
|
Cleft lip-retinopathy syndrome
|
ORPHAnet |
| 0‑L |
1997
|
Blepharo-cheilo-odontic syndrome
|
ORPHAnet |
| 0‑L |
2001
|
Cleft lip/palate-intestinal malrotation-cardiopathy syndrome
|
ORPHAnet |
| 0‑L |
2003
|
Cleft lip/palate-deafness-sacral lipoma syndrome
|
ORPHAnet |
| 0‑L |
2004
|
Laryngotracheoesophageal cleft
|
ORPHAnet |
| 0‑L |
2006
|
Median cleft lip/mandibule
|
ORPHAnet |
| 0‑L |
2007
|
Alar cartilages hypoplasia-coloboma-telecanthus syndrome
|
ORPHAnet |
| 0‑L |
2008
|
Acrocardiofacial syndrome
|
ORPHAnet |
| 0‑L |
2010
|
Cleft palate-stapes fixation-oligodontia syndrome
|
ORPHAnet |
| 0‑L |
2013
|
Cleft palate-large ears-small head syndrome
|
ORPHAnet |
| 0‑L |
2015
|
Cleft palate-short stature-vertebral anomalies syndrome
|
ORPHAnet |
| 0‑L |
2016
|
Cleft palate-lateral synechia syndrome
|
ORPHAnet |
| 0‑L |
2017
|
Sternal cleft
|
ORPHAnet |
| 0‑L |
2019
|
Femur-fibula-ulna complex
|
ORPHAnet |
| 0‑L |
2020
|
Congenital fiber-type disproportion myopathy
|
ORPHAnet |
| 0‑L |
2021
|
Fibrochondrogenesis
|
ORPHAnet |
| 0‑L |
2022
|
Endocardial fibroelastosis
|
ORPHAnet |
| 0‑L |
2023
|
Undifferentiated pleomorphic sarcoma
|
ORPHAnet |
| 0‑L |
2024
|
Hereditary gingival fibromatosis
|
ORPHAnet |
| 0‑L |
2025
|
Gingival fibromatosis-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
2026
|
Gingival fibromatosis-hypertrichosis syndrome
|
ORPHAnet |
| 0‑L |
2027
|
Gingival fibromatosis-progressive deafness syndrome
|
ORPHAnet |
| 0‑L |
2028
|
Juvenile hyaline fibromatosis
|
ORPHAnet |
| 0‑L |
2030
|
Fibrosarcoma
|
ORPHAnet |
| 0‑L |
2031
|
Hepatic fibrosis-renal cysts-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2032
|
Idiopathic pulmonary fibrosis
|
ORPHAnet |
| 0‑L |
2035
|
Lymphatic filariasis
|
ORPHAnet |
| 0‑L |
2036
|
Scalp-ear-nipple syndrome
|
ORPHAnet |
| 0‑L |
2037
|
Congenital aortopulmonary window
|
ORPHAnet |
| 0‑L |
2038
|
Pulmonary arteriovenous malformation
|
ORPHAnet |
| 0‑L |
2039
|
Congenital systemic arteriovenous fistula
|
ORPHAnet |
| 0‑L |
2040
|
Congenital respiratory-biliary fistula
|
ORPHAnet |
| 0‑L |
2041
|
Coronary arterial fistula
|
ORPHAnet |
| 0‑L |
2044
|
Floating-Harbor syndrome
|
ORPHAnet |
| 0‑L |
2045
|
FLOTCH syndrome
|
ORPHAnet |
| 0‑L |
2047
|
Flynn-Aird syndrome
|
ORPHAnet |
| 0‑L |
2048
|
Foix-Chavany-Marie syndrome
|
ORPHAnet |
| 0‑L |
2050
|
Cole-Carpenter syndrome
|
ORPHAnet |
| 0‑L |
2052
|
Fraser syndrome
|
ORPHAnet |
| 0‑L |
2053
|
Freeman-Sheldon syndrome
|
ORPHAnet |
| 0‑L |
2056
|
Essential fructosuria
|
ORPHAnet |
| 0‑L |
2057
|
Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome
|
ORPHAnet |
| 0‑L |
2058
|
Fryns-Smeets-Thiry syndrome
|
ORPHAnet |
| 0‑L |
2059
|
Fryns syndrome
|
ORPHAnet |
| 0‑L |
2062
|
Progressive non-infectious anterior vertebral fusion
|
ORPHAnet |
| 0‑L |
2063
|
Splenogonadal fusion-limb defects-micrognathia syndrome
|
ORPHAnet |
| 0‑L |
2064
|
Posterior fusion of lumbosacral vertebrae-blepharoptosis syndrome
|
ORPHAnet |
| 0‑L |
2065
|
Galloway-Mowat syndrome
|
ORPHAnet |
| 0‑L |
2066
|
Gamma-aminobutyric acid transaminase deficiency
|
ORPHAnet |
| 0‑L |
2067
|
GAPO syndrome
|
ORPHAnet |
| 0‑L |
2069
|
Gastrocutaneous syndrome
|
ORPHAnet |
| 0‑L |
2070
|
Eosinophilic gastroenteritis
|
ORPHAnet |
| 0‑L |
2072
|
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
|
ORPHAnet |
| 0‑L |
2073
|
Narcolepsy type 1
|
ORPHAnet |
| 0‑L |
2074
|
Gemignani syndrome
|
ORPHAnet |
| 0‑L |
2075
|
Genitopalatocardiac syndrome
|
ORPHAnet |
| 0‑L |
2077
|
German syndrome
|
ORPHAnet |
| 0‑L |
2078
|
Geroderma osteodysplastica
|
ORPHAnet |
| 0‑L |
2083
|
Prominent glabella-microcephaly-hypogenitalism syndrome
|
ORPHAnet |
| 0‑L |
2084
|
Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome
|
ORPHAnet |
| 0‑L |
2085
|
Glaucoma-sleep apnea syndrome
|
ORPHAnet |
| 0‑L |
2086
|
Optic pathway glioma
|
ORPHAnet |
| 0‑L |
2088
|
Fanconi-Bickel syndrome
|
ORPHAnet |
| 0‑L |
2089
|
Glycogen storage disease due to hepatic glycogen synthase deficiency
|
ORPHAnet |
| 0‑L |
2090
|
GMS syndrome
|
ORPHAnet |
| 0‑L |
2091
|
Multinodular goiter-cystic kidney-polydactyly syndrome
|
ORPHAnet |
| 0‑L |
2092
|
Focal dermal hypoplasia
|
ORPHAnet |
| 0‑L |
2095
|
Gorlin-Chaudhry-Moss syndrome
|
ORPHAnet |
| 0‑L |
2097
|
Grant syndrome
|
ORPHAnet |
| 0‑L |
2098
|
Acromesomelic dysplasia, Grebe type
|
ORPHAnet |
| 0‑L |
2101
|
Grubben-de Cock-Borghgraef syndrome
|
ORPHAnet |
| 0‑L |
2102
|
GTP cyclohydrolase I deficiency
|
ORPHAnet |
| 0‑L |
2104
|
Dysmorphism-pectus carinatum-joint laxity syndrome
|
ORPHAnet |
| 0‑L |
2107
|
Hall-Riggs syndrome
|
ORPHAnet |
| 0‑L |
2108
|
Hallermann-Streiff syndrome
|
ORPHAnet |
| 0‑L |
2109
|
Hallermann-Streiff-like syndrome
|
ORPHAnet |
| 0‑L |
2110
|
Hallux varus-preaxial polysyndactyly syndrome
|
ORPHAnet |
| 0‑L |
2111
|
Cystic hamartoma of lung and kidney
|
ORPHAnet |
| 0‑L |
2114
|
Hip dysplasia, Beukes type
|
ORPHAnet |
| 0‑L |
2115
|
Harrod syndrome
|
ORPHAnet |
| 0‑L |
2116
|
Hartnup disease
|
ORPHAnet |
| 0‑L |
2117
|
Hartsfield syndrome
|
ORPHAnet |
| 0‑L |
2118
|
Hawkinsinuria
|
ORPHAnet |
| 0‑L |
2119
|
HEC syndrome
|
ORPHAnet |
| 0‑L |
2122
|
Kaposiform hemangioendothelioma
|
ORPHAnet |
| 0‑L |
2123
|
Diffuse neonatal hemangiomatosis
|
ORPHAnet |
| 0‑L |
2126
|
Solitary fibrous tumor/hemangiopericytoma
|
ORPHAnet |
| 0‑L |
2128
|
Isolated hemihyperplasia
|
ORPHAnet |
| 0‑L |
2131
|
Alternating hemiplegia of childhood
|
ORPHAnet |
| 0‑L |
2132
|
Hemoglobin C disease
|
ORPHAnet |
| 0‑L |
2133
|
Hemoglobin E disease
|
ORPHAnet |
| 0‑L |
2134
|
Atypical hemolytic uremic syndrome
|
ORPHAnet |
| 0‑L |
2135
|
Hennekam-Beemer syndrome
|
ORPHAnet |
| 0‑L |
2136
|
Hennekam syndrome
|
ORPHAnet |
| 0‑L |
2137
|
Autoimmune hepatitis
|
ORPHAnet |
| 0‑L |
2138
|
46,XX ovotesticular disorder of sex development
|
ORPHAnet |
| 0‑L |
2139
|
Hernández-Aguirre Negrete syndrome
|
ORPHAnet |
| 0‑L |
2140
|
Congenital diaphragmatic hernia
|
ORPHAnet |
| 0‑L |
2141
|
Diaphragmatic defect-limb deficiency-skull defect syndrome
|
ORPHAnet |
| 0‑L |
2143
|
Donnai-Barrow syndrome
|
ORPHAnet |
| 0‑L |
2145
|
Craniosynostosis, Herrmann-Opitz type
|
ORPHAnet |
| 0‑L |
2148
|
Lissencephaly type 1 due to doublecortin gene mutation
|
ORPHAnet |
| 0‑L |
2149
|
Nodular neuronal heterotopia
|
ORPHAnet |
| 0‑L |
2150
|
Hirschsprung disease-type D brachydactyly syndrome
|
ORPHAnet |
| 0‑L |
2151
|
Hirschsprung disease-ganglioneuroblastoma syndrome
|
ORPHAnet |
| 0‑L |
2152
|
Mowat-Wilson syndrome
|
ORPHAnet |
| 0‑L |
2153
|
Hirschsprung disease-nail hypoplasia-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
2155
|
Hirschsprung disease-deafness-polydactyly syndrome
|
ORPHAnet |
| 0‑L |
2157
|
Histidinemia
|
ORPHAnet |
| 0‑L |
2158
|
Histidinuria-renal tubular defect syndrome
|
ORPHAnet |
| 0‑L |
2162
|
Holoprosencephaly
|
ORPHAnet |
| 0‑L |
2163
|
Holoprosencephaly-craniosynostosis syndrome
|
ORPHAnet |
| 0‑L |
2165
|
Holoprosencephaly-caudal dysgenesis syndrome
|
ORPHAnet |
| 0‑L |
2166
|
Holoprosencephaly-postaxial polydactyly syndrome
|
ORPHAnet |
| 0‑L |
2167
|
Holzgreve syndrome
|
ORPHAnet |
| 0‑L |
2169
|
Methylcobalamin deficiency type cblE
|
ORPHAnet |
| 0‑L |
2170
|
Methylcobalamin deficiency type cblG
|
ORPHAnet |
| 0‑L |
2172
|
Microcephaly-glomerulonephritis-marfanoid habitus syndrome
|
ORPHAnet |
| 0‑L |
2176
|
Infantile systemic hyalinosis
|
ORPHAnet |
| 0‑L |
2177
|
Hydranencephaly
|
ORPHAnet |
| 0‑L |
2180
|
Hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome
|
ORPHAnet |
| 0‑L |
2181
|
Hydrocephaly-tall stature-joint laxity syndrome
|
ORPHAnet |
| 0‑L |
2182
|
Hydrocephalus with stenosis of the aqueduct of Sylvius
|
ORPHAnet |
| 0‑L |
2183
|
Hydrocephalus-obesity-hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
2184
|
Hydrocephaly-low insertion umbilicus syndrome
|
ORPHAnet |
| 0‑L |
2185
|
Congenital hydrocephalus
|
ORPHAnet |
| 0‑L |
2186
|
Hydrocephalus-blue sclerae-nephropathy syndrome
|
ORPHAnet |
| 0‑L |
2189
|
Hydrolethalus
|
ORPHAnet |
| 0‑L |
2194
|
Anti-HLA hyperimmunization
|
ORPHAnet |
| 0‑L |
2195
|
Dicarboxylic aminoaciduria
|
ORPHAnet |
| 0‑L |
2196
|
Primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular
involvement
|
ORPHAnet |
| 0‑L |
2197
|
Idiopathic hypercalciuria
|
ORPHAnet |
| 0‑L |
2198
|
Palmoplantar keratoderma-esophageal carcinoma syndrome
|
ORPHAnet |
| 0‑L |
2199
|
Epidermolytic palmoplantar keratoderma
|
ORPHAnet |
| 0‑L |
2200
|
Focal palmoplantar and gingival keratoderma
|
ORPHAnet |
| 0‑L |
2201
|
Palmoplantar keratoderma-spastic paralysis syndrome
|
ORPHAnet |
| 0‑L |
2202
|
Palmoplantar keratoderma-deafness syndrome
|
ORPHAnet |
| 0‑L |
2203
|
Hyperlysinemia
|
ORPHAnet |
| 0‑L |
2204
|
Dysplastic cortical hyperostosis
|
ORPHAnet |
| 0‑L |
2206
|
Ankylosing vertebral hyperostosis with tylosis
|
ORPHAnet |
| 0‑L |
2209
|
Maternal phenylketonuria
|
ORPHAnet |
| 0‑L |
2211
|
Hypertelorism-hypospadias-polysyndactyly syndrome
|
ORPHAnet |
| 0‑L |
2213
|
Hypertelorism-microtia-facial clefting syndrome
|
ORPHAnet |
| 0‑L |
2215
|
Multiple pterygium-malignant hyperthermia syndrome
|
ORPHAnet |
| 0‑L |
2216
|
Maternal hyperthermia-induced birth defects
|
ORPHAnet |
| 0‑L |
2218
|
Cervical hypertrichosis-peripheral neuropathy syndrome
|
ORPHAnet |
| 0‑L |
2220
|
Hypertrichosis cubiti
|
ORPHAnet |
| 0‑L |
2221
|
Acquired hypertrichosis lanuginosa
|
ORPHAnet |
| 0‑L |
2222
|
Hypertrichosis lanuginosa congenita
|
ORPHAnet |
| 0‑L |
2224
|
Hypertryptophanemia
|
ORPHAnet |
| 0‑L |
2228
|
Hypodontia-dysplasia of nails syndrome
|
ORPHAnet |
| 0‑L |
2229
|
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
2230
|
Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome
|
ORPHAnet |
| 0‑L |
2232
|
Primary hypergonadotropic hypogonadism-partial alopecia syndrome
|
ORPHAnet |
| 0‑L |
2233
|
Hypogonadism-mitral valve prolapse-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2234
|
Male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome
|
ORPHAnet |
| 0‑L |
2235
|
Hypogonadotropic hypogonadism-retinitis pigmentosa syndrome
|
ORPHAnet |
| 0‑L |
2237
|
Hypoparathyroidism-sensorineural deafness-renal disease syndrome
|
ORPHAnet |
| 0‑L |
2238
|
Familial isolated hypoparathyroidism
|
ORPHAnet |
| 0‑L |
2239
|
Familial isolated hypoparathyroidism due to agenesis of parathyroid gland
|
ORPHAnet |
| 0‑L |
2241
|
Megacystis-microcolon-intestinal hypoperistalsis syndrome
|
ORPHAnet |
| 0‑L |
2246
|
Cerebellar hypoplasia-tapetoretinal degeneration syndrome
|
ORPHAnet |
| 0‑L |
2248
|
Hypoplastic left heart syndrome
|
ORPHAnet |
| 0‑L |
2249
|
Ulna hypoplasia-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2250
|
Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
2251
|
Thumb deformity-alopecia-pigmentation anomaly syndrome
|
ORPHAnet |
| 0‑L |
2252
|
Radial hypoplasia-triphalangeal thumbs-hypospadias-maxillary diastema syndrome
|
ORPHAnet |
| 0‑L |
2253
|
Foveal hypoplasia-presenile cataract syndrome
|
ORPHAnet |
| 0‑L |
2254
|
Pontocerebellar hypoplasia type 1
|
ORPHAnet |
| 0‑L |
2255
|
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome
|
ORPHAnet |
| 0‑L |
2256
|
Fibulo-ulnar hypoplasia-renal anomalies syndrome
|
ORPHAnet |
| 0‑L |
2257
|
Primary pulmonary hypoplasia
|
ORPHAnet |
| 0‑L |
2260
|
Oligomeganephronia
|
ORPHAnet |
| 0‑L |
2261
|
Hypospadias-intellectual disability, Goldblatt type syndrome
|
ORPHAnet |
| 0‑L |
2266
|
Hypotrichosis-intellectual disability, Lopes type
|
ORPHAnet |
| 0‑L |
2268
|
ICF syndrome
|
ORPHAnet |
| 0‑L |
2269
|
Ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2271
|
Congenital ichthyosis-microcephalus-tetraplegia syndrome
|
ORPHAnet |
| 0‑L |
2272
|
Ichthyosis-oral and digital anomalies syndrome
|
ORPHAnet |
| 0‑L |
2273
|
Ichthyosis follicularis-alopecia-photophobia syndrome
|
ORPHAnet |
| 0‑L |
2274
|
Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome
|
ORPHAnet |
| 0‑L |
2278
|
Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome
|
ORPHAnet |
| 0‑L |
2282
|
Dysmorphism-short stature-deafness-disorder of sex development syndrome
|
ORPHAnet |
| 0‑L |
2285
|
Primary basilar invagination
|
ORPHAnet |
| 0‑L |
2287
|
Fused mandibular incisors
|
ORPHAnet |
| 0‑L |
2289
|
Neuronal intranuclear inclusion disease
|
ORPHAnet |
| 0‑L |
2290
|
Microvillus inclusion disease
|
ORPHAnet |
| 0‑L |
2291
|
Congenital velopharyngeal incompetence
|
ORPHAnet |
| 0‑L |
2292
|
Congenital bowing of long bones
|
ORPHAnet |
| 0‑L |
2295
|
Familial articular hypermobility syndrome
|
ORPHAnet |
| 0‑L |
2297
|
Insulin-resistance syndrome type A
|
ORPHAnet |
| 0‑L |
2298
|
Insulin-resistance syndrome type B
|
ORPHAnet |
| 0‑L |
2299
|
Aortic arch interruption
|
ORPHAnet |
| 0‑L |
2300
|
Multiple intestinal atresia
|
ORPHAnet |
| 0‑L |
2301
|
Congenital short bowel syndrome
|
ORPHAnet |
| 0‑L |
2302
|
Asbestos intoxication
|
ORPHAnet |
| 0‑L |
2305
|
Isotretinoin syndrome
|
ORPHAnet |
| 0‑L |
2306
|
Isotretinoin-like syndrome
|
ORPHAnet |
| 0‑L |
2307
|
IVIC syndrome
|
ORPHAnet |
| 0‑L |
2308
|
Jacobsen syndrome
|
ORPHAnet |
| 0‑L |
2309
|
Pachyonychia congenita
|
ORPHAnet |
| 0‑L |
2310
|
Absence deformity of leg-cataract syndrome
|
ORPHAnet |
| 0‑L |
2311
|
Autosomal recessive spondylocostal dysostosis
|
ORPHAnet |
| 0‑L |
2312
|
Transient familial neonatal hyperbilirubinemia
|
ORPHAnet |
| 0‑L |
2314
|
Autosomal dominant hyper-IgE syndrome
|
ORPHAnet |
| 0‑L |
2315
|
Johanson-Blizzard syndrome
|
ORPHAnet |
| 0‑L |
2316
|
Johnson neuroectodermal syndrome
|
ORPHAnet |
| 0‑L |
2318
|
Joubert syndrome with oculorenal defect
|
ORPHAnet |
| 0‑L |
2319
|
Juberg-Hayward syndrome
|
ORPHAnet |
| 0‑L |
2321
|
Jung syndrome
|
ORPHAnet |
| 0‑L |
2322
|
Kabuki syndrome
|
ORPHAnet |
| 0‑L |
2323
|
Sanjad-Sakati syndrome
|
ORPHAnet |
| 0‑L |
2324
|
Osteopenia-intellectual disability-sparse hair syndrome
|
ORPHAnet |
| 0‑L |
2325
|
Epidermolysis bullosa simplex with anodontia/hypodontia
|
ORPHAnet |
| 0‑L |
2326
|
Kallmann syndrome-heart disease syndrome
|
ORPHAnet |
| 0‑L |
2328
|
Kapur-Toriello syndrome
|
ORPHAnet |
| 0‑L |
2329
|
Karsch-Neugebauer syndrome
|
ORPHAnet |
| 0‑L |
2330
|
Kasabach-Merritt syndrome
|
ORPHAnet |
| 0‑L |
2331
|
Kawasaki disease
|
ORPHAnet |
| 0‑L |
2332
|
KBG syndrome
|
ORPHAnet |
| 0‑L |
2333
|
Kenny-Caffey syndrome
|
ORPHAnet |
| 0‑L |
2334
|
Autosomal dominant keratitis
|
ORPHAnet |
| 0‑L |
2337
|
Non-epidermolytic palmoplantar keratoderma
|
ORPHAnet |
| 0‑L |
2339
|
Keratosis follicularis-dwarfism-cerebral atrophy syndrome
|
ORPHAnet |
| 0‑L |
2340
|
Keratosis follicularis spinulosa decalvans
|
ORPHAnet |
| 0‑L |
2342
|
Haim-Munk syndrome
|
ORPHAnet |
| 0‑L |
2345
|
Isolated Klippel-Feil syndrome
|
ORPHAnet |
| 0‑L |
2347
|
Lethal Kniest-like dysplasia
|
ORPHAnet |
| 0‑L |
2348
|
Familial partial lipodystrophy, Dunnigan type
|
ORPHAnet |
| 0‑L |
2349
|
Muscular pseudohypertrophy-hypothyroidism syndrome
|
ORPHAnet |
| 0‑L |
2351
|
Kousseff syndrome
|
ORPHAnet |
| 0‑L |
2353
|
Schilbach-Rott syndrome
|
ORPHAnet |
| 0‑L |
2356
|
Arachnoid cyst
|
ORPHAnet |
| 0‑L |
2357
|
Bronchogenic cyst
|
ORPHAnet |
| 0‑L |
2363
|
Lacrimoauriculodentodigital syndrome
|
ORPHAnet |
| 0‑L |
2364
|
Glycogen storage disease due to lactate dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
2368
|
Gastroschisis
|
ORPHAnet |
| 0‑L |
2369
|
Limb body wall complex
|
ORPHAnet |
| 0‑L |
2370
|
Larsen-like osseous dysplasia-short stature syndrome
|
ORPHAnet |
| 0‑L |
2371
|
Lethal Larsen-like syndrome
|
ORPHAnet |
| 0‑L |
2372
|
Laryngocele
|
ORPHAnet |
| 0‑L |
2373
|
Congenital laryngomalacia
|
ORPHAnet |
| 0‑L |
2374
|
Congenital laryngeal web
|
ORPHAnet |
| 0‑L |
2375
|
Laryngeal abductor paralysis-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2377
|
Laurence-Moon syndrome
|
ORPHAnet |
| 0‑L |
2378
|
Laurin-Sandrow syndrome
|
ORPHAnet |
| 0‑L |
2379
|
Early-onset parkinsonism-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2380
|
Legg-Calvé-Perthes disease
|
ORPHAnet |
| 0‑L |
2382
|
Lennox-Gastaut syndrome
|
ORPHAnet |
| 0‑L |
2386
|
Leukoencephalopathy-palmoplantar keratoderma syndrome
|
ORPHAnet |
| 0‑L |
2387
|
Leukonychia totalis
|
ORPHAnet |
| 0‑L |
2388
|
Choreoacanthocytosis
|
ORPHAnet |
| 0‑L |
2390
|
Lichtenstein syndrome
|
ORPHAnet |
| 0‑L |
2391
|
Congenitally short costocoracoid ligament
|
ORPHAnet |
| 0‑L |
2394
|
Pyruvate dehydrogenase E3 deficiency
|
ORPHAnet |
| 0‑L |
2396
|
Encephalocraniocutaneous lipomatosis
|
ORPHAnet |
| 0‑L |
2398
|
Multiple symmetric lipomatosis
|
ORPHAnet |
| 0‑L |
2399
|
Nasopalpebral lipoma-coloboma syndrome
|
ORPHAnet |
| 0‑L |
2400
|
Peripheral motor neuropathy-dysautonomia syndrome
|
ORPHAnet |
| 0‑L |
2404
|
Loiasis
|
ORPHAnet |
| 0‑L |
2405
|
Thickened earlobes-conductive deafness syndrome
|
ORPHAnet |
| 0‑L |
2406
|
Locked-in syndrome
|
ORPHAnet |
| 0‑L |
2407
|
Laryngo-onycho-cutaneous syndrome
|
ORPHAnet |
| 0‑L |
2408
|
Lowe-Kohn-Cohen syndrome
|
ORPHAnet |
| 0‑L |
2409
|
Lowry-MacLean syndrome
|
ORPHAnet |
| 0‑L |
2410
|
Hypergonadotropic hypogonadism-cataract syndrome
|
ORPHAnet |
| 0‑L |
2412
|
Dislocation of the hip-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
2414
|
Congenital pulmonary lymphangiectasia
|
ORPHAnet |
| 0‑L |
2420
|
Primary pulmonary lymphoma
|
ORPHAnet |
| 0‑L |
2427
|
Macrocephaly-short stature-paraplegia syndrome
|
ORPHAnet |
| 0‑L |
2429
|
Macrocephaly-spastic paraplegia-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
2430
|
Congenital macroglossia
|
ORPHAnet |
| 0‑L |
2432
|
Macrosomia-microphthalmia-cleft palate syndrome
|
ORPHAnet |
| 0‑L |
2435
|
Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability
syndrome
|
ORPHAnet |
| 0‑L |
2437
|
Czeizel-Losonci syndrome
|
ORPHAnet |
| 0‑L |
2438
|
Hand-foot-genital syndrome
|
ORPHAnet |
| 0‑L |
2439
|
Patterson-Stevenson-Fontaine syndrome
|
ORPHAnet |
| 0‑L |
2440
|
Isolated split hand-split foot malformation
|
ORPHAnet |
| 0‑L |
2444
|
Congenital pulmonary airway malformation
|
ORPHAnet |
| 0‑L |
2451
|
Mucocutaneous venous malformations
|
ORPHAnet |
| 0‑L |
2456
|
Familial supernumerary nipples
|
ORPHAnet |
| 0‑L |
2457
|
Mandibuloacral dysplasia
|
ORPHAnet |
| 0‑L |
2459
|
Mansonelliasis
|
ORPHAnet |
| 0‑L |
2460
|
Van den Ende-Gupta syndrome
|
ORPHAnet |
| 0‑L |
2461
|
Marden-Walker syndrome
|
ORPHAnet |
| 0‑L |
2462
|
Shprintzen-Goldberg syndrome
|
ORPHAnet |
| 0‑L |
2463
|
Marfanoid habitus-autosomal recessive intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2464
|
Marfanoid syndrome, De Silva type
|
ORPHAnet |
| 0‑L |
2466
|
MASA syndrome
|
ORPHAnet |
| 0‑L |
2470
|
Matthew-Wood syndrome
|
ORPHAnet |
| 0‑L |
2471
|
McDonough syndrome
|
ORPHAnet |
| 0‑L |
2473
|
McKusick-Kaufman syndrome
|
ORPHAnet |
| 0‑L |
2475
|
White forelock with malformations
|
ORPHAnet |
| 0‑L |
2476
|
Dysraphism-cleft lip/palate-limb reduction defects syndrome
|
ORPHAnet |
| 0‑L |
2477
|
Megalencephaly
|
ORPHAnet |
| 0‑L |
2478
|
Megalencephalic leukoencephalopathy with subcortical cysts
|
ORPHAnet |
| 0‑L |
2479
|
Megalocornea-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2481
|
Neurocutaneous melanocytosis
|
ORPHAnet |
| 0‑L |
2482
|
Melhem-Fahl syndrome
|
ORPHAnet |
| 0‑L |
2483
|
Melkersson-Rosenthal syndrome
|
ORPHAnet |
| 0‑L |
2484
|
Melnick-Needles syndrome
|
ORPHAnet |
| 0‑L |
2485
|
Melorheostosis
|
ORPHAnet |
| 0‑L |
2487
|
Lower limb malformation-hypospadias syndrome
|
ORPHAnet |
| 0‑L |
2489
|
Upper limb defect-eye and ear abnormalities syndrome
|
ORPHAnet |
| 0‑L |
2491
|
Müllerian duct anomalies-limb anomalies syndrome
|
ORPHAnet |
| 0‑L |
2492
|
FATCO syndrome
|
ORPHAnet |
| 0‑L |
2494
|
Ménétrier disease
|
ORPHAnet |
| 0‑L |
2495
|
Meningioma
|
ORPHAnet |
| 0‑L |
2496
|
Mesomelia-synostoses syndrome
|
ORPHAnet |
| 0‑L |
2497
|
Upper limb mesomelic dysplasia
|
ORPHAnet |
| 0‑L |
2498
|
Syndactyly type 8
|
ORPHAnet |
| 0‑L |
2499
|
Metachondromatosis
|
ORPHAnet |
| 0‑L |
2500
|
Acrogeria
|
ORPHAnet |
| 0‑L |
2501
|
Metaphyseal chondrodysplasia, Spahr type
|
ORPHAnet |
| 0‑L |
2502
|
Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome
|
ORPHAnet |
| 0‑L |
2504
|
Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome
|
ORPHAnet |
| 0‑L |
2505
|
Multiple benign circumferential skin creases on limbs
|
ORPHAnet |
| 0‑L |
2508
|
Corpus callosum agenesis-abnormal genitalia syndrome
|
ORPHAnet |
| 0‑L |
2510
|
Micro syndrome
|
ORPHAnet |
| 0‑L |
2511
|
Microbrachycephaly-ptosis-cleft lip syndrome
|
ORPHAnet |
| 0‑L |
2512
|
Autosomal recessive primary microcephaly
|
ORPHAnet |
| 0‑L |
2513
|
Microcephaly-albinism-digital anomalies syndrome
|
ORPHAnet |
| 0‑L |
2514
|
Autosomal dominant primary microcephaly
|
ORPHAnet |
| 0‑L |
2515
|
Microcephaly-cardiomyopathy syndrome
|
ORPHAnet |
| 0‑L |
2516
|
Microcephaly-cardiac defect-lung malsegmentation syndrome
|
ORPHAnet |
| 0‑L |
2518
|
Autosomal recessive chorioretinopathy-microcephaly syndrome
|
ORPHAnet |
| 0‑L |
2519
|
Microcephaly-seizures-intellectual disability-heart disease syndrome
|
ORPHAnet |
| 0‑L |
2521
|
Microcephaly-cleft palate-abnormal retinal pigmentation syndrome
|
ORPHAnet |
| 0‑L |
2522
|
Microcephaly-cervical spine fusion anomalies syndrome
|
ORPHAnet |
| 0‑L |
2523
|
Microcephaly-brain defect-spasticity-hypernatremia syndrome
|
ORPHAnet |
| 0‑L |
2524
|
Pontocerebellar hypoplasia type 2
|
ORPHAnet |
| 0‑L |
2526
|
Microcephaly-lymphedema-chorioretinopathy syndrome
|
ORPHAnet |
| 0‑L |
2528
|
Microcephaly-microcornea syndrome, Seemanova type
|
ORPHAnet |
| 0‑L |
2533
|
Microcephaly-deafness-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2536
|
Microcornea-glaucoma-absent frontal sinuses syndrome
|
ORPHAnet |
| 0‑L |
2538
|
Microgastria-limb reduction defect syndrome
|
ORPHAnet |
| 0‑L |
2547
|
Microphthalmia-microtia-fetal akinesia syndrome
|
ORPHAnet |
| 0‑L |
2549
|
Oculoauriculovertebral spectrum with radial defects
|
ORPHAnet |
| 0‑L |
2551
|
Microspherophakia-metaphyseal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
2552
|
Microsporidiosis
|
ORPHAnet |
| 0‑L |
2554
|
Ear-patella-short stature syndrome
|
ORPHAnet |
| 0‑L |
2556
|
Microphthalmia with linear skin defects syndrome
|
ORPHAnet |
| 0‑L |
2557
|
Mietens syndrome
|
ORPHAnet |
| 0‑L |
2558
|
Mikati-Najjar-Sahli syndrome
|
ORPHAnet |
| 0‑L |
2560
|
Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
2561
|
Pyramidal molars-abnormal upper lip syndrome
|
ORPHAnet |
| 0‑L |
2563
|
MOMO syndrome
|
ORPHAnet |
| 0‑L |
2564
|
Tetramelic monodactyly
|
ORPHAnet |
| 0‑L |
2565
|
Mononen-Karnes-Senac syndrome
|
ORPHAnet |
| 0‑L |
2566
|
Chronic Epstein-Barr virus infection syndrome
|
ORPHAnet |
| 0‑L |
2570
|
Lethal intrauterine growth restriction-cortical malformation-congenital contractures
syndrome
|
ORPHAnet |
| 0‑L |
2571
|
X-linked immunoneurologic disorder
|
ORPHAnet |
| 0‑L |
2572
|
Spastic ataxia-corneal dystrophy syndrome
|
ORPHAnet |
| 0‑L |
2573
|
Moyamoya disease
|
ORPHAnet |
| 0‑L |
2574
|
Moynahan syndrome
|
ORPHAnet |
| 0‑L |
2575
|
Cystic fibrosis-gastritis-megaloblastic anemia syndrome
|
ORPHAnet |
| 0‑L |
2576
|
Mulibrey nanism
|
ORPHAnet |
| 0‑L |
2578
|
Mayer-Rokitansky-Küster-Hauser syndrome type 2
|
ORPHAnet |
| 0‑L |
2579
|
Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome
|
ORPHAnet |
| 0‑L |
2582
|
Myalgia-eosinophilia syndrome associated with tryptophan
|
ORPHAnet |
| 0‑L |
2583
|
Mycetoma
|
ORPHAnet |
| 0‑L |
2584
|
Classic mycosis fungoides
|
ORPHAnet |
| 0‑L |
2585
|
Ataxia-pancytopenia syndrome
|
ORPHAnet |
| 0‑L |
2587
|
Myeloperoxidase deficiency
|
ORPHAnet |
| 0‑L |
2588
|
Myhre syndrome
|
ORPHAnet |
| 0‑L |
2589
|
Myoclonus-cerebellar ataxia-deafness syndrome
|
ORPHAnet |
| 0‑L |
2590
|
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome
|
ORPHAnet |
| 0‑L |
2591
|
Infantile myofibromatosis
|
ORPHAnet |
| 0‑L |
2593
|
Tubular aggregate myopathy
|
ORPHAnet |
| 0‑L |
2596
|
Myopathy and diabetes mellitus
|
ORPHAnet |
| 0‑L |
2597
|
Mitochondrial myopathy-lactic acidosis-deafness syndrome
|
ORPHAnet |
| 0‑L |
2598
|
Mitochondrial myopathy and sideroblastic anemia
|
ORPHAnet |
| 0‑L |
2604
|
Familial visceral myopathy
|
ORPHAnet |
| 0‑L |
2608
|
N syndrome
|
ORPHAnet |
| 0‑L |
2609
|
Isolated complex I deficiency
|
ORPHAnet |
| 0‑L |
2611
|
Linear verrucous nevus syndrome
|
ORPHAnet |
| 0‑L |
2612
|
Linear nevus sebaceus syndrome
|
ORPHAnet |
| 0‑L |
2613
|
Nail-patella-like renal disease
|
ORPHAnet |
| 0‑L |
2614
|
Nail-patella syndrome
|
ORPHAnet |
| 0‑L |
2616
|
3M syndrome
|
ORPHAnet |
| 0‑L |
2617
|
Microcephalic primordial dwarfism, Montreal type
|
ORPHAnet |
| 0‑L |
2619
|
Brachydactylous dwarfism, Mseleni type
|
ORPHAnet |
| 0‑L |
2623
|
Geleophysic dysplasia
|
ORPHAnet |
| 0‑L |
2631
|
Mesomelic dwarfism-cleft palate-camptodactyly syndrome
|
ORPHAnet |
| 0‑L |
2632
|
Langer mesomelic dysplasia
|
ORPHAnet |
| 0‑L |
2633
|
Mesomelic dysplasia, Nievergelt type
|
ORPHAnet |
| 0‑L |
2634
|
Mesomelic dwarfism, Reinhardt-Pfeiffer type
|
ORPHAnet |
| 0‑L |
2635
|
Metatropic dysplasia
|
ORPHAnet |
| 0‑L |
2636
|
Microcephalic osteodysplastic primordial dwarfism types I and III
|
ORPHAnet |
| 0‑L |
2637
|
Microcephalic osteodysplastic primordial dwarfism type II
|
ORPHAnet |
| 0‑L |
2639
|
Fibular aplasia-complex brachydactyly syndrome
|
ORPHAnet |
| 0‑L |
2643
|
Microcephalic primordial dwarfism, Toriello type
|
ORPHAnet |
| 0‑L |
2645
|
Osteoglosphonic dysplasia
|
ORPHAnet |
| 0‑L |
2646
|
Parastremmatic dwarfism
|
ORPHAnet |
| 0‑L |
2653
|
Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome
|
ORPHAnet |
| 0‑L |
2655
|
Thanatophoric dysplasia
|
ORPHAnet |
| 0‑L |
2658
|
Lenz-Majewski hyperostotic dwarfism
|
ORPHAnet |
| 0‑L |
2662
|
Keipert syndrome
|
ORPHAnet |
| 0‑L |
2663
|
Nathalie syndrome
|
ORPHAnet |
| 0‑L |
2665
|
Congenital mesoblastic nephroma
|
ORPHAnet |
| 0‑L |
2666
|
Adult familial nephronophthisis-spastic quadriparesia syndrome
|
ORPHAnet |
| 0‑L |
2668
|
Nephropathy-deafness-hyperparathyroidism syndrome
|
ORPHAnet |
| 0‑L |
2669
|
Nephrosis-deafness-urinary tract-digital malformations syndrome
|
ORPHAnet |
| 0‑L |
2670
|
Pierson syndrome
|
ORPHAnet |
| 0‑L |
2671
|
Neu-Laxova syndrome
|
ORPHAnet |
| 0‑L |
2672
|
Neuhauser-Eichner-Opitz syndrome
|
ORPHAnet |
| 0‑L |
2673
|
Neurofaciodigitorenal syndrome
|
ORPHAnet |
| 0‑L |
2674
|
Cyprus facial-neuromusculoskeletal syndrome
|
ORPHAnet |
| 0‑L |
2678
|
Neurofibromatosis type 6
|
ORPHAnet |
| 0‑L |
2680
|
Hypomyelination neuropathy-arthrogryposis syndrome
|
ORPHAnet |
| 0‑L |
2686
|
Cyclic neutropenia
|
ORPHAnet |
| 0‑L |
2688
|
Adult idiopathic neutropenia
|
ORPHAnet |
| 0‑L |
2690
|
Neutropenia-monocytopenia-deafness syndrome
|
ORPHAnet |
| 0‑L |
2695
|
Bifid nose
|
ORPHAnet |
| 0‑L |
2697
|
Arthrogryposis-renal dysfunction-cholestasis syndrome
|
ORPHAnet |
| 0‑L |
2698
|
Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome
|
ORPHAnet |
| 0‑L |
2699
|
Median nodule of the upper lip
|
ORPHAnet |
| 0‑L |
2700
|
Noma
|
ORPHAnet |
| 0‑L |
2701
|
Noonan syndrome-like disorder with loose anagen hair
|
ORPHAnet |
| 0‑L |
2703
|
Port-wine nevi-mega cisterna magna-hydrocephalus syndrome
|
ORPHAnet |
| 0‑L |
2704
|
Ochoa syndrome
|
ORPHAnet |
| 0‑L |
2707
|
Oculocerebrofacial syndrome, Kaufman type
|
ORPHAnet |
| 0‑L |
2709
|
Oculodental syndrome, Rutherfurd type
|
ORPHAnet |
| 0‑L |
2710
|
Oculodentodigital dysplasia
|
ORPHAnet |
| 0‑L |
2712
|
Oculofaciocardiodental syndrome
|
ORPHAnet |
| 0‑L |
2713
|
Oculoosteocutaneous syndrome
|
ORPHAnet |
| 0‑L |
2714
|
Oculo-palato-cerebral syndrome
|
ORPHAnet |
| 0‑L |
2715
|
Severe oculo-renal-cerebellar syndrome
|
ORPHAnet |
| 0‑L |
2717
|
Oculotrichoanal syndrome
|
ORPHAnet |
| 0‑L |
2718
|
Oculotrichodysplasia
|
ORPHAnet |
| 0‑L |
2719
|
Oculocerebral hypopigmentation syndrome, Cross type
|
ORPHAnet |
| 0‑L |
2720
|
Oculocerebral hypopigmentation syndrome, Preus type
|
ORPHAnet |
| 0‑L |
2721
|
Odonto-onycho-dermal dysplasia
|
ORPHAnet |
| 0‑L |
2722
|
Odonto-onycho dysplasia-alopecia syndrome
|
ORPHAnet |
| 0‑L |
2723
|
Odontotrichomelic syndrome
|
ORPHAnet |
| 0‑L |
2724
|
Odontomatosis-aortae esophagus stenosis syndrome
|
ORPHAnet |
| 0‑L |
2725
|
Eye defects-arachnodactyly-cardiopathy syndrome
|
ORPHAnet |
| 0‑L |
2728
|
Blepharophimosis-intellectual disability syndrome, Ohdo type
|
ORPHAnet |
| 0‑L |
2729
|
Okamoto syndrome
|
ORPHAnet |
| 0‑L |
2730
|
Postaxial tetramelic oligodactyly
|
ORPHAnet |
| 0‑L |
2732
|
Olivopontocerebellar atrophy-deafness syndrome
|
ORPHAnet |
| 0‑L |
2733
|
Omodysplasia
|
ORPHAnet |
| 0‑L |
2736
|
Lethal omphalocele-cleft palate syndrome
|
ORPHAnet |
| 0‑L |
2737
|
Onchocerciasis
|
ORPHAnet |
| 0‑L |
2741
|
Ophthalmomandibulomelic dysplasia
|
ORPHAnet |
| 0‑L |
2743
|
Ophthalmoplegia-intellectual disability-lingua scrotalis syndrome
|
ORPHAnet |
| 0‑L |
2744
|
Horizontal gaze palsy with progressive scoliosis
|
ORPHAnet |
| 0‑L |
2745
|
Opitz GBBB syndrome
|
ORPHAnet |
| 0‑L |
2746
|
Opsismodysplasia
|
ORPHAnet |
| 0‑L |
2750
|
Orofaciodigital syndrome type 1
|
ORPHAnet |
| 0‑L |
2751
|
Orofaciodigital syndrome type 2
|
ORPHAnet |
| 0‑L |
2752
|
Orofaciodigital syndrome type 3
|
ORPHAnet |
| 0‑L |
2753
|
Orofaciodigital syndrome type 4
|
ORPHAnet |
| 0‑L |
2754
|
Orofaciodigital syndrome type 6
|
ORPHAnet |
| 0‑L |
2755
|
Orofaciodigital syndrome type 8
|
ORPHAnet |
| 0‑L |
2756
|
Orofaciodigital syndrome type 10
|
ORPHAnet |
| 0‑L |
2759
|
Imperforate oropharynx-costovertebral anomalies syndrome
|
ORPHAnet |
| 0‑L |
2760
|
OSLAM syndrome
|
ORPHAnet |
| 0‑L |
2762
|
Progressive osseous heteroplasia
|
ORPHAnet |
| 0‑L |
2763
|
Osteocraniostenosis
|
ORPHAnet |
| 0‑L |
2764
|
Osteochondritis dissecans
|
ORPHAnet |
| 0‑L |
2767
|
Carpotarsal osteochondromatosis
|
ORPHAnet |
| 0‑L |
2768
|
Blount disease
|
ORPHAnet |
| 0‑L |
2769
|
Familial osteodysplasia, Anderson type
|
ORPHAnet |
| 0‑L |
2770
|
Nasu-Hakola disease
|
ORPHAnet |
| 0‑L |
2771
|
Bruck syndrome
|
ORPHAnet |
| 0‑L |
2772
|
Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome
|
ORPHAnet |
| 0‑L |
2773
|
Osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2774
|
Multicentric carpo-tarsal osteolysis with or without nephropathy
|
ORPHAnet |
| 0‑L |
2776
|
Autosomal recessive distal osteolysis syndrome
|
ORPHAnet |
| 0‑L |
2777
|
Osteomesopyknosis
|
ORPHAnet |
| 0‑L |
2779
|
Osteopathia striata-pigmentary dermopathy-white forelock syndrome
|
ORPHAnet |
| 0‑L |
2780
|
Osteopathia striata-cranial sclerosis syndrome
|
ORPHAnet |
| 0‑L |
2783
|
Autosomal dominant osteopetrosis type 1
|
ORPHAnet |
| 0‑L |
2785
|
Osteopetrosis with renal tubular acidosis
|
ORPHAnet |
| 0‑L |
2786
|
Osteoporosis-oculocutaneous hypopigmentation syndrome
|
ORPHAnet |
| 0‑L |
2787
|
Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome
|
ORPHAnet |
| 0‑L |
2788
|
Osteoporosis-pseudoglioma syndrome
|
ORPHAnet |
| 0‑L |
2789
|
Lateral meningocele syndrome
|
ORPHAnet |
| 0‑L |
2790
|
Endosteal hyperostosis, Worth type
|
ORPHAnet |
| 0‑L |
2791
|
Otodental syndrome
|
ORPHAnet |
| 0‑L |
2792
|
Otofaciocervical syndrome
|
ORPHAnet |
| 0‑L |
2793
|
Otoonychoperoneal syndrome
|
ORPHAnet |
| 0‑L |
2795
|
Fowler urethral sphincter dysfunction syndrome
|
ORPHAnet |
| 0‑L |
2796
|
Pachydermoperiostosis
|
ORPHAnet |
| 0‑L |
2798
|
Pachygyria-intellectual disability-epilepsy syndrome
|
ORPHAnet |
| 0‑L |
2800
|
Extramammary Paget disease
|
ORPHAnet |
| 0‑L |
2801
|
Juvenile Paget disease
|
ORPHAnet |
| 0‑L |
2802
|
X-linked sideroblastic anemia and spinocerebellar ataxia
|
ORPHAnet |
| 0‑L |
2804
|
W syndrome
|
ORPHAnet |
| 0‑L |
2805
|
Partial pancreatic agenesis
|
ORPHAnet |
| 0‑L |
2806
|
Subacute sclerosing leukoencephalitis
|
ORPHAnet |
| 0‑L |
2807
|
Papilloma of choroid plexus
|
ORPHAnet |
| 0‑L |
2808
|
Laryngeal abductor paralysis
|
ORPHAnet |
| 0‑L |
2809
|
Familial recurrent peripheral facial palsy
|
ORPHAnet |
| 0‑L |
2812
|
Parana hard skin syndrome
|
ORPHAnet |
| 0‑L |
2815
|
Spastic paraparesis-deafness syndrome
|
ORPHAnet |
| 0‑L |
2818
|
Spastic paraplegia-glaucoma-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2819
|
Spastic paraplegia-facial-cutaneous lesions syndrome
|
ORPHAnet |
| 0‑L |
2820
|
Spastic paraplegia-nephritis-deafness syndrome
|
ORPHAnet |
| 0‑L |
2821
|
Spastic paraplegia-neuropathy-poikiloderma syndrome
|
ORPHAnet |
| 0‑L |
2822
|
Autosomal recessive spastic paraplegia type 11
|
ORPHAnet |
| 0‑L |
2824
|
Paraplegia-intellectual disability-hyperkeratosis syndrome
|
ORPHAnet |
| 0‑L |
2825
|
PARC syndrome
|
ORPHAnet |
| 0‑L |
2826
|
Spastic paraplegia-precocious puberty syndrome
|
ORPHAnet |
| 0‑L |
2828
|
Young-onset Parkinson disease
|
ORPHAnet |
| 0‑L |
2831
|
Rhizomelic dysplasia, Patterson-Lowry type
|
ORPHAnet |
| 0‑L |
2832
|
Short tarsus-absence of lower eyelashes syndrome
|
ORPHAnet |
| 0‑L |
2833
|
Stiff skin syndrome
|
ORPHAnet |
| 0‑L |
2834
|
Wrinkly skin syndrome
|
ORPHAnet |
| 0‑L |
2835
|
Pectus excavatum-macrocephaly-dysplastic nails syndrome
|
ORPHAnet |
| 0‑L |
2836
|
PEHO syndrome
|
ORPHAnet |
| 0‑L |
2838
|
Renal caliceal diverticuli-deafness syndrome
|
ORPHAnet |
| 0‑L |
2839
|
Pelvis-shoulder dysplasia
|
ORPHAnet |
| 0‑L |
2840
|
Pelvic dysplasia-arthrogryposis of lower limbs syndrome
|
ORPHAnet |
| 0‑L |
2841
|
Familial benign chronic pemphigus
|
ORPHAnet |
| 0‑L |
2842
|
Penoscrotal transposition
|
ORPHAnet |
| 0‑L |
2843
|
Pentosuria
|
ORPHAnet |
| 0‑L |
2847
|
Pericardial and diaphragmatic defect
|
ORPHAnet |
| 0‑L |
2848
|
Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome
|
ORPHAnet |
| 0‑L |
2849
|
Perlman syndrome
|
ORPHAnet |
| 0‑L |
2850
|
Alopecia-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2854
|
Fuhrmann syndrome
|
ORPHAnet |
| 0‑L |
2855
|
Perrault syndrome
|
ORPHAnet |
| 0‑L |
2856
|
Persistent Müllerian duct syndrome
|
ORPHAnet |
| 0‑L |
2863
|
Short stature-wormian bones-dextrocardia syndrome
|
ORPHAnet |
| 0‑L |
2865
|
Short stature-webbed neck-heart disease syndrome
|
ORPHAnet |
| 0‑L |
2866
|
Short stature-deafness-neutrophil dysfunction-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
2867
|
Short stature, Brussels type
|
ORPHAnet |
| 0‑L |
2868
|
Short stature-valvular heart disease-characteristic facies syndrome
|
ORPHAnet |
| 0‑L |
2869
|
Peutz-Jeghers syndrome
|
ORPHAnet |
| 0‑L |
2871
|
Pfeiffer-Palm-Teller syndrome
|
ORPHAnet |
| 0‑L |
2872
|
Cardiocranial syndrome, Pfeiffer type
|
ORPHAnet |
| 0‑L |
2874
|
Phakomatosis pigmentokeratotica
|
ORPHAnet |
| 0‑L |
2875
|
Phakomatosis pigmentovascularis
|
ORPHAnet |
| 0‑L |
2876
|
PHAVER syndrome
|
ORPHAnet |
| 0‑L |
2878
|
Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome
|
ORPHAnet |
| 0‑L |
2879
|
Phocomelia, Schinzel type
|
ORPHAnet |
| 0‑L |
2880
|
Phosphoenolpyruvate carboxykinase deficiency
|
ORPHAnet |
| 0‑L |
2881
|
Cutaneous photosensitivity-lethal colitis syndrome
|
ORPHAnet |
| 0‑L |
2882
|
Sitosterolemia
|
ORPHAnet |
| 0‑L |
2884
|
Piebaldism
|
ORPHAnet |
| 0‑L |
2885
|
Piebald trait-neurologic defects syndrome
|
ORPHAnet |
| 0‑L |
2886
|
TARP syndrome
|
ORPHAnet |
| 0‑L |
2888
|
Pierre Robin syndrome-faciodigital anomaly syndrome
|
ORPHAnet |
| 0‑L |
2889
|
Pili torti
|
ORPHAnet |
| 0‑L |
2890
|
Pili torti-onychodysplasia syndrome
|
ORPHAnet |
| 0‑L |
2891
|
Pili torti-developmental delay-neurological abnormalities syndrome
|
ORPHAnet |
| 0‑L |
2892
|
Pilodental dysplasia-refractive errors syndrome
|
ORPHAnet |
| 0‑L |
2896
|
Pitt-Hopkins syndrome
|
ORPHAnet |
| 0‑L |
2897
|
Pityriasis rubra pilaris
|
ORPHAnet |
| 0‑L |
2898
|
X-linked intellectual disability-plagiocephaly syndrome
|
ORPHAnet |
| 0‑L |
2899
|
Brachyolmia-amelogenesis imperfecta syndrome
|
ORPHAnet |
| 0‑L |
2900
|
Leri pleonosteosis
|
ORPHAnet |
| 0‑L |
2901
|
Neuralgic amyotrophy
|
ORPHAnet |
| 0‑L |
2902
|
Idiopathic chronic eosinophilic pneumonia
|
ORPHAnet |
| 0‑L |
2903
|
Familial spontaneous pneumothorax
|
ORPHAnet |
| 0‑L |
2905
|
POEMS syndrome
|
ORPHAnet |
| 0‑L |
2907
|
Hereditary acrokeratotic poikiloderma
|
ORPHAnet |
| 0‑L |
2908
|
Kindler epidermolysis bullosa
|
ORPHAnet |
| 0‑L |
2909
|
Rothmund-Thomson syndrome
|
ORPHAnet |
| 0‑L |
2911
|
Poland syndrome
|
ORPHAnet |
| 0‑L |
2912
|
Poliomyelitis
|
ORPHAnet |
| 0‑L |
2916
|
Postaxial polydactyly-dental and vertebral anomalies syndrome
|
ORPHAnet |
| 0‑L |
2917
|
Polydactyly-myopia syndrome
|
ORPHAnet |
| 0‑L |
2919
|
Orofaciodigital syndrome type 5
|
ORPHAnet |
| 0‑L |
2920
|
Oliver syndrome
|
ORPHAnet |
| 0‑L |
2921
|
Preaxial polydactyly-colobomata-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2924
|
Isolated polycystic liver disease
|
ORPHAnet |
| 0‑L |
2926
|
Digital extensor muscle aplasia-polyneuropathy
|
ORPHAnet |
| 0‑L |
2928
|
Polyneuropathy-intellectual disability-acromicria-premature menopause syndrome
|
ORPHAnet |
| 0‑L |
2929
|
Juvenile polyposis syndrome
|
ORPHAnet |
| 0‑L |
2930
|
Cronkhite-Canada syndrome
|
ORPHAnet |
| 0‑L |
2932
|
Chronic inflammatory demyelinating polyneuropathy
|
ORPHAnet |
| 0‑L |
2934
|
Polysyndactyly-cardiac malformation syndrome
|
ORPHAnet |
| 0‑L |
2935
|
Crossed polysyndactyly
|
ORPHAnet |
| 0‑L |
2940
|
Porencephaly
|
ORPHAnet |
| 0‑L |
2941
|
Porencephaly-cerebellar hypoplasia-internal malformations syndrome
|
ORPHAnet |
| 0‑L |
2942
|
Postpoliomyelitis syndrome
|
ORPHAnet |
| 0‑L |
2946
|
Brachydactyly-long thumb syndrome
|
ORPHAnet |
| 0‑L |
2947
|
Triphalangeal thumbs-brachyectrodactyly syndrome
|
ORPHAnet |
| 0‑L |
2951
|
Absent thumb-short stature-immunodeficiency syndrome
|
ORPHAnet |
| 0‑L |
2952
|
Adducted thumbs-arthrogryposis syndrome, Christian type
|
ORPHAnet |
| 0‑L |
2953
|
Musculocontractural Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
2956
|
Acrodysplasia scoliosis
|
ORPHAnet |
| 0‑L |
2957
|
Guttmacher syndrome
|
ORPHAnet |
| 0‑L |
2958
|
X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome
|
ORPHAnet |
| 0‑L |
2959
|
Progeria-short stature-pigmented nevi syndrome
|
ORPHAnet |
| 0‑L |
2962
|
De Barsy syndrome
|
ORPHAnet |
| 0‑L |
2963
|
Progeroid syndrome, Petty type
|
ORPHAnet |
| 0‑L |
2964
|
Autosomal dominant prognathism
|
ORPHAnet |
| 0‑L |
2965
|
Prolactinoma
|
ORPHAnet |
| 0‑L |
2966
|
Properdin deficiency
|
ORPHAnet |
| 0‑L |
2967
|
Transcobalamin I deficiency
|
ORPHAnet |
| 0‑L |
2968
|
Leukocyte adhesion deficiency
|
ORPHAnet |
| 0‑L |
2969
|
Proteus-like syndrome
|
ORPHAnet |
| 0‑L |
2970
|
Prune belly syndrome
|
ORPHAnet |
| 0‑L |
2971
|
Peroxisomal acyl-CoA oxidase deficiency
|
ORPHAnet |
| 0‑L |
2972
|
Non-eruption of teeth-maxillary hypoplasia-genu valgum syndrome
|
ORPHAnet |
| 0‑L |
2973
|
46,XX disorder of sex development-anorectal anomalies syndrome
|
ORPHAnet |
| 0‑L |
2975
|
46,XX disorder of sex development-skeletal anomalies syndrome
|
ORPHAnet |
| 0‑L |
2976
|
Pseudoleprechaunism syndrome, Patterson type
|
ORPHAnet |
| 0‑L |
2978
|
Chronic intestinal pseudoobstruction
|
ORPHAnet |
| 0‑L |
2980
|
Acrootoocular syndrome
|
ORPHAnet |
| 0‑L |
2983
|
Disorder of sex development-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
2985
|
Pseudoprogeria syndrome
|
ORPHAnet |
| 0‑L |
2987
|
Antecubital pterygium syndrome
|
ORPHAnet |
| 0‑L |
2988
|
Pterygium colli-intellectual disability-digital anomalies syndrome
|
ORPHAnet |
| 0‑L |
2989
|
Familial pterygium of the conjunctiva
|
ORPHAnet |
| 0‑L |
2990
|
Autosomal recessive multiple pterygium syndrome
|
ORPHAnet |
| 0‑L |
2994
|
Short stature-craniofacial anomalies-genital hypoplasia syndrome
|
ORPHAnet |
| 0‑L |
2995
|
Baraitser-Winter cerebrofrontofacial syndrome
|
ORPHAnet |
| 0‑L |
2997
|
Ptosis-vocal cord paralysis syndrome
|
ORPHAnet |
| 0‑L |
2999
|
Ptosis-strabismus-ectopic pupils syndrome
|
ORPHAnet |
| 0‑L |
3000
|
Familial male-limited precocious puberty
|
ORPHAnet |
| 0‑L |
3002
|
Immune thrombocytopenia
|
ORPHAnet |
| 0‑L |
3003
|
Pyknoachondrogenesis
|
ORPHAnet |
| 0‑L |
3004
|
Mirror polydactyly-vertebral segmentation-limbs defects syndrome
|
ORPHAnet |
| 0‑L |
3005
|
Pyle disease
|
ORPHAnet |
| 0‑L |
3006
|
Pyridoxine-dependent epilepsy
|
ORPHAnet |
| 0‑L |
3008
|
Pyruvate carboxylase deficiency
|
ORPHAnet |
| 0‑L |
3010
|
Qazi-Markouizos syndrome
|
ORPHAnet |
| 0‑L |
3011
|
Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
3015
|
Radio-renal syndrome
|
ORPHAnet |
| 0‑L |
3016
|
Absent radius-anogenital anomalies syndrome
|
ORPHAnet |
| 0‑L |
3018
|
Retinal ischemic syndrome-digestive tract small vessel hyalinosis-diffuse cerebral
calcifications syndrome
|
ORPHAnet |
| 0‑L |
3019
|
Ramon syndrome
|
ORPHAnet |
| 0‑L |
3020
|
Ramsay Hunt syndrome
|
ORPHAnet |
| 0‑L |
3021
|
RAPADILINO syndrome
|
ORPHAnet |
| 0‑L |
3023
|
External auditory canal atresia-vertical talus-hypertelorism syndrome
|
ORPHAnet |
| 0‑L |
3026
|
Radial ray hypoplasia-choanal atresia syndrome
|
ORPHAnet |
| 0‑L |
3027
|
Caudal regression syndrome
|
ORPHAnet |
| 0‑L |
3032
|
NPHP3-related Meckel-like syndrome
|
ORPHAnet |
| 0‑L |
3033
|
Renal tubular dysgenesis
|
ORPHAnet |
| 0‑L |
3034
|
Delayed membranous cranial ossification
|
ORPHAnet |
| 0‑L |
3035
|
Growth delay-hydrocephaly-lung hypoplasia syndrome
|
ORPHAnet |
| 0‑L |
3038
|
Delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome
|
ORPHAnet |
| 0‑L |
3041
|
Intellectual disability-balding-patella luxation-acromicria syndrome
|
ORPHAnet |
| 0‑L |
3042
|
Intellectual disability-cataracts-calcified pinnae-myopathy syndrome
|
ORPHAnet |
| 0‑L |
3044
|
Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome
|
ORPHAnet |
| 0‑L |
3047
|
Blepharophimosis-intellectual disability syndrome, SBBYS type
|
ORPHAnet |
| 0‑L |
3051
|
Nicolaides-Baraitser syndrome
|
ORPHAnet |
| 0‑L |
3052
|
X-linked intellectual disability-seizures-psoriasis syndrome
|
ORPHAnet |
| 0‑L |
3055
|
X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome
|
ORPHAnet |
| 0‑L |
3057
|
Monoamine oxidase A deficiency
|
ORPHAnet |
| 0‑L |
3063
|
X-linked intellectual disability, Snyder type
|
ORPHAnet |
| 0‑L |
3068
|
Intellectual disability-myopathy-short stature-endocrine defect syndrome
|
ORPHAnet |
| 0‑L |
3071
|
Costello syndrome
|
ORPHAnet |
| 0‑L |
3074
|
Intellectual disability-short stature-hypertelorism syndrome
|
ORPHAnet |
| 0‑L |
3077
|
X-linked intellectual disability-psychosis-macroorchidism syndrome
|
ORPHAnet |
| 0‑L |
3078
|
Severe X-linked intellectual disability, Gustavson type
|
ORPHAnet |
| 0‑L |
3079
|
Intellectual disability, Buenos-Aires type
|
ORPHAnet |
| 0‑L |
3080
|
Intellectual disability, Wolff type
|
ORPHAnet |
| 0‑L |
3082
|
Intellectual disability-polydactyly-uncombable hair syndrome
|
ORPHAnet |
| 0‑L |
3085
|
Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
3086
|
Autosomal dominant vitreoretinochoroidopathy
|
ORPHAnet |
| 0‑L |
3088
|
Revesz syndrome
|
ORPHAnet |
| 0‑L |
3092
|
Fixed subaortic stenosis
|
ORPHAnet |
| 0‑L |
3093
|
Congenital aortic valve stenosis
|
ORPHAnet |
| 0‑L |
3095
|
Atypical Rett syndrome
|
ORPHAnet |
| 0‑L |
3096
|
Reye syndrome
|
ORPHAnet |
| 0‑L |
3097
|
Meacham syndrome
|
ORPHAnet |
| 0‑L |
3098
|
Rhizomelic syndrome, Urbach type
|
ORPHAnet |
| 0‑L |
3099
|
Rheumatic fever
|
ORPHAnet |
| 0‑L |
3101
|
Richieri Costa-da Silva syndrome
|
ORPHAnet |
| 0‑L |
3102
|
Richieri Costa-Pereira syndrome
|
ORPHAnet |
| 0‑L |
3103
|
Roberts syndrome
|
ORPHAnet |
| 0‑L |
3104
|
Robin sequence-oligodactyly syndrome
|
ORPHAnet |
| 0‑L |
3107
|
Autosomal dominant Robinow syndrome
|
ORPHAnet |
| 0‑L |
3109
|
Mayer-Rokitansky-Küster-Hauser syndrome
|
ORPHAnet |
| 0‑L |
3110
|
Rombo syndrome
|
ORPHAnet |
| 0‑L |
3111
|
Rotor syndrome
|
ORPHAnet |
| 0‑L |
3115
|
Roussy-Lévy syndrome
|
ORPHAnet |
| 0‑L |
3121
|
Ruvalcaba syndrome
|
ORPHAnet |
| 0‑L |
3124
|
Saccharopinuria
|
ORPHAnet |
| 0‑L |
3129
|
Sarcosinemia
|
ORPHAnet |
| 0‑L |
3130
|
Satoyoshi syndrome
|
ORPHAnet |
| 0‑L |
3132
|
Say-Barber-Miller syndrome
|
ORPHAnet |
| 0‑L |
3134
|
SCARF syndrome
|
ORPHAnet |
| 0‑L |
3135
|
Familial Scheuermann disease
|
ORPHAnet |
| 0‑L |
3137
|
Alpha-N-acetylgalactosaminidase deficiency
|
ORPHAnet |
| 0‑L |
3138
|
Ulnar-mammary syndrome
|
ORPHAnet |
| 0‑L |
3143
|
Autoimmune polyendocrinopathy type 2
|
ORPHAnet |
| 0‑L |
3144
|
Schneckenbecken dysplasia
|
ORPHAnet |
| 0‑L |
3145
|
Nephrogenic diabetes insipidus-intracranial calcification-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
3148
|
Malignant peripheral nerve sheath tumor
|
ORPHAnet |
| 0‑L |
3151
|
Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome
|
ORPHAnet |
| 0‑L |
3152
|
Sclerosteosis
|
ORPHAnet |
| 0‑L |
3156
|
Senior-Loken syndrome
|
ORPHAnet |
| 0‑L |
3157
|
Septo-optic dysplasia spectrum
|
ORPHAnet |
| 0‑L |
3161
|
Congenital pulmonary sequestration
|
ORPHAnet |
| 0‑L |
3162
|
Sézary syndrome
|
ORPHAnet |
| 0‑L |
3163
|
SHORT syndrome
|
ORPHAnet |
| 0‑L |
3164
|
Omphalocele syndrome, Shprintzen-Goldberg type
|
ORPHAnet |
| 0‑L |
3165
|
Eosinophilic fasciitis
|
ORPHAnet |
| 0‑L |
3166
|
Sialuria
|
ORPHAnet |
| 0‑L |
3167
|
Siegler-Brewer-Carey syndrome
|
ORPHAnet |
| 0‑L |
3168
|
Sillence syndrome
|
ORPHAnet |
| 0‑L |
3169
|
Sirenomelia
|
ORPHAnet |
| 0‑L |
3172
|
Eyebrow duplication-syndactyly syndrome
|
ORPHAnet |
| 0‑L |
3173
|
Infantile spasms-broad thumbs syndrome
|
ORPHAnet |
| 0‑L |
3175
|
X-linked spasticity-intellectual disability-epilepsy syndrome
|
ORPHAnet |
| 0‑L |
3176
|
Spina bifida-hypospadias syndrome
|
ORPHAnet |
| 0‑L |
3177
|
Spinocerebellar degeneration-corneal dystrophy syndrome
|
ORPHAnet |
| 0‑L |
3180
|
Spondylocamptodactyly syndrome
|
ORPHAnet |
| 0‑L |
3181
|
Sprengel deformity
|
ORPHAnet |
| 0‑L |
3184
|
Steatocystoma multiplex-natal teeth syndrome
|
ORPHAnet |
| 0‑L |
3186
|
Holoprosencephaly-radial heart renal anomalies syndrome
|
ORPHAnet |
| 0‑L |
3188
|
Congenital pulmonary veins atresia or stenosis
|
ORPHAnet |
| 0‑L |
3189
|
Congenital pulmonary valvar stenosis
|
ORPHAnet |
| 0‑L |
3190
|
Subpulmonary stenosis
|
ORPHAnet |
| 0‑L |
3191
|
Subaortic stenosis-short stature syndrome
|
ORPHAnet |
| 0‑L |
3192
|
Supravalvular pulmonary stenosis
|
ORPHAnet |
| 0‑L |
3193
|
Supravalvular aortic stenosis
|
ORPHAnet |
| 0‑L |
3194
|
Corneodermatoosseous syndrome
|
ORPHAnet |
| 0‑L |
3196
|
Steroid dehydrogenase deficiency-dental anomalies syndrome
|
ORPHAnet |
| 0‑L |
3197
|
Hereditary hyperekplexia
|
ORPHAnet |
| 0‑L |
3198
|
Stiff person spectrum disorder
|
ORPHAnet |
| 0‑L |
3199
|
Stimmler syndrome
|
ORPHAnet |
| 0‑L |
3200
|
Arthrogryposis-ectodermal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
3201
|
Ventricular extrasystoles with syncopal episodes-perodactyly-Robin sequence syndrome
|
ORPHAnet |
| 0‑L |
3202
|
Dehydrated hereditary stomatocytosis
|
ORPHAnet |
| 0‑L |
3203
|
Overhydrated hereditary stomatocytosis
|
ORPHAnet |
| 0‑L |
3204
|
Stormorken-Sjaastad-Langslet syndrome
|
ORPHAnet |
| 0‑L |
3205
|
Sturge-Weber syndrome
|
ORPHAnet |
| 0‑L |
3206
|
Stüve-Wiedemann syndrome
|
ORPHAnet |
| 0‑L |
3207
|
White matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
3208
|
Isolated succinate-CoQ reductase deficiency
|
ORPHAnet |
| 0‑L |
3210
|
Summitt syndrome
|
ORPHAnet |
| 0‑L |
3214
|
Deaf blind hypopigmentation syndrome, Yemenite type
|
ORPHAnet |
| 0‑L |
3216
|
Conductive deafness-malformed external ear syndrome
|
ORPHAnet |
| 0‑L |
3217
|
Deafness-small bowel diverticulosis-neuropathy syndrome
|
ORPHAnet |
| 0‑L |
3218
|
Deafness-epiphyseal dysplasia-short stature syndrome
|
ORPHAnet |
| 0‑L |
3219
|
Fountain syndrome
|
ORPHAnet |
| 0‑L |
3220
|
Deafness-enamel hypoplasia-nail defects syndrome
|
ORPHAnet |
| 0‑L |
3222
|
Phosphoribosylpyrophosphate synthetase superactivity
|
ORPHAnet |
| 0‑L |
3224
|
Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome
|
ORPHAnet |
| 0‑L |
3225
|
Hearing loss-familial salivary gland insensitivity to aldosterone syndrome
|
ORPHAnet |
| 0‑L |
3226
|
Deafness-lymphedema-leukemia syndrome
|
ORPHAnet |
| 0‑L |
3230
|
Deafness-oligodontia syndrome
|
ORPHAnet |
| 0‑L |
3232
|
Deafness-ear malformation-facial palsy syndrome
|
ORPHAnet |
| 0‑L |
3233
|
Cochleosaccular degeneration-cataract syndrome
|
ORPHAnet |
| 0‑L |
3235
|
Progressive deafness with stapes fixation
|
ORPHAnet |
| 0‑L |
3236
|
Conductive deafness-ptosis-skeletal anomalies syndrome
|
ORPHAnet |
| 0‑L |
3237
|
Multiple synostoses syndrome
|
ORPHAnet |
| 0‑L |
3238
|
Cardiospondylocarpofacial syndrome
|
ORPHAnet |
| 0‑L |
3239
|
Deafness-vitiligo-achalasia syndrome
|
ORPHAnet |
| 0‑L |
3240
|
Central nervous system calcification-deafness-tubular acidosis-anemia syndrome
|
ORPHAnet |
| 0‑L |
3241
|
Deafness-craniofacial syndrome
|
ORPHAnet |
| 0‑L |
3242
|
Renpenning syndrome
|
ORPHAnet |
| 0‑L |
3243
|
Sweet syndrome
|
ORPHAnet |
| 0‑L |
3246
|
Symphalangism with multiple anomalies of hands and feet
|
ORPHAnet |
| 0‑L |
3248
|
Distal symphalangism
|
ORPHAnet |
| 0‑L |
3250
|
Proximal symphalangism
|
ORPHAnet |
| 0‑L |
3253
|
Cleft lip/palate-ectodermal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
3255
|
Filippi syndrome
|
ORPHAnet |
| 0‑L |
3258
|
Cenani-Lenz syndrome
|
ORPHAnet |
| 0‑L |
3259
|
Syndactyly-polydactyly-ear lobe syndrome
|
ORPHAnet |
| 0‑L |
3260
|
Idiopathic hypereosinophilic syndrome
|
ORPHAnet |
| 0‑L |
3261
|
Autoimmune lymphoproliferative syndrome
|
ORPHAnet |
| 0‑L |
3262
|
Dobrow syndrome
|
ORPHAnet |
| 0‑L |
3263
|
Syngnathia-cleft palate syndrome
|
ORPHAnet |
| 0‑L |
3265
|
Humero-radial synostosis
|
ORPHAnet |
| 0‑L |
3266
|
Humero-radio-ulnar synostosis
|
ORPHAnet |
| 0‑L |
3268
|
Radioulnar synostosis-microcephaly-scoliosis syndrome
|
ORPHAnet |
| 0‑L |
3269
|
Congenital radioulnar synostosis
|
ORPHAnet |
| 0‑L |
3270
|
Radioulnar synostosis-developmental delay-hypotonia syndrome
|
ORPHAnet |
| 0‑L |
3273
|
Synovial sarcoma
|
ORPHAnet |
| 0‑L |
3275
|
Spondylocarpotarsal synostosis
|
ORPHAnet |
| 0‑L |
3282
|
Multifocal atrial tachycardia
|
ORPHAnet |
| 0‑L |
3283
|
His bundle tachycardia
|
ORPHAnet |
| 0‑L |
3286
|
Catecholaminergic polymorphic ventricular tachycardia
|
ORPHAnet |
| 0‑L |
3287
|
Takayasu arteritis
|
ORPHAnet |
| 0‑L |
3291
|
Teebi-Shaltout syndrome
|
ORPHAnet |
| 0‑L |
3292
|
Tel Hashomer camptodactyly syndrome
|
ORPHAnet |
| 0‑L |
3293
|
Telecanthus-hypertelorism-strabismus-pes cavus syndrome
|
ORPHAnet |
| 0‑L |
3294
|
Extensor tendons of finger anomalies
|
ORPHAnet |
| 0‑L |
3299
|
Tetanus
|
ORPHAnet |
| 0‑L |
3301
|
Tetraamelia-multiple malformations syndrome
|
ORPHAnet |
| 0‑L |
3303
|
Tetralogy of Fallot
|
ORPHAnet |
| 0‑L |
3304
|
Fallot complex-intellectual disability-growth delay syndrome
|
ORPHAnet |
| 0‑L |
3305
|
Tetraploidy
|
ORPHAnet |
| 0‑L |
3306
|
Inverted duplicated chromosome 15 syndrome
|
ORPHAnet |
| 0‑L |
3307
|
Tetrasomy 18p
|
ORPHAnet |
| 0‑L |
3309
|
Tetrasomy 5p
|
ORPHAnet |
| 0‑L |
3310
|
Tetrasomy 9p
|
ORPHAnet |
| 0‑L |
3312
|
Thalidomide embryopathy
|
ORPHAnet |
| 0‑L |
3314
|
Thiemann disease, familial form
|
ORPHAnet |
| 0‑L |
3316
|
Thomas syndrome
|
ORPHAnet |
| 0‑L |
3317
|
Thoracolaryngopelvic dysplasia
|
ORPHAnet |
| 0‑L |
3318
|
Essential thrombocythemia
|
ORPHAnet |
| 0‑L |
3319
|
Congenital amegakaryocytic thrombocytopenia
|
ORPHAnet |
| 0‑L |
3320
|
Thrombocytopenia-absent radius syndrome
|
ORPHAnet |
| 0‑L |
3322
|
Hoyeraal-Hreidarsson syndrome
|
ORPHAnet |
| 0‑L |
3324
|
Familial thrombomodulin anomalies
|
ORPHAnet |
| 0‑L |
3325
|
Heparin-induced thrombocytopenia
|
ORPHAnet |
| 0‑L |
3326
|
Thymic-renal-anal-lung dysplasia
|
ORPHAnet |
| 0‑L |
3327
|
Thyrocerebrorenal syndrome
|
ORPHAnet |
| 0‑L |
3328
|
Absent tibia-polydactyly-arachnoid cyst syndrome
|
ORPHAnet |
| 0‑L |
3329
|
Tibial aplasia-ectrodactyly syndrome
|
ORPHAnet |
| 0‑L |
3337
|
Primary Fanconi renotubular syndrome
|
ORPHAnet |
| 0‑L |
3338
|
Toriello-Carey syndrome
|
ORPHAnet |
| 0‑L |
3339
|
Toriello-Lacassie-Droste syndrome
|
ORPHAnet |
| 0‑L |
3341
|
Torticollis-keloids-cryptorchidism-renal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
3342
|
Arterial tortuosity syndrome
|
ORPHAnet |
| 0‑L |
3343
|
Toxocariasis
|
ORPHAnet |
| 0‑L |
3344
|
Weismann-Netter syndrome
|
ORPHAnet |
| 0‑L |
3346
|
Tracheal agenesis
|
ORPHAnet |
| 0‑L |
3347
|
Mounier-Kühn syndrome
|
ORPHAnet |
| 0‑L |
3348
|
Tracheobronchopathia osteochondroplastica
|
ORPHAnet |
| 0‑L |
3350
|
Tremor-nystagmus-duodenal ulcer syndrome
|
ORPHAnet |
| 0‑L |
3351
|
Trichodental syndrome
|
ORPHAnet |
| 0‑L |
3352
|
Tricho-dento-osseous syndrome
|
ORPHAnet |
| 0‑L |
3353
|
Trichodermodysplasia-dental alterations syndrome
|
ORPHAnet |
| 0‑L |
3355
|
Trichoodontoonychial dysplasia
|
ORPHAnet |
| 0‑L |
3361
|
Trichodysplasia-xeroderma syndrome
|
ORPHAnet |
| 0‑L |
3363
|
Trichomegaly-retina pigmentary degeneration-dwarfism syndrome
|
ORPHAnet |
| 0‑L |
3365
|
Trigonocephaly-broad thumbs syndrome
|
ORPHAnet |
| 0‑L |
3366
|
Non-syndromic metopic craniosynostosis
|
ORPHAnet |
| 0‑L |
3368
|
Trigonocephaly-bifid nose-acral anomalies syndrome
|
ORPHAnet |
| 0‑L |
3369
|
Trigonocephaly-short stature-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
3374
|
Triopia
|
ORPHAnet |
| 0‑L |
3375
|
Trisomy X
|
ORPHAnet |
| 0‑L |
3376
|
Triploidy
|
ORPHAnet |
| 0‑L |
3377
|
Trismus-pseudocamptodactyly syndrome
|
ORPHAnet |
| 0‑L |
3378
|
Trisomy 13
|
ORPHAnet |
| 0‑L |
3379
|
Distal trisomy 17q
|
ORPHAnet |
| 0‑L |
3380
|
Trisomy 18
|
ORPHAnet |
| 0‑L |
3383
|
Humerus trochlea aplasia
|
ORPHAnet |
| 0‑L |
3384
|
Truncus arteriosus
|
ORPHAnet |
| 0‑L |
3385
|
African trypanosomiasis
|
ORPHAnet |
| 0‑L |
3386
|
American trypanosomiasis
|
ORPHAnet |
| 0‑L |
3387
|
Isolated anterior cervical hypertrichosis
|
ORPHAnet |
| 0‑L |
3389
|
Tuberculosis
|
ORPHAnet |
| 0‑L |
3392
|
Tularemia
|
ORPHAnet |
| 0‑L |
3400
|
Aorto-ventricular tunnel
|
ORPHAnet |
| 0‑L |
3402
|
Transient tyrosinemia of the newborn
|
ORPHAnet |
| 0‑L |
3403
|
Uhl anomaly
|
ORPHAnet |
| 0‑L |
3404
|
Ulbright-Hodes syndrome
|
ORPHAnet |
| 0‑L |
3405
|
Umbilical cord ulceration-intestinal atresia syndrome
|
ORPHAnet |
| 0‑L |
3406
|
Ulerythema ophryogenesis
|
ORPHAnet |
| 0‑L |
3408
|
Upington disease
|
ORPHAnet |
| 0‑L |
3409
|
Urban-Rogers-Meyer syndrome
|
ORPHAnet |
| 0‑L |
3411
|
Double uterus-hemivagina-renal agenesis syndrome
|
ORPHAnet |
| 0‑L |
3412
|
VACTERL with hydrocephalus
|
ORPHAnet |
| 0‑L |
3416
|
Hyperostosis corticalis generalisata
|
ORPHAnet |
| 0‑L |
3417
|
Van den Bosch syndrome
|
ORPHAnet |
| 0‑L |
3424
|
Velo-facial-skeletal syndrome
|
ORPHAnet |
| 0‑L |
3426
|
Double outlet right ventricle
|
ORPHAnet |
| 0‑L |
3427
|
Double outlet left ventricle
|
ORPHAnet |
| 0‑L |
3429
|
Verloove Vanhorick-Brubakk syndrome
|
ORPHAnet |
| 0‑L |
3433
|
Microcephaly-brachydactyly-kyphoscoliosis syndrome
|
ORPHAnet |
| 0‑L |
3434
|
MMEP syndrome
|
ORPHAnet |
| 0‑L |
3437
|
Vogt-Koyanagi-Harada disease
|
ORPHAnet |
| 0‑L |
3439
|
Von Voss-Cherstvoy syndrome
|
ORPHAnet |
| 0‑L |
3440
|
Waardenburg syndrome
|
ORPHAnet |
| 0‑L |
3447
|
Weaver syndrome
|
ORPHAnet |
| 0‑L |
3448
|
Weaver-Williams syndrome
|
ORPHAnet |
| 0‑L |
3449
|
Weill-Marchesani syndrome
|
ORPHAnet |
| 0‑L |
3451
|
Infantile spasms syndrome
|
ORPHAnet |
| 0‑L |
3452
|
Whipple disease
|
ORPHAnet |
| 0‑L |
3453
|
Autoimmune polyendocrinopathy type 1
|
ORPHAnet |
| 0‑L |
3454
|
Intellectual disability-developmental delay-contractures syndrome
|
ORPHAnet |
| 0‑L |
3455
|
Wiedemann-Rautenstrauch syndrome
|
ORPHAnet |
| 0‑L |
3456
|
Wildervanck syndrome
|
ORPHAnet |
| 0‑L |
3459
|
Wilson-Turner syndrome
|
ORPHAnet |
| 0‑L |
3463
|
Wolfram syndrome
|
ORPHAnet |
| 0‑L |
3464
|
Woodhouse-Sakati syndrome
|
ORPHAnet |
| 0‑L |
3465
|
Worster-Drought syndrome
|
ORPHAnet |
| 0‑L |
3466
|
WT limb-blood syndrome
|
ORPHAnet |
| 0‑L |
3467
|
Hereditary xanthinuria
|
ORPHAnet |
| 0‑L |
3469
|
XK aprosencephaly syndrome
|
ORPHAnet |
| 0‑L |
3471
|
Young syndrome
|
ORPHAnet |
| 0‑L |
3472
|
Yunis-Varon syndrome
|
ORPHAnet |
| 0‑L |
3473
|
Zimmermann-Laband syndrome
|
ORPHAnet |
| 0‑L |
3474
|
CHIME syndrome
|
ORPHAnet |
| 0‑L |
25968
|
Benign occipital epilepsy
|
ORPHAnet |
| 0‑L |
25980
|
X-linked myopathy with excessive autophagy
|
ORPHAnet |
| 0‑L |
26106
|
Hereditary diffuse gastric cancer
|
ORPHAnet |
| 0‑L |
26137
|
Juvenile temporal arteritis
|
ORPHAnet |
| 0‑L |
26348
|
Acquired prothrombin deficiency
|
ORPHAnet |
| 0‑L |
26349
|
Protein S acquired deficiency
|
ORPHAnet |
| 0‑L |
26790
|
Pseudomyxoma peritonei
|
ORPHAnet |
| 0‑L |
26791
|
Multiple acyl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
26792
|
Short chain acyl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
26793
|
Very long chain acyl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
28378
|
Tyrosinemia type 2
|
ORPHAnet |
| 0‑L |
29072
|
Hereditary pheochromocytoma-paraganglioma
|
ORPHAnet |
| 0‑L |
29073
|
Multiple myeloma
|
ORPHAnet |
| 0‑L |
29207
|
Reactive arthritis
|
ORPHAnet |
| 0‑L |
29822
|
Spontaneous periodic hypothermia
|
ORPHAnet |
| 0‑L |
30391
|
Isolated biliary atresia
|
ORPHAnet |
| 0‑L |
30924
|
Primary hypomagnesemia with secondary hypocalcemia
|
ORPHAnet |
| 0‑L |
30925
|
Hereditary central diabetes insipidus
|
ORPHAnet |
| 0‑L |
31043
|
Primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular
involvement
|
ORPHAnet |
| 0‑L |
31112
|
Dermatofibrosarcoma protuberans
|
ORPHAnet |
| 0‑L |
31142
|
Oral erosive lichen
|
ORPHAnet |
| 0‑L |
31150
|
Tangier disease
|
ORPHAnet |
| 0‑L |
31202
|
Melioidosis
|
ORPHAnet |
| 0‑L |
31204
|
Nocardiosis
|
ORPHAnet |
| 0‑L |
31205
|
Rat-bite fever
|
ORPHAnet |
| 0‑L |
31709
|
Infantile convulsions and choreoathetosis
|
ORPHAnet |
| 0‑L |
31824
|
Colchicine poisoning
|
ORPHAnet |
| 0‑L |
31825
|
Methanol poisoning
|
ORPHAnet |
| 0‑L |
31826
|
Ethylene glycol poisoning
|
ORPHAnet |
| 0‑L |
31827
|
Paraquat poisoning
|
ORPHAnet |
| 0‑L |
31828
|
Digitalis poisoning
|
ORPHAnet |
| 0‑L |
31837
|
Pulmonary venoocclusive disease
|
ORPHAnet |
| 0‑L |
32960
|
Tumor necrosis factor receptor 1 associated periodic syndrome
|
ORPHAnet |
| 0‑L |
33001
|
Lymphedema-distichiasis syndrome
|
ORPHAnet |
| 0‑L |
33067
|
Metaphyseal chondrodysplasia, Jansen type
|
ORPHAnet |
| 0‑L |
33069
|
Dravet syndrome
|
ORPHAnet |
| 0‑L |
33108
|
Lethal multiple pterygium syndrome
|
ORPHAnet |
| 0‑L |
33110
|
Autosomal agammaglobulinemia
|
ORPHAnet |
| 0‑L |
33111
|
Granulomatous slack skin
|
ORPHAnet |
| 0‑L |
33208
|
Idiopathic hypersomnia
|
ORPHAnet |
| 0‑L |
33226
|
Waldenström macroglobulinemia
|
ORPHAnet |
| 0‑L |
33276
|
Kaposi sarcoma
|
ORPHAnet |
| 0‑L |
33314
|
Jessner lymphocytic infiltration of the skin
|
ORPHAnet |
| 0‑L |
33355
|
Reticular dysgenesis
|
ORPHAnet |
| 0‑L |
33364
|
Trichothiodystrophy
|
ORPHAnet |
| 0‑L |
33402
|
Pediatric hepatocellular carcinoma
|
ORPHAnet |
| 0‑L |
33408
|
Bullous lichen planus
|
ORPHAnet |
| 0‑L |
33445
|
Neuroectodermal melanolysosomal disease
|
ORPHAnet |
| 0‑L |
33475
|
Meningococcal meningitis
|
ORPHAnet |
| 0‑L |
33543
|
Kleine-Levin syndrome
|
ORPHAnet |
| 0‑L |
33572
|
5-oxoprolinase deficiency
|
ORPHAnet |
| 0‑L |
33573
|
Gamma-glutamyl transpeptidase deficiency
|
ORPHAnet |
| 0‑L |
33574
|
Glutamate-cysteine ligase deficiency
|
ORPHAnet |
| 0‑L |
33577
|
Nodular non-suppurative panniculitis
|
ORPHAnet |
| 0‑L |
34149
|
Autosomal dominant tubulointerstitial kidney disease
|
ORPHAnet |
| 0‑L |
34217
|
Naxos disease
|
ORPHAnet |
| 0‑L |
34514
|
Telethonin-related limb-girdle muscular dystrophy R7
|
ORPHAnet |
| 0‑L |
34515
|
FKRP-related limb-girdle muscular dystrophy R9
|
ORPHAnet |
| 0‑L |
34516
|
DNAJB6-related limb-girdle muscular dystrophy D1
|
ORPHAnet |
| 0‑L |
34520
|
Congenital muscular dystrophy with integrin alpha-7 deficiency
|
ORPHAnet |
| 0‑L |
34528
|
Autosomal dominant primary hypomagnesemia with hypocalciuria
|
ORPHAnet |
| 0‑L |
34587
|
Glycogen storage disease due to LAMP-2 deficiency
|
ORPHAnet |
| 0‑L |
34592
|
Immunodeficiency by defective expression of MHC class I
|
ORPHAnet |
| 0‑L |
35062
|
Severe disseminated cytomegalovirus infection in immunocompetent patients
|
ORPHAnet |
| 0‑L |
35063
|
Fulminant viral hepatitis
|
ORPHAnet |
| 0‑L |
35069
|
Infantile neuroaxonal dystrophy
|
ORPHAnet |
| 0‑L |
35078
|
T-B+ severe combined immunodeficiency due to JAK3 deficiency
|
ORPHAnet |
| 0‑L |
35093
|
Non-syndromic sagittal craniosynostosis
|
ORPHAnet |
| 0‑L |
35099
|
Non-syndromic bicoronal craniosynostosis
|
ORPHAnet |
| 0‑L |
35107
|
Desmosterolosis
|
ORPHAnet |
| 0‑L |
35120
|
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency
|
ORPHAnet |
| 0‑L |
35121
|
Lysosomal acid phosphatase deficiency
|
ORPHAnet |
| 0‑L |
35122
|
Congenital sucrase-isomaltase deficiency
|
ORPHAnet |
| 0‑L |
35125
|
Epidermal nevus syndrome
|
ORPHAnet |
| 0‑L |
35173
|
X-linked dominant chondrodysplasia punctata
|
ORPHAnet |
| 0‑L |
35612
|
Nanophthalmos
|
ORPHAnet |
| 0‑L |
35664
|
ALDH18A1-related De Barsy syndrome
|
ORPHAnet |
| 0‑L |
35686
|
Serpiginous choroiditis
|
ORPHAnet |
| 0‑L |
35687
|
Erdheim-Chester disease
|
ORPHAnet |
| 0‑L |
35689
|
Primary lateral sclerosis
|
ORPHAnet |
| 0‑L |
35701
|
3-hydroxy-3-methylglutaryl-CoA synthase deficiency
|
ORPHAnet |
| 0‑L |
35704
|
L-Arginine:glycine amidinotransferase deficiency
|
ORPHAnet |
| 0‑L |
35706
|
Glutaric acidemia type 3
|
ORPHAnet |
| 0‑L |
35708
|
Aromatic L-amino acid decarboxylase deficiency
|
ORPHAnet |
| 0‑L |
35710
|
Glucose-galactose malabsorption
|
ORPHAnet |
| 0‑L |
35737
|
Morning glory disc anomaly
|
ORPHAnet |
| 0‑L |
35858
|
Imerslund-Gräsbeck syndrome
|
ORPHAnet |
| 0‑L |
35878
|
Hyperinsulinism-hyperammonemia syndrome
|
ORPHAnet |
| 0‑L |
35889
|
Acute opioid poisoning
|
ORPHAnet |
| 0‑L |
35909
|
Combined deficiency of factor V and factor VIII
|
ORPHAnet |
| 0‑L |
36234
|
Bacterial toxic-shock syndrome
|
ORPHAnet |
| 0‑L |
36235
|
Staphylococcal scarlet fever
|
ORPHAnet |
| 0‑L |
36236
|
Staphylococcal scalded skin syndrome
|
ORPHAnet |
| 0‑L |
36237
|
Bullous impetigo
|
ORPHAnet |
| 0‑L |
36238
|
Staphylococcal necrotizing pneumonia
|
ORPHAnet |
| 0‑L |
36258
|
Buerger disease
|
ORPHAnet |
| 0‑L |
36273
|
Gastric linitis plastica
|
ORPHAnet |
| 0‑L |
36355
|
Bleeding disorder due to P2Y12 defect
|
ORPHAnet |
| 0‑L |
36367
|
Distal monosomy 1q
|
ORPHAnet |
| 0‑L |
36382
|
Familial cervical artery dissection
|
ORPHAnet |
| 0‑L |
36383
|
COL4A1-related familial vascular leukoencephalopathy
|
ORPHAnet |
| 0‑L |
36386
|
Hereditary sensory and autonomic neuropathy type 1
|
ORPHAnet |
| 0‑L |
36387
|
Generalized epilepsy with febrile seizures-plus
|
ORPHAnet |
| 0‑L |
36397
|
Adiposis dolorosa
|
ORPHAnet |
| 0‑L |
36412
|
Hypocomplementemic urticarial vasculitis
|
ORPHAnet |
| 0‑L |
36426
|
Stevens-Johnson syndrome
|
ORPHAnet |
| 0‑L |
36899
|
Myoclonus-dystonia syndrome
|
ORPHAnet |
| 0‑L |
36913
|
Autoimmune hypoparathyroidism
|
ORPHAnet |
| 0‑L |
37042
|
Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome
|
ORPHAnet |
| 0‑L |
37202
|
Interstitial cystitis
|
ORPHAnet |
| 0‑L |
37553
|
Andersen-Tawil syndrome
|
ORPHAnet |
| 0‑L |
37559
|
Acquired kinky hair syndrome
|
ORPHAnet |
| 0‑L |
37612
|
Episodic ataxia type 1
|
ORPHAnet |
| 0‑L |
37748
|
Schnitzler syndrome
|
ORPHAnet |
| 0‑L |
38874
|
Dihydropyrimidinuria
|
ORPHAnet |
| 0‑L |
39041
|
Omenn syndrome
|
ORPHAnet |
| 0‑L |
39044
|
Uveal melanoma
|
ORPHAnet |
| 0‑L |
39812
|
Graft versus host disease
|
ORPHAnet |
| 0‑L |
40366
|
Acitretin/etretinate embryopathy
|
ORPHAnet |
| 0‑L |
40923
|
Eales disease
|
ORPHAnet |
| 0‑L |
41751
|
Bietti crystalline dystrophy
|
ORPHAnet |
| 0‑L |
42062
|
Iminoglycinuria
|
ORPHAnet |
| 0‑L |
42642
|
PFAPA syndrome
|
ORPHAnet |
| 0‑L |
42665
|
Tietz syndrome
|
ORPHAnet |
| 0‑L |
42775
|
PHACE syndrome
|
ORPHAnet |
| 0‑L |
43115
|
Hereditary myopathy with lactic acidosis due to ISCU deficiency
|
ORPHAnet |
| 0‑L |
43116
|
Serotonin syndrome
|
ORPHAnet |
| 0‑L |
43117
|
Acute tricyclic antidepressant poisoning
|
ORPHAnet |
| 0‑L |
43119
|
Acute poisoning by drugs with membrane-stabilizing effect
|
ORPHAnet |
| 0‑L |
43393
|
Lambert-Eaton myasthenic syndrome
|
ORPHAnet |
| 0‑L |
44890
|
Gastrointestinal stromal tumor
|
ORPHAnet |
| 0‑L |
45358
|
Congenital fibrosis of extraocular muscles
|
ORPHAnet |
| 0‑L |
45448
|
Miyoshi myopathy
|
ORPHAnet |
| 0‑L |
45452
|
Idiopathic neonatal atrial flutter
|
ORPHAnet |
| 0‑L |
45453
|
Incessant infant ventricular tachycardia
|
ORPHAnet |
| 0‑L |
46059
|
Lathosterolosis
|
ORPHAnet |
| 0‑L |
46135
|
Primary central nervous system lymphoma
|
ORPHAnet |
| 0‑L |
46348
|
Paroxysmal extreme pain disorder
|
ORPHAnet |
| 0‑L |
46486
|
Mucous membrane pemphigoid
|
ORPHAnet |
| 0‑L |
46487
|
Epidermolysis bullosa acquisita
|
ORPHAnet |
| 0‑L |
46488
|
Linear IgA dermatosis
|
ORPHAnet |
| 0‑L |
46532
|
Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
|
ORPHAnet |
| 0‑L |
46627
|
Char syndrome
|
ORPHAnet |
| 0‑L |
46724
|
Cerebral arteriovenous malformation
|
ORPHAnet |
| 0‑L |
47044
|
Hereditary papillary renal cell carcinoma
|
ORPHAnet |
| 0‑L |
47045
|
Familial cold urticaria
|
ORPHAnet |
| 0‑L |
47159
|
Proximal renal tubular acidosis
|
ORPHAnet |
| 0‑L |
47612
|
Felty syndrome
|
ORPHAnet |
| 0‑L |
48104
|
Pyoderma gangrenosum
|
ORPHAnet |
| 0‑L |
48162
|
Lewis-Sumner syndrome
|
ORPHAnet |
| 0‑L |
48372
|
Nodular regenerative hyperplasia of the liver
|
ORPHAnet |
| 0‑L |
48377
|
Subcorneal pustular dermatosis
|
ORPHAnet |
| 0‑L |
48431
|
Congenital cataracts-facial dysmorphism-neuropathy syndrome
|
ORPHAnet |
| 0‑L |
48435
|
Postinfectious vasculitis
|
ORPHAnet |
| 0‑L |
48652
|
Monosomy 22q13.3
|
ORPHAnet |
| 0‑L |
48686
|
Primary effusion lymphoma
|
ORPHAnet |
| 0‑L |
48736
|
Embryonal carcinoma of the central nervous system
|
ORPHAnet |
| 0‑L |
48818
|
Aceruloplasminemia
|
ORPHAnet |
| 0‑L |
48918
|
Focal myositis
|
ORPHAnet |
| 0‑L |
49041
|
IgG4-related retroperitoneal fibrosis
|
ORPHAnet |
| 0‑L |
49042
|
Dentinogenesis imperfecta
|
ORPHAnet |
| 0‑L |
49382
|
Achromatopsia
|
ORPHAnet |
| 0‑L |
49566
|
Acquired purpura fulminans
|
ORPHAnet |
| 0‑L |
49804
|
Lichen amyloidosis
|
ORPHAnet |
| 0‑L |
49827
|
Thiamine-responsive megaloblastic anemia syndrome
|
ORPHAnet |
| 0‑L |
50251
|
Pleural mesothelioma
|
ORPHAnet |
| 0‑L |
50809
|
Talo-patello-scaphoid osteolysis
|
ORPHAnet |
| 0‑L |
50810
|
Microlissencephaly-micromelia syndrome
|
ORPHAnet |
| 0‑L |
50811
|
Lipodystrophy-intellectual disability-deafness syndrome
|
ORPHAnet |
| 0‑L |
50812
|
Zellweger-like syndrome without peroxisomal anomalies
|
ORPHAnet |
| 0‑L |
50814
|
Craniolenticulosutural dysplasia
|
ORPHAnet |
| 0‑L |
50815
|
Branchiogenic deafness syndrome
|
ORPHAnet |
| 0‑L |
50817
|
Duane anomaly-myopathy-scoliosis syndrome
|
ORPHAnet |
| 0‑L |
50839
|
Cat-scratch disease
|
ORPHAnet |
| 0‑L |
50918
|
Kikuchi-Fujimoto disease
|
ORPHAnet |
| 0‑L |
50942
|
Striate palmoplantar keratoderma
|
ORPHAnet |
| 0‑L |
50943
|
Keratolytic winter erythema
|
ORPHAnet |
| 0‑L |
50944
|
Schöpf-Schulz-Passarge syndrome
|
ORPHAnet |
| 0‑L |
50945
|
Blomstrand lethal chondrodysplasia
|
ORPHAnet |
| 0‑L |
51083
|
Familial short QT syndrome
|
ORPHAnet |
| 0‑L |
51084
|
Torsade-de-pointes syndrome with short coupling interval
|
ORPHAnet |
| 0‑L |
51188
|
Ethylmalonic encephalopathy
|
ORPHAnet |
| 0‑L |
51208
|
Formiminoglutamic aciduria
|
ORPHAnet |
| 0‑L |
51608
|
Generalized arterial calcification of infancy
|
ORPHAnet |
| 0‑L |
51636
|
WHIM syndrome
|
ORPHAnet |
| 0‑L |
51890
|
Anterior cutaneous nerve entrapment syndrome
|
ORPHAnet |
| 0‑L |
52022
|
Potocki-Shaffer syndrome
|
ORPHAnet |
| 0‑L |
52047
|
Braddock syndrome
|
ORPHAnet |
| 0‑L |
52054
|
Craniosynostosis-intracranial calcifications syndrome
|
ORPHAnet |
| 0‑L |
52055
|
Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome
|
ORPHAnet |
| 0‑L |
52056
|
Ulnar/fibula ray defect-brachydactyly syndrome
|
ORPHAnet |
| 0‑L |
52368
|
Mohr-Tranebjaerg syndrome
|
ORPHAnet |
| 0‑L |
52416
|
Mantle cell lymphoma
|
ORPHAnet |
| 0‑L |
52417
|
MALT lymphoma
|
ORPHAnet |
| 0‑L |
52427
|
Retinitis punctata albescens
|
ORPHAnet |
| 0‑L |
52429
|
Branchiootic syndrome
|
ORPHAnet |
| 0‑L |
52430
|
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
|
ORPHAnet |
| 0‑L |
52503
|
X-linked creatine transporter deficiency
|
ORPHAnet |
| 0‑L |
52530
|
Pseudo-von Willebrand disease
|
ORPHAnet |
| 0‑L |
52901
|
Isolated follicle stimulating hormone deficiency
|
ORPHAnet |
| 0‑L |
52994
|
Orbital leiomyoma
|
ORPHAnet |
| 0‑L |
53035
|
Caroli disease
|
ORPHAnet |
| 0‑L |
53271
|
Muenke syndrome
|
ORPHAnet |
| 0‑L |
53296
|
Familial cutaneous collagenoma
|
ORPHAnet |
| 0‑L |
53347
|
Brody myopathy
|
ORPHAnet |
| 0‑L |
53351
|
X-linked dystonia-parkinsonism
|
ORPHAnet |
| 0‑L |
53372
|
Hereditary geniospasm
|
ORPHAnet |
| 0‑L |
53540
|
Goldmann-Favre syndrome
|
ORPHAnet |
| 0‑L |
53583
|
Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity
|
ORPHAnet |
| 0‑L |
53689
|
Congenital chloride diarrhea
|
ORPHAnet |
| 0‑L |
53690
|
Congenital lactase deficiency
|
ORPHAnet |
| 0‑L |
53691
|
Congenital cornea plana
|
ORPHAnet |
| 0‑L |
53693
|
GRACILE syndrome
|
ORPHAnet |
| 0‑L |
53696
|
Arthrogryposis-anterior horn cell disease syndrome
|
ORPHAnet |
| 0‑L |
53697
|
Gnathodiaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
53698
|
Hyaline body myopathy
|
ORPHAnet |
| 0‑L |
53715
|
Familial tumoral calcinosis
|
ORPHAnet |
| 0‑L |
53719
|
Wyburn-Mason syndrome
|
ORPHAnet |
| 0‑L |
53721
|
Spinal arteriovenous metameric syndrome
|
ORPHAnet |
| 0‑L |
54028
|
Plummer-Vinson syndrome
|
ORPHAnet |
| 0‑L |
54057
|
Thrombotic thrombocytopenic purpura
|
ORPHAnet |
| 0‑L |
54247
|
Posterior cortical atrophy
|
ORPHAnet |
| 0‑L |
54251
|
Corticosteroid-sensitive aseptic abscess syndrome
|
ORPHAnet |
| 0‑L |
54260
|
Left ventricular noncompaction
|
ORPHAnet |
| 0‑L |
54272
|
Hepatocellular adenoma
|
ORPHAnet |
| 0‑L |
54368
|
Sarcocystosis
|
ORPHAnet |
| 0‑L |
54370
|
Primary membranoproliferative glomerulonephritis
|
ORPHAnet |
| 0‑L |
54595
|
Craniopharyngioma
|
ORPHAnet |
| 0‑L |
55595
|
TNP03-related limb-girdle muscular dystrophy D2
|
ORPHAnet |
| 0‑L |
55596
|
HNRNPDL-related limb-girdle muscular dystrophy D3
|
ORPHAnet |
| 0‑L |
55654
|
Hypotrichosis simplex
|
ORPHAnet |
| 0‑L |
55655
|
Pneumococcal meningitis
|
ORPHAnet |
| 0‑L |
55880
|
Chondrosarcoma
|
ORPHAnet |
| 0‑L |
55881
|
Adamantinoma
|
ORPHAnet |
| 0‑L |
56304
|
Atelosteogenesis type II
|
ORPHAnet |
| 0‑L |
56305
|
Atelosteogenesis type III
|
ORPHAnet |
| 0‑L |
56425
|
Cold agglutinin disease
|
ORPHAnet |
| 0‑L |
57145
|
SUNCT syndrome
|
ORPHAnet |
| 0‑L |
57196
|
Medial condensing osteitis of the clavicle
|
ORPHAnet |
| 0‑L |
57777
|
Cirrhotic cardiomyopathy
|
ORPHAnet |
| 0‑L |
57782
|
Mazabraud syndrome
|
ORPHAnet |
| 0‑L |
58017
|
Classic hairy cell leukemia
|
ORPHAnet |
| 0‑L |
58040
|
Osteoblastoma
|
ORPHAnet |
| 0‑L |
59135
|
Laing early-onset distal myopathy
|
ORPHAnet |
| 0‑L |
59181
|
Sorsby pseudoinflammatory fundus dystrophy
|
ORPHAnet |
| 0‑L |
59298
|
Schilder disease
|
ORPHAnet |
| 0‑L |
59303
|
Neonatal ichthyosis-sclerosing cholangitis syndrome
|
ORPHAnet |
| 0‑L |
59306
|
McLeod neuroacanthocytosis syndrome
|
ORPHAnet |
| 0‑L |
59315
|
Rhombencephalosynapsis
|
ORPHAnet |
| 0‑L |
60014
|
Argyria
|
ORPHAnet |
| 0‑L |
60015
|
Enlarged parietal foramina
|
ORPHAnet |
| 0‑L |
60025
|
Pulmonary alveolar microlithiasis
|
ORPHAnet |
| 0‑L |
60026
|
Pulmonary nodular lymphoid hyperplasia
|
ORPHAnet |
| 0‑L |
60030
|
Loeys-Dietz syndrome
|
ORPHAnet |
| 0‑L |
60032
|
Recurrent respiratory papillomatosis
|
ORPHAnet |
| 0‑L |
60033
|
Idiopathic bronchiectasis
|
ORPHAnet |
| 0‑L |
60039
|
Pudendal neuralgia
|
ORPHAnet |
| 0‑L |
60040
|
Megalencephaly-capillary malformation-polymicrogyria syndrome
|
ORPHAnet |
| 0‑L |
60041
|
Congenital heart block
|
ORPHAnet |
| 0‑L |
63259
|
Iniencephaly
|
ORPHAnet |
| 0‑L |
63260
|
Craniorachischisis
|
ORPHAnet |
| 0‑L |
63269
|
Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis
|
ORPHAnet |
| 0‑L |
63273
|
Distal myopathy with posterior leg and anterior hand involvement
|
ORPHAnet |
| 0‑L |
63275
|
Pemphigoid gestationis
|
ORPHAnet |
| 0‑L |
63442
|
Angel-shaped phalango-epiphyseal dysplasia
|
ORPHAnet |
| 0‑L |
63446
|
Acrocapitofemoral dysplasia
|
ORPHAnet |
| 0‑L |
63455
|
Paraneoplastic pemphigus
|
ORPHAnet |
| 0‑L |
63862
|
Schisis association
|
ORPHAnet |
| 0‑L |
63999
|
IgG4-related mediastinitis
|
ORPHAnet |
| 0‑L |
64280
|
Childhood absence epilepsy
|
ORPHAnet |
| 0‑L |
64542
|
Acrofacial dysostosis, Kennedy-Teebi type
|
ORPHAnet |
| 0‑L |
64545
|
Benign idiopathic neonatal seizures
|
ORPHAnet |
| 0‑L |
64686
|
Tolosa-Hunt syndrome
|
ORPHAnet |
| 0‑L |
64692
|
Oroya fever
|
ORPHAnet |
| 0‑L |
64694
|
Trench fever
|
ORPHAnet |
| 0‑L |
64720
|
Leiomyosarcoma
|
ORPHAnet |
| 0‑L |
64722
|
Granulomatous mastitis
|
ORPHAnet |
| 0‑L |
64734
|
Iridocorneal endothelial syndrome
|
ORPHAnet |
| 0‑L |
64739
|
Ovarian hyperstimulation syndrome
|
ORPHAnet |
| 0‑L |
64741
|
Pulmonary blastoma
|
ORPHAnet |
| 0‑L |
64742
|
Pleuropulmonary blastoma
|
ORPHAnet |
| 0‑L |
64743
|
Hepatoportal sclerosis
|
ORPHAnet |
| 0‑L |
64744
|
IgG4-related thyroid disease
|
ORPHAnet |
| 0‑L |
64745
|
Pruritic urticarial papules and plaques of pregnancy
|
ORPHAnet |
| 0‑L |
64748
|
Dejerine-Sottas syndrome
|
ORPHAnet |
| 0‑L |
64751
|
Hereditary motor and sensory neuropathy type 5
|
ORPHAnet |
| 0‑L |
64752
|
Hereditary sensory and autonomic neuropathy type 5
|
ORPHAnet |
| 0‑L |
64753
|
Spinocerebellar ataxia with axonal neuropathy type 2
|
ORPHAnet |
| 0‑L |
64754
|
Nevus comedonicus syndrome
|
ORPHAnet |
| 0‑L |
64755
|
Becker nevus syndrome
|
ORPHAnet |
| 0‑L |
65250
|
Perineural cyst
|
ORPHAnet |
| 0‑L |
65282
|
Carvajal syndrome
|
ORPHAnet |
| 0‑L |
65283
|
Timothy syndrome
|
ORPHAnet |
| 0‑L |
65284
|
Biotin-thiamine-responsive basal ganglia disease
|
ORPHAnet |
| 0‑L |
65285
|
Lhermitte-Duclos disease
|
ORPHAnet |
| 0‑L |
65286
|
3q29 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
65287
|
Beta-ureidopropionase deficiency
|
ORPHAnet |
| 0‑L |
65288
|
Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome
|
ORPHAnet |
| 0‑L |
65681
|
Vaginal atresia
|
ORPHAnet |
| 0‑L |
65682
|
Benign recurrent intrahepatic cholestasis
|
ORPHAnet |
| 0‑L |
65683
|
Isolated focal cortical dysplasia
|
ORPHAnet |
| 0‑L |
65684
|
Monomelic amyotrophy
|
ORPHAnet |
| 0‑L |
65720
|
Arthrogryposis-severe scoliosis syndrome
|
ORPHAnet |
| 0‑L |
65743
|
Autosomal dominant multiple pterygium syndrome
|
ORPHAnet |
| 0‑L |
65748
|
Multiple self-healing squamous epithelioma
|
ORPHAnet |
| 0‑L |
65759
|
Carpenter syndrome
|
ORPHAnet |
| 0‑L |
65798
|
Goodman syndrome
|
ORPHAnet |
| 0‑L |
66518
|
Short fifth metacarpals-insulin resistance syndrome
|
ORPHAnet |
| 0‑L |
66529
|
Tako-Tsubo cardiomyopathy
|
ORPHAnet |
| 0‑L |
66624
|
PANDAS
|
ORPHAnet |
| 0‑L |
66625
|
Cerebrooculonasal syndrome
|
ORPHAnet |
| 0‑L |
66627
|
Tenosynovial giant cell tumor
|
ORPHAnet |
| 0‑L |
66628
|
Obesity due to congenital leptin deficiency
|
ORPHAnet |
| 0‑L |
66629
|
Goldberg-Shprintzen megacolon syndrome
|
ORPHAnet |
| 0‑L |
66630
|
Congenital pseudoarthrosis of the clavicle
|
ORPHAnet |
| 0‑L |
66631
|
CEDNIK syndrome
|
ORPHAnet |
| 0‑L |
66633
|
Sensorineural hearing loss-early graying-essential tremor syndrome
|
ORPHAnet |
| 0‑L |
66634
|
Dilated cardiomyopathy with ataxia
|
ORPHAnet |
| 0‑L |
66637
|
Diaphanospondylodysostosis
|
ORPHAnet |
| 0‑L |
66661
|
Mast cell sarcoma
|
ORPHAnet |
| 0‑L |
66662
|
Extracutaneous mastocytoma
|
ORPHAnet |
| 0‑L |
67036
|
Autosomal dominant optic atrophy and cataract
|
ORPHAnet |
| 0‑L |
67038
|
B-cell chronic lymphocytic leukemia
|
ORPHAnet |
| 0‑L |
67039
|
Segmental odontomaxillary dysplasia
|
ORPHAnet |
| 0‑L |
67041
|
Hyaluronidase deficiency
|
ORPHAnet |
| 0‑L |
67042
|
Late-onset retinal degeneration
|
ORPHAnet |
| 0‑L |
67043
|
Amoebic keratitis
|
ORPHAnet |
| 0‑L |
67044
|
Thrombocytopenia with congenital dyserythropoietic anemia
|
ORPHAnet |
| 0‑L |
67045
|
X-linked intellectual disability with isolated growth hormone deficiency
|
ORPHAnet |
| 0‑L |
67046
|
3-methylglutaconic aciduria type 1
|
ORPHAnet |
| 0‑L |
67047
|
3-methylglutaconic aciduria type 3
|
ORPHAnet |
| 0‑L |
67048
|
3-methylglutaconic aciduria type 4
|
ORPHAnet |
| 0‑L |
69061
|
Idiopathic steroid-sensitive nephrotic syndrome
|
ORPHAnet |
| 0‑L |
69063
|
Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization
|
ORPHAnet |
| 0‑L |
69076
|
Familial renal glucosuria
|
ORPHAnet |
| 0‑L |
69077
|
Rhabdoid tumor
|
ORPHAnet |
| 0‑L |
69078
|
Liposarcoma
|
ORPHAnet |
| 0‑L |
69082
|
Odonto-tricho-ungual-digito-palmar syndrome
|
ORPHAnet |
| 0‑L |
69083
|
Ectodermal dysplasia with natal teeth, Turnpenny type
|
ORPHAnet |
| 0‑L |
69084
|
Pure hair and nail ectodermal dysplasia
|
ORPHAnet |
| 0‑L |
69085
|
Limb-mammary syndrome
|
ORPHAnet |
| 0‑L |
69087
|
Naegeli-Franceschetti-Jadassohn syndrome
|
ORPHAnet |
| 0‑L |
69088
|
Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome
|
ORPHAnet |
| 0‑L |
69125
|
Anonychia with flexural pigmentation
|
ORPHAnet |
| 0‑L |
69126
|
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome
|
ORPHAnet |
| 0‑L |
69663
|
Low phospholipid-associated cholelithiasis
|
ORPHAnet |
| 0‑L |
69665
|
Intrahepatic cholestasis of pregnancy
|
ORPHAnet |
| 0‑L |
69723
|
Tyrosinemia type 3
|
ORPHAnet |
| 0‑L |
69735
|
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome
|
ORPHAnet |
| 0‑L |
69736
|
Bilateral acute depigmentation of the iris
|
ORPHAnet |
| 0‑L |
69737
|
Bosley-Salih-Alorainy syndrome
|
ORPHAnet |
| 0‑L |
69739
|
Athabaskan brainstem dysgenesis syndrome
|
ORPHAnet |
| 0‑L |
69744
|
Circumscribed palmoplantar hypokeratosis
|
ORPHAnet |
| 0‑L |
69745
|
Warty dyskeratoma
|
ORPHAnet |
| 0‑L |
70472
|
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type
|
ORPHAnet |
| 0‑L |
70474
|
Leigh syndrome with cardiomyopathy
|
ORPHAnet |
| 0‑L |
70475
|
Radiation proctitis
|
ORPHAnet |
| 0‑L |
70476
|
Vernal keratoconjunctivitis
|
ORPHAnet |
| 0‑L |
70567
|
Cholangiocarcinoma
|
ORPHAnet |
| 0‑L |
70568
|
Post-transplant lymphoproliferative disease
|
ORPHAnet |
| 0‑L |
70573
|
Small cell lung cancer
|
ORPHAnet |
| 0‑L |
70578
|
Adult acute respiratory distress syndrome
|
ORPHAnet |
| 0‑L |
70587
|
Infant acute respiratory distress syndrome
|
ORPHAnet |
| 0‑L |
70588
|
Meconium aspiration syndrome
|
ORPHAnet |
| 0‑L |
70589
|
Bronchopulmonary dysplasia
|
ORPHAnet |
| 0‑L |
70590
|
Infantile apnea
|
ORPHAnet |
| 0‑L |
70591
|
Chronic thromboembolic pulmonary hypertension
|
ORPHAnet |
| 0‑L |
70592
|
Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency
|
ORPHAnet |
| 0‑L |
70593
|
Immunodeficiency due to selective anti-polysaccharide antibody deficiency
|
ORPHAnet |
| 0‑L |
70594
|
Dopa-responsive dystonia due to sepiapterin reductase deficiency
|
ORPHAnet |
| 0‑L |
70595
|
Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome
|
ORPHAnet |
| 0‑L |
70596
|
Congenital Epstein-Barr virus infection
|
ORPHAnet |
| 0‑L |
71211
|
Neuromyelitis optica spectrum disorder
|
ORPHAnet |
| 0‑L |
71212
|
Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
71213
|
Retinal capillary malformation
|
ORPHAnet |
| 0‑L |
71267
|
Dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
71271
|
Split hand-split foot-deafness syndrome
|
ORPHAnet |
| 0‑L |
71272
|
Sandifer syndrome
|
ORPHAnet |
| 0‑L |
71273
|
Renal nutcracker syndrome
|
ORPHAnet |
| 0‑L |
71274
|
Disseminated peritoneal leiomyomatosis
|
ORPHAnet |
| 0‑L |
71275
|
Rh deficiency syndrome
|
ORPHAnet |
| 0‑L |
71276
|
Silent sinus syndrome
|
ORPHAnet |
| 0‑L |
71277
|
Classic glucose transporter type 1 deficiency syndrome
|
ORPHAnet |
| 0‑L |
71278
|
Congenital brain dysgenesis due to glutamine synthetase deficiency
|
ORPHAnet |
| 0‑L |
71279
|
CANOMAD syndrome
|
ORPHAnet |
| 0‑L |
71289
|
Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome
|
ORPHAnet |
| 0‑L |
71290
|
Familial platelet disorder with associated myeloid malignancy
|
ORPHAnet |
| 0‑L |
71493
|
Familial thrombocytosis
|
ORPHAnet |
| 0‑L |
71505
|
Cancer-associated retinopathy
|
ORPHAnet |
| 0‑L |
71517
|
Rapid-onset dystonia-parkinsonism
|
ORPHAnet |
| 0‑L |
71518
|
Benign paroxysmal torticollis of infancy
|
ORPHAnet |
| 0‑L |
71519
|
Psychogenic movement disorders
|
ORPHAnet |
| 0‑L |
71526
|
Obesity due to pro-opiomelanocortin deficiency
|
ORPHAnet |
| 0‑L |
71528
|
Obesity due to prohormone convertase I deficiency
|
ORPHAnet |
| 0‑L |
71529
|
Obesity due to melanocortin 4 receptor deficiency
|
ORPHAnet |
| 0‑L |
73223
|
Global developmental delay-osteopenia-ectodermal defect syndrome
|
ORPHAnet |
| 0‑L |
73224
|
Kidney tubulopathy-dilated cardiomyopathy syndrome
|
ORPHAnet |
| 0‑L |
73229
|
HANAC syndrome
|
ORPHAnet |
| 0‑L |
73230
|
Ossification anomalies-psychomotor developmental delay syndrome
|
ORPHAnet |
| 0‑L |
73245
|
Spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome
|
ORPHAnet |
| 0‑L |
73246
|
Visceral neuropathy-brain anomalies-facial dysmorphism-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
73256
|
Central neurocytoma
|
ORPHAnet |
| 0‑L |
73260
|
Paracoccidioidomycosis
|
ORPHAnet |
| 0‑L |
73263
|
Zygomycosis
|
ORPHAnet |
| 0‑L |
73267
|
Non-24-hour sleep-wake syndrome
|
ORPHAnet |
| 0‑L |
73271
|
Bleeding diathesis due to a collagen receptor defect
|
ORPHAnet |
| 0‑L |
73272
|
Growth delay due to insulin-like growth factor type 1 deficiency
|
ORPHAnet |
| 0‑L |
73273
|
Growth delay due to insulin-like growth factor I resistance
|
ORPHAnet |
| 0‑L |
73423
|
Acute ackee fruit intoxication
|
ORPHAnet |
| 0‑L |
75233
|
Wolman disease
|
ORPHAnet |
| 0‑L |
75234
|
Cholesteryl ester storage disease
|
ORPHAnet |
| 0‑L |
75249
|
Familial isolated restrictive cardiomyopathy
|
ORPHAnet |
| 0‑L |
75325
|
Osteosclerosis-ichthyosis-premature ovarian failure syndrome
|
ORPHAnet |
| 0‑L |
75326
|
Retinal arterial tortuosity
|
ORPHAnet |
| 0‑L |
75327
|
North Carolina macular dystrophy
|
ORPHAnet |
| 0‑L |
75373
|
Progressive bifocal chorioretinal atrophy
|
ORPHAnet |
| 0‑L |
75374
|
Bradyopsia
|
ORPHAnet |
| 0‑L |
75376
|
Familial drusen
|
ORPHAnet |
| 0‑L |
75377
|
Central areolar choroidal dystrophy
|
ORPHAnet |
| 0‑L |
75378
|
Oligocone trichromacy
|
ORPHAnet |
| 0‑L |
75381
|
Cystoid macular dystrophy
|
ORPHAnet |
| 0‑L |
75382
|
Oguchi disease
|
ORPHAnet |
| 0‑L |
75389
|
Brain malformation-congenital heart disease-postaxial polydactyly syndrome
|
ORPHAnet |
| 0‑L |
75391
|
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency
|
ORPHAnet |
| 0‑L |
75392
|
Periodontal Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
75496
|
B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
75497
|
X-linked Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
75508
|
Angioosteohypotrophic syndrome
|
ORPHAnet |
| 0‑L |
75563
|
X-linked sideroblastic anemia
|
ORPHAnet |
| 0‑L |
75564
|
Acquired idiopathic sideroblastic anemia
|
ORPHAnet |
| 0‑L |
75565
|
Tropical endomyocardial fibrosis
|
ORPHAnet |
| 0‑L |
75566
|
Loeffler endocarditis
|
ORPHAnet |
| 0‑L |
75567
|
Primary progressive freezing gait
|
ORPHAnet |
| 0‑L |
75840
|
Congenital muscular dystrophy, Ullrich type
|
ORPHAnet |
| 0‑L |
75857
|
6q terminal deletion syndrome
|
ORPHAnet |
| 0‑L |
75858
|
MORM syndrome
|
ORPHAnet |
| 0‑L |
77258
|
Trichorhinophalangeal syndrome type 1 and 3
|
ORPHAnet |
| 0‑L |
77259
|
Gaucher disease type 1
|
ORPHAnet |
| 0‑L |
77260
|
Gaucher disease type 2
|
ORPHAnet |
| 0‑L |
77261
|
Gaucher disease type 3
|
ORPHAnet |
| 0‑L |
77292
|
Infantile neurovisceral acid sphingomyelinase deficiency
|
ORPHAnet |
| 0‑L |
77293
|
Chronic visceral acid sphingomyelinase deficiency
|
ORPHAnet |
| 0‑L |
77295
|
Odontoleukodystrophy
|
ORPHAnet |
| 0‑L |
77296
|
Morgagni-Stewart-Morel syndrome
|
ORPHAnet |
| 0‑L |
77297
|
Majeed syndrome
|
ORPHAnet |
| 0‑L |
77298
|
Anophthalmia/microphthalmia-esophageal atresia syndrome
|
ORPHAnet |
| 0‑L |
77299
|
Microphthalmia-brain atrophy syndrome
|
ORPHAnet |
| 0‑L |
77300
|
Auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities
syndrome
|
ORPHAnet |
| 0‑L |
77301
|
Monosomy 9q22.3
|
ORPHAnet |
| 0‑L |
79076
|
Juvenile polyposis of infancy
|
ORPHAnet |
| 0‑L |
79078
|
IgG4-related dacryoadenitis and sialadenitis
|
ORPHAnet |
| 0‑L |
79083
|
PPARG-related familial partial lipodystrophy
|
ORPHAnet |
| 0‑L |
79084
|
Familial partial lipodystrophy, Köbberling type
|
ORPHAnet |
| 0‑L |
79085
|
AKT2-related familial partial lipodystrophy
|
ORPHAnet |
| 0‑L |
79086
|
Acquired generalized lipodystrophy
|
ORPHAnet |
| 0‑L |
79087
|
Acquired partial lipodystrophy
|
ORPHAnet |
| 0‑L |
79091
|
Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome
|
ORPHAnet |
| 0‑L |
79093
|
Foix-Alajouanine syndrome
|
ORPHAnet |
| 0‑L |
79094
|
Grange syndrome
|
ORPHAnet |
| 0‑L |
79095
|
Congenital bile acid synthesis defect type 4
|
ORPHAnet |
| 0‑L |
79096
|
Pyridoxal phosphate-responsive seizures
|
ORPHAnet |
| 0‑L |
79097
|
Folinic acid-responsive seizures
|
ORPHAnet |
| 0‑L |
79098
|
Sympathetic ophthalmia
|
ORPHAnet |
| 0‑L |
79099
|
Interstitial granulomatous dermatitis with arthritis
|
ORPHAnet |
| 0‑L |
79100
|
Atrophoderma vermiculata
|
ORPHAnet |
| 0‑L |
79101
|
Hyperprolinemia type 2
|
ORPHAnet |
| 0‑L |
79102
|
Thyrotoxic periodic paralysis
|
ORPHAnet |
| 0‑L |
79105
|
Myxofibrosarcoma
|
ORPHAnet |
| 0‑L |
79106
|
Eiken syndrome
|
ORPHAnet |
| 0‑L |
79107
|
Developmental malformations-deafness-dystonia syndrome
|
ORPHAnet |
| 0‑L |
79113
|
Mandibulofacial dysostosis-microcephaly syndrome
|
ORPHAnet |
| 0‑L |
79118
|
Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic
kidneys syndrome
|
ORPHAnet |
| 0‑L |
79124
|
Hepatic veno-occlusive disease-immunodeficiency syndrome
|
ORPHAnet |
| 0‑L |
79126
|
Acute interstitial pneumonia
|
ORPHAnet |
| 0‑L |
79127
|
Respiratory bronchiolitis-interstitial lung disease syndrome
|
ORPHAnet |
| 0‑L |
79128
|
Lymphoid interstitial pneumonia
|
ORPHAnet |
| 0‑L |
79129
|
Trichodysplasia-amelogenesis imperfecta syndrome
|
ORPHAnet |
| 0‑L |
79133
|
Focal facial dermal dysplasia type I
|
ORPHAnet |
| 0‑L |
79134
|
DEND syndrome
|
ORPHAnet |
| 0‑L |
79135
|
Episodic ataxia type 3
|
ORPHAnet |
| 0‑L |
79136
|
Episodic ataxia type 4
|
ORPHAnet |
| 0‑L |
79137
|
Generalized epilepsy-paroxysmal dyskinesia syndrome
|
ORPHAnet |
| 0‑L |
79138
|
Bickerstaff brainstem encephalitis
|
ORPHAnet |
| 0‑L |
79139
|
Japanese encephalitis
|
ORPHAnet |
| 0‑L |
79140
|
Cutaneous neuroendocrine carcinoma
|
ORPHAnet |
| 0‑L |
79141
|
Hereditary painful callosities
|
ORPHAnet |
| 0‑L |
79143
|
Isolated congenital anonychia
|
ORPHAnet |
| 0‑L |
79144
|
Isolated congenital onychodysplasia
|
ORPHAnet |
| 0‑L |
79145
|
Dowling-Degos disease
|
ORPHAnet |
| 0‑L |
79146
|
Familial progressive hyperpigmentation
|
ORPHAnet |
| 0‑L |
79147
|
Familial reactive perforating collagenosis
|
ORPHAnet |
| 0‑L |
79148
|
Elastosis perforans serpiginosa
|
ORPHAnet |
| 0‑L |
79149
|
Dermochondrocorneal dystrophy
|
ORPHAnet |
| 0‑L |
79150
|
Linear and whorled nevoid hypermelanosis
|
ORPHAnet |
| 0‑L |
79151
|
Acrokeratosis verruciformis of Hopf
|
ORPHAnet |
| 0‑L |
79152
|
Disseminated superficial actinic porokeratosis
|
ORPHAnet |
| 0‑L |
79153
|
Idiopathic trachyonychia
|
ORPHAnet |
| 0‑L |
79154
|
2-aminoadipic 2-oxoadipic aciduria
|
ORPHAnet |
| 0‑L |
79155
|
Hydroxykynureninuria
|
ORPHAnet |
| 0‑L |
79156
|
Seizures-intellectual disability due to hydroxylysinuria syndrome
|
ORPHAnet |
| 0‑L |
79157
|
2-methylbutyryl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
79159
|
Isobutyryl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
79230
|
Hemochromatosis type 2
|
ORPHAnet |
| 0‑L |
79233
|
Hypoxanthine guanine phosphoribosyltransferase partial deficiency
|
ORPHAnet |
| 0‑L |
79234
|
Crigler-Najjar syndrome type 1
|
ORPHAnet |
| 0‑L |
79235
|
Crigler-Najjar syndrome type 2
|
ORPHAnet |
| 0‑L |
79237
|
Galactokinase deficiency
|
ORPHAnet |
| 0‑L |
79238
|
Galactose epimerase deficiency
|
ORPHAnet |
| 0‑L |
79239
|
Classic galactosemia
|
ORPHAnet |
| 0‑L |
79240
|
Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency
|
ORPHAnet |
| 0‑L |
79241
|
Biotinidase deficiency
|
ORPHAnet |
| 0‑L |
79242
|
Holocarboxylase synthetase deficiency
|
ORPHAnet |
| 0‑L |
79243
|
Pyruvate dehydrogenase E1-alpha deficiency
|
ORPHAnet |
| 0‑L |
79244
|
Pyruvate dehydrogenase E2 deficiency
|
ORPHAnet |
| 0‑L |
79246
|
Pyruvate dehydrogenase phosphatase deficiency
|
ORPHAnet |
| 0‑L |
79253
|
Mild phenylketonuria
|
ORPHAnet |
| 0‑L |
79254
|
Classic phenylketonuria
|
ORPHAnet |
| 0‑L |
79255
|
GM1 gangliosidosis type 1
|
ORPHAnet |
| 0‑L |
79256
|
GM1 gangliosidosis type 2
|
ORPHAnet |
| 0‑L |
79257
|
GM1 gangliosidosis type 3
|
ORPHAnet |
| 0‑L |
79258
|
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
|
ORPHAnet |
| 0‑L |
79259
|
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
|
ORPHAnet |
| 0‑L |
79262
|
Adult neuronal ceroid lipofuscinosis
|
ORPHAnet |
| 0‑L |
79263
|
Infantile neuronal ceroid lipofuscinosis
|
ORPHAnet |
| 0‑L |
79264
|
Juvenile neuronal ceroid lipofuscinosis
|
ORPHAnet |
| 0‑L |
79269
|
Sanfilippo syndrome type A
|
ORPHAnet |
| 0‑L |
79270
|
Sanfilippo syndrome type B
|
ORPHAnet |
| 0‑L |
79271
|
Sanfilippo syndrome type C
|
ORPHAnet |
| 0‑L |
79272
|
Sanfilippo syndrome type D
|
ORPHAnet |
| 0‑L |
79273
|
Hereditary coproporphyria
|
ORPHAnet |
| 0‑L |
79276
|
Acute intermittent porphyria
|
ORPHAnet |
| 0‑L |
79277
|
Congenital erythropoietic porphyria
|
ORPHAnet |
| 0‑L |
79278
|
Autosomal erythropoietic protoporphyria
|
ORPHAnet |
| 0‑L |
79279
|
Alpha-N-acetylgalactosaminidase deficiency type 1
|
ORPHAnet |
| 0‑L |
79280
|
Alpha-N-acetylgalactosaminidase deficiency type 2
|
ORPHAnet |
| 0‑L |
79281
|
Alpha-N-acetylgalactosaminidase deficiency type 3
|
ORPHAnet |
| 0‑L |
79282
|
Methylmalonic acidemia with homocystinuria, type cblC
|
ORPHAnet |
| 0‑L |
79283
|
Methylmalonic acidemia with homocystinuria, type cblD
|
ORPHAnet |
| 0‑L |
79284
|
Methylmalonic acidemia with homocystinuria type cblF
|
ORPHAnet |
| 0‑L |
79292
|
Fish-eye disease
|
ORPHAnet |
| 0‑L |
79293
|
Familial LCAT deficiency
|
ORPHAnet |
| 0‑L |
79299
|
Hyperinsulinism due to glucokinase deficiency
|
ORPHAnet |
| 0‑L |
79301
|
Congenital bile acid synthesis defect type 1
|
ORPHAnet |
| 0‑L |
79302
|
Congenital bile acid synthesis defect type 3
|
ORPHAnet |
| 0‑L |
79303
|
Congenital bile acid synthesis defect type 2
|
ORPHAnet |
| 0‑L |
79304
|
Progressive familial intrahepatic cholestasis type 2
|
ORPHAnet |
| 0‑L |
79305
|
Progressive familial intrahepatic cholestasis type 3
|
ORPHAnet |
| 0‑L |
79306
|
Progressive familial intrahepatic cholestasis type 1
|
ORPHAnet |
| 0‑L |
79310
|
Vitamin B12-responsive methylmalonic acidemia type cblA
|
ORPHAnet |
| 0‑L |
79311
|
Vitamin B12-responsive methylmalonic acidemia type cblB
|
ORPHAnet |
| 0‑L |
79312
|
Vitamin B12-unresponsive methylmalonic acidemia type mut-
|
ORPHAnet |
| 0‑L |
79314
|
L-2-hydroxyglutaric aciduria
|
ORPHAnet |
| 0‑L |
79315
|
D-2-hydroxyglutaric aciduria
|
ORPHAnet |
| 0‑L |
79318
|
PMM2-CDG
|
ORPHAnet |
| 0‑L |
79319
|
MPI-CDG
|
ORPHAnet |
| 0‑L |
79320
|
ALG6-CDG
|
ORPHAnet |
| 0‑L |
79321
|
ALG3-CDG
|
ORPHAnet |
| 0‑L |
79322
|
DPM1-CDG
|
ORPHAnet |
| 0‑L |
79323
|
MPDU1-CDG
|
ORPHAnet |
| 0‑L |
79324
|
ALG12-CDG
|
ORPHAnet |
| 0‑L |
79325
|
ALG8-CDG
|
ORPHAnet |
| 0‑L |
79326
|
ALG2-CDG
|
ORPHAnet |
| 0‑L |
79327
|
ALG1-CDG
|
ORPHAnet |
| 0‑L |
79328
|
ALG9-CDG
|
ORPHAnet |
| 0‑L |
79329
|
MGAT2-CDG
|
ORPHAnet |
| 0‑L |
79330
|
MOGS-CDG
|
ORPHAnet |
| 0‑L |
79332
|
B4GALT1-CDG
|
ORPHAnet |
| 0‑L |
79333
|
COG7-CDG
|
ORPHAnet |
| 0‑L |
79345
|
Brachytelephalangic chondrodysplasia punctata
|
ORPHAnet |
| 0‑L |
79346
|
Chondrodysplasia punctata, tibial-metacarpal type
|
ORPHAnet |
| 0‑L |
79347
|
Chondrodysplasia punctata, Toriello type
|
ORPHAnet |
| 0‑L |
79350
|
3-phosphoserine phosphatase deficiency, infantile/juvenile form
|
ORPHAnet |
| 0‑L |
79351
|
3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form
|
ORPHAnet |
| 0‑L |
79394
|
Congenital non-bullous ichthyosiform erythroderma
|
ORPHAnet |
| 0‑L |
79395
|
Keratoderma hereditarium mutilans with ichthyosis
|
ORPHAnet |
| 0‑L |
79396
|
Autosomal dominant generalized epidermolysis bullosa simplex, severe form
|
ORPHAnet |
| 0‑L |
79397
|
Epidermolysis bullosa simplex with mottled pigmentation
|
ORPHAnet |
| 0‑L |
79399
|
Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form
|
ORPHAnet |
| 0‑L |
79400
|
Localized epidermolysis bullosa simplex
|
ORPHAnet |
| 0‑L |
79401
|
PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement
|
ORPHAnet |
| 0‑L |
79402
|
Intermediate generalized junctional epidermolysis bullosa
|
ORPHAnet |
| 0‑L |
79403
|
Junctional epidermolysis bullosa with pyloric atresia
|
ORPHAnet |
| 0‑L |
79404
|
Severe generalized junctional epidermolysis bullosa
|
ORPHAnet |
| 0‑L |
79405
|
Junctional epidermolysis bullosa inversa
|
ORPHAnet |
| 0‑L |
79406
|
Late-onset junctional epidermolysis bullosa
|
ORPHAnet |
| 0‑L |
79408
|
Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form
|
ORPHAnet |
| 0‑L |
79409
|
Recessive dystrophic epidermolysis bullosa inversa
|
ORPHAnet |
| 0‑L |
79410
|
Localized dystrophic epidermolysis bullosa, pretibial form
|
ORPHAnet |
| 0‑L |
79411
|
Self-improving dystrophic epidermolysis bullosa
|
ORPHAnet |
| 0‑L |
79414
|
Woolly hair nevus
|
ORPHAnet |
| 0‑L |
79430
|
Hermansky-Pudlak syndrome
|
ORPHAnet |
| 0‑L |
79431
|
Oculocutaneous albinism type 1A
|
ORPHAnet |
| 0‑L |
79432
|
Oculocutaneous albinism type 2
|
ORPHAnet |
| 0‑L |
79433
|
Oculocutaneous albinism type 3
|
ORPHAnet |
| 0‑L |
79434
|
Oculocutaneous albinism type 1B
|
ORPHAnet |
| 0‑L |
79435
|
Oculocutaneous albinism type 4
|
ORPHAnet |
| 0‑L |
79443
|
Pseudohypoparathyroidism type 1A
|
ORPHAnet |
| 0‑L |
79444
|
Pseudohypoparathyroidism type 1C
|
ORPHAnet |
| 0‑L |
79445
|
Pseudopseudohypoparathyroidism
|
ORPHAnet |
| 0‑L |
79447
|
X-linked lethal multiple pterygium syndrome
|
ORPHAnet |
| 0‑L |
79452
|
Milroy disease
|
ORPHAnet |
| 0‑L |
79455
|
Cutaneous mastocytoma
|
ORPHAnet |
| 0‑L |
79456
|
Diffuse cutaneous mastocytosis
|
ORPHAnet |
| 0‑L |
79457
|
Maculopapular cutaneous mastocytosis
|
ORPHAnet |
| 0‑L |
79466
|
Inflammatory linear verrucous epidermal nevus
|
ORPHAnet |
| 0‑L |
79467
|
Verrucous nevus
|
ORPHAnet |
| 0‑L |
79468
|
Acanthokeratolytic verrucous nevus
|
ORPHAnet |
| 0‑L |
79473
|
Porphyria variegata
|
ORPHAnet |
| 0‑L |
79474
|
Atypical Werner syndrome
|
ORPHAnet |
| 0‑L |
79476
|
Griscelli syndrome type 1
|
ORPHAnet |
| 0‑L |
79477
|
Griscelli syndrome type 2
|
ORPHAnet |
| 0‑L |
79478
|
Griscelli syndrome type 3
|
ORPHAnet |
| 0‑L |
79479
|
Pemphigus vegetans
|
ORPHAnet |
| 0‑L |
79480
|
Pemphigus erythematosus
|
ORPHAnet |
| 0‑L |
79481
|
Pemphigus foliaceus
|
ORPHAnet |
| 0‑L |
79483
|
Phakomatosis cesioflammea
|
ORPHAnet |
| 0‑L |
79484
|
Phakomatosis cesiomarmorata
|
ORPHAnet |
| 0‑L |
79485
|
Phakomatosis spilorosea
|
ORPHAnet |
| 0‑L |
79489
|
Macrocystic lymphatic malformation
|
ORPHAnet |
| 0‑L |
79490
|
Microcystic lymphatic malformation
|
ORPHAnet |
| 0‑L |
79492
|
Pili gemini
|
ORPHAnet |
| 0‑L |
79493
|
Brooke-Spiegler syndrome
|
ORPHAnet |
| 0‑L |
79495
|
X-linked congenital generalized hypertrichosis
|
ORPHAnet |
| 0‑L |
79499
|
Autosomal dominant deafness-onychodystrophy syndrome
|
ORPHAnet |
| 0‑L |
79500
|
DOORS syndrome
|
ORPHAnet |
| 0‑L |
79501
|
Punctate palmoplantar keratoderma type 1
|
ORPHAnet |
| 0‑L |
79502
|
Punctate palmoplantar keratoderma type 2
|
ORPHAnet |
| 0‑L |
79503
|
Ichthyosis hystrix of Curth-Macklin
|
ORPHAnet |
| 0‑L |
79506
|
Cholesterol-ester transfer protein deficiency
|
ORPHAnet |
| 0‑L |
79507
|
Hypotonia-failure to thrive-microcephaly syndrome
|
ORPHAnet |
| 0‑L |
79643
|
Autosomal recessive hyperinsulinism due to SUR1 deficiency
|
ORPHAnet |
| 0‑L |
79644
|
Autosomal recessive hyperinsulinism due to Kir6.2 deficiency
|
ORPHAnet |
| 0‑L |
79651
|
Mild hyperphenylalaninemia
|
ORPHAnet |
| 0‑L |
79665
|
Gardner syndrome
|
ORPHAnet |
| 0‑L |
83311
|
Rocky Mountain spotted fever
|
ORPHAnet |
| 0‑L |
83312
|
Rickettsialpox
|
ORPHAnet |
| 0‑L |
83313
|
Boutonneuse fever
|
ORPHAnet |
| 0‑L |
83314
|
Epidemic typhus
|
ORPHAnet |
| 0‑L |
83315
|
Murine typhus
|
ORPHAnet |
| 0‑L |
83316
|
Pseudotyphus of California
|
ORPHAnet |
| 0‑L |
83317
|
Scrub typhus
|
ORPHAnet |
| 0‑L |
83330
|
Proximal spinal muscular atrophy type 1
|
ORPHAnet |
| 0‑L |
83418
|
Proximal spinal muscular atrophy type 2
|
ORPHAnet |
| 0‑L |
83419
|
Proximal spinal muscular atrophy type 3
|
ORPHAnet |
| 0‑L |
83420
|
Proximal spinal muscular atrophy type 4
|
ORPHAnet |
| 0‑L |
83450
|
Regional odontodysplasia
|
ORPHAnet |
| 0‑L |
83451
|
Florid cemento-osseous dysplasia
|
ORPHAnet |
| 0‑L |
83452
|
Complex regional pain syndrome
|
ORPHAnet |
| 0‑L |
83453
|
Vulvovaginal gingival syndrome
|
ORPHAnet |
| 0‑L |
83454
|
Glomuvenous malformation
|
ORPHAnet |
| 0‑L |
83461
|
Congenital primary aphakia
|
ORPHAnet |
| 0‑L |
83463
|
Microtia
|
ORPHAnet |
| 0‑L |
83465
|
Narcolepsy type 2
|
ORPHAnet |
| 0‑L |
83467
|
Morvan syndrome
|
ORPHAnet |
| 0‑L |
83468
|
Solitary bone cyst
|
ORPHAnet |
| 0‑L |
83469
|
Desmoplastic small round cell tumor
|
ORPHAnet |
| 0‑L |
83471
|
Thymic aplasia
|
ORPHAnet |
| 0‑L |
83472
|
CAMOS syndrome
|
ORPHAnet |
| 0‑L |
83473
|
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
|
ORPHAnet |
| 0‑L |
83476
|
West-Nile encephalitis
|
ORPHAnet |
| 0‑L |
83482
|
Mycoplasma encephalitis
|
ORPHAnet |
| 0‑L |
83483
|
La Crosse encephalitis
|
ORPHAnet |
| 0‑L |
83484
|
St. Louis encephalitis
|
ORPHAnet |
| 0‑L |
83593
|
Western equine encephalitis
|
ORPHAnet |
| 0‑L |
83594
|
Eastern equine encephalitis
|
ORPHAnet |
| 0‑L |
83595
|
Colorado tick fever
|
ORPHAnet |
| 0‑L |
83597
|
Acute disseminated encephalomyelitis
|
ORPHAnet |
| 0‑L |
83600
|
Encephalitis lethargica
|
ORPHAnet |
| 0‑L |
83601
|
Steroid-responsive encephalopathy associated with autoimmune thyroiditis
|
ORPHAnet |
| 0‑L |
83616
|
Rubella panencephalitis
|
ORPHAnet |
| 0‑L |
83617
|
Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome
|
ORPHAnet |
| 0‑L |
83619
|
Macrostomia-preauricular tags-external ophthalmoplegia syndrome
|
ORPHAnet |
| 0‑L |
83620
|
Enteric anendocrinosis
|
ORPHAnet |
| 0‑L |
83628
|
LUMBAR syndrome
|
ORPHAnet |
| 0‑L |
83629
|
Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
83639
|
Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency
|
ORPHAnet |
| 0‑L |
83642
|
Microcytic anemia with liver iron overload
|
ORPHAnet |
| 0‑L |
84064
|
Syndromic diarrhea
|
ORPHAnet |
| 0‑L |
84065
|
Idiopathic malabsorption due to bile acid synthesis defects
|
ORPHAnet |
| 0‑L |
84081
|
Senior-Boichis syndrome
|
ORPHAnet |
| 0‑L |
84085
|
Hinman syndrome
|
ORPHAnet |
| 0‑L |
84087
|
Collagen type III glomerulopathy
|
ORPHAnet |
| 0‑L |
84090
|
Fibronectin glomerulopathy
|
ORPHAnet |
| 0‑L |
84093
|
Hereditary thermosensitive neuropathy
|
ORPHAnet |
| 0‑L |
84132
|
Desmin-related myopathy with Mallory body-like inclusions
|
ORPHAnet |
| 0‑L |
84142
|
Isaacs syndrome
|
ORPHAnet |
| 0‑L |
85110
|
Familial encephalopathy with neuroserpin inclusion bodies
|
ORPHAnet |
| 0‑L |
85112
|
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma
syndrome
|
ORPHAnet |
| 0‑L |
85128
|
Bothnia retinal dystrophy
|
ORPHAnet |
| 0‑L |
85136
|
Cystic leukoencephalopathy without megalencephaly
|
ORPHAnet |
| 0‑L |
85138
|
Addison disease
|
ORPHAnet |
| 0‑L |
85146
|
Neurogenic scapuloperoneal syndrome, Kaeser type
|
ORPHAnet |
| 0‑L |
85162
|
Facial onset sensory and motor neuronopathy
|
ORPHAnet |
| 0‑L |
85163
|
Hypomyelination-congenital cataract syndrome
|
ORPHAnet |
| 0‑L |
85164
|
Camptodactyly-tall stature-scoliosis-hearing loss syndrome
|
ORPHAnet |
| 0‑L |
85165
|
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome
|
ORPHAnet |
| 0‑L |
85166
|
Platyspondylic dysplasia, Torrance type
|
ORPHAnet |
| 0‑L |
85167
|
Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome
|
ORPHAnet |
| 0‑L |
85168
|
Craniofacial conodysplasia
|
ORPHAnet |
| 0‑L |
85169
|
Familial digital arthropathy-brachydactyly
|
ORPHAnet |
| 0‑L |
85170
|
Mesomelic dysplasia, Savarirayan type
|
ORPHAnet |
| 0‑L |
85172
|
Microcephalic osteodysplastic dysplasia, Saul-Wilson type
|
ORPHAnet |
| 0‑L |
85173
|
IMAGe syndrome
|
ORPHAnet |
| 0‑L |
85174
|
Pseudodiastrophic dysplasia
|
ORPHAnet |
| 0‑L |
85175
|
Astley-Kendall dysplasia
|
ORPHAnet |
| 0‑L |
85179
|
Infantile osteopetrosis with neuroaxonal dysplasia
|
ORPHAnet |
| 0‑L |
85182
|
Diaphyseal medullary stenosis-bone malignancy syndrome
|
ORPHAnet |
| 0‑L |
85184
|
Craniometadiaphyseal dysplasia, wormian bone type
|
ORPHAnet |
| 0‑L |
85186
|
Endosteal sclerosis-cerebellar hypoplasia syndrome
|
ORPHAnet |
| 0‑L |
85188
|
Metaphyseal dysplasia, Braun-Tinschert type
|
ORPHAnet |
| 0‑L |
85191
|
Singleton-Merten dysplasia
|
ORPHAnet |
| 0‑L |
85192
|
Calvarial doughnut lesions-bone fragility syndrome
|
ORPHAnet |
| 0‑L |
85193
|
Idiopathic juvenile osteoporosis
|
ORPHAnet |
| 0‑L |
85194
|
Spondylo-ocular syndrome
|
ORPHAnet |
| 0‑L |
85195
|
Familial expansile osteolysis
|
ORPHAnet |
| 0‑L |
85197
|
Genochondromatosis type 1
|
ORPHAnet |
| 0‑L |
85198
|
Dysspondyloenchondromatosis
|
ORPHAnet |
| 0‑L |
85199
|
Craniosynostosis-anal anomalies-porokeratosis syndrome
|
ORPHAnet |
| 0‑L |
85200
|
Ischiovertebral syndrome
|
ORPHAnet |
| 0‑L |
85201
|
Genitopatellar syndrome
|
ORPHAnet |
| 0‑L |
85202
|
Keutel syndrome
|
ORPHAnet |
| 0‑L |
85203
|
Acropectoral syndrome
|
ORPHAnet |
| 0‑L |
85212
|
Fetal Gaucher disease
|
ORPHAnet |
| 0‑L |
85273
|
X-linked intellectual disability, Abidi type
|
ORPHAnet |
| 0‑L |
85274
|
Syndromic X-linked intellectual disability 7
|
ORPHAnet |
| 0‑L |
85275
|
Microphthalmia-ankyloblepharon-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
85276
|
X-linked intellectual disability, Armfield type
|
ORPHAnet |
| 0‑L |
85277
|
X-linked intellectual disability, Cantagrel type
|
ORPHAnet |
| 0‑L |
85278
|
Christianson syndrome
|
ORPHAnet |
| 0‑L |
85279
|
KDM5C-related syndromic X-linked intellectual disability
|
ORPHAnet |
| 0‑L |
85280
|
X-linked intellectual disability-cubitus valgus-dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
85282
|
MEHMO syndrome
|
ORPHAnet |
| 0‑L |
85283
|
X-linked intellectual disability, Miles-Carpenter type
|
ORPHAnet |
| 0‑L |
85284
|
BRESEK syndrome
|
ORPHAnet |
| 0‑L |
85285
|
X-linked intellectual disability, Schimke type
|
ORPHAnet |
| 0‑L |
85286
|
X-linked intellectual disability, Shashi type
|
ORPHAnet |
| 0‑L |
85287
|
X-linked intellectual disability, Siderius type
|
ORPHAnet |
| 0‑L |
85288
|
X-linked intellectual disability, Stocco Dos Santos type
|
ORPHAnet |
| 0‑L |
85290
|
X-linked intellectual disability, Wilson type
|
ORPHAnet |
| 0‑L |
85292
|
X-linked spinocerebellar ataxia type 4
|
ORPHAnet |
| 0‑L |
85293
|
X-linked intellectual disability, Cabezas type
|
ORPHAnet |
| 0‑L |
85294
|
X-linked epilepsy-learning disabilities-behavior disorders syndrome
|
ORPHAnet |
| 0‑L |
85295
|
HSD10 disease, atypical type
|
ORPHAnet |
| 0‑L |
85297
|
X-linked spinocerebellar ataxia type 3
|
ORPHAnet |
| 0‑L |
85317
|
X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration
syndrome
|
ORPHAnet |
| 0‑L |
85319
|
X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism
syndrome
|
ORPHAnet |
| 0‑L |
85320
|
X-linked intellectual disability-macrocephaly-macroorchidism syndrome
|
ORPHAnet |
| 0‑L |
85321
|
Deafness-intellectual disability syndrome, Martin-Probst type
|
ORPHAnet |
| 0‑L |
85322
|
X-linked intellectual disability, Pai type
|
ORPHAnet |
| 0‑L |
85323
|
X-linked intellectual disability, Seemanova type
|
ORPHAnet |
| 0‑L |
85324
|
X-linked intellectual disability, Shrimpton type
|
ORPHAnet |
| 0‑L |
85325
|
X-linked intellectual disability, Stevenson type
|
ORPHAnet |
| 0‑L |
85326
|
X-linked intellectual disability, Stoll type
|
ORPHAnet |
| 0‑L |
85327
|
X-linked intellectual disability-acromegaly-hyperactivity syndrome
|
ORPHAnet |
| 0‑L |
85329
|
X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior
syndrome
|
ORPHAnet |
| 0‑L |
85332
|
X-linked intellectual disability-retinitis pigmentosa syndrome
|
ORPHAnet |
| 0‑L |
85334
|
X-linked neurodegenerative syndrome, Bertini type
|
ORPHAnet |
| 0‑L |
85335
|
Fried syndrome
|
ORPHAnet |
| 0‑L |
85336
|
X-linked neurodegenerative syndrome, Hamel type
|
ORPHAnet |
| 0‑L |
85338
|
X-linked intellectual disability-ataxia-apraxia syndrome
|
ORPHAnet |
| 0‑L |
85408
|
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis
|
ORPHAnet |
| 0‑L |
85410
|
Oligoarticular juvenile idiopathic arthritis
|
ORPHAnet |
| 0‑L |
85414
|
Systemic-onset juvenile idiopathic arthritis
|
ORPHAnet |
| 0‑L |
85435
|
Rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
|
ORPHAnet |
| 0‑L |
85436
|
Psoriasis-related juvenile idiopathic arthritis
|
ORPHAnet |
| 0‑L |
85438
|
Enthesitis-related juvenile idiopathic arthritis
|
ORPHAnet |
| 0‑L |
85442
|
Short stature-pituitary and cerebellar defects-small sella turcica syndrome
|
ORPHAnet |
| 0‑L |
85443
|
AL amyloidosis
|
ORPHAnet |
| 0‑L |
85445
|
AA amyloidosis
|
ORPHAnet |
| 0‑L |
85446
|
Wild type ABeta2M amyloidosis
|
ORPHAnet |
| 0‑L |
85447
|
ATTRV30M amyloidosis
|
ORPHAnet |
| 0‑L |
85448
|
AGel amyloidosis
|
ORPHAnet |
| 0‑L |
85450
|
Hereditary amyloidosis with primary renal involvement
|
ORPHAnet |
| 0‑L |
85451
|
ATTRV122I amyloidosis
|
ORPHAnet |
| 0‑L |
85453
|
X-linked reticulate pigmentary disorder
|
ORPHAnet |
| 0‑L |
85458
|
Hereditary cerebral hemorrhage with amyloidosis
|
ORPHAnet |
| 0‑L |
86309
|
DPAGT1-CDG
|
ORPHAnet |
| 0‑L |
86788
|
X-linked severe congenital neutropenia
|
ORPHAnet |
| 0‑L |
86789
|
Patella aplasia/hypoplasia
|
ORPHAnet |
| 0‑L |
86797
|
Atypical lichen myxedematosus
|
ORPHAnet |
| 0‑L |
86812
|
POMT1-related limb-girdle muscular dystrophy R11
|
ORPHAnet |
| 0‑L |
86813
|
Helicoid peripapillary chorioretinal degeneration
|
ORPHAnet |
| 0‑L |
86814
|
Benign adult familial myoclonic epilepsy
|
ORPHAnet |
| 0‑L |
86815
|
Aplasia of lacrimal and salivary glands
|
ORPHAnet |
| 0‑L |
86816
|
Congenital analbuminemia
|
ORPHAnet |
| 0‑L |
86817
|
Hemolytic anemia due to adenylate kinase deficiency
|
ORPHAnet |
| 0‑L |
86818
|
Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome
|
ORPHAnet |
| 0‑L |
86819
|
Atrichia with papular lesions
|
ORPHAnet |
| 0‑L |
86820
|
Familial avascular necrosis of femoral head
|
ORPHAnet |
| 0‑L |
86821
|
Lissencephaly type 3-familial fetal akinesia sequence syndrome
|
ORPHAnet |
| 0‑L |
86822
|
Lissencephaly type 3-metacarpal bone dysplasia syndrome
|
ORPHAnet |
| 0‑L |
86829
|
Chronic neutrophilic leukemia
|
ORPHAnet |
| 0‑L |
86830
|
Chronic myeloproliferative disease, unclassifiable
|
ORPHAnet |
| 0‑L |
86834
|
Juvenile myelomonocytic leukemia
|
ORPHAnet |
| 0‑L |
86839
|
Refractory anemia with excess blasts
|
ORPHAnet |
| 0‑L |
86841
|
Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
|
ORPHAnet |
| 0‑L |
86843
|
Acute panmyelosis with myelofibrosis
|
ORPHAnet |
| 0‑L |
86845
|
Acute myeloid leukaemia with myelodysplasia-related features
|
ORPHAnet |
| 0‑L |
86849
|
Acute basophilic leukemia
|
ORPHAnet |
| 0‑L |
86850
|
Myeloid sarcoma
|
ORPHAnet |
| 0‑L |
86852
|
B-cell prolymphocytic leukemia
|
ORPHAnet |
| 0‑L |
86854
|
Splenic marginal zone lymphoma
|
ORPHAnet |
| 0‑L |
86855
|
Plasmacytoma
|
ORPHAnet |
| 0‑L |
86861
|
Non-amyloid monoclonal immunoglobulin deposition disease
|
ORPHAnet |
| 0‑L |
86864
|
Heavy chain disease
|
ORPHAnet |
| 0‑L |
86867
|
Nodal marginal zone B-cell lymphoma
|
ORPHAnet |
| 0‑L |
86869
|
Lymphomatoid granulomatosis
|
ORPHAnet |
| 0‑L |
86870
|
CD4+/CD56+ hematodermic neoplasm
|
ORPHAnet |
| 0‑L |
86871
|
T-cell prolymphocytic leukemia
|
ORPHAnet |
| 0‑L |
86872
|
T-cell large granular lymphocyte leukemia
|
ORPHAnet |
| 0‑L |
86873
|
Aggressive NK-cell leukemia
|
ORPHAnet |
| 0‑L |
86875
|
Adult T-cell leukemia/lymphoma
|
ORPHAnet |
| 0‑L |
86879
|
Extranodal nasal NK/T cell lymphoma
|
ORPHAnet |
| 0‑L |
86880
|
Enteropathy-associated T-cell lymphoma
|
ORPHAnet |
| 0‑L |
86882
|
Hepatosplenic T-cell lymphoma
|
ORPHAnet |
| 0‑L |
86884
|
Subcutaneous panniculitis-like T-cell lymphoma
|
ORPHAnet |
| 0‑L |
86885
|
Primary cutaneous peripheral T-cell lymphoma not otherwise specified
|
ORPHAnet |
| 0‑L |
86886
|
Angioimmunoblastic T-cell lymphoma
|
ORPHAnet |
| 0‑L |
86893
|
Nodular lymphocyte predominant Hodgkin lymphoma
|
ORPHAnet |
| 0‑L |
86896
|
Histiocytic sarcoma
|
ORPHAnet |
| 0‑L |
86897
|
Langerhans cell sarcoma
|
ORPHAnet |
| 0‑L |
86900
|
Interdigitating dendritic cell sarcoma
|
ORPHAnet |
| 0‑L |
86902
|
Follicular dendritic cell sarcoma
|
ORPHAnet |
| 0‑L |
86903
|
Dendritic cell sarcoma not otherwise specified
|
ORPHAnet |
| 0‑L |
86904
|
Methotrexate-associated lymphoproliferative disorders
|
ORPHAnet |
| 0‑L |
86906
|
Hypothalamic hamartomas with gelastic seizures
|
ORPHAnet |
| 0‑L |
86908
|
Idiopathic hemiconvulsion-hemiplegia syndrome
|
ORPHAnet |
| 0‑L |
86909
|
Myoclonic epilepsy of infancy
|
ORPHAnet |
| 0‑L |
86911
|
Epilepsy with myoclonic absences
|
ORPHAnet |
| 0‑L |
86913
|
Myoclonic epilepsy in non-progressive encephalopathies
|
ORPHAnet |
| 0‑L |
86914
|
Lymphedema-cerebral arteriovenous anomaly syndrome
|
ORPHAnet |
| 0‑L |
86915
|
Lymphedema-atrial septal defects-facial changes syndrome
|
ORPHAnet |
| 0‑L |
86918
|
Diffuse palmoplantar keratoderma-acrocyanosis syndrome
|
ORPHAnet |
| 0‑L |
86919
|
Keratosis palmaris et plantaris-clinodactyly syndrome
|
ORPHAnet |
| 0‑L |
86920
|
Dermatopathia pigmentosa reticularis
|
ORPHAnet |
| 0‑L |
86923
|
Hereditary palmoplantar keratoderma, Gamborg-Nielsen type
|
ORPHAnet |
| 0‑L |
87503
|
Mal de Meleda
|
ORPHAnet |
| 0‑L |
87876
|
Sialidosis type 2
|
ORPHAnet |
| 0‑L |
87884
|
Non-syndromic genetic deafness
|
ORPHAnet |
| 0‑L |
88616
|
Autosomal recessive non-syndromic intellectual disability
|
ORPHAnet |
| 0‑L |
88618
|
S-adenosylhomocysteine hydrolase deficiency
|
ORPHAnet |
| 0‑L |
88619
|
Familial acute necrotizing encephalopathy
|
ORPHAnet |
| 0‑L |
88620
|
Isolated congenital anosmia
|
ORPHAnet |
| 0‑L |
88621
|
Ichthyosis-prematurity syndrome
|
ORPHAnet |
| 0‑L |
88628
|
Posterior column ataxia-retinitis pigmentosa syndrome
|
ORPHAnet |
| 0‑L |
88629
|
Tritanopia
|
ORPHAnet |
| 0‑L |
88630
|
Terminal osseous dysplasia-pigmentary defects syndrome
|
ORPHAnet |
| 0‑L |
88633
|
Superior limbic keratoconjunctivitis
|
ORPHAnet |
| 0‑L |
88635
|
Vacuolar myopathy with sarcoplasmic reticulum protein aggregates
|
ORPHAnet |
| 0‑L |
88637
|
Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome
|
ORPHAnet |
| 0‑L |
88639
|
Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency
|
ORPHAnet |
| 0‑L |
88642
|
Congenital insensitivity to pain-anosmia-neuropathic arthropathy
|
ORPHAnet |
| 0‑L |
88643
|
Obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
88644
|
Autosomal recessive ataxia, Beauce type
|
ORPHAnet |
| 0‑L |
88659
|
Autosomal dominant progressive nephropathy with hypertension
|
ORPHAnet |
| 0‑L |
88660
|
Hypertension due to gain-of-function mutations in the mineralocorticoid receptor
|
ORPHAnet |
| 0‑L |
88661
|
Amelogenesis imperfecta
|
ORPHAnet |
| 0‑L |
88917
|
X-linked Alport syndrome
|
ORPHAnet |
| 0‑L |
88918
|
Autosomal dominant Alport syndrome
|
ORPHAnet |
| 0‑L |
88919
|
Autosomal recessive Alport syndrome
|
ORPHAnet |
| 0‑L |
88924
|
Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis
|
ORPHAnet |
| 0‑L |
88938
|
Pseudohypoaldosteronism type 2A
|
ORPHAnet |
| 0‑L |
88939
|
Pseudohypoaldosteronism type 2B
|
ORPHAnet |
| 0‑L |
88940
|
Pseudohypoaldosteronism type 2C
|
ORPHAnet |
| 0‑L |
88949
|
MUC1-related autosomal dominant tubulointerstitial kidney disease
|
ORPHAnet |
| 0‑L |
88950
|
UMOD-related autosomal dominant tubulointerstitial kidney disease
|
ORPHAnet |
| 0‑L |
89838
|
Autosomal recessive generalized epidermolysis bullosa simplex
|
ORPHAnet |
| 0‑L |
89842
|
Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form
|
ORPHAnet |
| 0‑L |
89843
|
Dystrophic epidermolysis bullosa pruriginosa
|
ORPHAnet |
| 0‑L |
89844
|
Lissencephaly syndrome, Norman-Roberts type
|
ORPHAnet |
| 0‑L |
89936
|
X-linked hypophosphatemia
|
ORPHAnet |
| 0‑L |
89937
|
Autosomal dominant hypophosphatemic rickets
|
ORPHAnet |
| 0‑L |
89938
|
Bartter syndrome type 4
|
ORPHAnet |
| 0‑L |
90000
|
Erythema elevatum diutinum
|
ORPHAnet |
| 0‑L |
90001
|
X-linked cone dysfunction syndrome with myopia
|
ORPHAnet |
| 0‑L |
90002
|
Undifferentiated connective tissue syndrome
|
ORPHAnet |
| 0‑L |
90003
|
Inflammatory pseudotumor of the liver
|
ORPHAnet |
| 0‑L |
90020
|
Parkinson-dementia complex of Guam
|
ORPHAnet |
| 0‑L |
90021
|
Radiation myelitis
|
ORPHAnet |
| 0‑L |
90023
|
Primary immunodeficiency syndrome due to LAMTOR2 deficiency
|
ORPHAnet |
| 0‑L |
90024
|
Deafness with labyrinthine aplasia, microtia, and microdontia
|
ORPHAnet |
| 0‑L |
90026
|
Primary erythromelalgia
|
ORPHAnet |
| 0‑L |
90030
|
Hemolytic anemia due to glutathione reductase deficiency
|
ORPHAnet |
| 0‑L |
90031
|
Non-spherocytic hemolytic anemia due to hexokinase deficiency
|
ORPHAnet |
| 0‑L |
90033
|
Autoimmune hemolytic anemia, warm type
|
ORPHAnet |
| 0‑L |
90035
|
Paroxysmal cold hemoglobinuria
|
ORPHAnet |
| 0‑L |
90036
|
Mixed-type autoimmune hemolytic anemia
|
ORPHAnet |
| 0‑L |
90037
|
Drug-induced autoimmune hemolytic anemia
|
ORPHAnet |
| 0‑L |
90038
|
Shiga toxin-associated hemolytic uremic syndrome
|
ORPHAnet |
| 0‑L |
90039
|
Hemoglobin D disease
|
ORPHAnet |
| 0‑L |
90041
|
Gaisböck syndrome
|
ORPHAnet |
| 0‑L |
90042
|
Primary familial polycythemia
|
ORPHAnet |
| 0‑L |
90044
|
Familial pseudohyperkalemia
|
ORPHAnet |
| 0‑L |
90045
|
Hereditary folate malabsorption
|
ORPHAnet |
| 0‑L |
90050
|
Retinopathy of prematurity
|
ORPHAnet |
| 0‑L |
90051
|
Sepsis in premature infants
|
ORPHAnet |
| 0‑L |
90052
|
Recurrent hepatitis C virus induced liver disease in liver transplant recipients
|
ORPHAnet |
| 0‑L |
90053
|
Complications after hematopoietic stem cell transplantation
|
ORPHAnet |
| 0‑L |
90056
|
Moderate and severe traumatic brain injury
|
ORPHAnet |
| 0‑L |
90058
|
Spinal cord injury
|
ORPHAnet |
| 0‑L |
90059
|
Acute sensorineural hearing loss by acute acoustic trauma or sudden deafness or surgery
induced acoustic trauma
|
ORPHAnet |
| 0‑L |
90060
|
Diffuse alveolar hemorrhage
|
ORPHAnet |
| 0‑L |
90062
|
Acute liver failure
|
ORPHAnet |
| 0‑L |
90064
|
Acute peripheral arterial occlusion
|
ORPHAnet |
| 0‑L |
90065
|
Acquired aneurysmal subarachnoid hemorrhage
|
ORPHAnet |
| 0‑L |
90066
|
Pneumonia caused by Pseudomonas aeruginosa infection
|
ORPHAnet |
| 0‑L |
90068
|
Cocaine intoxication
|
ORPHAnet |
| 0‑L |
90069
|
Systemic monochloroacetate poisoning
|
ORPHAnet |
| 0‑L |
90073
|
Hepatitis B reinfection following liver transplantation
|
ORPHAnet |
| 0‑L |
90076
|
Partial deep dermal and full thickness burns
|
ORPHAnet |
| 0‑L |
90078
|
Invasive infections due to vancomycin-resistant enterococci
|
ORPHAnet |
| 0‑L |
90080
|
Scarring in glaucoma filtration surgical procedures
|
ORPHAnet |
| 0‑L |
90081
|
AIDS wasting syndrome
|
ORPHAnet |
| 0‑L |
90103
|
Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
90117
|
Hereditary motor and sensory neuropathy, Okinawa type
|
ORPHAnet |
| 0‑L |
90118
|
Severe early-onset axonal neuropathy due to MFN2 deficiency
|
ORPHAnet |
| 0‑L |
90119
|
Hereditary motor and sensory neuropathy with acrodystrophy
|
ORPHAnet |
| 0‑L |
90120
|
Hereditary motor and sensory neuropathy type 6
|
ORPHAnet |
| 0‑L |
90153
|
Mandibuloacral dysplasia with type A lipodystrophy
|
ORPHAnet |
| 0‑L |
90154
|
Mandibuloacral dysplasia with type B lipodystrophy
|
ORPHAnet |
| 0‑L |
90156
|
Centrifugal lipodystrophy
|
ORPHAnet |
| 0‑L |
90157
|
Drug-induced localized lipodystrophy
|
ORPHAnet |
| 0‑L |
90158
|
Idiopathic localized lipodystrophy
|
ORPHAnet |
| 0‑L |
90159
|
Panniculitis-induced localized lipodystrophy
|
ORPHAnet |
| 0‑L |
90160
|
Pressure-induced localized lipoatrophy
|
ORPHAnet |
| 0‑L |
90186
|
Meige disease
|
ORPHAnet |
| 0‑L |
90280
|
Chilblain lupus
|
ORPHAnet |
| 0‑L |
90281
|
Discoid lupus erythematosus
|
ORPHAnet |
| 0‑L |
90282
|
Hypertrophic or verrucous lupus erythematosus
|
ORPHAnet |
| 0‑L |
90283
|
Lupus erythematosus tumidus
|
ORPHAnet |
| 0‑L |
90285
|
Lupus erythematosus panniculitis
|
ORPHAnet |
| 0‑L |
90289
|
Localized scleroderma
|
ORPHAnet |
| 0‑L |
90291
|
Systemic sclerosis
|
ORPHAnet |
| 0‑L |
90301
|
Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome
|
ORPHAnet |
| 0‑L |
90307
|
Parkes Weber syndrome
|
ORPHAnet |
| 0‑L |
90308
|
Klippel-Trénaunay syndrome
|
ORPHAnet |
| 0‑L |
90321
|
Cockayne syndrome type 1
|
ORPHAnet |
| 0‑L |
90322
|
Cockayne syndrome type 2
|
ORPHAnet |
| 0‑L |
90324
|
Cockayne syndrome type 3
|
ORPHAnet |
| 0‑L |
90340
|
Blau syndrome
|
ORPHAnet |
| 0‑L |
90342
|
Xeroderma pigmentosum variant
|
ORPHAnet |
| 0‑L |
90348
|
Autosomal dominant cutis laxa
|
ORPHAnet |
| 0‑L |
90349
|
Autosomal recessive cutis laxa type 1
|
ORPHAnet |
| 0‑L |
90354
|
Brittle cornea syndrome
|
ORPHAnet |
| 0‑L |
90362
|
Primary intestinal lymphangiectasia
|
ORPHAnet |
| 0‑L |
90363
|
Secondary intestinal lymphangiectasia
|
ORPHAnet |
| 0‑L |
90368
|
Hypotrichosis simplex of the scalp
|
ORPHAnet |
| 0‑L |
90389
|
Telangiectasia macularis eruptiva perstans
|
ORPHAnet |
| 0‑L |
90390
|
Anonychia-onychodystrophy syndrome
|
ORPHAnet |
| 0‑L |
90393
|
Nodular lichen myxedematosus
|
ORPHAnet |
| 0‑L |
90394
|
Discrete papular lichen myxedematosus
|
ORPHAnet |
| 0‑L |
90395
|
Papular mucinosis of infancy
|
ORPHAnet |
| 0‑L |
90396
|
Acral persistent papular mucinosis
|
ORPHAnet |
| 0‑L |
90397
|
Self-healing papular mucinosis
|
ORPHAnet |
| 0‑L |
90398
|
Localized lichen myxedematosus with mixed features of different subtypes
|
ORPHAnet |
| 0‑L |
90399
|
Localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms
|
ORPHAnet |
| 0‑L |
90400
|
Scleromyxedema without monoclonal gammopathy
|
ORPHAnet |
| 0‑L |
90625
|
X-linked non-syndromic sensorineural deafness type DFN
|
ORPHAnet |
| 0‑L |
90635
|
Autosomal dominant non-syndromic sensorineural deafness type DFNA
|
ORPHAnet |
| 0‑L |
90636
|
Autosomal recessive non-syndromic sensorineural deafness type DFNB
|
ORPHAnet |
| 0‑L |
90641
|
Mitochondrial non-syndromic sensorineural deafness
|
ORPHAnet |
| 0‑L |
90646
|
Deafness-hypogonadism syndrome
|
ORPHAnet |
| 0‑L |
90647
|
Jervell and Lange-Nielsen syndrome
|
ORPHAnet |
| 0‑L |
90650
|
Otopalatodigital syndrome type 1
|
ORPHAnet |
| 0‑L |
90652
|
Otopalatodigital syndrome type 2
|
ORPHAnet |
| 0‑L |
90653
|
Stickler syndrome type 1
|
ORPHAnet |
| 0‑L |
90654
|
Stickler syndrome type 2
|
ORPHAnet |
| 0‑L |
90658
|
Charcot-Marie-Tooth disease type 1E
|
ORPHAnet |
| 0‑L |
90673
|
Hypothyroidism due to TSH receptor mutations
|
ORPHAnet |
| 0‑L |
90674
|
Isolated thyroid-stimulating hormone deficiency
|
ORPHAnet |
| 0‑L |
90695
|
Non-acquired panhypopituitarism
|
ORPHAnet |
| 0‑L |
90790
|
Congenital lipoid adrenal hyperplasia due to STAR deficency
|
ORPHAnet |
| 0‑L |
90791
|
Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
90793
|
Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency
|
ORPHAnet |
| 0‑L |
90794
|
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
|
ORPHAnet |
| 0‑L |
90795
|
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency
|
ORPHAnet |
| 0‑L |
90796
|
46,XY disorder of sex development due to isolated 17,20-lyase deficiency
|
ORPHAnet |
| 0‑L |
90797
|
Partial androgen insensitivity syndrome
|
ORPHAnet |
| 0‑L |
91127
|
Adenovirus infection in immunocompromised patients
|
ORPHAnet |
| 0‑L |
91130
|
Cardiomyopathy-hypotonia-lactic acidosis syndrome
|
ORPHAnet |
| 0‑L |
91131
|
DK1-CDG
|
ORPHAnet |
| 0‑L |
91132
|
Ichthyosis-hypotrichosis syndrome
|
ORPHAnet |
| 0‑L |
91135
|
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency
|
ORPHAnet |
| 0‑L |
91136
|
Acquired monoclonal Ig light chain-associated Fanconi syndrome
|
ORPHAnet |
| 0‑L |
91138
|
Cryoglobulinemic vasculitis
|
ORPHAnet |
| 0‑L |
91139
|
Simple cryoglobulinemia
|
ORPHAnet |
| 0‑L |
91140
|
Unspecified juvenile idiopathic arthritis
|
ORPHAnet |
| 0‑L |
91347
|
TSH-secreting pituitary adenoma
|
ORPHAnet |
| 0‑L |
91348
|
Functioning gonadotropic adenoma
|
ORPHAnet |
| 0‑L |
91349
|
Non-functioning pituitary adenoma
|
ORPHAnet |
| 0‑L |
91350
|
Pituitary deficiency due to Rathke cleft cysts
|
ORPHAnet |
| 0‑L |
91351
|
Pituitary dermoid and epidermoid cysts
|
ORPHAnet |
| 0‑L |
91352
|
Germinoma of the central nervous system
|
ORPHAnet |
| 0‑L |
91354
|
Pituitary deficiency due to empty sella turcica syndrome
|
ORPHAnet |
| 0‑L |
91355
|
Sheehan syndrome
|
ORPHAnet |
| 0‑L |
91358
|
Congenital esophageal diverticulum
|
ORPHAnet |
| 0‑L |
91359
|
Chronic pneumonitis of infancy
|
ORPHAnet |
| 0‑L |
91364
|
Non-specific interstitial pneumonia
|
ORPHAnet |
| 0‑L |
91387
|
Familial thoracic aortic aneurysm and aortic dissection
|
ORPHAnet |
| 0‑L |
91396
|
Isolated cryptophthalmia
|
ORPHAnet |
| 0‑L |
91397
|
Isolated ankyloblepharon filiforme adnatum
|
ORPHAnet |
| 0‑L |
91411
|
Congenital ptosis
|
ORPHAnet |
| 0‑L |
91412
|
Marcus-Gunn syndrome
|
ORPHAnet |
| 0‑L |
91413
|
Congenital Horner syndrome
|
ORPHAnet |
| 0‑L |
91414
|
Pilomatrixoma
|
ORPHAnet |
| 0‑L |
91416
|
Isolated congenital alacrima
|
ORPHAnet |
| 0‑L |
91481
|
Ring dermoid of cornea
|
ORPHAnet |
| 0‑L |
91483
|
Rieger anomaly
|
ORPHAnet |
| 0‑L |
91489
|
Isolated congenital megalocornea
|
ORPHAnet |
| 0‑L |
91490
|
Isolated congenital sclerocornea
|
ORPHAnet |
| 0‑L |
91491
|
Congenital ectropion uveae
|
ORPHAnet |
| 0‑L |
91492
|
Early-onset non-syndromic cataract
|
ORPHAnet |
| 0‑L |
91494
|
Macular coloboma-cleft palate-hallux valgus syndrome
|
ORPHAnet |
| 0‑L |
91495
|
Persistent hyperplastic primary vitreous
|
ORPHAnet |
| 0‑L |
91496
|
Snowflake vitreoretinal degeneration
|
ORPHAnet |
| 0‑L |
91498
|
Familial congenital palsy of trochlear nerve
|
ORPHAnet |
| 0‑L |
91500
|
Tubulointerstitial nephritis and uveitis syndrome
|
ORPHAnet |
| 0‑L |
91546
|
Lyme disease
|
ORPHAnet |
| 0‑L |
91547
|
Relapsing fever
|
ORPHAnet |
| 0‑L |
92050
|
Congenital tufting enteropathy
|
ORPHAnet |
| 0‑L |
93100
|
Renal agenesis, unilateral
|
ORPHAnet |
| 0‑L |
93101
|
Renal hypoplasia
|
ORPHAnet |
| 0‑L |
93108
|
Renal dysplasia
|
ORPHAnet |
| 0‑L |
93109
|
Congenital megacalycosis
|
ORPHAnet |
| 0‑L |
93110
|
Posterior urethral valve
|
ORPHAnet |
| 0‑L |
93111
|
HNF1B-related autosomal dominant tubulointerstitial kidney disease
|
ORPHAnet |
| 0‑L |
93114
|
Autosomal dominant intermediate Charcot-Marie-Tooth disease type E
|
ORPHAnet |
| 0‑L |
93126
|
Pauci-immune glomerulonephritis
|
ORPHAnet |
| 0‑L |
93160
|
Hypocalcemic vitamin D-resistant rickets
|
ORPHAnet |
| 0‑L |
93164
|
Transient pseudohypoaldosteronism
|
ORPHAnet |
| 0‑L |
93172
|
Renal dysplasia, unilateral
|
ORPHAnet |
| 0‑L |
93173
|
Renal dysplasia, bilateral
|
ORPHAnet |
| 0‑L |
93176
|
Unilateral congenital megacalycosis
|
ORPHAnet |
| 0‑L |
93177
|
Congenital bilateral megacalycosis
|
ORPHAnet |
| 0‑L |
93256
|
Fragile X-associated tremor/ataxia syndrome
|
ORPHAnet |
| 0‑L |
93258
|
Pfeiffer syndrome type 1
|
ORPHAnet |
| 0‑L |
93259
|
Pfeiffer syndrome type 2
|
ORPHAnet |
| 0‑L |
93260
|
Pfeiffer syndrome type 3
|
ORPHAnet |
| 0‑L |
93262
|
Crouzon syndrome-acanthosis nigricans syndrome
|
ORPHAnet |
| 0‑L |
93267
|
Cloverleaf skull-multiple congenital anomalies syndrome
|
ORPHAnet |
| 0‑L |
93268
|
Short rib-polydactyly syndrome, Beemer-Langer type
|
ORPHAnet |
| 0‑L |
93269
|
Short rib-polydactyly syndrome, Majewski type
|
ORPHAnet |
| 0‑L |
93270
|
Short rib-polydactyly syndrome, Saldino-Noonan type
|
ORPHAnet |
| 0‑L |
93271
|
Short rib-polydactyly syndrome, Verma-Naumoff type
|
ORPHAnet |
| 0‑L |
93274
|
Thanatophoric dysplasia type 2
|
ORPHAnet |
| 0‑L |
93276
|
Polyostotic fibrous dysplasia
|
ORPHAnet |
| 0‑L |
93277
|
Monostotic fibrous dysplasia
|
ORPHAnet |
| 0‑L |
93279
|
Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis
|
ORPHAnet |
| 0‑L |
93282
|
Spondyloepimetaphyseal dysplasia, PAPSS2 type
|
ORPHAnet |
| 0‑L |
93283
|
Spondyloepiphyseal dysplasia, Kimberley type
|
ORPHAnet |
| 0‑L |
93284
|
Spondyloepiphyseal dysplasia tarda
|
ORPHAnet |
| 0‑L |
93292
|
Adenoma of pancreas
|
ORPHAnet |
| 0‑L |
93293
|
Okihiro syndrome
|
ORPHAnet |
| 0‑L |
93296
|
Achondrogenesis type 2
|
ORPHAnet |
| 0‑L |
93297
|
Hypochondrogenesis
|
ORPHAnet |
| 0‑L |
93298
|
Achondrogenesis type 1B
|
ORPHAnet |
| 0‑L |
93299
|
Achondrogenesis type 1A
|
ORPHAnet |
| 0‑L |
93302
|
Brachyolmia, Maroteaux type
|
ORPHAnet |
| 0‑L |
93304
|
Autosomal dominant brachyolmia
|
ORPHAnet |
| 0‑L |
93307
|
Multiple epiphyseal dysplasia type 4
|
ORPHAnet |
| 0‑L |
93308
|
Multiple epiphyseal dysplasia type 1
|
ORPHAnet |
| 0‑L |
93311
|
Multiple epiphyseal dysplasia type 5
|
ORPHAnet |
| 0‑L |
93314
|
Spondylometaphyseal dysplasia, Kozlowski type
|
ORPHAnet |
| 0‑L |
93315
|
Spondylometaphyseal dysplasia, 'corner fracture' type
|
ORPHAnet |
| 0‑L |
93316
|
Spondylometaphyseal dysplasia, Schmidt type
|
ORPHAnet |
| 0‑L |
93317
|
Spondylometaphyseal dysplasia, Sedaghatian type
|
ORPHAnet |
| 0‑L |
93320
|
Ulnar hemimelia
|
ORPHAnet |
| 0‑L |
93321
|
Radial hemimelia
|
ORPHAnet |
| 0‑L |
93322
|
Tibial hemimelia
|
ORPHAnet |
| 0‑L |
93323
|
Fibular hemimelia
|
ORPHAnet |
| 0‑L |
93324
|
Autosomal recessive Kenny-Caffey syndrome
|
ORPHAnet |
| 0‑L |
93325
|
Autosomal dominant Kenny-Caffey syndrome
|
ORPHAnet |
| 0‑L |
93328
|
Autosomal dominant omodysplasia
|
ORPHAnet |
| 0‑L |
93329
|
Autosomal recessive omodysplasia
|
ORPHAnet |
| 0‑L |
93333
|
Pelviscapular dysplasia
|
ORPHAnet |
| 0‑L |
93334
|
Postaxial polydactyly type A
|
ORPHAnet |
| 0‑L |
93335
|
Postaxial polydactyly type B
|
ORPHAnet |
| 0‑L |
93336
|
Polydactyly of a triphalangeal thumb
|
ORPHAnet |
| 0‑L |
93337
|
Polydactyly of an index finger
|
ORPHAnet |
| 0‑L |
93338
|
Polysyndactyly
|
ORPHAnet |
| 0‑L |
93339
|
Polydactyly of a biphalangeal thumb
|
ORPHAnet |
| 0‑L |
93346
|
Spondyloepimetaphyseal dysplasia congenita, Strudwick type
|
ORPHAnet |
| 0‑L |
93347
|
Anauxetic dysplasia
|
ORPHAnet |
| 0‑L |
93349
|
X-linked spondyloepimetaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
93351
|
Spondyloepimetaphyseal dysplasia, Irapa type
|
ORPHAnet |
| 0‑L |
93352
|
Spondyloepimetaphyseal dysplasia, Shohat type
|
ORPHAnet |
| 0‑L |
93356
|
Spondyloepimetaphyseal dysplasia, Missouri type
|
ORPHAnet |
| 0‑L |
93357
|
SPONASTRIME dysplasia
|
ORPHAnet |
| 0‑L |
93358
|
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome
|
ORPHAnet |
| 0‑L |
93359
|
Spondyloepimetaphyseal dysplasia with joint laxity
|
ORPHAnet |
| 0‑L |
93360
|
Spondyloepimetaphyseal dysplasia with multiple dislocations
|
ORPHAnet |
| 0‑L |
93372
|
Familial hypocalciuric hypercalcemia type 1
|
ORPHAnet |
| 0‑L |
93382
|
Brachydactyly type A6
|
ORPHAnet |
| 0‑L |
93383
|
Brachydactyly type B
|
ORPHAnet |
| 0‑L |
93384
|
Brachydactyly type C
|
ORPHAnet |
| 0‑L |
93387
|
Brachydactyly type E
|
ORPHAnet |
| 0‑L |
93388
|
Brachydactyly type A1
|
ORPHAnet |
| 0‑L |
93394
|
Brachydactyly type A4
|
ORPHAnet |
| 0‑L |
93396
|
Brachydactyly type A2
|
ORPHAnet |
| 0‑L |
93397
|
Brachydactyly type A7
|
ORPHAnet |
| 0‑L |
93398
|
Genochondromatosis type 2
|
ORPHAnet |
| 0‑L |
93399
|
Juvenile sialidosis type 2
|
ORPHAnet |
| 0‑L |
93400
|
Congenital sialidosis type 2
|
ORPHAnet |
| 0‑L |
93402
|
Syndactyly type 1
|
ORPHAnet |
| 0‑L |
93403
|
Syndactyly type 2
|
ORPHAnet |
| 0‑L |
93404
|
Syndactyly type 3
|
ORPHAnet |
| 0‑L |
93405
|
Syndactyly type 4
|
ORPHAnet |
| 0‑L |
93406
|
Syndactyly type 5
|
ORPHAnet |
| 0‑L |
93409
|
Brachydactyly-syndactyly, Zhao type
|
ORPHAnet |
| 0‑L |
93473
|
Hurler syndrome
|
ORPHAnet |
| 0‑L |
93474
|
Scheie syndrome
|
ORPHAnet |
| 0‑L |
93476
|
Hurler-Scheie syndrome
|
ORPHAnet |
| 0‑L |
93552
|
Pediatric systemic lupus erythematosus
|
ORPHAnet |
| 0‑L |
93554
|
Mixed cryoglobulinemia type II
|
ORPHAnet |
| 0‑L |
93555
|
Mixed cryoglobulinemia type III
|
ORPHAnet |
| 0‑L |
93556
|
Heavy chain deposition disease
|
ORPHAnet |
| 0‑L |
93557
|
Light and heavy chain deposition disease
|
ORPHAnet |
| 0‑L |
93558
|
Light chain deposition disease
|
ORPHAnet |
| 0‑L |
93560
|
AApoAI amyloidosis
|
ORPHAnet |
| 0‑L |
93561
|
ALys amyloidosis
|
ORPHAnet |
| 0‑L |
93562
|
AFib amyloidosis
|
ORPHAnet |
| 0‑L |
93568
|
Juvenile polymyositis
|
ORPHAnet |
| 0‑L |
93569
|
Polymyalgia rheumatica
|
ORPHAnet |
| 0‑L |
93571
|
Dense deposit disease
|
ORPHAnet |
| 0‑L |
93581
|
Atypical hemolytic uremic syndrome with anti-factor H antibodies
|
ORPHAnet |
| 0‑L |
93583
|
Congenital thrombotic thrombocytopenic purpura
|
ORPHAnet |
| 0‑L |
93585
|
Immune-mediated thrombotic thrombocytopenic purpura
|
ORPHAnet |
| 0‑L |
93589
|
Late-onset nephronophthisis
|
ORPHAnet |
| 0‑L |
93591
|
Infantile nephronophthisis
|
ORPHAnet |
| 0‑L |
93592
|
Juvenile nephronophthisis
|
ORPHAnet |
| 0‑L |
93598
|
Primary hyperoxaluria type 1
|
ORPHAnet |
| 0‑L |
93599
|
Primary hyperoxaluria type 2
|
ORPHAnet |
| 0‑L |
93600
|
Primary hyperoxaluria type 3
|
ORPHAnet |
| 0‑L |
93601
|
Xanthinuria type I
|
ORPHAnet |
| 0‑L |
93602
|
Xanthinuria type II
|
ORPHAnet |
| 0‑L |
93605
|
Bartter syndrome type 3
|
ORPHAnet |
| 0‑L |
93606
|
Nephrogenic syndrome of inappropriate antidiuresis
|
ORPHAnet |
| 0‑L |
93607
|
Autosomal recessive proximal renal tubular acidosis
|
ORPHAnet |
| 0‑L |
93608
|
Autosomal dominant distal renal tubular acidosis
|
ORPHAnet |
| 0‑L |
93610
|
Distal renal tubular acidosis with anemia
|
ORPHAnet |
| 0‑L |
93612
|
Cystinuria type A
|
ORPHAnet |
| 0‑L |
93613
|
Cystinuria type B
|
ORPHAnet |
| 0‑L |
93616
|
Hemoglobin H disease
|
ORPHAnet |
| 0‑L |
93622
|
Dent disease type 1
|
ORPHAnet |
| 0‑L |
93623
|
Dent disease type 2
|
ORPHAnet |
| 0‑L |
93672
|
Juvenile dermatomyositis
|
ORPHAnet |
| 0‑L |
93685
|
Unicentric Castleman disease
|
ORPHAnet |
| 0‑L |
93921
|
Schwannomatosis
|
ORPHAnet |
| 0‑L |
93924
|
Lobar holoprosencephaly
|
ORPHAnet |
| 0‑L |
93925
|
Alobar holoprosencephaly
|
ORPHAnet |
| 0‑L |
93926
|
Midline interhemispheric variant of holoprosencephaly
|
ORPHAnet |
| 0‑L |
93928
|
Isolated epispadias
|
ORPHAnet |
| 0‑L |
93929
|
Cloacal exstrophy
|
ORPHAnet |
| 0‑L |
93930
|
Bladder exstrophy
|
ORPHAnet |
| 0‑L |
93932
|
FG syndrome type 1
|
ORPHAnet |
| 0‑L |
93938
|
Laryngotracheoesophageal cleft type 1
|
ORPHAnet |
| 0‑L |
93939
|
Laryngotracheoesophageal cleft type 2
|
ORPHAnet |
| 0‑L |
93940
|
Laryngotracheoesophageal cleft type 3
|
ORPHAnet |
| 0‑L |
93941
|
Laryngotracheoesophageal cleft type 4
|
ORPHAnet |
| 0‑L |
93945
|
X-linked intellectual disability, Porteous type
|
ORPHAnet |
| 0‑L |
93946
|
Hamel cerebro-palato-cardiac syndrome
|
ORPHAnet |
| 0‑L |
93947
|
X-linked intellectual disability, Golabi-Ito-Hall type
|
ORPHAnet |
| 0‑L |
93950
|
X-linked intellectual disability, Sutherland-Haan type
|
ORPHAnet |
| 0‑L |
93952
|
X-linked intellectual disability, Hedera type
|
ORPHAnet |
| 0‑L |
93953
|
Familial thyroglossal duct cyst
|
ORPHAnet |
| 0‑L |
93958
|
Oromandibular dystonia
|
ORPHAnet |
| 0‑L |
93964
|
Blepharospasm-oromandibular dystonia syndrome
|
ORPHAnet |
| 0‑L |
93969
|
Myelomeningocele
|
ORPHAnet |
| 0‑L |
93976
|
Anotia
|
ORPHAnet |
| 0‑L |
94056
|
Humero-ulnar synostosis
|
ORPHAnet |
| 0‑L |
94058
|
Neovascular glaucoma
|
ORPHAnet |
| 0‑L |
94059
|
Uremic pruritus
|
ORPHAnet |
| 0‑L |
94063
|
12q14 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
94064
|
Deafness-infertility syndrome
|
ORPHAnet |
| 0‑L |
94065
|
15q24 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
94066
|
Severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia
|
ORPHAnet |
| 0‑L |
94068
|
Spondyloepiphyseal dysplasia congenita
|
ORPHAnet |
| 0‑L |
94080
|
Non-functioning paraganglioma
|
ORPHAnet |
| 0‑L |
94083
|
Partington syndrome
|
ORPHAnet |
| 0‑L |
94086
|
Blue diaper syndrome
|
ORPHAnet |
| 0‑L |
94087
|
Cytophagic histiocytic panniculitis
|
ORPHAnet |
| 0‑L |
94088
|
Hereditary renal hypouricemia
|
ORPHAnet |
| 0‑L |
94089
|
Pseudohypoparathyroidism type 1B
|
ORPHAnet |
| 0‑L |
94090
|
Pseudohypoparathyroidism type 2
|
ORPHAnet |
| 0‑L |
94091
|
Mills syndrome
|
ORPHAnet |
| 0‑L |
94093
|
Neuroleptic malignant syndrome
|
ORPHAnet |
| 0‑L |
94122
|
Cerebellar ataxia, Cayman type
|
ORPHAnet |
| 0‑L |
94124
|
Spinocerebellar ataxia with axonal neuropathy type 1
|
ORPHAnet |
| 0‑L |
94125
|
Recessive mitochondrial ataxia syndrome
|
ORPHAnet |
| 0‑L |
94147
|
Spinocerebellar ataxia type 7
|
ORPHAnet |
| 0‑L |
94150
|
Anonychia congenita totalis
|
ORPHAnet |
| 0‑L |
95159
|
Hepatoerythropoietic porphyria
|
ORPHAnet |
| 0‑L |
95232
|
Lissencephaly due to LIS1 mutation
|
ORPHAnet |
| 0‑L |
95409
|
Acute adrenal insufficiency
|
ORPHAnet |
| 0‑L |
95427
|
Secondary short bowel syndrome
|
ORPHAnet |
| 0‑L |
95428
|
COG8-CDG
|
ORPHAnet |
| 0‑L |
95429
|
Angioma serpiginosum
|
ORPHAnet |
| 0‑L |
95430
|
Congenital tracheomalacia
|
ORPHAnet |
| 0‑L |
95431
|
Twin to twin transfusion syndrome
|
ORPHAnet |
| 0‑L |
95433
|
Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome
|
ORPHAnet |
| 0‑L |
95434
|
Autosomal recessive cerebellar ataxia-movement disorder syndrome
|
ORPHAnet |
| 0‑L |
95443
|
Mesocardia
|
ORPHAnet |
| 0‑L |
95448
|
Congenital aortic valve atresia
|
ORPHAnet |
| 0‑L |
95455
|
Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
|
ORPHAnet |
| 0‑L |
95457
|
Tricuspid valve agenesis
|
ORPHAnet |
| 0‑L |
95459
|
Congenital tricuspid stenosis
|
ORPHAnet |
| 0‑L |
95461
|
Straddling or overriding tricuspid valve
|
ORPHAnet |
| 0‑L |
95462
|
Accessory tricuspid valve tissue
|
ORPHAnet |
| 0‑L |
95465
|
Cleft mitral valve
|
ORPHAnet |
| 0‑L |
95474
|
Double-orifice mitral valve
|
ORPHAnet |
| 0‑L |
95486
|
Premature closure of the arterial duct
|
ORPHAnet |
| 0‑L |
95491
|
Congenital coronary artery aneurysm
|
ORPHAnet |
| 0‑L |
95494
|
Combined pituitary hormone deficiencies, genetic forms
|
ORPHAnet |
| 0‑L |
95496
|
Pituitary stalk interruption syndrome
|
ORPHAnet |
| 0‑L |
95507
|
Congenital anomaly of hepatic vein
|
ORPHAnet |
| 0‑L |
95512
|
Adenohypophysitis
|
ORPHAnet |
| 0‑L |
95513
|
Panhypophysitis
|
ORPHAnet |
| 0‑L |
95613
|
Pituitary apoplexy
|
ORPHAnet |
| 0‑L |
95619
|
Post-traumatic pituitary deficiency
|
ORPHAnet |
| 0‑L |
95626
|
Acquired central diabetes insipidus
|
ORPHAnet |
| 0‑L |
95699
|
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
|
ORPHAnet |
| 0‑L |
95700
|
Familial adrenal hypoplasia with absent pituitary luteinizing hormone
|
ORPHAnet |
| 0‑L |
95702
|
X-linked adrenal hypoplasia congenita
|
ORPHAnet |
| 0‑L |
95706
|
Non-syndromic posterior hypospadias
|
ORPHAnet |
| 0‑L |
95707
|
Idiopathic isolated micropenis
|
ORPHAnet |
| 0‑L |
95712
|
Thyroid ectopia
|
ORPHAnet |
| 0‑L |
95713
|
Athyreosis
|
ORPHAnet |
| 0‑L |
95715
|
Congenital hypothyroidism due to transplacental passage of TSH-binding inhibitory
antibodies
|
ORPHAnet |
| 0‑L |
95716
|
Familial thyroid dyshormonogenesis
|
ORPHAnet |
| 0‑L |
95717
|
Idiopathic congenital hypothyroidism
|
ORPHAnet |
| 0‑L |
95719
|
Thyroid hemiagenesis
|
ORPHAnet |
| 0‑L |
95720
|
Thyroid hypoplasia
|
ORPHAnet |
| 0‑L |
95854
|
Levocardia
|
ORPHAnet |
| 0‑L |
96055
|
Tetrasomy 21
|
ORPHAnet |
| 0‑L |
96059
|
Mosaic trisomy 4
|
ORPHAnet |
| 0‑L |
96060
|
Mosaic trisomy 5
|
ORPHAnet |
| 0‑L |
96061
|
Mosaic trisomy 8
|
ORPHAnet |
| 0‑L |
96063
|
Mosaic trisomy 10
|
ORPHAnet |
| 0‑L |
96068
|
Mosaic trisomy 22
|
ORPHAnet |
| 0‑L |
96069
|
Distal trisomy 1p36
|
ORPHAnet |
| 0‑L |
96070
|
Distal trisomy 2p
|
ORPHAnet |
| 0‑L |
96071
|
Distal trisomy 3p
|
ORPHAnet |
| 0‑L |
96072
|
4p16.3 microduplication syndrome
|
ORPHAnet |
| 0‑L |
96074
|
Distal trisomy 7p
|
ORPHAnet |
| 0‑L |
96076
|
Beckwith-Wiedemann syndrome due to 11p15 microduplication
|
ORPHAnet |
| 0‑L |
96078
|
16p13.3 microduplication syndrome
|
ORPHAnet |
| 0‑L |
96092
|
8p inverted duplication/deletion syndrome
|
ORPHAnet |
| 0‑L |
96094
|
Distal trisomy 2q
|
ORPHAnet |
| 0‑L |
96095
|
3q26 microduplication syndrome
|
ORPHAnet |
| 0‑L |
96096
|
Distal trisomy 4q
|
ORPHAnet |
| 0‑L |
96097
|
Distal trisomy 5q
|
ORPHAnet |
| 0‑L |
96098
|
Distal trisomy 6q
|
ORPHAnet |
| 0‑L |
96100
|
Distal trisomy 8q
|
ORPHAnet |
| 0‑L |
96101
|
Distal trisomy 9q
|
ORPHAnet |
| 0‑L |
96102
|
Distal trisomy 10q
|
ORPHAnet |
| 0‑L |
96103
|
Distal trisomy 11q
|
ORPHAnet |
| 0‑L |
96105
|
Distal trisomy 13q
|
ORPHAnet |
| 0‑L |
96106
|
Distal trisomy 16q
|
ORPHAnet |
| 0‑L |
96107
|
Distal trisomy 20q
|
ORPHAnet |
| 0‑L |
96109
|
Distal trisomy 22q
|
ORPHAnet |
| 0‑L |
96112
|
Non-distal trisomy 9q
|
ORPHAnet |
| 0‑L |
96121
|
7q11.23 microduplication syndrome
|
ORPHAnet |
| 0‑L |
96123
|
Monosomy 22
|
ORPHAnet |
| 0‑L |
96125
|
Distal monosomy 6p
|
ORPHAnet |
| 0‑L |
96126
|
Distal monosomy 7p
|
ORPHAnet |
| 0‑L |
96129
|
Distal monosomy 19p13.3
|
ORPHAnet |
| 0‑L |
96145
|
Distal monosomy 4q
|
ORPHAnet |
| 0‑L |
96147
|
Kleefstra syndrome due to 9q34 microdeletion
|
ORPHAnet |
| 0‑L |
96148
|
Distal monosomy 10q
|
ORPHAnet |
| 0‑L |
96149
|
Distal monosomy 12q
|
ORPHAnet |
| 0‑L |
96150
|
Distal monosomy 14q
|
ORPHAnet |
| 0‑L |
96160
|
Non-distal monosomy 12q
|
ORPHAnet |
| 0‑L |
96167
|
Recombinant 8 syndrome
|
ORPHAnet |
| 0‑L |
96168
|
Monosomy 13q34
|
ORPHAnet |
| 0‑L |
96169
|
Koolen-De Vries syndrome
|
ORPHAnet |
| 0‑L |
96170
|
Emanuel syndrome
|
ORPHAnet |
| 0‑L |
96171
|
Ring chromosome 2 syndrome
|
ORPHAnet |
| 0‑L |
96172
|
Ring chromosome 3 syndrome
|
ORPHAnet |
| 0‑L |
96173
|
Ring chromosome 9 syndrome
|
ORPHAnet |
| 0‑L |
96175
|
Ring chromosome 11 syndrome
|
ORPHAnet |
| 0‑L |
96176
|
Ring chromosome 13 syndrome
|
ORPHAnet |
| 0‑L |
96177
|
Ring chromosome 15 syndrome
|
ORPHAnet |
| 0‑L |
96178
|
Ring chromosome 16 syndrome
|
ORPHAnet |
| 0‑L |
96179
|
Maternal uniparental disomy of chromosome 2
|
ORPHAnet |
| 0‑L |
96180
|
Maternal uniparental disomy of chromosome 4
|
ORPHAnet |
| 0‑L |
96181
|
Maternal uniparental disomy of chromosome 6
|
ORPHAnet |
| 0‑L |
96182
|
Silver-Russell syndrome due to maternal uniparental disomy of chromosome 7
|
ORPHAnet |
| 0‑L |
96183
|
Maternal uniparental disomy of chromosome 9
|
ORPHAnet |
| 0‑L |
96184
|
Temple syndrome due to maternal uniparental disomy of chromosome 14
|
ORPHAnet |
| 0‑L |
96185
|
Maternal uniparental disomy of chromosome 16
|
ORPHAnet |
| 0‑L |
96186
|
Maternal uniparental disomy of chromosome 20
|
ORPHAnet |
| 0‑L |
96187
|
Maternal uniparental disomy of chromosome 21
|
ORPHAnet |
| 0‑L |
96188
|
Maternal uniparental disomy of chromosome 22
|
ORPHAnet |
| 0‑L |
96190
|
Paternal uniparental disomy of chromosome 5
|
ORPHAnet |
| 0‑L |
96191
|
Paternal uniparental disomy of chromosome 6
|
ORPHAnet |
| 0‑L |
96192
|
Paternal uniparental disomy of chromosome 7
|
ORPHAnet |
| 0‑L |
96193
|
Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11
|
ORPHAnet |
| 0‑L |
96194
|
Paternal uniparental disomy of chromosome 20
|
ORPHAnet |
| 0‑L |
96195
|
Paternal uniparental disomy of chromosome 21
|
ORPHAnet |
| 0‑L |
96201
|
X small rings
|
ORPHAnet |
| 0‑L |
96253
|
Cushing disease
|
ORPHAnet |
| 0‑L |
96263
|
48,XXXY syndrome
|
ORPHAnet |
| 0‑L |
96264
|
49,XXXXY syndrome
|
ORPHAnet |
| 0‑L |
96265
|
Leydig cell hypoplasia due to complete LH resistance
|
ORPHAnet |
| 0‑L |
96266
|
Leydig cell hypoplasia due to partial LH resistance
|
ORPHAnet |
| 0‑L |
96269
|
Isolated partial vaginal agenesis
|
ORPHAnet |
| 0‑L |
96334
|
Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14
|
ORPHAnet |
| 0‑L |
96369
|
Early-onset schizophrenia
|
ORPHAnet |
| 0‑L |
97214
|
Eisenmenger syndrome
|
ORPHAnet |
| 0‑L |
97229
|
Riboflavin transporter deficiency
|
ORPHAnet |
| 0‑L |
97230
|
Solar urticaria
|
ORPHAnet |
| 0‑L |
97232
|
Fingerprint body myopathy
|
ORPHAnet |
| 0‑L |
97234
|
Glycogen storage disease due to phosphoglycerate mutase deficiency
|
ORPHAnet |
| 0‑L |
97238
|
Rippling muscle disease
|
ORPHAnet |
| 0‑L |
97239
|
Reducing body myopathy
|
ORPHAnet |
| 0‑L |
97240
|
Zebra body myopathy
|
ORPHAnet |
| 0‑L |
97244
|
Rigid spine syndrome
|
ORPHAnet |
| 0‑L |
97249
|
Pontocerebellar hypoplasia type 3
|
ORPHAnet |
| 0‑L |
97252
|
Mega-cisterna magna
|
ORPHAnet |
| 0‑L |
97261
|
GRFoma
|
ORPHAnet |
| 0‑L |
97278
|
PPoma
|
ORPHAnet |
| 0‑L |
97279
|
Insulinoma
|
ORPHAnet |
| 0‑L |
97280
|
Glucagonoma
|
ORPHAnet |
| 0‑L |
97282
|
VIPoma
|
ORPHAnet |
| 0‑L |
97283
|
Somatostatinoma
|
ORPHAnet |
| 0‑L |
97285
|
Thyroid lymphoma
|
ORPHAnet |
| 0‑L |
97286
|
Carney-Stratakis syndrome
|
ORPHAnet |
| 0‑L |
97287
|
Bronchial neuroendocrine tumor
|
ORPHAnet |
| 0‑L |
97289
|
Thymic neuroendocrine tumor
|
ORPHAnet |
| 0‑L |
97290
|
Familial papillary thyroid carcinoma with renal papillary neoplasia
|
ORPHAnet |
| 0‑L |
97292
|
Cardiogenic shock
|
ORPHAnet |
| 0‑L |
97297
|
Bohring-Opitz syndrome
|
ORPHAnet |
| 0‑L |
97330
|
Thoracic outlet syndrome
|
ORPHAnet |
| 0‑L |
97332
|
Kienbock disease
|
ORPHAnet |
| 0‑L |
97335
|
Osgood-Schlatter disease
|
ORPHAnet |
| 0‑L |
97336
|
Panner disease
|
ORPHAnet |
| 0‑L |
97337
|
Sinding-Larsen-Johansson disease
|
ORPHAnet |
| 0‑L |
97338
|
Melanoma of soft tissue
|
ORPHAnet |
| 0‑L |
97339
|
Dural sinus malformation
|
ORPHAnet |
| 0‑L |
97340
|
Hunter-McAlpine syndrome
|
ORPHAnet |
| 0‑L |
97341
|
Persistent placoid maculopathy
|
ORPHAnet |
| 0‑L |
97345
|
ABri amyloidosis
|
ORPHAnet |
| 0‑L |
97346
|
ADan amyloidosis
|
ORPHAnet |
| 0‑L |
97349
|
Postencephalitic parkinsonism
|
ORPHAnet |
| 0‑L |
97352
|
Pellagra
|
ORPHAnet |
| 0‑L |
97353
|
Dementia pugilistica
|
ORPHAnet |
| 0‑L |
97355
|
Caribbean parkinsonism
|
ORPHAnet |
| 0‑L |
97360
|
Robinow syndrome
|
ORPHAnet |
| 0‑L |
97361
|
Renal hypoplasia, unilateral
|
ORPHAnet |
| 0‑L |
97362
|
Renal hypoplasia, bilateral
|
ORPHAnet |
| 0‑L |
97363
|
Unilateral multicystic dysplastic kidney
|
ORPHAnet |
| 0‑L |
97364
|
Bilateral multicystic dysplastic kidney
|
ORPHAnet |
| 0‑L |
97366
|
Multiloculated renal cyst
|
ORPHAnet |
| 0‑L |
97367
|
Renal tubular dysgenesis due to twin-twin transfusion
|
ORPHAnet |
| 0‑L |
97368
|
Drug-related renal tubular dysgenesis
|
ORPHAnet |
| 0‑L |
97369
|
Renal tubular dysgenesis of genetic origin
|
ORPHAnet |
| 0‑L |
97548
|
Right sided atrial isomerism
|
ORPHAnet |
| 0‑L |
97560
|
Primary membranous glomerulonephritis
|
ORPHAnet |
| 0‑L |
97563
|
Pauci-immune glomerulonephritis with ANCA
|
ORPHAnet |
| 0‑L |
97564
|
Pauci-immune glomerulonephritis without ANCA
|
ORPHAnet |
| 0‑L |
97566
|
Non-amyloid fibrillary glomerulopathy
|
ORPHAnet |
| 0‑L |
97567
|
Immunotactoid glomerulopathy
|
ORPHAnet |
| 0‑L |
97598
|
Congenital renal artery stenosis
|
ORPHAnet |
| 0‑L |
97678
|
Maternal uniparental disomy of chromosome 13
|
ORPHAnet |
| 0‑L |
97685
|
17q11 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
98267
|
Genetic non-syndromic obesity
|
ORPHAnet |
| 0‑L |
98434
|
Hereditary combined deficiency of vitamin K-dependent clotting factors
|
ORPHAnet |
| 0‑L |
98606
|
Syndromic orbital border hypoplasia
|
ORPHAnet |
| 0‑L |
98619
|
Rare isolated myopia
|
ORPHAnet |
| 0‑L |
98673
|
Autosomal dominant optic atrophy, classic form
|
ORPHAnet |
| 0‑L |
98676
|
Autosomal recessive isolated optic atrophy
|
ORPHAnet |
| 0‑L |
98686
|
Congenital trochlear nerve palsy
|
ORPHAnet |
| 0‑L |
98754
|
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15
|
ORPHAnet |
| 0‑L |
98755
|
Spinocerebellar ataxia type 1
|
ORPHAnet |
| 0‑L |
98756
|
Spinocerebellar ataxia type 2
|
ORPHAnet |
| 0‑L |
98757
|
Spinocerebellar ataxia type 3
|
ORPHAnet |
| 0‑L |
98758
|
Spinocerebellar ataxia type 6
|
ORPHAnet |
| 0‑L |
98759
|
Spinocerebellar ataxia type 17
|
ORPHAnet |
| 0‑L |
98760
|
Spinocerebellar ataxia type 8
|
ORPHAnet |
| 0‑L |
98761
|
Spinocerebellar ataxia type 10
|
ORPHAnet |
| 0‑L |
98762
|
Spinocerebellar ataxia type 12
|
ORPHAnet |
| 0‑L |
98763
|
Spinocerebellar ataxia type 14
|
ORPHAnet |
| 0‑L |
98764
|
Spinocerebellar ataxia type 27
|
ORPHAnet |
| 0‑L |
98765
|
Spinocerebellar ataxia type 4
|
ORPHAnet |
| 0‑L |
98766
|
Spinocerebellar ataxia type 5
|
ORPHAnet |
| 0‑L |
98767
|
Spinocerebellar ataxia type 11
|
ORPHAnet |
| 0‑L |
98768
|
Spinocerebellar ataxia type 13
|
ORPHAnet |
| 0‑L |
98769
|
Spinocerebellar ataxia type 15/16
|
ORPHAnet |
| 0‑L |
98771
|
Spinocerebellar ataxia type 18
|
ORPHAnet |
| 0‑L |
98772
|
Spinocerebellar ataxia type 19/22
|
ORPHAnet |
| 0‑L |
98773
|
Spinocerebellar ataxia type 21
|
ORPHAnet |
| 0‑L |
98784
|
Autosomal dominant nocturnal frontal lobe epilepsy
|
ORPHAnet |
| 0‑L |
98791
|
Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16
|
ORPHAnet |
| 0‑L |
98793
|
Prader-Willi syndrome due to paternal 15q11q13 deletion
|
ORPHAnet |
| 0‑L |
98794
|
Angelman syndrome due to maternal 15q11q13 deletion
|
ORPHAnet |
| 0‑L |
98795
|
Angelman syndrome due to paternal uniparental disomy of chromosome 15
|
ORPHAnet |
| 0‑L |
98797
|
Isochromosomy Yp
|
ORPHAnet |
| 0‑L |
98798
|
Isochromosomy Yq
|
ORPHAnet |
| 0‑L |
98805
|
Primary dystonia, DYT4 type
|
ORPHAnet |
| 0‑L |
98806
|
Primary dystonia, DYT6 type
|
ORPHAnet |
| 0‑L |
98807
|
Primary dystonia, DYT13 type
|
ORPHAnet |
| 0‑L |
98808
|
Autosomal dominant dopa-responsive dystonia
|
ORPHAnet |
| 0‑L |
98809
|
Paroxysmal kinesigenic dyskinesia
|
ORPHAnet |
| 0‑L |
98810
|
Paroxysmal non-kinesigenic dyskinesia
|
ORPHAnet |
| 0‑L |
98811
|
Paroxysmal exertion-induced dyskinesia
|
ORPHAnet |
| 0‑L |
98813
|
Hypohidrotic ectodermal dysplasia with immunodeficiency
|
ORPHAnet |
| 0‑L |
98815
|
Benign childhood occipital epilepsy, Panayiotopoulos type
|
ORPHAnet |
| 0‑L |
98816
|
Benign childhood occipital epilepsy, Gastaut type
|
ORPHAnet |
| 0‑L |
98818
|
Landau-Kleffner syndrome
|
ORPHAnet |
| 0‑L |
98819
|
Familial temporal lobe epilepsy
|
ORPHAnet |
| 0‑L |
98820
|
Familial focal epilepsy with variable foci
|
ORPHAnet |
| 0‑L |
98823
|
Chronic myelomonocytic leukemia
|
ORPHAnet |
| 0‑L |
98824
|
Atypical chronic myeloid leukemia
|
ORPHAnet |
| 0‑L |
98825
|
Unclassified myelodysplastic/myeloproliferative disease
|
ORPHAnet |
| 0‑L |
98826
|
Refractory anemia
|
ORPHAnet |
| 0‑L |
98827
|
Unclassified myelodysplastic syndrome
|
ORPHAnet |
| 0‑L |
98829
|
Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)
|
ORPHAnet |
| 0‑L |
98831
|
Acute myeloid leukemia with 11q23 abnormalities
|
ORPHAnet |
| 0‑L |
98832
|
Acute myeloid leukemia with minimal differentiation
|
ORPHAnet |
| 0‑L |
98833
|
Acute myeloblastic leukemia without maturation
|
ORPHAnet |
| 0‑L |
98834
|
Acute myeloblastic leukemia with maturation
|
ORPHAnet |
| 0‑L |
98835
|
Acute undifferentiated leukemia
|
ORPHAnet |
| 0‑L |
98838
|
Primary mediastinal large B-cell lymphoma
|
ORPHAnet |
| 0‑L |
98839
|
Intravascular large B-cell lymphoma
|
ORPHAnet |
| 0‑L |
98841
|
Anaplastic large cell lymphoma
|
ORPHAnet |
| 0‑L |
98842
|
Lymphomatoid papulosis
|
ORPHAnet |
| 0‑L |
98843
|
Classic Hodgkin lymphoma, nodular sclerosis type
|
ORPHAnet |
| 0‑L |
98844
|
Classic Hodgkin lymphoma, mixed cellularity type
|
ORPHAnet |
| 0‑L |
98845
|
Classic Hodgkin lymphoma, lymphocyte-rich type
|
ORPHAnet |
| 0‑L |
98846
|
Classic Hodgkin lymphoma, lymphocyte-depleted type
|
ORPHAnet |
| 0‑L |
98848
|
Indolent systemic mastocytosis
|
ORPHAnet |
| 0‑L |
98849
|
Systemic mastocytosis with associated hematologic neoplasm
|
ORPHAnet |
| 0‑L |
98850
|
Aggressive systemic mastocytosis
|
ORPHAnet |
| 0‑L |
98851
|
Mast cell leukemia
|
ORPHAnet |
| 0‑L |
98852
|
Desquamative interstitial pneumonia
|
ORPHAnet |
| 0‑L |
98853
|
Autosomal dominant Emery-Dreifuss muscular dystrophy
|
ORPHAnet |
| 0‑L |
98855
|
Autosomal recessive Emery-Dreifuss muscular dystrophy
|
ORPHAnet |
| 0‑L |
98856
|
Charcot-Marie-Tooth disease type 2B1
|
ORPHAnet |
| 0‑L |
98863
|
X-linked Emery-Dreifuss muscular dystrophy
|
ORPHAnet |
| 0‑L |
98868
|
Southeast Asian ovalocytosis
|
ORPHAnet |
| 0‑L |
98869
|
Congenital dyserythropoietic anemia type I
|
ORPHAnet |
| 0‑L |
98870
|
Congenital dyserythropoietic anemia type III
|
ORPHAnet |
| 0‑L |
98871
|
Transient erythroblastopenia of childhood
|
ORPHAnet |
| 0‑L |
98872
|
Primary acquired pure red cell aplasia
|
ORPHAnet |
| 0‑L |
98873
|
Congenital dyserythropoietic anemia type II
|
ORPHAnet |
| 0‑L |
98878
|
Hemophilia A
|
ORPHAnet |
| 0‑L |
98879
|
Hemophilia B
|
ORPHAnet |
| 0‑L |
98880
|
Familial afibrinogenemia
|
ORPHAnet |
| 0‑L |
98881
|
Familial dysfibrinogenemia
|
ORPHAnet |
| 0‑L |
98885
|
Bleeding diathesis due to glycoprotein VI deficiency
|
ORPHAnet |
| 0‑L |
98886
|
Bleeding diathesis due to integrin alpha2-beta1 deficiency
|
ORPHAnet |
| 0‑L |
98889
|
Bilateral perisylvian polymicrogyria
|
ORPHAnet |
| 0‑L |
98890
|
Early-onset X-linked optic atrophy
|
ORPHAnet |
| 0‑L |
98892
|
Periventricular nodular heterotopia
|
ORPHAnet |
| 0‑L |
98893
|
Congenital muscular dystrophy type 1B
|
ORPHAnet |
| 0‑L |
98895
|
Becker muscular dystrophy
|
ORPHAnet |
| 0‑L |
98896
|
Duchenne muscular dystrophy
|
ORPHAnet |
| 0‑L |
98897
|
Oculopharyngodistal myopathy
|
ORPHAnet |
| 0‑L |
98902
|
Amish nemaline myopathy
|
ORPHAnet |
| 0‑L |
98904
|
Congenital myopathy with excess of thin filaments
|
ORPHAnet |
| 0‑L |
98905
|
Congenital multicore myopathy with external ophthalmoplegia
|
ORPHAnet |
| 0‑L |
98907
|
Neutral lipid storage disease with ichthyosis
|
ORPHAnet |
| 0‑L |
98908
|
Neutral lipid storage myopathy
|
ORPHAnet |
| 0‑L |
98909
|
Desminopathy
|
ORPHAnet |
| 0‑L |
98911
|
Distal myotilinopathy
|
ORPHAnet |
| 0‑L |
98912
|
Late-onset distal myopathy, Markesbery-Griggs type
|
ORPHAnet |
| 0‑L |
98913
|
Postsynaptic congenital myasthenic syndromes
|
ORPHAnet |
| 0‑L |
98914
|
Presynaptic congenital myasthenic syndromes
|
ORPHAnet |
| 0‑L |
98915
|
Synaptic congenital myasthenic syndromes
|
ORPHAnet |
| 0‑L |
98916
|
Acute inflammatory demyelinating polyradiculoneuropathy
|
ORPHAnet |
| 0‑L |
98917
|
Acute motor and sensory axonal neuropathy
|
ORPHAnet |
| 0‑L |
98918
|
Acute motor axonal neuropathy
|
ORPHAnet |
| 0‑L |
98919
|
Miller Fisher syndrome
|
ORPHAnet |
| 0‑L |
98920
|
Spinal muscular atrophy with respiratory distress type 1
|
ORPHAnet |
| 0‑L |
98922
|
Blake pouch cyst
|
ORPHAnet |
| 0‑L |
98933
|
Multiple system atrophy, parkinsonian type
|
ORPHAnet |
| 0‑L |
98934
|
Huntington disease-like 2
|
ORPHAnet |
| 0‑L |
98938
|
Colobomatous microphthalmia
|
ORPHAnet |
| 0‑L |
98942
|
Coloboma of choroid and retina
|
ORPHAnet |
| 0‑L |
98943
|
Coloboma of eye lens
|
ORPHAnet |
| 0‑L |
98944
|
Coloboma of iris
|
ORPHAnet |
| 0‑L |
98945
|
Coloboma of macula
|
ORPHAnet |
| 0‑L |
98946
|
Coloboma of eyelid
|
ORPHAnet |
| 0‑L |
98947
|
Coloboma of optic disc
|
ORPHAnet |
| 0‑L |
98948
|
Congenital symblepharon
|
ORPHAnet |
| 0‑L |
98949
|
Complete cryptophthalmia
|
ORPHAnet |
| 0‑L |
98950
|
Partial cryptophthalmia
|
ORPHAnet |
| 0‑L |
98951
|
Inverse Marcus-Gunn phenomenon
|
ORPHAnet |
| 0‑L |
98954
|
Meesmann corneal dystrophy
|
ORPHAnet |
| 0‑L |
98955
|
Lisch epithelial corneal dystrophy
|
ORPHAnet |
| 0‑L |
98956
|
Epithelial basement membrane dystrophy
|
ORPHAnet |
| 0‑L |
98957
|
Gelatinous drop-like corneal dystrophy
|
ORPHAnet |
| 0‑L |
98958
|
Climatic droplet keratopathy
|
ORPHAnet |
| 0‑L |
98959
|
Subepithelial mucinous corneal dystrophy
|
ORPHAnet |
| 0‑L |
98960
|
Thiel-Behnke corneal dystrophy
|
ORPHAnet |
| 0‑L |
98961
|
Reis-Bücklers corneal dystrophy
|
ORPHAnet |
| 0‑L |
98962
|
Granular corneal dystrophy type I
|
ORPHAnet |
| 0‑L |
98963
|
Granular corneal dystrophy type II
|
ORPHAnet |
| 0‑L |
98964
|
Lattice corneal dystrophy type I
|
ORPHAnet |
| 0‑L |
98967
|
Schnyder corneal dystrophy
|
ORPHAnet |
| 0‑L |
98969
|
Macular corneal dystrophy
|
ORPHAnet |
| 0‑L |
98970
|
Fleck corneal dystrophy
|
ORPHAnet |
| 0‑L |
98971
|
Posterior amorphous corneal dystrophy
|
ORPHAnet |
| 0‑L |
98972
|
Central cloudy dystrophy of François
|
ORPHAnet |
| 0‑L |
98973
|
Posterior polymorphous corneal dystrophy
|
ORPHAnet |
| 0‑L |
98974
|
Fuchs endothelial corneal dystrophy
|
ORPHAnet |
| 0‑L |
98975
|
Congenital hereditary endothelial dystrophy type I
|
ORPHAnet |
| 0‑L |
98976
|
Congenital glaucoma
|
ORPHAnet |
| 0‑L |
98977
|
Juvenile glaucoma
|
ORPHAnet |
| 0‑L |
98978
|
Axenfeld anomaly
|
ORPHAnet |
| 0‑L |
98979
|
Chandler syndrome
|
ORPHAnet |
| 0‑L |
98980
|
Cogan-Reese syndrome
|
ORPHAnet |
| 0‑L |
98981
|
Essential iris atrophy
|
ORPHAnet |
| 0‑L |
98984
|
Pulverulent cataract
|
ORPHAnet |
| 0‑L |
98985
|
Early-onset sutural cataract
|
ORPHAnet |
| 0‑L |
98988
|
Early-onset anterior polar cataract
|
ORPHAnet |
| 0‑L |
98989
|
Cerulean cataract
|
ORPHAnet |
| 0‑L |
98990
|
Coralliform cataract
|
ORPHAnet |
| 0‑L |
98991
|
Early-onset nuclear cataract
|
ORPHAnet |
| 0‑L |
98992
|
Early-onset partial cataract
|
ORPHAnet |
| 0‑L |
98993
|
Early-onset posterior polar cataract
|
ORPHAnet |
| 0‑L |
98994
|
Total early-onset cataract
|
ORPHAnet |
| 0‑L |
98995
|
Early-onset zonular cataract
|
ORPHAnet |
| 0‑L |
99000
|
Adult-onset foveomacular vitelliform dystrophy
|
ORPHAnet |
| 0‑L |
99001
|
Butterfly-shaped pigment dystrophy
|
ORPHAnet |
| 0‑L |
99002
|
Reticular dystrophy of the retinal pigment epithelium
|
ORPHAnet |
| 0‑L |
99003
|
Multifocal pattern dystrophy simulating fundus flavimaculatus
|
ORPHAnet |
| 0‑L |
99004
|
Fundus pulverulentus
|
ORPHAnet |
| 0‑L |
99013
|
Spastic paraplegia type 7
|
ORPHAnet |
| 0‑L |
99014
|
X-linked Charcot-Marie-Tooth disease type 5
|
ORPHAnet |
| 0‑L |
99015
|
Spastic paraplegia type 2
|
ORPHAnet |
| 0‑L |
99027
|
Adult-onset autosomal dominant leukodystrophy
|
ORPHAnet |
| 0‑L |
99042
|
Congenitally uncorrected transposition of the great arteries with coarctation
|
ORPHAnet |
| 0‑L |
99043
|
Double outlet right ventricle with subaortic or doubly committed ventricular septal
defect with pulmonary stenosis
|
ORPHAnet |
| 0‑L |
99045
|
Double outlet right ventricle with subpulmonary ventricular septal defect
|
ORPHAnet |
| 0‑L |
99046
|
Double outlet right ventricle with non-committed subpulmonary ventricular septal defect
|
ORPHAnet |
| 0‑L |
99048
|
Pulmonary valve agenesis-intact ventricular septum-persistent ductus arteriosus syndrome
|
ORPHAnet |
| 0‑L |
99049
|
Pulmonary artery coming from patent ductus arteriosus
|
ORPHAnet |
| 0‑L |
99050
|
Abnormal origin of right or left pulmonary artery from the aorta
|
ORPHAnet |
| 0‑L |
99051
|
Discrete fixed membranous subaortic stenosis
|
ORPHAnet |
| 0‑L |
99052
|
Discrete fibromuscular subaortic stenosis
|
ORPHAnet |
| 0‑L |
99053
|
Tunnel subaortic stenosis
|
ORPHAnet |
| 0‑L |
99054
|
Valvular pulmonary stenosis
|
ORPHAnet |
| 0‑L |
99055
|
Congenital anomaly of the tricuspid valve chordae
|
ORPHAnet |
| 0‑L |
99056
|
Parachute tricuspid valve
|
ORPHAnet |
| 0‑L |
99057
|
Congenital mitral stenosis
|
ORPHAnet |
| 0‑L |
99058
|
Hypoplasia of the mitral valve annulus
|
ORPHAnet |
| 0‑L |
99059
|
Congenital supravalvular mitral ring
|
ORPHAnet |
| 0‑L |
99060
|
Congenital unguarded mitral orifice
|
ORPHAnet |
| 0‑L |
99061
|
Accessory mitral valve tissue
|
ORPHAnet |
| 0‑L |
99062
|
Mitral valve agenesis
|
ORPHAnet |
| 0‑L |
99063
|
Shone complex
|
ORPHAnet |
| 0‑L |
99064
|
Straddling and/or overriding mitral valve
|
ORPHAnet |
| 0‑L |
99067
|
Complete atrioventricular septal defect with ventricular hypoplasia
|
ORPHAnet |
| 0‑L |
99068
|
Complete atrioventricular septal defect-tetralogy of Fallot
|
ORPHAnet |
| 0‑L |
99070
|
Aorto-right ventricular tunnel
|
ORPHAnet |
| 0‑L |
99071
|
Aorto-left ventricular tunnel
|
ORPHAnet |
| 0‑L |
99072
|
Congenital patent ductus arteriosus aneurysm
|
ORPHAnet |
| 0‑L |
99075
|
Encircling double aortic arch
|
ORPHAnet |
| 0‑L |
99076
|
Persistent fifth aortic arch
|
ORPHAnet |
| 0‑L |
99077
|
Kommerell diverticulum
|
ORPHAnet |
| 0‑L |
99078
|
Neuhauser anomaly
|
ORPHAnet |
| 0‑L |
99079
|
Cervical aortic arch
|
ORPHAnet |
| 0‑L |
99081
|
Right aortic arch
|
ORPHAnet |
| 0‑L |
99082
|
Dysphagia lusoria
|
ORPHAnet |
| 0‑L |
99083
|
Pulmonary artery hypoplasia
|
ORPHAnet |
| 0‑L |
99084
|
Peripheral pulmonary stenosis
|
ORPHAnet |
| 0‑L |
99087
|
Coronary ostial stenosis or atresia
|
ORPHAnet |
| 0‑L |
99089
|
Abnormal number of coronary ostia
|
ORPHAnet |
| 0‑L |
99090
|
Malposition of a coronary ostium
|
ORPHAnet |
| 0‑L |
99092
|
Interventricular septum aneurysm
|
ORPHAnet |
| 0‑L |
99094
|
Laubry-Pezzi syndrome
|
ORPHAnet |
| 0‑L |
99095
|
Congenital Gerbode defect
|
ORPHAnet |
| 0‑L |
99098
|
Cor triatriatum dexter
|
ORPHAnet |
| 0‑L |
99099
|
Cor triatriatum sinister
|
ORPHAnet |
| 0‑L |
99100
|
Juxtaposition of the atrial appendages
|
ORPHAnet |
| 0‑L |
99101
|
Ectasia of the right atrial appendage
|
ORPHAnet |
| 0‑L |
99102
|
Ectasia of the left atrial appendage
|
ORPHAnet |
| 0‑L |
99103
|
Atrial septal defect, ostium secundum type
|
ORPHAnet |
| 0‑L |
99104
|
Atrial septal defect, coronary sinus type
|
ORPHAnet |
| 0‑L |
99105
|
Atrial septal defect, sinus venosus type
|
ORPHAnet |
| 0‑L |
99106
|
Atrial septal defect, ostium primum type
|
ORPHAnet |
| 0‑L |
99107
|
Atrial septal aneurysm
|
ORPHAnet |
| 0‑L |
99109
|
Persistent left superior vena cava connecting through coronary sinus to left-sided
atrium
|
ORPHAnet |
| 0‑L |
99110
|
Right superior vena cava connecting to left-sided atrium
|
ORPHAnet |
| 0‑L |
99111
|
Persistent left superior vena cava connecting to the roof of left-sided atrium
|
ORPHAnet |
| 0‑L |
99112
|
Absence of innominate vein
|
ORPHAnet |
| 0‑L |
99113
|
Subaortic course of innominate vein
|
ORPHAnet |
| 0‑L |
99114
|
Agenesis of the superior vena cava
|
ORPHAnet |
| 0‑L |
99117
|
Coronary sinus stenosis
|
ORPHAnet |
| 0‑L |
99118
|
Coronary sinus atresia
|
ORPHAnet |
| 0‑L |
99119
|
Right inferior vena cava connecting to left-sided atrium
|
ORPHAnet |
| 0‑L |
99120
|
Persistent eustachian valve
|
ORPHAnet |
| 0‑L |
99121
|
Azygos continuation of the inferior vena cava
|
ORPHAnet |
| 0‑L |
99122
|
Congenital stenosis of the inferior vena cava
|
ORPHAnet |
| 0‑L |
99123
|
Inferior vena cava interruption without azygos continuation
|
ORPHAnet |
| 0‑L |
99124
|
Congenital partial pulmonary venous return anomaly
|
ORPHAnet |
| 0‑L |
99125
|
Congenital total pulmonary venous return anomaly
|
ORPHAnet |
| 0‑L |
99129
|
Congenital complete agenesis of pericardium
|
ORPHAnet |
| 0‑L |
99130
|
Congenital partial agenesis of pericardium
|
ORPHAnet |
| 0‑L |
99131
|
Pleuro-pericardial cyst
|
ORPHAnet |
| 0‑L |
99135
|
6-phosphogluconate dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
99138
|
Hemolytic anemia due to erythrocyte adenosine deaminase overproduction
|
ORPHAnet |
| 0‑L |
99139
|
Unstable hemoglobin disease
|
ORPHAnet |
| 0‑L |
99141
|
Lymphedema-posterior choanal atresia syndrome
|
ORPHAnet |
| 0‑L |
99147
|
Acquired von Willebrand syndrome
|
ORPHAnet |
| 0‑L |
99169
|
Epiblepharon
|
ORPHAnet |
| 0‑L |
99170
|
Tarsal kink syndrome
|
ORPHAnet |
| 0‑L |
99171
|
Isolated congenital ectropion
|
ORPHAnet |
| 0‑L |
99172
|
Euryblepharon
|
ORPHAnet |
| 0‑L |
99176
|
Congenital eyelid retraction
|
ORPHAnet |
| 0‑L |
99177
|
Isolated distichiasis
|
ORPHAnet |
| 0‑L |
99179
|
Kandori fleck retina
|
ORPHAnet |
| 0‑L |
99226
|
Monosomy X
|
ORPHAnet |
| 0‑L |
99228
|
Mosaic monosomy X
|
ORPHAnet |
| 0‑L |
99324
|
Paternal uniparental disomy of chromosome 13
|
ORPHAnet |
| 0‑L |
99329
|
48,XYYY syndrome
|
ORPHAnet |
| 0‑L |
99330
|
49,XYYYY syndrome
|
ORPHAnet |
| 0‑L |
99361
|
Familial medullary thyroid carcinoma
|
ORPHAnet |
| 0‑L |
99413
|
Turner syndrome due to structural X chromosome anomalies
|
ORPHAnet |
| 0‑L |
99429
|
Complete androgen insensitivity syndrome
|
ORPHAnet |
| 0‑L |
99642
|
Spondyloepimetaphyseal dysplasia, Handigodu type
|
ORPHAnet |
| 0‑L |
99646
|
Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria
|
ORPHAnet |
| 0‑L |
99647
|
Cheirospondyloenchondromatosis
|
ORPHAnet |
| 0‑L |
99657
|
Primary dystonia, DYT2 type
|
ORPHAnet |
| 0‑L |
99672
|
Fried's tooth and nail syndrome
|
ORPHAnet |
| 0‑L |
99688
|
Dermotrichic syndrome
|
ORPHAnet |
| 0‑L |
99701
|
Mesial temporal lobe epilepsy with hippocampal sclerosis
|
ORPHAnet |
| 0‑L |
99704
|
Early-onset obesity-hyperphagia-severe developmental delay syndrome
|
ORPHAnet |
| 0‑L |
99710
|
Punctate acrokeratoderma freckle-like pigmentation
|
ORPHAnet |
| 0‑L |
99718
|
Leber plus disease
|
ORPHAnet |
| 0‑L |
99725
|
Pituitary gigantism
|
ORPHAnet |
| 0‑L |
99731
|
Isolated sulfite oxidase deficiency
|
ORPHAnet |
| 0‑L |
99732
|
Sulfite oxidase deficiency due to molybdenum cofactor deficiency
|
ORPHAnet |
| 0‑L |
99734
|
Myotonia fluctuans
|
ORPHAnet |
| 0‑L |
99735
|
Myotonia permanens
|
ORPHAnet |
| 0‑L |
99736
|
Acetazolamide-responsive myotonia
|
ORPHAnet |
| 0‑L |
99741
|
King-Denborough syndrome
|
ORPHAnet |
| 0‑L |
99742
|
Amish lethal microcephaly
|
ORPHAnet |
| 0‑L |
99745
|
Typhoid
|
ORPHAnet |
| 0‑L |
99748
|
Pontiac fever
|
ORPHAnet |
| 0‑L |
99749
|
Kostmann syndrome
|
ORPHAnet |
| 0‑L |
99750
|
Atypical progressive supranuclear palsy syndrome
|
ORPHAnet |
| 0‑L |
99756
|
Alveolar rhabdomyosarcoma
|
ORPHAnet |
| 0‑L |
99757
|
Embryonal rhabdomyosarcoma
|
ORPHAnet |
| 0‑L |
99771
|
Bifid uvula
|
ORPHAnet |
| 0‑L |
99772
|
Cleft velum
|
ORPHAnet |
| 0‑L |
99776
|
Mosaic trisomy 9
|
ORPHAnet |
| 0‑L |
99789
|
Dentin dysplasia type I
|
ORPHAnet |
| 0‑L |
99791
|
Dentin dysplasia type II
|
ORPHAnet |
| 0‑L |
99792
|
Dentin dysplasia-sclerotic bones syndrome
|
ORPHAnet |
| 0‑L |
99796
|
Subcortical band heterotopia
|
ORPHAnet |
| 0‑L |
99797
|
Anodontia
|
ORPHAnet |
| 0‑L |
99798
|
Oligodontia
|
ORPHAnet |
| 0‑L |
99802
|
Hemimegalencephaly
|
ORPHAnet |
| 0‑L |
99803
|
Haddad syndrome
|
ORPHAnet |
| 0‑L |
99806
|
Oculootodental syndrome
|
ORPHAnet |
| 0‑L |
99807
|
PEHO-like syndrome
|
ORPHAnet |
| 0‑L |
99810
|
Familial porencephaly
|
ORPHAnet |
| 0‑L |
99811
|
Neuronal intestinal pseudoobstruction
|
ORPHAnet |
| 0‑L |
99812
|
LIG4 syndrome
|
ORPHAnet |
| 0‑L |
99818
|
Turcot syndrome with polyposis
|
ORPHAnet |
| 0‑L |
99819
|
Familial gestational hyperthyroidism
|
ORPHAnet |
| 0‑L |
99824
|
Lassa fever
|
ORPHAnet |
| 0‑L |
99825
|
Nipah virus disease
|
ORPHAnet |
| 0‑L |
99826
|
Marburg hemorrhagic fever
|
ORPHAnet |
| 0‑L |
99827
|
Crimean-Congo hemorrhagic fever
|
ORPHAnet |
| 0‑L |
99828
|
Dengue fever
|
ORPHAnet |
| 0‑L |
99829
|
Yellow fever
|
ORPHAnet |
| 0‑L |
99832
|
Resistance to thyrotropin-releasing hormone syndrome
|
ORPHAnet |
| 0‑L |
99842
|
Leukocyte adhesion deficiency type I
|
ORPHAnet |
| 0‑L |
99843
|
Leukocyte adhesion deficiency type II
|
ORPHAnet |
| 0‑L |
99844
|
Leukocyte adhesion deficiency type III
|
ORPHAnet |
| 0‑L |
99845
|
Genetic recurrent myoglobinuria
|
ORPHAnet |
| 0‑L |
99846
|
Autosomal dominant myoglobinuria
|
ORPHAnet |
| 0‑L |
99849
|
Glycogen storage disease due to muscle beta-enolase deficiency
|
ORPHAnet |
| 0‑L |
99852
|
Ravine syndrome
|
ORPHAnet |
| 0‑L |
99853
|
Ovarioleukodystrophy
|
ORPHAnet |
| 0‑L |
99854
|
Cree leukoencephalopathy
|
ORPHAnet |
| 0‑L |
99856
|
Primary syringomyelia
|
ORPHAnet |
| 0‑L |
99857
|
Secondary syringomyelia
|
ORPHAnet |
| 0‑L |
99858
|
Idiopathic syringomyelia
|
ORPHAnet |
| 0‑L |
99860
|
Precursor B-cell acute lymphoblastic leukemia
|
ORPHAnet |
| 0‑L |
99861
|
Precursor T-cell acute lymphoblastic leukemia
|
ORPHAnet |
| 0‑L |
99865
|
Spermatocytic seminoma
|
ORPHAnet |
| 0‑L |
99867
|
Thymoma
|
ORPHAnet |
| 0‑L |
99868
|
Thymic carcinoma
|
ORPHAnet |
| 0‑L |
99869
|
Thymic neuroendocrine carcinoma
|
ORPHAnet |
| 0‑L |
99879
|
Familial isolated hyperparathyroidism
|
ORPHAnet |
| 0‑L |
99880
|
Hyperparathyroidism-jaw tumor syndrome
|
ORPHAnet |
| 0‑L |
99885
|
Isolated permanent neonatal diabetes mellitus
|
ORPHAnet |
| 0‑L |
99886
|
Transient neonatal diabetes mellitus
|
ORPHAnet |
| 0‑L |
99887
|
Acute megakaryoblastic leukemia in Down syndrome
|
ORPHAnet |
| 0‑L |
99889
|
Cushing syndrome due to ectopic ACTH secretion
|
ORPHAnet |
| 0‑L |
99898
|
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency
|
ORPHAnet |
| 0‑L |
99901
|
Acyl-CoA dehydrogenase 9 deficiency
|
ORPHAnet |
| 0‑L |
99903
|
Spirillary rat-bite fever
|
ORPHAnet |
| 0‑L |
99905
|
Streptobacillary rat-bite fever
|
ORPHAnet |
| 0‑L |
99906
|
Farmer's lung disease
|
ORPHAnet |
| 0‑L |
99907
|
House allergic alveolitis
|
ORPHAnet |
| 0‑L |
99908
|
Pigeon-breeder lung disease
|
ORPHAnet |
| 0‑L |
99912
|
Malignant dysgerminomatous germ cell tumor of the ovary
|
ORPHAnet |
| 0‑L |
99914
|
Gynandroblastoma
|
ORPHAnet |
| 0‑L |
99915
|
Maligant granulosa cell tumor of the ovary
|
ORPHAnet |
| 0‑L |
99916
|
Malignant Sertoli-Leydig cell tumor of the ovary
|
ORPHAnet |
| 0‑L |
99917
|
Theca steroid-producing cell malignant tumor of ovary, not further specified
|
ORPHAnet |
| 0‑L |
99918
|
Streptococcal toxic-shock syndrome
|
ORPHAnet |
| 0‑L |
99919
|
Staphylococcal toxic-shock syndrome
|
ORPHAnet |
| 0‑L |
99920
|
Acute graft versus host disease
|
ORPHAnet |
| 0‑L |
99921
|
Chronic graft versus host disease
|
ORPHAnet |
| 0‑L |
99922
|
Ocular cicatricial pemphigoid
|
ORPHAnet |
| 0‑L |
99925
|
Invasive mole
|
ORPHAnet |
| 0‑L |
99926
|
Gestational choriocarcinoma
|
ORPHAnet |
| 0‑L |
99927
|
Hydatidiform mole
|
ORPHAnet |
| 0‑L |
99928
|
Placental site trophoblastic tumor
|
ORPHAnet |
| 0‑L |
99930
|
Secondary pulmonary hemosiderosis
|
ORPHAnet |
| 0‑L |
99931
|
Idiopathic pulmonary hemosiderosis
|
ORPHAnet |
| 0‑L |
99932
|
Heiner syndrome
|
ORPHAnet |
| 0‑L |
99933
|
Pleuropulmonary blastoma type 1
|
ORPHAnet |
| 0‑L |
99934
|
Pleuropulmonary blastoma type 2
|
ORPHAnet |
| 0‑L |
99935
|
Pleuropulmonary blastoma type 3
|
ORPHAnet |
| 0‑L |
99936
|
Autosomal dominant Charcot-Marie-Tooth disease type 2B
|
ORPHAnet |
| 0‑L |
99937
|
Autosomal dominant Charcot-Marie-Tooth disease type 2C
|
ORPHAnet |
| 0‑L |
99938
|
Autosomal dominant Charcot-Marie-Tooth disease type 2D
|
ORPHAnet |
| 0‑L |
99939
|
Autosomal dominant Charcot-Marie-Tooth disease type 2E
|
ORPHAnet |
| 0‑L |
99940
|
Autosomal dominant Charcot-Marie-Tooth disease type 2F
|
ORPHAnet |
| 0‑L |
99941
|
Autosomal dominant Charcot-Marie-Tooth disease type 2G
|
ORPHAnet |
| 0‑L |
99942
|
Autosomal dominant Charcot-Marie-Tooth disease type 2I
|
ORPHAnet |
| 0‑L |
99943
|
Autosomal dominant Charcot-Marie-Tooth disease type 2J
|
ORPHAnet |
| 0‑L |
99944
|
Autosomal dominant Charcot-Marie-Tooth disease type 2K
|
ORPHAnet |
| 0‑L |
99945
|
Autosomal dominant Charcot-Marie-Tooth disease type 2L
|
ORPHAnet |
| 0‑L |
99946
|
Autosomal dominant Charcot-Marie-Tooth disease type 2A1
|
ORPHAnet |
| 0‑L |
99947
|
Autosomal dominant Charcot-Marie-Tooth disease type 2A2
|
ORPHAnet |
| 0‑L |
99948
|
Charcot-Marie-Tooth disease type 4A
|
ORPHAnet |
| 0‑L |
99949
|
Charcot-Marie-Tooth disease type 4C
|
ORPHAnet |
| 0‑L |
99950
|
Charcot-Marie-Tooth disease type 4D
|
ORPHAnet |
| 0‑L |
99951
|
Charcot-Marie-Tooth disease type 4E
|
ORPHAnet |
| 0‑L |
99952
|
Charcot-Marie-Tooth disease type 4F
|
ORPHAnet |
| 0‑L |
99953
|
Charcot-Marie-Tooth disease type 4G
|
ORPHAnet |
| 0‑L |
99954
|
Charcot-Marie-Tooth disease type 4H
|
ORPHAnet |
| 0‑L |
99955
|
Charcot-Marie-Tooth disease type 4B1
|
ORPHAnet |
| 0‑L |
99956
|
Charcot-Marie-Tooth disease type 4B2
|
ORPHAnet |
| 0‑L |
99960
|
Benign recurrent intrahepatic cholestasis type 1
|
ORPHAnet |
| 0‑L |
99961
|
Benign recurrent intrahepatic cholestasis type 2
|
ORPHAnet |
| 0‑L |
99965
|
O'Sullivan-McLeod syndrome
|
ORPHAnet |
| 0‑L |
99966
|
Atypical teratoid rhabdoid tumor
|
ORPHAnet |
| 0‑L |
99967
|
Myxoid/round cell liposarcoma
|
ORPHAnet |
| 0‑L |
99969
|
Pleomorphic liposarcoma
|
ORPHAnet |
| 0‑L |
99970
|
Dedifferentiated liposarcoma
|
ORPHAnet |
| 0‑L |
99971
|
Well-differentiated liposarcoma
|
ORPHAnet |
| 0‑L |
99976
|
Adenocarcinoma of the esophagus
|
ORPHAnet |
| 0‑L |
99977
|
Squamous cell carcinoma of the esophagus
|
ORPHAnet |
| 0‑L |
99978
|
Klatskin tumor
|
ORPHAnet |
| 0‑L |
99981
|
Apnea of prematurity
|
ORPHAnet |
| 0‑L |
99989
|
Intermediate DEND syndrome
|
ORPHAnet |
| 0‑L |
99990
|
Brill-Zinsser disease
|
ORPHAnet |
| 0‑L |
99991
|
Relapsing epidemic typhus
|
ORPHAnet |
| 0‑L |
99994
|
Complex regional pain syndrome type 2
|
ORPHAnet |
| 0‑L |
99995
|
Complex regional pain syndrome type 1
|
ORPHAnet |
| 0‑L |
100000
|
Reticular perineurioma
|
ORPHAnet |
| 0‑L |
100001
|
Sclerosing perineurioma
|
ORPHAnet |
| 0‑L |
100002
|
Extraneural perineurioma
|
ORPHAnet |
| 0‑L |
100003
|
Intraneural perineurioma
|
ORPHAnet |
| 0‑L |
100006
|
ABeta amyloidosis, Dutch type
|
ORPHAnet |
| 0‑L |
100008
|
ACys amyloidosis
|
ORPHAnet |
| 0‑L |
100011
|
Lissencephaly with cerebellar hypoplasia type A
|
ORPHAnet |
| 0‑L |
100012
|
Lissencephaly with cerebellar hypoplasia type B
|
ORPHAnet |
| 0‑L |
100013
|
Lissencephaly with cerebellar hypoplasia type C
|
ORPHAnet |
| 0‑L |
100014
|
Lissencephaly with cerebellar hypoplasia type D
|
ORPHAnet |
| 0‑L |
100015
|
Lissencephaly with cerebellar hypoplasia type E
|
ORPHAnet |
| 0‑L |
100016
|
Lissencephaly with cerebellar hypoplasia type F
|
ORPHAnet |
| 0‑L |
100019
|
Refractory anemia with excess blasts type 1
|
ORPHAnet |
| 0‑L |
100020
|
Refractory anemia with excess blasts type 2
|
ORPHAnet |
| 0‑L |
100021
|
Primary plasmacytoma of the bone
|
ORPHAnet |
| 0‑L |
100022
|
Extramedullary soft tissue plasmacytoma
|
ORPHAnet |
| 0‑L |
100024
|
Mu-heavy chain disease
|
ORPHAnet |
| 0‑L |
100025
|
Alpha-heavy chain disease
|
ORPHAnet |
| 0‑L |
100026
|
Gamma-heavy chain disease
|
ORPHAnet |
| 0‑L |
100031
|
Hypoplastic amelogenesis imperfecta
|
ORPHAnet |
| 0‑L |
100032
|
Hypocalcified amelogenesis imperfecta
|
ORPHAnet |
| 0‑L |
100033
|
Hypomaturation amelogenesis imperfecta
|
ORPHAnet |
| 0‑L |
100034
|
Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism
|
ORPHAnet |
| 0‑L |
100035
|
Solitary necrotic nodule of the liver
|
ORPHAnet |
| 0‑L |
100043
|
Autosomal dominant intermediate Charcot-Marie-Tooth disease type A
|
ORPHAnet |
| 0‑L |
100044
|
Autosomal dominant intermediate Charcot-Marie-Tooth disease type B
|
ORPHAnet |
| 0‑L |
100045
|
Autosomal dominant intermediate Charcot-Marie-Tooth disease type C
|
ORPHAnet |
| 0‑L |
100046
|
Autosomal dominant intermediate Charcot-Marie-Tooth disease type D
|
ORPHAnet |
| 0‑L |
100047
|
Esophageal duplication cyst
|
ORPHAnet |
| 0‑L |
100048
|
Tubular duplication of the esophagus
|
ORPHAnet |
| 0‑L |
100050
|
Hereditary angioedema type 1
|
ORPHAnet |
| 0‑L |
100051
|
Hereditary angioedema type 2
|
ORPHAnet |
| 0‑L |
100054
|
F12-related hereditary angioedema with normal C1Inh
|
ORPHAnet |
| 0‑L |
100055
|
Acquired angioedema type 2
|
ORPHAnet |
| 0‑L |
100056
|
Acquired angioedema type 1
|
ORPHAnet |
| 0‑L |
100057
|
Renin-angiotensin-aldosterone system-blocker-induced angioedema
|
ORPHAnet |
| 0‑L |
100067
|
Waterhouse-Friderichsen syndrome
|
ORPHAnet |
| 0‑L |
100069
|
Semantic dementia
|
ORPHAnet |
| 0‑L |
100070
|
Progressive non-fluent aphasia
|
ORPHAnet |
| 0‑L |
100071
|
Mosaic trisomy 3
|
ORPHAnet |
| 0‑L |
100073
|
Neurogenic thoracic outlet syndrome
|
ORPHAnet |
| 0‑L |
100075
|
Neuroendocrine tumor of stomach
|
ORPHAnet |
| 0‑L |
100078
|
Ileal neuroendocrine tumor
|
ORPHAnet |
| 0‑L |
100079
|
Neuroendocrine neoplasm of appendix
|
ORPHAnet |
| 0‑L |
100080
|
Neuroendocrine tumor of the colon
|
ORPHAnet |
| 0‑L |
100081
|
Neuroendocrine tumor of the rectum
|
ORPHAnet |
| 0‑L |
100082
|
Neuroendocrine tumor of anal canal
|
ORPHAnet |
| 0‑L |
100083
|
Laryngeal neuroendocrine tumor
|
ORPHAnet |
| 0‑L |
100084
|
Middle ear neuroendocrine tumor
|
ORPHAnet |
| 0‑L |
100085
|
Primary hepatic neuroendocrine carcinoma
|
ORPHAnet |
| 0‑L |
100086
|
Gallbladder neuroendocrine tumor
|
ORPHAnet |
| 0‑L |
100093
|
Carcinoid syndrome
|
ORPHAnet |
| 0‑L |
100924
|
Porphyria due to ALA dehydratase deficiency
|
ORPHAnet |
| 0‑L |
100973
|
FRAXE intellectual disability
|
ORPHAnet |
| 0‑L |
100974
|
FRAXF syndrome
|
ORPHAnet |
| 0‑L |
100976
|
Bathing suit ichthyosis
|
ORPHAnet |
| 0‑L |
100978
|
Cloverleaf skull-asphyxiating thoracic dysplasia syndrome
|
ORPHAnet |
| 0‑L |
100984
|
Autosomal dominant spastic paraplegia type 3
|
ORPHAnet |
| 0‑L |
100985
|
Autosomal dominant spastic paraplegia type 4
|
ORPHAnet |
| 0‑L |
100986
|
Autosomal recessive spastic paraplegia type 5A
|
ORPHAnet |
| 0‑L |
100988
|
Autosomal dominant spastic paraplegia type 6
|
ORPHAnet |
| 0‑L |
100989
|
Autosomal dominant spastic paraplegia type 8
|
ORPHAnet |
| 0‑L |
100991
|
Autosomal dominant spastic paraplegia type 10
|
ORPHAnet |
| 0‑L |
100993
|
Autosomal dominant spastic paraplegia type 12
|
ORPHAnet |
| 0‑L |
100994
|
Autosomal dominant spastic paraplegia type 13
|
ORPHAnet |
| 0‑L |
100995
|
Autosomal recessive spastic paraplegia type 14
|
ORPHAnet |
| 0‑L |
100996
|
Autosomal recessive spastic paraplegia type 15
|
ORPHAnet |
| 0‑L |
100997
|
X-linked spastic paraplegia type 16
|
ORPHAnet |
| 0‑L |
100998
|
Autosomal dominant spastic paraplegia type 17
|
ORPHAnet |
| 0‑L |
100999
|
Autosomal dominant spastic paraplegia type 19
|
ORPHAnet |
| 0‑L |
101000
|
Autosomal recessive spastic paraplegia type 20
|
ORPHAnet |
| 0‑L |
101001
|
Autosomal recessive spastic paraplegia type 21
|
ORPHAnet |
| 0‑L |
101003
|
Autosomal recessive spastic paraplegia type 23
|
ORPHAnet |
| 0‑L |
101004
|
Autosomal recessive spastic paraplegia type 24
|
ORPHAnet |
| 0‑L |
101005
|
Autosomal recessive spastic paraplegia type 25
|
ORPHAnet |
| 0‑L |
101006
|
Autosomal recessive spastic paraplegia type 26
|
ORPHAnet |
| 0‑L |
101007
|
Autosomal recessive spastic paraplegia type 27
|
ORPHAnet |
| 0‑L |
101008
|
Autosomal recessive spastic paraplegia type 28
|
ORPHAnet |
| 0‑L |
101009
|
Autosomal dominant spastic paraplegia type 29
|
ORPHAnet |
| 0‑L |
101010
|
Autosomal spastic paraplegia type 30
|
ORPHAnet |
| 0‑L |
101011
|
Autosomal dominant spastic paraplegia type 31
|
ORPHAnet |
| 0‑L |
101016
|
Romano-Ward syndrome
|
ORPHAnet |
| 0‑L |
101023
|
Cleft hard palate
|
ORPHAnet |
| 0‑L |
101028
|
Transaldolase deficiency
|
ORPHAnet |
| 0‑L |
101029
|
Sub-cortical nodular heterotopia
|
ORPHAnet |
| 0‑L |
101030
|
Subependymal nodular heterotopia
|
ORPHAnet |
| 0‑L |
101039
|
Female restricted epilepsy with intellectual disability
|
ORPHAnet |
| 0‑L |
101041
|
Familial hypofibrinogenemia
|
ORPHAnet |
| 0‑L |
101043
|
Congenital aortic valve dysplasia
|
ORPHAnet |
| 0‑L |
101046
|
Autosomal dominant epilepsy with auditory features
|
ORPHAnet |
| 0‑L |
101049
|
Familial hypocalciuric hypercalcemia type 2
|
ORPHAnet |
| 0‑L |
101050
|
Familial hypocalciuric hypercalcemia type 3
|
ORPHAnet |
| 0‑L |
101063
|
Situs inversus totalis
|
ORPHAnet |
| 0‑L |
101068
|
Congenital stromal corneal dystrophy
|
ORPHAnet |
| 0‑L |
101070
|
Bilateral frontoparietal polymicrogyria
|
ORPHAnet |
| 0‑L |
101071
|
Unilateral hemispheric polymicrogyria
|
ORPHAnet |
| 0‑L |
101075
|
X-linked Charcot-Marie-Tooth disease type 1
|
ORPHAnet |
| 0‑L |
101076
|
X-linked Charcot-Marie-Tooth disease type 2
|
ORPHAnet |
| 0‑L |
101077
|
X-linked Charcot-Marie-Tooth disease type 3
|
ORPHAnet |
| 0‑L |
101078
|
X-linked Charcot-Marie-Tooth disease type 4
|
ORPHAnet |
| 0‑L |
101081
|
Charcot-Marie-Tooth disease type 1A
|
ORPHAnet |
| 0‑L |
101082
|
Charcot-Marie-Tooth disease type 1B
|
ORPHAnet |
| 0‑L |
101083
|
Charcot-Marie-Tooth disease type 1C
|
ORPHAnet |
| 0‑L |
101084
|
Charcot-Marie-Tooth disease type 1D
|
ORPHAnet |
| 0‑L |
101085
|
Charcot-Marie-Tooth disease type 1F
|
ORPHAnet |
| 0‑L |
101088
|
X-linked hyper-IgM syndrome
|
ORPHAnet |
| 0‑L |
101089
|
Hyper-IgM syndrome type 2
|
ORPHAnet |
| 0‑L |
101090
|
Hyper-IgM syndrome type 3
|
ORPHAnet |
| 0‑L |
101091
|
Hyper-IgM syndrome type 4
|
ORPHAnet |
| 0‑L |
101092
|
Hyper-IgM syndrome type 5
|
ORPHAnet |
| 0‑L |
101096
|
Aregenerative anemia
|
ORPHAnet |
| 0‑L |
101097
|
Autosomal recessive Charcot-Marie-Tooth disease with hoarseness
|
ORPHAnet |
| 0‑L |
101101
|
Charcot-Marie-Tooth disease type 2B2
|
ORPHAnet |
| 0‑L |
101102
|
Charcot-Marie-Tooth disease type 2H
|
ORPHAnet |
| 0‑L |
101104
|
Marin-Amat syndrome
|
ORPHAnet |
| 0‑L |
101108
|
Spinocerebellar ataxia type 23
|
ORPHAnet |
| 0‑L |
101109
|
Spinocerebellar ataxia type 28
|
ORPHAnet |
| 0‑L |
101110
|
Spinocerebellar ataxia type 20
|
ORPHAnet |
| 0‑L |
101111
|
Spinocerebellar ataxia type 25
|
ORPHAnet |
| 0‑L |
101112
|
Spinocerebellar ataxia type 26
|
ORPHAnet |
| 0‑L |
101150
|
Autosomal recessive dopa-responsive dystonia
|
ORPHAnet |
| 0‑L |
101206
|
Pulmonary valve agenesis-tetralogy of Fallot-absence of ductus arteriosus syndrome
|
ORPHAnet |
| 0‑L |
101330
|
Porphyria cutanea tarda
|
ORPHAnet |
| 0‑L |
101334
|
African tick typhus
|
ORPHAnet |
| 0‑L |
101351
|
Familial isolated congenital asplenia
|
ORPHAnet |
| 0‑L |
101685
|
Rare non-syndromic intellectual disability
|
ORPHAnet |
| 0‑L |
101932
|
Anomaly of the mitral subvalvular apparatus
|
ORPHAnet |
| 0‑L |
102379
|
Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent
|
ORPHAnet |
| 0‑L |
102381
|
Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type
2 inhibitor
|
ORPHAnet |
| 0‑L |
102724
|
Acute myeloid leukemia with t(8;21)(q22;q22) translocation
|
ORPHAnet |
| 0‑L |
103907
|
Chronic diarrhea due to glucoamylase deficiency
|
ORPHAnet |
| 0‑L |
103908
|
Congenital sodium diarrhea
|
ORPHAnet |
| 0‑L |
103909
|
Trehalase deficiency
|
ORPHAnet |
| 0‑L |
103910
|
Congenital enterocyte heparan sulfate deficiency
|
ORPHAnet |
| 0‑L |
103918
|
Tropical pancreatitis
|
ORPHAnet |
| 0‑L |
103920
|
Undetermined colitis
|
ORPHAnet |
| 0‑L |
104075
|
Adenocarcinoma of the small intestine
|
ORPHAnet |
| 0‑L |
104076
|
Leiomyosarcoma of small intestine
|
ORPHAnet |
| 0‑L |
104077
|
Myopathic intestinal pseudoobstruction
|
ORPHAnet |
| 0‑L |
104078
|
Unclassified intestinal pseudoobstruction
|
ORPHAnet |
| 0‑L |
137577
|
Neonatal hypoxic and ischemic brain injury
|
ORPHAnet |
| 0‑L |
137583
|
Vulvar intraepithelial neoplasia
|
ORPHAnet |
| 0‑L |
137593
|
Infectious epithelial keratitis
|
ORPHAnet |
| 0‑L |
137596
|
Neurotrophic keratopathy
|
ORPHAnet |
| 0‑L |
137599
|
Herpes simplex virus stromal keratitis
|
ORPHAnet |
| 0‑L |
137602
|
Corneal endotheliitis
|
ORPHAnet |
| 0‑L |
137605
|
Legius syndrome
|
ORPHAnet |
| 0‑L |
137608
|
Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome
|
ORPHAnet |
| 0‑L |
137617
|
Nephrogenic systemic fibrosis
|
ORPHAnet |
| 0‑L |
137622
|
Intractable diarrhea-choanal atresia-eye anomalies syndrome
|
ORPHAnet |
| 0‑L |
137625
|
Glycogen storage disease due to muscle and heart glycogen synthase deficiency
|
ORPHAnet |
| 0‑L |
137628
|
Cardiac anomalies-heterotaxy syndrome
|
ORPHAnet |
| 0‑L |
137631
|
Lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome
|
ORPHAnet |
| 0‑L |
137634
|
Overgrowth-macrocephaly-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
137639
|
Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome
|
ORPHAnet |
| 0‑L |
137667
|
Capillary malformation-arteriovenous malformation
|
ORPHAnet |
| 0‑L |
137672
|
Pellucid marginal degeneration
|
ORPHAnet |
| 0‑L |
137675
|
Histiocytoid cardiomyopathy
|
ORPHAnet |
| 0‑L |
137678
|
Spondyloepiphyseal dysplasia with metatarsal shortening
|
ORPHAnet |
| 0‑L |
137681
|
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1
|
ORPHAnet |
| 0‑L |
137686
|
Asherman syndrome
|
ORPHAnet |
| 0‑L |
137698
|
Cytomegalovirus disease in patients with impaired cell mediated immunity deemed at
risk
|
ORPHAnet |
| 0‑L |
137754
|
Neurological conditions associated with aminoacylase 1 deficiency
|
ORPHAnet |
| 0‑L |
137776
|
Lethal congenital contracture syndrome type 2
|
ORPHAnet |
| 0‑L |
137783
|
Lethal congenital contracture syndrome type 3
|
ORPHAnet |
| 0‑L |
137810
|
Nodular cutaneous amyloidosis
|
ORPHAnet |
| 0‑L |
137814
|
Macular amyloidosis
|
ORPHAnet |
| 0‑L |
137817
|
Arachnoiditis
|
ORPHAnet |
| 0‑L |
137820
|
Extrapelvic endometriosis
|
ORPHAnet |
| 0‑L |
137831
|
X-linked intellectual disability-cerebellar hypoplasia syndrome
|
ORPHAnet |
| 0‑L |
137834
|
Frank-Ter Haar syndrome
|
ORPHAnet |
| 0‑L |
137839
|
Lemierre syndrome
|
ORPHAnet |
| 0‑L |
137867
|
Madras motor neuron disease
|
ORPHAnet |
| 0‑L |
137888
|
Auriculocondylar syndrome
|
ORPHAnet |
| 0‑L |
137893
|
Male infertility due to large-headed multiflagellar polyploid spermatozoa
|
ORPHAnet |
| 0‑L |
137898
|
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome
|
ORPHAnet |
| 0‑L |
137902
|
Isolated optic nerve hypoplasia/aplasia
|
ORPHAnet |
| 0‑L |
137908
|
Hypotonia with lactic acidemia and hyperammonemia
|
ORPHAnet |
| 0‑L |
137911
|
Autism-facial port-wine stain syndrome
|
ORPHAnet |
| 0‑L |
137914
|
Choanal atresia
|
ORPHAnet |
| 0‑L |
137917
|
Choanal atresia, unilateral
|
ORPHAnet |
| 0‑L |
137920
|
Choanal atresia, bilateral
|
ORPHAnet |
| 0‑L |
137926
|
Primary laryngeal lymphangioma
|
ORPHAnet |
| 0‑L |
137929
|
Neonatal brainstem dysfunction
|
ORPHAnet |
| 0‑L |
137932
|
Congenital laryngeal palsy
|
ORPHAnet |
| 0‑L |
137935
|
Laryngotracheal angioma
|
ORPHAnet |
| 0‑L |
139396
|
X-linked cerebral adrenoleukodystrophy
|
ORPHAnet |
| 0‑L |
139399
|
Adrenomyeloneuropathy
|
ORPHAnet |
| 0‑L |
139402
|
Drug reaction with eosinophilia and systemic symptoms
|
ORPHAnet |
| 0‑L |
139406
|
Encephalopathy due to prosaposin deficiency
|
ORPHAnet |
| 0‑L |
139411
|
Carney triad
|
ORPHAnet |
| 0‑L |
139414
|
Congenital panfollicular nevus
|
ORPHAnet |
| 0‑L |
139417
|
Acute transverse myelitis
|
ORPHAnet |
| 0‑L |
139423
|
Idiopathic acute transverse myelitis
|
ORPHAnet |
| 0‑L |
139426
|
Perioral myoclonia with absences
|
ORPHAnet |
| 0‑L |
139431
|
Jeavons syndrome
|
ORPHAnet |
| 0‑L |
139436
|
Multicentric reticulohistiocytosis
|
ORPHAnet |
| 0‑L |
139441
|
Hypomyelination with atrophy of basal ganglia and cerebellum
|
ORPHAnet |
| 0‑L |
139444
|
Leukoencephalopathy with bilateral anterior temporal lobe cysts
|
ORPHAnet |
| 0‑L |
139447
|
Progressive cavitating leukoencephalopathy
|
ORPHAnet |
| 0‑L |
139450
|
Microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome
|
ORPHAnet |
| 0‑L |
139455
|
Autosomal recessive bestrophinopathy
|
ORPHAnet |
| 0‑L |
139466
|
SERKAL syndrome
|
ORPHAnet |
| 0‑L |
139471
|
Microphthalmia with brain and digit anomalies
|
ORPHAnet |
| 0‑L |
139474
|
17q11.2 microduplication syndrome
|
ORPHAnet |
| 0‑L |
139480
|
Autosomal recessive spastic paraplegia type 39
|
ORPHAnet |
| 0‑L |
139485
|
Autosomal recessive ataxia due to ubiquinone deficiency
|
ORPHAnet |
| 0‑L |
139491
|
Hemochromatosis type 4
|
ORPHAnet |
| 0‑L |
139507
|
African iron overload
|
ORPHAnet |
| 0‑L |
139512
|
Neuropathy with hearing impairment
|
ORPHAnet |
| 0‑L |
139515
|
Charcot-Marie-Tooth disease type 4J
|
ORPHAnet |
| 0‑L |
139518
|
Distal hereditary motor neuropathy type 1
|
ORPHAnet |
| 0‑L |
139525
|
Distal hereditary motor neuropathy type 2
|
ORPHAnet |
| 0‑L |
139536
|
Distal hereditary motor neuropathy type 5
|
ORPHAnet |
| 0‑L |
139547
|
Distal spinal muscular atrophy type 3
|
ORPHAnet |
| 0‑L |
139552
|
Distal hereditary motor neuropathy, Jerash type
|
ORPHAnet |
| 0‑L |
139557
|
X-linked distal spinal muscular atrophy type 3
|
ORPHAnet |
| 0‑L |
139564
|
Hereditary sensory and autonomic neuropathy type 1B
|
ORPHAnet |
| 0‑L |
139573
|
Hereditary sensory and autonomic neuropathy with deafness and global delay
|
ORPHAnet |
| 0‑L |
139578
|
Mutilating hereditary sensory neuropathy with spastic paraplegia
|
ORPHAnet |
| 0‑L |
139583
|
X-linked hereditary sensory and autonomic neuropathy with deafness
|
ORPHAnet |
| 0‑L |
139589
|
Distal hereditary motor neuropathy type 7
|
ORPHAnet |
| 0‑L |
140286
|
Secondary hypoparathyroidism due to impaired parathormon secretion
|
ORPHAnet |
| 0‑L |
140436
|
Primary intraosseous venous malformation
|
ORPHAnet |
| 0‑L |
140481
|
Autosomal dominant slowed nerve conduction velocity
|
ORPHAnet |
| 0‑L |
140896
|
Severe acute respiratory syndrome
|
ORPHAnet |
| 0‑L |
140905
|
Hyperlipidemia due to hepatic triacylglycerol lipase deficiency
|
ORPHAnet |
| 0‑L |
140908
|
Brachydactyly type B2
|
ORPHAnet |
| 0‑L |
140917
|
Stapes ankylosis with broad thumbs and toes
|
ORPHAnet |
| 0‑L |
140922
|
Titin-related limb-girdle muscular dystrophy R10
|
ORPHAnet |
| 0‑L |
140927
|
Benign familial neonatal-infantile seizures
|
ORPHAnet |
| 0‑L |
140933
|
Linear atrophoderma of Moulin
|
ORPHAnet |
| 0‑L |
140936
|
Lelis syndrome
|
ORPHAnet |
| 0‑L |
140941
|
Short stature due to primary acid-labile subunit deficiency
|
ORPHAnet |
| 0‑L |
140944
|
CLOVES syndrome
|
ORPHAnet |
| 0‑L |
140949
|
Low-flow priapism
|
ORPHAnet |
| 0‑L |
140952
|
Syndactyly-telecanthus-anogenital and renal malformations syndrome
|
ORPHAnet |
| 0‑L |
140957
|
Autosomal dominant macrothrombocytopenia
|
ORPHAnet |
| 0‑L |
140963
|
Bilateral microtia-deafness-cleft palate syndrome
|
ORPHAnet |
| 0‑L |
140966
|
Palmoplantar keratoderma, Nagashima type
|
ORPHAnet |
| 0‑L |
140969
|
Saldino-Mainzer syndrome
|
ORPHAnet |
| 0‑L |
140976
|
RHYNS syndrome
|
ORPHAnet |
| 0‑L |
140989
|
Primary angiitis of the central nervous system
|
ORPHAnet |
| 0‑L |
141000
|
Orofaciodigital syndrome type 11
|
ORPHAnet |
| 0‑L |
141007
|
Orofaciodigital syndrome type 9
|
ORPHAnet |
| 0‑L |
141013
|
First branchial cleft anomaly
|
ORPHAnet |
| 0‑L |
141022
|
Second branchial cleft anomaly
|
ORPHAnet |
| 0‑L |
141030
|
Third branchial cleft anomaly
|
ORPHAnet |
| 0‑L |
141037
|
Fourth branchial cleft anomaly
|
ORPHAnet |
| 0‑L |
141046
|
Cervical dermoid cyst
|
ORPHAnet |
| 0‑L |
141051
|
Facial dermoid cyst
|
ORPHAnet |
| 0‑L |
141061
|
Commissural lip fistula
|
ORPHAnet |
| 0‑L |
141064
|
Lower lip fistula
|
ORPHAnet |
| 0‑L |
141067
|
Cervicofacial fibrochondroma
|
ORPHAnet |
| 0‑L |
141071
|
Digestive duplication cyst of the tongue
|
ORPHAnet |
| 0‑L |
141074
|
External auditory canal aplasia/hypoplasia
|
ORPHAnet |
| 0‑L |
141077
|
Epignathus
|
ORPHAnet |
| 0‑L |
141083
|
Nasolacrimal duct cyst
|
ORPHAnet |
| 0‑L |
141091
|
Polyrrhinia
|
ORPHAnet |
| 0‑L |
141096
|
Supernumerary nostril
|
ORPHAnet |
| 0‑L |
141099
|
Proboscis lateralis
|
ORPHAnet |
| 0‑L |
141103
|
Nasal dermoid cyst
|
ORPHAnet |
| 0‑L |
141107
|
Nasopharyngeal teratoma
|
ORPHAnet |
| 0‑L |
141112
|
Nasal glial heterotopia
|
ORPHAnet |
| 0‑L |
141115
|
Nasal ganglioglioma
|
ORPHAnet |
| 0‑L |
141118
|
Nasal encephalocele
|
ORPHAnet |
| 0‑L |
141121
|
Congenital subglottic stenosis
|
ORPHAnet |
| 0‑L |
141124
|
Congenital laryngeal cyst
|
ORPHAnet |
| 0‑L |
141127
|
Congenital tracheal stenosis
|
ORPHAnet |
| 0‑L |
141132
|
Oculo-auriculo-vertebral spectrum
|
ORPHAnet |
| 0‑L |
141145
|
Hemifacial hyperplasia
|
ORPHAnet |
| 0‑L |
141148
|
Hemifacial myohyperplasia
|
ORPHAnet |
| 0‑L |
141152
|
Isolated congenital hypoglossia/aglossia
|
ORPHAnet |
| 0‑L |
141163
|
Glossopalatine ankylosis
|
ORPHAnet |
| 0‑L |
141168
|
Frontonasal arteriovenous malformation
|
ORPHAnet |
| 0‑L |
141171
|
Maxillary arteriovenous malformation
|
ORPHAnet |
| 0‑L |
141174
|
Mandibular arteriovenous malformation
|
ORPHAnet |
| 0‑L |
141179
|
Non-involuting congenital hemangioma
|
ORPHAnet |
| 0‑L |
141184
|
Rapidly involuting congenital hemangioma
|
ORPHAnet |
| 0‑L |
141194
|
Cerebrofacial arteriovenous metameric syndrome type 1
|
ORPHAnet |
| 0‑L |
141199
|
Cerebrofacial arteriovenous metameric syndrome type 3
|
ORPHAnet |
| 0‑L |
141209
|
Diffuse lymphatic malformation
|
ORPHAnet |
| 0‑L |
141214
|
Isolated congenital syngnathia
|
ORPHAnet |
| 0‑L |
141219
|
Nasal dorsum fistula
|
ORPHAnet |
| 0‑L |
141239
|
Median cleft of the upper lip and maxilla
|
ORPHAnet |
| 0‑L |
141242
|
Paramedian nasal cleft
|
ORPHAnet |
| 0‑L |
141258
|
Tessier number 4 facial cleft
|
ORPHAnet |
| 0‑L |
141261
|
Tessier number 5 facial cleft
|
ORPHAnet |
| 0‑L |
141265
|
Tessier number 6 facial cleft
|
ORPHAnet |
| 0‑L |
141276
|
Tessier number 7 facial cleft
|
ORPHAnet |
| 0‑L |
141288
|
Midline cervical cleft
|
ORPHAnet |
| 0‑L |
141291
|
Cleft lip and alveolus
|
ORPHAnet |
| 0‑L |
141327
|
Orofaciodigital syndrome type 12
|
ORPHAnet |
| 0‑L |
141330
|
Orofaciodigital syndrome type 13
|
ORPHAnet |
| 0‑L |
141333
|
Biemond syndrome type 2
|
ORPHAnet |
| 0‑L |
155838
|
Pinnae fistula or cyst
|
ORPHAnet |
| 0‑L |
155878
|
Submucosal cleft palate
|
ORPHAnet |
| 0‑L |
155884
|
Coloboma of superior eyelid
|
ORPHAnet |
| 0‑L |
155889
|
Coloboma of inferior eyelid
|
ORPHAnet |
| 0‑L |
156728
|
Spondyloepimetaphyseal dysplasia, matrilin-3 type
|
ORPHAnet |
| 0‑L |
156731
|
Dyssegmental dysplasia, Rolland-Desbuquois type
|
ORPHAnet |
| 0‑L |
157215
|
Hereditary hypophosphatemic rickets with hypercalciuria
|
ORPHAnet |
| 0‑L |
157713
|
Congenital or early infantile CACH syndrome
|
ORPHAnet |
| 0‑L |
157716
|
Late infantile CACH syndrome
|
ORPHAnet |
| 0‑L |
157719
|
Juvenile or adult CACH syndrome
|
ORPHAnet |
| 0‑L |
157769
|
Situs ambiguus
|
ORPHAnet |
| 0‑L |
157791
|
Epithelioid hemangioendothelioma
|
ORPHAnet |
| 0‑L |
157794
|
Hereditary mixed polyposis syndrome
|
ORPHAnet |
| 0‑L |
157798
|
Serrated polyposis syndrome
|
ORPHAnet |
| 0‑L |
157801
|
Mesoaxial synostotic syndactyly with phalangeal reduction
|
ORPHAnet |
| 0‑L |
157808
|
Congenital pseudoarthrosis of the limbs
|
ORPHAnet |
| 0‑L |
157820
|
Cold-induced sweating syndrome
|
ORPHAnet |
| 0‑L |
157823
|
Klüver-Bucy syndrome
|
ORPHAnet |
| 0‑L |
157826
|
Congenital epulis
|
ORPHAnet |
| 0‑L |
157832
|
Craniorhiny
|
ORPHAnet |
| 0‑L |
157835
|
Paroxysmal hemicrania
|
ORPHAnet |
| 0‑L |
157846
|
Neuroferritinopathy
|
ORPHAnet |
| 0‑L |
157850
|
Pantothenate kinase-associated neurodegeneration
|
ORPHAnet |
| 0‑L |
157941
|
Huntington disease-like 1
|
ORPHAnet |
| 0‑L |
157946
|
Huntington disease-like 3
|
ORPHAnet |
| 0‑L |
157949
|
Combined immunodeficiency with granulomatosis
|
ORPHAnet |
| 0‑L |
157954
|
ANE syndrome
|
ORPHAnet |
| 0‑L |
157962
|
Oculoauricular syndrome, Schorderet type
|
ORPHAnet |
| 0‑L |
157965
|
SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
157973
|
Congenital muscular dystrophy due to LMNA mutation
|
ORPHAnet |
| 0‑L |
157991
|
Generalized eruptive histiocytosis
|
ORPHAnet |
| 0‑L |
157997
|
Benign cephalic histiocytosis
|
ORPHAnet |
| 0‑L |
158000
|
Juvenile xanthogranuloma
|
ORPHAnet |
| 0‑L |
158003
|
Xanthoma disseminatum
|
ORPHAnet |
| 0‑L |
158008
|
Papular xanthoma
|
ORPHAnet |
| 0‑L |
158011
|
Necrobiotic xanthogranuloma
|
ORPHAnet |
| 0‑L |
158014
|
Rosaï-Dorfman disease
|
ORPHAnet |
| 0‑L |
158019
|
Indeterminate cell histiocytosis
|
ORPHAnet |
| 0‑L |
158022
|
Progressive nodular histiocytosis
|
ORPHAnet |
| 0‑L |
158025
|
Hereditary progressive mucinous histiocytosis
|
ORPHAnet |
| 0‑L |
158029
|
Sea-blue histiocytosis
|
ORPHAnet |
| 0‑L |
158048
|
Hemophagocytic syndrome associated with an infection
|
ORPHAnet |
| 0‑L |
158057
|
Acquired hemophagocytic lymphohistiocytosis associated with malignant disease
|
ORPHAnet |
| 0‑L |
158061
|
Macrophage activation syndrome
|
ORPHAnet |
| 0‑L |
158668
|
Ectodermal dysplasia-skin fragility syndrome
|
ORPHAnet |
| 0‑L |
158673
|
Localized dystrophic epidermolysis bullosa, acral form
|
ORPHAnet |
| 0‑L |
158676
|
Localized dystrophic epidermolysis bullosa, nails only
|
ORPHAnet |
| 0‑L |
158681
|
Epidermolysis bullosa simplex with circinate migratory erythema
|
ORPHAnet |
| 0‑L |
158684
|
Epidermolysis bullosa simplex with pyloric atresia
|
ORPHAnet |
| 0‑L |
158687
|
Lethal acantholytic erosive disorder
|
ORPHAnet |
| 0‑L |
158766
|
Typical urticaria pigmentosa
|
ORPHAnet |
| 0‑L |
158769
|
Plaque-form urticaria pigmentosa
|
ORPHAnet |
| 0‑L |
158772
|
Nodular urticaria pigmentosa
|
ORPHAnet |
| 0‑L |
158775
|
Smoldering systemic mastocytosis
|
ORPHAnet |
| 0‑L |
158778
|
Isolated bone marrow mastocytosis
|
ORPHAnet |
| 0‑L |
160148
|
Cap polyposis
|
ORPHAnet |
| 0‑L |
162516
|
Isolated congenital nasal pyriform aperture stenosis
|
ORPHAnet |
| 0‑L |
162526
|
Isolated congenital auditory ossicle malformation
|
ORPHAnet |
| 0‑L |
163525
|
Subacute cutaneous lupus erythematosus
|
ORPHAnet |
| 0‑L |
163596
|
Hb Bart's hydrops fetalis
|
ORPHAnet |
| 0‑L |
163634
|
Maffucci syndrome
|
ORPHAnet |
| 0‑L |
163649
|
Spondyloepiphyseal dysplasia-craniosynostosis-cleft palate-cataracts-intellectual
disability syndrome
|
ORPHAnet |
| 0‑L |
163654
|
Spondyloepiphyseal dysplasia-brachydactyly-speech disorder syndrome
|
ORPHAnet |
| 0‑L |
163662
|
Spondyloepiphyseal dysplasia, Reardon type
|
ORPHAnet |
| 0‑L |
163665
|
Spondyloepiphyseal dysplasia tarda, Kohn type
|
ORPHAnet |
| 0‑L |
163668
|
Spondyloepiphyseal dysplasia, MacDermot type
|
ORPHAnet |
| 0‑L |
163681
|
CNTNAP2-related developmental and epileptic encephalopathy
|
ORPHAnet |
| 0‑L |
163684
|
Leukoencephalopathy-dystonia-motor neuropathy syndrome
|
ORPHAnet |
| 0‑L |
163690
|
Hypotonia-cystinuria syndrome
|
ORPHAnet |
| 0‑L |
163693
|
2p21 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
163696
|
Action myoclonus-renal failure syndrome
|
ORPHAnet |
| 0‑L |
163699
|
Alveolar soft tissue sarcoma
|
ORPHAnet |
| 0‑L |
163703
|
Febrile infection-related epilepsy syndrome
|
ORPHAnet |
| 0‑L |
163708
|
Cryptogenic late-onset epileptic spasms
|
ORPHAnet |
| 0‑L |
163717
|
Benign familial mesial temporal lobe epilepsy
|
ORPHAnet |
| 0‑L |
163721
|
Rolandic epilepsy-speech dyspraxia syndrome
|
ORPHAnet |
| 0‑L |
163727
|
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome
|
ORPHAnet |
| 0‑L |
163746
|
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg
syndrome-Hirschsprung disease
|
ORPHAnet |
| 0‑L |
163921
|
Posttransplant acute limbic encephalitis
|
ORPHAnet |
| 0‑L |
163927
|
Pustulosis palmaris et plantaris
|
ORPHAnet |
| 0‑L |
163931
|
Acrodermatitis continua of Hallopeau
|
ORPHAnet |
| 0‑L |
163934
|
Atopic keratoconjunctivitis
|
ORPHAnet |
| 0‑L |
163937
|
X-linked intellectual disability, Najm type
|
ORPHAnet |
| 0‑L |
163956
|
X-linked intellectual disability, Nascimento type
|
ORPHAnet |
| 0‑L |
163961
|
X-linked cerebral-cerebellar-coloboma syndrome
|
ORPHAnet |
| 0‑L |
163966
|
X-linked dominant chondrodysplasia, Chassaing-Lacombe type
|
ORPHAnet |
| 0‑L |
163971
|
X-linked intellectual disability, Cilliers type
|
ORPHAnet |
| 0‑L |
163976
|
X-linked intellectual disability, Van Esch type
|
ORPHAnet |
| 0‑L |
163979
|
X-linked intellectual disability-craniofacioskeletal syndrome
|
ORPHAnet |
| 0‑L |
163985
|
Hyperekplexia-epilepsy syndrome
|
ORPHAnet |
| 0‑L |
164726
|
Acute myeloid leukemia and myelodysplastic syndromes related to radiation
|
ORPHAnet |
| 0‑L |
164736
|
Familial advanced sleep-phase syndrome
|
ORPHAnet |
| 0‑L |
165805
|
Familial mesial temporal lobe epilepsy with febrile seizures
|
ORPHAnet |
| 0‑L |
165955
|
Wound myiasis
|
ORPHAnet |
| 0‑L |
165958
|
Cavitary myiasis
|
ORPHAnet |
| 0‑L |
165991
|
Exercise-induced hyperinsulinism
|
ORPHAnet |
| 0‑L |
166002
|
Multiple epiphyseal dysplasia due to collagen 9 anomaly
|
ORPHAnet |
| 0‑L |
166011
|
Multiple epiphyseal dysplasia, Beighton type
|
ORPHAnet |
| 0‑L |
166016
|
Multiple epiphyseal dysplasia, Lowry type
|
ORPHAnet |
| 0‑L |
166024
|
Multiple epiphyseal dysplasia, Al-Gazali type
|
ORPHAnet |
| 0‑L |
166029
|
Multiple epiphyseal dysplasia, with severe proximal femoral dysplasia
|
ORPHAnet |
| 0‑L |
166032
|
Multiple epiphyseal dysplasia, with miniepiphyses
|
ORPHAnet |
| 0‑L |
166035
|
Brachydactyly-short stature-retinitis pigmentosa syndrome
|
ORPHAnet |
| 0‑L |
166038
|
Metaphyseal chondrodysplasia, Kaitila type
|
ORPHAnet |
| 0‑L |
166063
|
Pontocerebellar hypoplasia type 4
|
ORPHAnet |
| 0‑L |
166073
|
Pontocerebellar hypoplasia type 6
|
ORPHAnet |
| 0‑L |
166078
|
Von Willebrand disease type 1
|
ORPHAnet |
| 0‑L |
166081
|
Von Willebrand disease type 2
|
ORPHAnet |
| 0‑L |
166084
|
Von Willebrand disease type 2A
|
ORPHAnet |
| 0‑L |
166087
|
Von Willebrand disease type 2B
|
ORPHAnet |
| 0‑L |
166090
|
Von Willebrand disease type 2M
|
ORPHAnet |
| 0‑L |
166093
|
Von Willebrand disease type 2N
|
ORPHAnet |
| 0‑L |
166096
|
Von Willebrand disease type 3
|
ORPHAnet |
| 0‑L |
166100
|
Autosomal dominant otospondylomegaepiphyseal dysplasia
|
ORPHAnet |
| 0‑L |
166105
|
FASTKD2-related infantile mitochondrial encephalomyopathy
|
ORPHAnet |
| 0‑L |
166108
|
Intellectual disability, Birk-Barel type
|
ORPHAnet |
| 0‑L |
166113
|
Bazex syndrome
|
ORPHAnet |
| 0‑L |
166119
|
Isolated osteopoikilosis
|
ORPHAnet |
| 0‑L |
166260
|
Dentinogenesis imperfecta type 2
|
ORPHAnet |
| 0‑L |
166265
|
Dentinogenesis imperfecta type 3
|
ORPHAnet |
| 0‑L |
166272
|
Odontochondrodysplasia
|
ORPHAnet |
| 0‑L |
166277
|
Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia
|
ORPHAnet |
| 0‑L |
166282
|
Familial sick sinus syndrome
|
ORPHAnet |
| 0‑L |
166286
|
Porokeratotic eccrine ostial and dermal duct nevus
|
ORPHAnet |
| 0‑L |
166291
|
Dirofilariasis
|
ORPHAnet |
| 0‑L |
166299
|
Benign partial epilepsy of infancy with complex partial seizures
|
ORPHAnet |
| 0‑L |
166302
|
Benign partial epilepsy with secondarily generalized seizures in infancy
|
ORPHAnet |
| 0‑L |
166305
|
Benign infantile seizures associated with mild gastroenteritis
|
ORPHAnet |
| 0‑L |
166308
|
Benign infantile focal epilepsy with midline spikes and waves during sleep
|
ORPHAnet |
| 0‑L |
166409
|
Photosensitive epilepsy
|
ORPHAnet |
| 0‑L |
166412
|
Hot water reflex epilepsy
|
ORPHAnet |
| 0‑L |
166415
|
Audiogenic seizures
|
ORPHAnet |
| 0‑L |
166418
|
Eating reflex epilepsy
|
ORPHAnet |
| 0‑L |
166421
|
Orgasm-induced seizures
|
ORPHAnet |
| 0‑L |
166424
|
Thinking seizures
|
ORPHAnet |
| 0‑L |
166427
|
Startle epilepsy
|
ORPHAnet |
| 0‑L |
166430
|
Micturation-induced seizures
|
ORPHAnet |
| 0‑L |
166433
|
Reading seizures
|
ORPHAnet |
| 0‑L |
167635
|
Scleromyxedema
|
ORPHAnet |
| 0‑L |
168443
|
Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome
|
ORPHAnet |
| 0‑L |
168451
|
Spondyloepimetaphyseal dysplasia-abnormal dentition syndrome
|
ORPHAnet |
| 0‑L |
168454
|
Spondyloepimetaphyseal dysplasia, Geneviève type
|
ORPHAnet |
| 0‑L |
168486
|
Congenital neuronal ceroid lipofuscinosis
|
ORPHAnet |
| 0‑L |
168491
|
Late infantile neuronal ceroid lipofuscinosis
|
ORPHAnet |
| 0‑L |
168544
|
Spondylometaphyseal dysplasia, Golden type
|
ORPHAnet |
| 0‑L |
168549
|
Axial spondylometaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
168552
|
Spondylometaphyseal dysplasia-bowed forearms-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
168555
|
Spondylometaphyseal dysplasia, A4 type
|
ORPHAnet |
| 0‑L |
168558
|
46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency
|
ORPHAnet |
| 0‑L |
168563
|
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome
|
ORPHAnet |
| 0‑L |
168566
|
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type
3
|
ORPHAnet |
| 0‑L |
168569
|
H syndrome
|
ORPHAnet |
| 0‑L |
168572
|
Native American myopathy
|
ORPHAnet |
| 0‑L |
168577
|
Hereditary cryohydrocytosis with reduced stomatin
|
ORPHAnet |
| 0‑L |
168583
|
Hereditary North American Indian childhood cirrhosis
|
ORPHAnet |
| 0‑L |
168588
|
Hyperandrogenism due to cortisone reductase deficiency
|
ORPHAnet |
| 0‑L |
168593
|
Sudden infant death-dysgenesis of the testes syndrome
|
ORPHAnet |
| 0‑L |
168598
|
Brain demyelination due to methionine adenosyltransferase deficiency
|
ORPHAnet |
| 0‑L |
168601
|
Congenital enteropathy due to enteropeptidase deficiency
|
ORPHAnet |
| 0‑L |
168606
|
Seborrhea-like dermatitis with psoriasiform elements
|
ORPHAnet |
| 0‑L |
168612
|
Congenital deficiency in alpha-fetoprotein
|
ORPHAnet |
| 0‑L |
168615
|
Hereditary persistence of alpha-fetoprotein
|
ORPHAnet |
| 0‑L |
168621
|
Dysplasia of head of femur, Meyer type
|
ORPHAnet |
| 0‑L |
168624
|
Familial scaphocephaly syndrome, McGillivray type
|
ORPHAnet |
| 0‑L |
168629
|
Autosomal thrombocytopenia with normal platelets
|
ORPHAnet |
| 0‑L |
168632
|
Generalized basaloid follicular hamartoma syndrome
|
ORPHAnet |
| 0‑L |
168782
|
Childhood disintegrative disorder
|
ORPHAnet |
| 0‑L |
168796
|
Heart-hand syndrome, Slovenian type
|
ORPHAnet |
| 0‑L |
168811
|
Malignant peritoneal mesothelioma
|
ORPHAnet |
| 0‑L |
168816
|
Peritoneal cystic mesothelioma
|
ORPHAnet |
| 0‑L |
168829
|
Primary peritoneal carcinoma
|
ORPHAnet |
| 0‑L |
168940
|
Chronic eosinophilic leukemia
|
ORPHAnet |
| 0‑L |
168947
|
Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement
|
ORPHAnet |
| 0‑L |
168950
|
Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement
|
ORPHAnet |
| 0‑L |
168953
|
Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement
|
ORPHAnet |
| 0‑L |
168960
|
Refractory anemia with excess blasts in transformation
|
ORPHAnet |
| 0‑L |
168966
|
Composite lymphoma
|
ORPHAnet |
| 0‑L |
168984
|
CLAPO syndrome
|
ORPHAnet |
| 0‑L |
168999
|
Malignant melanoma of the mucosa
|
ORPHAnet |
| 0‑L |
169079
|
Cernunnos-XLF deficiency
|
ORPHAnet |
| 0‑L |
169082
|
Combined immunodeficiency due to CD3gamma deficiency
|
ORPHAnet |
| 0‑L |
169085
|
Susceptibility to respiratory infections associated with CD8alpha chain mutation
|
ORPHAnet |
| 0‑L |
169090
|
Combined immunodeficiency due to CRAC channel dysfunction
|
ORPHAnet |
| 0‑L |
169095
|
Severe combined immunodeficiency due to FOXN1 deficiency
|
ORPHAnet |
| 0‑L |
169100
|
Immunodeficiency due to CD25 deficiency
|
ORPHAnet |
| 0‑L |
169105
|
Good syndrome
|
ORPHAnet |
| 0‑L |
169110
|
Immunoglobulin heavy chain deficiency
|
ORPHAnet |
| 0‑L |
169139
|
Transient hypogammaglobulinemia of infancy
|
ORPHAnet |
| 0‑L |
169142
|
Recurrent infection due to specific granule deficiency
|
ORPHAnet |
| 0‑L |
169147
|
Immunodeficiency due to a classical component pathway complement deficiency
|
ORPHAnet |
| 0‑L |
169150
|
Immunodeficiency due to a late component of complement deficiency
|
ORPHAnet |
| 0‑L |
169154
|
T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency
|
ORPHAnet |
| 0‑L |
169157
|
T-B+ severe combined immunodeficiency due to CD45 deficiency
|
ORPHAnet |
| 0‑L |
169160
|
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta
|
ORPHAnet |
| 0‑L |
169186
|
Autosomal recessive centronuclear myopathy
|
ORPHAnet |
| 0‑L |
169189
|
Autosomal dominant centronuclear myopathy
|
ORPHAnet |
| 0‑L |
169464
|
Primary CD59 deficiency
|
ORPHAnet |
| 0‑L |
169467
|
Recurrent Neisseria infections due to factor D deficiency
|
ORPHAnet |
| 0‑L |
169615
|
Idiopathic central precocious puberty
|
ORPHAnet |
| 0‑L |
169618
|
Secondary central precocious puberty
|
ORPHAnet |
| 0‑L |
169793
|
Severe hemophilia B
|
ORPHAnet |
| 0‑L |
169796
|
Moderate hemophilia B
|
ORPHAnet |
| 0‑L |
169799
|
Mild hemophilia B
|
ORPHAnet |
| 0‑L |
169802
|
Severe hemophilia A
|
ORPHAnet |
| 0‑L |
169805
|
Moderate hemophilia A
|
ORPHAnet |
| 0‑L |
169808
|
Mild hemophilia A
|
ORPHAnet |
| 0‑L |
171220
|
Rectal duplication
|
ORPHAnet |
| 0‑L |
171430
|
Severe congenital nemaline myopathy
|
ORPHAnet |
| 0‑L |
171433
|
Intermediate nemaline myopathy
|
ORPHAnet |
| 0‑L |
171436
|
Typical nemaline myopathy
|
ORPHAnet |
| 0‑L |
171439
|
Childhood-onset nemaline myopathy
|
ORPHAnet |
| 0‑L |
171442
|
Adult-onset nemaline myopathy
|
ORPHAnet |
| 0‑L |
171445
|
Muscle filaminopathy
|
ORPHAnet |
| 0‑L |
171607
|
X-linked spastic paraplegia type 34
|
ORPHAnet |
| 0‑L |
171612
|
Autosomal dominant spastic paraplegia type 37
|
ORPHAnet |
| 0‑L |
171617
|
Autosomal dominant spastic paraplegia type 38
|
ORPHAnet |
| 0‑L |
171622
|
Autosomal recessive spastic paraplegia type 32
|
ORPHAnet |
| 0‑L |
171629
|
Autosomal recessive spastic paraplegia type 35
|
ORPHAnet |
| 0‑L |
171673
|
Limbal stem cell deficiency
|
ORPHAnet |
| 0‑L |
171680
|
Lissencephaly due to TUBA1A mutation
|
ORPHAnet |
| 0‑L |
171684
|
Idiopathic bilateral vestibulopathy
|
ORPHAnet |
| 0‑L |
171690
|
Metabolic myopathy due to lactate transporter defect
|
ORPHAnet |
| 0‑L |
171695
|
Parkinsonian-pyramidal syndrome
|
ORPHAnet |
| 0‑L |
171700
|
Diffuse panbronchiolitis
|
ORPHAnet |
| 0‑L |
171703
|
Microcephaly-polymicrogyria-corpus callosum agenesis syndrome
|
ORPHAnet |
| 0‑L |
171706
|
Short stature-delayed bone age due to thyroid hormone metabolism deficiency
|
ORPHAnet |
| 0‑L |
171709
|
Male infertility due to globozoospermia
|
ORPHAnet |
| 0‑L |
171719
|
Cutis laxa-Marfanoid syndrome
|
ORPHAnet |
| 0‑L |
171723
|
White sponge nevus
|
ORPHAnet |
| 0‑L |
171829
|
6q16 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
171839
|
Craniosynostosis-hydrocephalus-Arnold-Chiari malformation type I-radioulnar synostosis
syndrome
|
ORPHAnet |
| 0‑L |
171844
|
Blindness-scoliosis-arachnodactyly syndrome
|
ORPHAnet |
| 0‑L |
171848
|
Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome
|
ORPHAnet |
| 0‑L |
171851
|
MEDNIK syndrome
|
ORPHAnet |
| 0‑L |
171860
|
Intellectual disability-cataracts-kyphosis syndrome
|
ORPHAnet |
| 0‑L |
171863
|
Autosomal dominant spastic paraplegia type 42
|
ORPHAnet |
| 0‑L |
171866
|
Spondyloepimetaphyseal dysplasia, aggrecan type
|
ORPHAnet |
| 0‑L |
171871
|
Renal pseudohypoaldosteronism type 1
|
ORPHAnet |
| 0‑L |
171876
|
Generalized pseudohypoaldosteronism type 1
|
ORPHAnet |
| 0‑L |
171881
|
Cap myopathy
|
ORPHAnet |
| 0‑L |
171886
|
Cylindrical spirals myopathy
|
ORPHAnet |
| 0‑L |
171889
|
Myopathy with hexagonally cross-linked tubular arrays
|
ORPHAnet |
| 0‑L |
171929
|
Trisomy 10p
|
ORPHAnet |
| 0‑L |
177901
|
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1
|
ORPHAnet |
| 0‑L |
177904
|
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2
|
ORPHAnet |
| 0‑L |
177907
|
Prader-Willi syndrome due to translocation
|
ORPHAnet |
| 0‑L |
177910
|
Prader-Willi syndrome due to imprinting mutation
|
ORPHAnet |
| 0‑L |
177926
|
Bleeding disorder in hemophilia A carriers
|
ORPHAnet |
| 0‑L |
177929
|
Bleeding disorder in hemophilia B carriers
|
ORPHAnet |
| 0‑L |
178029
|
Central diabetes insipidus
|
ORPHAnet |
| 0‑L |
178145
|
Moderate multiminicore disease with hand involvement
|
ORPHAnet |
| 0‑L |
178148
|
Antenatal multiminicore disease with arthrogryposis multiplex congenita
|
ORPHAnet |
| 0‑L |
178303
|
8q22.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
178307
|
Reticulate acropigmentation of Kitamura
|
ORPHAnet |
| 0‑L |
178311
|
Isolated sternocostoclavicular hyperostosis
|
ORPHAnet |
| 0‑L |
178315
|
Undifferentiated embryonal sarcoma of the liver
|
ORPHAnet |
| 0‑L |
178320
|
Acute lung injury
|
ORPHAnet |
| 0‑L |
178333
|
Åland Islands eye disease
|
ORPHAnet |
| 0‑L |
178338
|
UV-sensitive syndrome
|
ORPHAnet |
| 0‑L |
178342
|
Inflammatory myofibroblastic tumor
|
ORPHAnet |
| 0‑L |
178345
|
Aromatase excess syndrome
|
ORPHAnet |
| 0‑L |
178355
|
Smith-McCort dysplasia
|
ORPHAnet |
| 0‑L |
178364
|
Syndromic microphthalmia type 5
|
ORPHAnet |
| 0‑L |
178377
|
Osteosclerosis-developmental delay-craniosynostosis syndrome
|
ORPHAnet |
| 0‑L |
178382
|
Congenital vertical talus
|
ORPHAnet |
| 0‑L |
178389
|
Osteopetrosis-hypogammaglobulinemia syndrome
|
ORPHAnet |
| 0‑L |
178396
|
Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation
|
ORPHAnet |
| 0‑L |
178400
|
Distal myopathy with anterior tibial onset
|
ORPHAnet |
| 0‑L |
178461
|
X-linked myopathy with postural muscle atrophy
|
ORPHAnet |
| 0‑L |
178464
|
Hereditary myopathy with early respiratory failure
|
ORPHAnet |
| 0‑L |
178469
|
Autosomal dominant non-syndromic intellectual disability
|
ORPHAnet |
| 0‑L |
178475
|
Wound botulism
|
ORPHAnet |
| 0‑L |
178478
|
Infant botulism
|
ORPHAnet |
| 0‑L |
178481
|
Intestinal botulism
|
ORPHAnet |
| 0‑L |
178487
|
Adult intestinal botulism
|
ORPHAnet |
| 0‑L |
178493
|
Myopic macular degeneration
|
ORPHAnet |
| 0‑L |
178506
|
Brain calcification, Rajab type
|
ORPHAnet |
| 0‑L |
178509
|
Perry syndrome
|
ORPHAnet |
| 0‑L |
178512
|
Folliculotropic mycosis fungoides
|
ORPHAnet |
| 0‑L |
178517
|
Localized pagetoid reticulosis
|
ORPHAnet |
| 0‑L |
178522
|
Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma
|
ORPHAnet |
| 0‑L |
178528
|
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma
|
ORPHAnet |
| 0‑L |
178533
|
Primary cutaneous gamma/delta-positive T-cell lymphoma
|
ORPHAnet |
| 0‑L |
178536
|
Primary cutaneous marginal zone B-cell lymphoma
|
ORPHAnet |
| 0‑L |
178540
|
Primary cutaneous follicle center lymphoma
|
ORPHAnet |
| 0‑L |
178544
|
Primary cutaneous diffuse large B-cell lymphoma, leg type
|
ORPHAnet |
| 0‑L |
179490
|
Obesity due to congenital leptin resistance
|
ORPHAnet |
| 0‑L |
179494
|
Obesity due to leptin receptor gene deficiency
|
ORPHAnet |
| 0‑L |
180074
|
True unicornuate uterus
|
ORPHAnet |
| 0‑L |
180079
|
Pseudounicornuate uterus
|
ORPHAnet |
| 0‑L |
180086
|
Didelphys uterus
|
ORPHAnet |
| 0‑L |
180106
|
Bicervical bicornuate uterus and blind hemivagina
|
ORPHAnet |
| 0‑L |
180111
|
Bicervical bicornuate uterus with patent cervix and vagina
|
ORPHAnet |
| 0‑L |
180114
|
Unicervical bicornuate uterus
|
ORPHAnet |
| 0‑L |
180126
|
Complete septate uterus
|
ORPHAnet |
| 0‑L |
180129
|
Partial septate uterus
|
ORPHAnet |
| 0‑L |
180139
|
Uterine hypoplasia
|
ORPHAnet |
| 0‑L |
180142
|
Absence of uterine body
|
ORPHAnet |
| 0‑L |
180145
|
Uterine cervical aplasia and agenesis
|
ORPHAnet |
| 0‑L |
180154
|
Septate vagina
|
ORPHAnet |
| 0‑L |
180157
|
Longitudinal vaginal septum
|
ORPHAnet |
| 0‑L |
180160
|
Transverse vaginal septum
|
ORPHAnet |
| 0‑L |
180176
|
Familial juvenile hypertrophy of the breast
|
ORPHAnet |
| 0‑L |
180182
|
Supernumerary breasts
|
ORPHAnet |
| 0‑L |
180188
|
Isolated congenital breast hypoplasia/aplasia
|
ORPHAnet |
| 0‑L |
180226
|
Embryonal carcinoma
|
ORPHAnet |
| 0‑L |
180229
|
Polyembryoma
|
ORPHAnet |
| 0‑L |
180234
|
Mixed germ cell tumor
|
ORPHAnet |
| 0‑L |
180237
|
Benign tumor of fallopian tubes
|
ORPHAnet |
| 0‑L |
180242
|
Malignant tumor of fallopian tubes
|
ORPHAnet |
| 0‑L |
180247
|
Vaginal carcinoma
|
ORPHAnet |
| 0‑L |
180261
|
Phyllodes tumor of the breast
|
ORPHAnet |
| 0‑L |
180267
|
Giant adenofibroma of the breast
|
ORPHAnet |
| 0‑L |
180275
|
Paget disease of the nipple
|
ORPHAnet |
| 0‑L |
182050
|
MYH9-related disease
|
ORPHAnet |
| 0‑L |
182127
|
Extragonadal germinoma
|
ORPHAnet |
| 0‑L |
183663
|
Hyper-IgM syndrome with susceptibility to opportunistic infections
|
ORPHAnet |
| 0‑L |
183666
|
Hyper-IgM syndrome without susceptibility to opportunistic infections
|
ORPHAnet |
| 0‑L |
183675
|
Recurrent infections associated with rare immunoglobulin isotypes deficiency
|
ORPHAnet |
| 0‑L |
183678
|
Hermansky-Pudlak syndrome due to AP-3 deficiency
|
ORPHAnet |
| 0‑L |
183707
|
Neutrophil immunodeficiency syndrome
|
ORPHAnet |
| 0‑L |
183713
|
Bacterial susceptibility due to TLR signaling pathway deficiency
|
ORPHAnet |
| 0‑L |
189427
|
Cushing syndrome due to macronodular adrenal hyperplasia
|
ORPHAnet |
| 0‑L |
189439
|
Primary pigmented nodular adrenocortical disease
|
ORPHAnet |
| 0‑L |
189466
|
Familial isolated hypoparathyroidism due to impaired PTH secretion
|
ORPHAnet |
| 0‑L |
199241
|
Pulmonary capillary hemangiomatosis
|
ORPHAnet |
| 0‑L |
199244
|
Nelson syndrome
|
ORPHAnet |
| 0‑L |
199247
|
Corticosteroid-binding globulin deficiency
|
ORPHAnet |
| 0‑L |
199251
|
Ledderhose disease
|
ORPHAnet |
| 0‑L |
199260
|
Calcifying aponeurotic fibroma
|
ORPHAnet |
| 0‑L |
199267
|
Infantile digital fibromatosis
|
ORPHAnet |
| 0‑L |
199276
|
Familial multiple lipomatosis
|
ORPHAnet |
| 0‑L |
199279
|
Familial angiolipomatosis
|
ORPHAnet |
| 0‑L |
199282
|
Harlequin syndrome
|
ORPHAnet |
| 0‑L |
199285
|
Hereditary hypercarotenemia and vitamin A deficiency
|
ORPHAnet |
| 0‑L |
199293
|
Congenital microgastria
|
ORPHAnet |
| 0‑L |
199296
|
Congenital isolated ACTH deficiency
|
ORPHAnet |
| 0‑L |
199299
|
Late-onset isolated ACTH deficiency
|
ORPHAnet |
| 0‑L |
199302
|
Isolated cleft lip
|
ORPHAnet |
| 0‑L |
199306
|
Cleft lip/palate
|
ORPHAnet |
| 0‑L |
199310
|
Tetragametic chimerism
|
ORPHAnet |
| 0‑L |
199315
|
Familial clubfoot with or without associated lower limb anomalies
|
ORPHAnet |
| 0‑L |
199318
|
15q13.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
199323
|
Endophthalmitis
|
ORPHAnet |
| 0‑L |
199326
|
Isolated autosomal dominant hypomagnesemia, Glaudemans type
|
ORPHAnet |
| 0‑L |
199329
|
Congenital myopathy, Paradas type
|
ORPHAnet |
| 0‑L |
199332
|
Endocrine-cerebro-osteodysplasia syndrome
|
ORPHAnet |
| 0‑L |
199337
|
Pancreatic insufficiency-anemia-hyperostosis syndrome
|
ORPHAnet |
| 0‑L |
199340
|
Muscular dystrophy, Selcen type
|
ORPHAnet |
| 0‑L |
199343
|
EAST syndrome
|
ORPHAnet |
| 0‑L |
199348
|
Thiamine-responsive encephalopathy
|
ORPHAnet |
| 0‑L |
199351
|
Adult-onset dystonia-parkinsonism
|
ORPHAnet |
| 0‑L |
199354
|
Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy
|
ORPHAnet |
| 0‑L |
199627
|
Atypical autism
|
ORPHAnet |
| 0‑L |
199630
|
Isolated cerebellar vermis hypoplasia
|
ORPHAnet |
| 0‑L |
199642
|
Isolated congenital microcephaly
|
ORPHAnet |
| 0‑L |
199647
|
Isolated encephalocele
|
ORPHAnet |
| 0‑L |
200418
|
Immunodeficiency with factor I anomaly
|
ORPHAnet |
| 0‑L |
200421
|
Immunodeficiency with factor H anomaly
|
ORPHAnet |
| 0‑L |
206436
|
Infantile Krabbe disease
|
ORPHAnet |
| 0‑L |
206443
|
Late-infantile/juvenile Krabbe disease
|
ORPHAnet |
| 0‑L |
206448
|
Adult Krabbe disease
|
ORPHAnet |
| 0‑L |
206470
|
Cystadenoma of childhood
|
ORPHAnet |
| 0‑L |
206473
|
Borderline epithelial tumor of ovary
|
ORPHAnet |
| 0‑L |
206484
|
Gonadoblastoma
|
ORPHAnet |
| 0‑L |
206489
|
Malignant germ cell tumor of the vagina
|
ORPHAnet |
| 0‑L |
206492
|
Vulvovaginal rhabdomyosarcoma
|
ORPHAnet |
| 0‑L |
206538
|
Malignant non-dysgerminomatous germ cell tumor of ovary
|
ORPHAnet |
| 0‑L |
206546
|
Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
|
ORPHAnet |
| 0‑L |
206549
|
Anoctamin-5-related limb-girdle muscular dystrophy R12
|
ORPHAnet |
| 0‑L |
206554
|
Fukutin-related limb-girdle muscular dystrophy R13
|
ORPHAnet |
| 0‑L |
206559
|
POMT2-related limb-girdle muscular dystrophy R14
|
ORPHAnet |
| 0‑L |
206564
|
POMGNT1-related limb-girdle muscular dystrophy R15
|
ORPHAnet |
| 0‑L |
206569
|
Immune-mediated necrotizing myopathy
|
ORPHAnet |
| 0‑L |
206572
|
Overlap myositis
|
ORPHAnet |
| 0‑L |
206575
|
Rippling muscle disease with myasthenia gravis
|
ORPHAnet |
| 0‑L |
206580
|
Autosomal recessive lower motor neuron disease with childhood onset
|
ORPHAnet |
| 0‑L |
206583
|
Adult polyglucosan body disease
|
ORPHAnet |
| 0‑L |
206586
|
Neurolymphomatosis
|
ORPHAnet |
| 0‑L |
206594
|
Subacute inflammatory demyelinating polyneuropathy
|
ORPHAnet |
| 0‑L |
206599
|
Isolated asymptomatic elevation of creatine phosphokinase
|
ORPHAnet |
| 0‑L |
206991
|
Viral myositis
|
ORPHAnet |
| 0‑L |
206994
|
Bacterial myositis
|
ORPHAnet |
| 0‑L |
207000
|
Fungal myositis
|
ORPHAnet |
| 0‑L |
208441
|
Bilateral parasagittal parieto-occipital polymicrogyria
|
ORPHAnet |
| 0‑L |
208444
|
Bilateral frontal polymicrogyria
|
ORPHAnet |
| 0‑L |
208447
|
Bilateral generalized polymicrogyria
|
ORPHAnet |
| 0‑L |
208513
|
Spinocerebellar ataxia type 29
|
ORPHAnet |
| 0‑L |
208524
|
Herpetiform pemphigus
|
ORPHAnet |
| 0‑L |
208981
|
Polyradiculoneuropathy associated with IgG/IgA/IgM monoclonal gammopathy without known
antibodies
|
ORPHAnet |
| 0‑L |
208989
|
Non-paraneoplastic sensory ganglionopathy
|
ORPHAnet |
| 0‑L |
208999
|
Paraneoplastic sensory ganglionopathy
|
ORPHAnet |
| 0‑L |
209004
|
Axonal polyneuropathy associated with IgG/IgM/IgA monoclonal gammopathy
|
ORPHAnet |
| 0‑L |
209335
|
Autosomal dominant adult-onset proximal spinal muscular atrophy
|
ORPHAnet |
| 0‑L |
209341
|
DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy
|
ORPHAnet |
| 0‑L |
209370
|
Severe neonatal-onset encephalopathy with microcephaly
|
ORPHAnet |
| 0‑L |
209867
|
Autosomal dominant rhegmatogenous retinal detachment
|
ORPHAnet |
| 0‑L |
209902
|
Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency
|
ORPHAnet |
| 0‑L |
209905
|
Brain-lung-thyroid syndrome
|
ORPHAnet |
| 0‑L |
209908
|
Isolated childhood apraxia of speech
|
ORPHAnet |
| 0‑L |
209916
|
Extraskeletal myxoid chondrosarcoma
|
ORPHAnet |
| 0‑L |
209919
|
Idiopathic copper-associated cirrhosis
|
ORPHAnet |
| 0‑L |
209932
|
Cone dystrophy with supernormal rod response
|
ORPHAnet |
| 0‑L |
209943
|
IRVAN syndrome
|
ORPHAnet |
| 0‑L |
209951
|
Autosomal recessive spastic paraplegia type 18
|
ORPHAnet |
| 0‑L |
209956
|
Idiopathic uveal effusion syndrome
|
ORPHAnet |
| 0‑L |
209959
|
Phacoanaphylactic uveitis
|
ORPHAnet |
| 0‑L |
209964
|
Solitary rectal ulcer syndrome
|
ORPHAnet |
| 0‑L |
209967
|
Episodic ataxia type 6
|
ORPHAnet |
| 0‑L |
209970
|
Episodic ataxia type 7
|
ORPHAnet |
| 0‑L |
209973
|
Benign nocturnal alternating hemiplegia of childhood
|
ORPHAnet |
| 0‑L |
209981
|
IRIDA syndrome
|
ORPHAnet |
| 0‑L |
209989
|
Non-papillary transitional cell carcinoma of the bladder
|
ORPHAnet |
| 0‑L |
210110
|
Intermediate osteopetrosis
|
ORPHAnet |
| 0‑L |
210115
|
Sterile multifocal osteomyelitis with periostitis and pustulosis
|
ORPHAnet |
| 0‑L |
210122
|
Congenital alveolar capillary dysplasia
|
ORPHAnet |
| 0‑L |
210128
|
Urocanic aciduria
|
ORPHAnet |
| 0‑L |
210133
|
Leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome
|
ORPHAnet |
| 0‑L |
210136
|
Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome
|
ORPHAnet |
| 0‑L |
210141
|
Inherited congenital spastic tetraplegia
|
ORPHAnet |
| 0‑L |
210144
|
Lethal polymalformative syndrome, Boissel type
|
ORPHAnet |
| 0‑L |
210159
|
Adult hepatocellular carcinoma
|
ORPHAnet |
| 0‑L |
210163
|
Congenital lethal myopathy, Compton-North type
|
ORPHAnet |
| 0‑L |
210272
|
Mal de débarquement
|
ORPHAnet |
| 0‑L |
210548
|
Macrocephaly-intellectual disability-autism syndrome
|
ORPHAnet |
| 0‑L |
210571
|
Dystonia 16
|
ORPHAnet |
| 0‑L |
210576
|
Congenital temporomandibular joint ankylosis
|
ORPHAnet |
| 0‑L |
210584
|
Spindle cell hemangioma
|
ORPHAnet |
| 0‑L |
211017
|
Spinocerebellar ataxia type 30
|
ORPHAnet |
| 0‑L |
211067
|
Episodic ataxia type 5
|
ORPHAnet |
| 0‑L |
213504
|
Adenocarcinoma of ovary
|
ORPHAnet |
| 0‑L |
213512
|
Malignant mixed Müllerian tumor of the ovary
|
ORPHAnet |
| 0‑L |
213524
|
Hereditary site-specific ovarian cancer syndrome
|
ORPHAnet |
| 0‑L |
213528
|
Rare adenocarcinoma of the breast
|
ORPHAnet |
| 0‑L |
213531
|
Metaplastic carcinoma of the breast
|
ORPHAnet |
| 0‑L |
213557
|
Salivary gland type cancer of the breast
|
ORPHAnet |
| 0‑L |
213574
|
Rare variants of adenocarcinoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213600
|
Adenosarcoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213605
|
Carcinofibroma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213610
|
Carcinosarcoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213615
|
Rhabdomyosarcoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213625
|
Leiomyosarcoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213630
|
Primitive neuroectodermal tumor of the corpus uteri
|
ORPHAnet |
| 0‑L |
213711
|
Endometrial stromal sarcoma
|
ORPHAnet |
| 0‑L |
213716
|
Squamous cell carcinoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213721
|
Undifferentiated carcinoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213726
|
Serous carcinoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213731
|
High-grade neuroendocrine carcinoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213736
|
Low-grade neuroendocrine tumor of the corpus uteri
|
ORPHAnet |
| 0‑L |
213746
|
Transitional cell carcinoma of the corpus uteri
|
ORPHAnet |
| 0‑L |
213751
|
Malignant germ cell tumor of the corpus uteri
|
ORPHAnet |
| 0‑L |
213767
|
Squamous cell carcinoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213772
|
Adenocarcinoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213777
|
High-grade neuroendocrine carcinoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213787
|
Carcinosarcoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213792
|
Adenosarcoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213802
|
Rhabdomyosarcoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213807
|
Leiomyosarcoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213812
|
Primitive neuroectodermal tumor of the cervix uteri
|
ORPHAnet |
| 0‑L |
213817
|
Papillary carcinoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213823
|
Adenoid cystic carcinoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213828
|
Adenoid basal carcinoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213833
|
Glassy cell carcinoma of the cervix uteri
|
ORPHAnet |
| 0‑L |
213837
|
Malignant germ cell tumor of the cervix uteri
|
ORPHAnet |
| 0‑L |
216694
|
Congenitally corrected transposition of the great arteries
|
ORPHAnet |
| 0‑L |
216718
|
Isolated congenitally uncorrected transposition of the great arteries
|
ORPHAnet |
| 0‑L |
216729
|
Congenitally uncorrected transposition of the great arteries with cardiac malformation
|
ORPHAnet |
| 0‑L |
216796
|
Osteogenesis imperfecta type 1
|
ORPHAnet |
| 0‑L |
216804
|
Osteogenesis imperfecta type 2
|
ORPHAnet |
| 0‑L |
216812
|
Osteogenesis imperfecta type 3
|
ORPHAnet |
| 0‑L |
216820
|
Osteogenesis imperfecta type 4
|
ORPHAnet |
| 0‑L |
216828
|
Osteogenesis imperfecta type 5
|
ORPHAnet |
| 0‑L |
216866
|
Classic pantothenate kinase-associated neurodegeneration
|
ORPHAnet |
| 0‑L |
216873
|
Atypical pantothenate kinase-associated neurodegeneration
|
ORPHAnet |
| 0‑L |
216972
|
Niemann-Pick disease type C, severe perinatal form
|
ORPHAnet |
| 0‑L |
216975
|
Niemann-Pick disease type C, severe early infantile neurologic onset
|
ORPHAnet |
| 0‑L |
216978
|
Niemann-Pick disease type C, late infantile neurologic onset
|
ORPHAnet |
| 0‑L |
216981
|
Niemann-Pick disease type C, juvenile neurologic onset
|
ORPHAnet |
| 0‑L |
216986
|
Niemann-Pick disease type C, adult neurologic onset
|
ORPHAnet |
| 0‑L |
217008
|
Bockenheimer syndrome
|
ORPHAnet |
| 0‑L |
217012
|
Spinocerebellar ataxia type 31
|
ORPHAnet |
| 0‑L |
217017
|
Zechi-Ceide syndrome
|
ORPHAnet |
| 0‑L |
217026
|
Microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type
|
ORPHAnet |
| 0‑L |
217055
|
Autosomal recessive intermediate Charcot-Marie-Tooth disease type A
|
ORPHAnet |
| 0‑L |
217059
|
Isolated congenital digital clubbing
|
ORPHAnet |
| 0‑L |
217064
|
5-fluorouracil poisoning
|
ORPHAnet |
| 0‑L |
217067
|
Pouchitis
|
ORPHAnet |
| 0‑L |
217080
|
Pulmonary fungal infections in patients deemed at risk
|
ORPHAnet |
| 0‑L |
217085
|
Mucopolysaccharidosis type 2, severe form
|
ORPHAnet |
| 0‑L |
217093
|
Mucopolysaccharidosis type 2, attenuated form
|
ORPHAnet |
| 0‑L |
217253
|
NMDA receptor encephalitis
|
ORPHAnet |
| 0‑L |
217260
|
Progressive multifocal leukoencephalopathy
|
ORPHAnet |
| 0‑L |
217266
|
BNAR syndrome
|
ORPHAnet |
| 0‑L |
217330
|
REN-related autosomal dominant tubulointerstitial kidney disease
|
ORPHAnet |
| 0‑L |
217335
|
RIN2 syndrome
|
ORPHAnet |
| 0‑L |
217340
|
17q21.31 microduplication syndrome
|
ORPHAnet |
| 0‑L |
217346
|
19q13.11 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
217371
|
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins
|
ORPHAnet |
| 0‑L |
217377
|
Microduplication Xp11.22p11.23 syndrome
|
ORPHAnet |
| 0‑L |
217382
|
Neurodegenerative syndrome due to cerebral folate transport deficiency
|
ORPHAnet |
| 0‑L |
217385
|
17p13.3 microduplication syndrome
|
ORPHAnet |
| 0‑L |
217390
|
Combined immunodeficiency due to DOCK8 deficiency
|
ORPHAnet |
| 0‑L |
217396
|
Progressive polyneuropathy with bilateral striatal necrosis
|
ORPHAnet |
| 0‑L |
217399
|
Congenital insensitivity to pain-hyperhidrosis-absence of C-fiber innervation
|
ORPHAnet |
| 0‑L |
217407
|
Hereditary hypotrichosis with recurrent skin vesicles
|
ORPHAnet |
| 0‑L |
217467
|
Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency
|
ORPHAnet |
| 0‑L |
217557
|
Pulmonary interstitial glycogenosis
|
ORPHAnet |
| 0‑L |
217560
|
Neuroendocrine cell hyperplasia of infancy
|
ORPHAnet |
| 0‑L |
217563
|
Neonatal acute respiratory distress due to SP-B deficiency
|
ORPHAnet |
| 0‑L |
217566
|
Chronic respiratory distress with surfactant metabolism deficiency
|
ORPHAnet |
| 0‑L |
217622
|
Sensorineural deafness with dilated cardiomyopathy
|
ORPHAnet |
| 0‑L |
217656
|
Familial isolated arrhythmogenic right ventricular dysplasia
|
ORPHAnet |
| 0‑L |
220295
|
Xeroderma pigmentosum-Cockayne syndrome complex
|
ORPHAnet |
| 0‑L |
220386
|
Semilobar holoprosencephaly
|
ORPHAnet |
| 0‑L |
220393
|
Diffuse cutaneous systemic sclerosis
|
ORPHAnet |
| 0‑L |
220402
|
Limited cutaneous systemic sclerosis
|
ORPHAnet |
| 0‑L |
220407
|
Limited systemic sclerosis
|
ORPHAnet |
| 0‑L |
220436
|
Quebec platelet disorder
|
ORPHAnet |
| 0‑L |
220443
|
Bleeding diathesis due to thromboxane synthesis deficiency
|
ORPHAnet |
| 0‑L |
220448
|
Macrothrombocytopenia with mitral valve insufficiency
|
ORPHAnet |
| 0‑L |
220460
|
Attenuated familial adenomatous polyposis
|
ORPHAnet |
| 0‑L |
220465
|
Laron syndrome with immunodeficiency
|
ORPHAnet |
| 0‑L |
220493
|
Joubert syndrome with ocular defect
|
ORPHAnet |
| 0‑L |
220497
|
Joubert syndrome with renal defect
|
ORPHAnet |
| 0‑L |
221008
|
Rothmund-Thomson syndrome type 1
|
ORPHAnet |
| 0‑L |
221016
|
Rothmund-Thomson syndrome type 2
|
ORPHAnet |
| 0‑L |
221039
|
Hereditary sclerosing poikiloderma, Weary type
|
ORPHAnet |
| 0‑L |
221043
|
Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis
syndrome
|
ORPHAnet |
| 0‑L |
221046
|
Poikiloderma with neutropenia
|
ORPHAnet |
| 0‑L |
221054
|
Acrocephalopolydactyly
|
ORPHAnet |
| 0‑L |
221061
|
Familial cerebral cavernous malformation
|
ORPHAnet |
| 0‑L |
221074
|
Marchiafava-Bignami disease
|
ORPHAnet |
| 0‑L |
221078
|
Combined hyperactive dysfunction syndrome of the cranial nerves
|
ORPHAnet |
| 0‑L |
221083
|
Hemifacial spasm
|
ORPHAnet |
| 0‑L |
221091
|
Trigeminal neuralgia
|
ORPHAnet |
| 0‑L |
221098
|
Glossopharyngeal neuralgia
|
ORPHAnet |
| 0‑L |
221117
|
Gerstmann syndrome
|
ORPHAnet |
| 0‑L |
221120
|
Pseudoaminopterin syndrome
|
ORPHAnet |
| 0‑L |
221126
|
Fowler vasculopaty
|
ORPHAnet |
| 0‑L |
221139
|
Combined immunodeficiency with faciooculoskeletal anomalies
|
ORPHAnet |
| 0‑L |
221142
|
Confetti-like macular atrophy
|
ORPHAnet |
| 0‑L |
221145
|
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies
|
ORPHAnet |
| 0‑L |
225123
|
Hemochromatosis type 3
|
ORPHAnet |
| 0‑L |
225147
|
Sporadic infantile bilateral striatal necrosis
|
ORPHAnet |
| 0‑L |
225154
|
Familial infantile bilateral striatal necrosis
|
ORPHAnet |
| 0‑L |
226307
|
Hypothyroidism due to deficient transcription factors involved in pituitary development
or function
|
ORPHAnet |
| 0‑L |
226313
|
Congenital hypothyroidism due to maternal intake of antithyroid drugs
|
ORPHAnet |
| 0‑L |
226316
|
Genetic transient congenital hypothyroidism
|
ORPHAnet |
| 0‑L |
227510
|
Multiple system atrophy, cerebellar type
|
ORPHAnet |
| 0‑L |
227535
|
Hereditary breast cancer
|
ORPHAnet |
| 0‑L |
227796
|
Fundus albipunctatus
|
ORPHAnet |
| 0‑L |
227972
|
Toxic oil syndrome
|
ORPHAnet |
| 0‑L |
227976
|
Autosomal recessive optic atrophy, OPA7 type
|
ORPHAnet |
| 0‑L |
227982
|
Autoimmune polyendocrinopathy type 3
|
ORPHAnet |
| 0‑L |
227990
|
Autoimmune polyendocrinopathy type 4
|
ORPHAnet |
| 0‑L |
228000
|
Idiopathic CD4 lymphocytopenia
|
ORPHAnet |
| 0‑L |
228003
|
Severe combined immunodeficiency due to CORO1A deficiency
|
ORPHAnet |
| 0‑L |
228012
|
Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome
|
ORPHAnet |
| 0‑L |
228113
|
Anal fistula
|
ORPHAnet |
| 0‑L |
228116
|
Hughes-Stovin syndrome
|
ORPHAnet |
| 0‑L |
228119
|
Fusariosis
|
ORPHAnet |
| 0‑L |
228123
|
Coccidioidomycosis
|
ORPHAnet |
| 0‑L |
228140
|
Idiopathic ventricular fibrillation, non Brugada type
|
ORPHAnet |
| 0‑L |
228157
|
Marburg acute multiple sclerosis
|
ORPHAnet |
| 0‑L |
228165
|
Baló concentric sclerosis
|
ORPHAnet |
| 0‑L |
228169
|
Autosomal dominant striatal neurodegeneration
|
ORPHAnet |
| 0‑L |
228174
|
Autosomal dominant Charcot-Marie-Tooth disease type 2N
|
ORPHAnet |
| 0‑L |
228179
|
Autosomal dominant Charcot-Marie-Tooth disease type 2M
|
ORPHAnet |
| 0‑L |
228190
|
Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome
|
ORPHAnet |
| 0‑L |
228227
|
Late-onset focal dermal elastosis
|
ORPHAnet |
| 0‑L |
228236
|
Linear focal elastosis
|
ORPHAnet |
| 0‑L |
228240
|
Elastoderma
|
ORPHAnet |
| 0‑L |
228243
|
Elastofibroma dorsi
|
ORPHAnet |
| 0‑L |
228247
|
Acquired pseudoxanthoma elasticum
|
ORPHAnet |
| 0‑L |
228254
|
Elastoma
|
ORPHAnet |
| 0‑L |
228264
|
Papular elastorrhexis
|
ORPHAnet |
| 0‑L |
228272
|
Primary anetoderma
|
ORPHAnet |
| 0‑L |
228277
|
Familial anetoderma
|
ORPHAnet |
| 0‑L |
228285
|
Acquired cutis laxa
|
ORPHAnet |
| 0‑L |
228290
|
White fibrous papulosis of the neck
|
ORPHAnet |
| 0‑L |
228293
|
Pseudoxanthoma elasticum-like papillary dermal elastolysis
|
ORPHAnet |
| 0‑L |
228299
|
Mid-dermal elastolysis
|
ORPHAnet |
| 0‑L |
228302
|
Carnitine palmitoyl transferase II deficiency, myopathic form
|
ORPHAnet |
| 0‑L |
228305
|
Carnitine palmitoyl transferase II deficiency, severe infantile form
|
ORPHAnet |
| 0‑L |
228308
|
Carnitine palmitoyl transferase II deficiency, neonatal form
|
ORPHAnet |
| 0‑L |
228329
|
CLN1 disease
|
ORPHAnet |
| 0‑L |
228337
|
CLN10 disease
|
ORPHAnet |
| 0‑L |
228340
|
CLN4A disease
|
ORPHAnet |
| 0‑L |
228343
|
CLN4B disease
|
ORPHAnet |
| 0‑L |
228346
|
CLN3 disease
|
ORPHAnet |
| 0‑L |
228349
|
CLN2 disease
|
ORPHAnet |
| 0‑L |
228354
|
CLN8 disease
|
ORPHAnet |
| 0‑L |
228357
|
CLN9 disease
|
ORPHAnet |
| 0‑L |
228360
|
CLN5 disease
|
ORPHAnet |
| 0‑L |
228363
|
CLN6 disease
|
ORPHAnet |
| 0‑L |
228366
|
CLN7 disease
|
ORPHAnet |
| 0‑L |
228371
|
Foodborne botulism
|
ORPHAnet |
| 0‑L |
228374
|
Charcot-Marie-Tooth disease type 2B5
|
ORPHAnet |
| 0‑L |
228379
|
Virus-associated trichodysplasia spinulosa
|
ORPHAnet |
| 0‑L |
228384
|
5q14.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
228387
|
Spondylo-megaepiphyseal-metaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
228390
|
Frontonasal dysplasia-alopecia-genital anomalies syndrome
|
ORPHAnet |
| 0‑L |
228396
|
Ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome
|
ORPHAnet |
| 0‑L |
228399
|
8q12 microduplication syndrome
|
ORPHAnet |
| 0‑L |
228402
|
2q23.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
228410
|
Polyvalvular heart disease syndrome
|
ORPHAnet |
| 0‑L |
228415
|
5q35 microduplication syndrome
|
ORPHAnet |
| 0‑L |
228423
|
Monocytopenia with susceptibility to infections
|
ORPHAnet |
| 0‑L |
228426
|
Syndromic multisystem autoimmune disease due to Itch deficiency
|
ORPHAnet |
| 0‑L |
229717
|
Isolated agammaglobulinemia
|
ORPHAnet |
| 0‑L |
230800
|
Toxin-mediated infectious botulism
|
ORPHAnet |
| 0‑L |
230839
|
Classical-like Ehlers-Danlos syndrome type 1
|
ORPHAnet |
| 0‑L |
230851
|
Cardiac-valvular Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
230857
|
Ehlers-Danlos/osteogenesis imperfecta syndrome
|
ORPHAnet |
| 0‑L |
231013
|
Congenital trigeminal anesthesia
|
ORPHAnet |
| 0‑L |
231031
|
Erythema palmare hereditarium
|
ORPHAnet |
| 0‑L |
231040
|
Familial generalized lentiginosis
|
ORPHAnet |
| 0‑L |
231080
|
High-grade dysplasia in patients with Barrett esophagus
|
ORPHAnet |
| 0‑L |
231108
|
Familial rhabdoid tumor
|
ORPHAnet |
| 0‑L |
231111
|
Drug-induced lupus erythematosus
|
ORPHAnet |
| 0‑L |
231117
|
Beckwith-Wiedemann syndrome due to imprinting defect of 11p15
|
ORPHAnet |
| 0‑L |
231120
|
Beckwith-Wiedemann syndrome due to CDKN1C mutation
|
ORPHAnet |
| 0‑L |
231127
|
Beckwith-Wiedemann syndrome due to 11p15 microdeletion
|
ORPHAnet |
| 0‑L |
231130
|
Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion
|
ORPHAnet |
| 0‑L |
231137
|
Silver-Russell syndrome due to 7p11.2p13 microduplication
|
ORPHAnet |
| 0‑L |
231140
|
Silver-Russell syndrome due to an imprinting defect of 11p15
|
ORPHAnet |
| 0‑L |
231144
|
Silver-Russell syndrome due to 11p15 microduplication
|
ORPHAnet |
| 0‑L |
231147
|
Silver-Russell syndrome due to maternal uniparental disomy of chromosome 11
|
ORPHAnet |
| 0‑L |
231154
|
Combined immunodeficiency due to partial RAG1 deficiency
|
ORPHAnet |
| 0‑L |
231160
|
Familial cerebral saccular aneurysm
|
ORPHAnet |
| 0‑L |
231169
|
Usher syndrome type 1
|
ORPHAnet |
| 0‑L |
231178
|
Usher syndrome type 2
|
ORPHAnet |
| 0‑L |
231183
|
Usher syndrome type 3
|
ORPHAnet |
| 0‑L |
231214
|
Beta-thalassemia major
|
ORPHAnet |
| 0‑L |
231222
|
Beta-thalassemia intermedia
|
ORPHAnet |
| 0‑L |
231226
|
Dominant beta-thalassemia
|
ORPHAnet |
| 0‑L |
231237
|
Delta-beta-thalassemia
|
ORPHAnet |
| 0‑L |
231242
|
Hemoglobin C-beta-thalassemia syndrome
|
ORPHAnet |
| 0‑L |
231249
|
Hemoglobin E-beta-thalassemia syndrome
|
ORPHAnet |
| 0‑L |
231393
|
Beta-thalassemia-X-linked thrombocytopenia syndrome
|
ORPHAnet |
| 0‑L |
231401
|
Alpha-thalassemia-myelodysplastic syndrome
|
ORPHAnet |
| 0‑L |
231426
|
Pharyngeal-cervical-brachial variant of Guillain-Barré syndrome
|
ORPHAnet |
| 0‑L |
231445
|
Paraparetic variant of Guillain-Barré syndrome
|
ORPHAnet |
| 0‑L |
231450
|
Acute pure sensory neuropathy
|
ORPHAnet |
| 0‑L |
231457
|
Acute pandysautonomia
|
ORPHAnet |
| 0‑L |
231466
|
Acute sensory ataxic neuropathy
|
ORPHAnet |
| 0‑L |
231500
|
Hermansky-Pudlak syndrome due to BLOC-3 deficiency
|
ORPHAnet |
| 0‑L |
231512
|
Hermansky-Pudlak syndrome due to BLOC-2 deficiency
|
ORPHAnet |
| 0‑L |
231531
|
Hermansky-Pudlak syndrome due to BLOC-1 deficiency
|
ORPHAnet |
| 0‑L |
231556
|
Late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
231568
|
Autosomal dominant generalized dystrophic epidermolysis bullosa
|
ORPHAnet |
| 0‑L |
231573
|
Congenital erosive and vesicular dermatosis
|
ORPHAnet |
| 0‑L |
231580
|
Primary unilateral adrenal hyperplasia
|
ORPHAnet |
| 0‑L |
231625
|
Adrenocortical carcinoma with pure aldosterone hypersecretion
|
ORPHAnet |
| 0‑L |
231632
|
Ectopic aldosterone-producing tumor
|
ORPHAnet |
| 0‑L |
231662
|
Isolated growth hormone deficiency type IA
|
ORPHAnet |
| 0‑L |
231671
|
Isolated growth hormone deficiency type IB
|
ORPHAnet |
| 0‑L |
231679
|
Isolated growth hormone deficiency type II
|
ORPHAnet |
| 0‑L |
231692
|
Isolated growth hormone deficiency type III
|
ORPHAnet |
| 0‑L |
231720
|
Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine
abnormalities syndrome
|
ORPHAnet |
| 0‑L |
231736
|
Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome
|
ORPHAnet |
| 0‑L |
231742
|
Epibulbar lipodermoid-preauricular appendage-polythelia syndrome
|
ORPHAnet |
| 0‑L |
238269
|
AApoAII amyloidosis
|
ORPHAnet |
| 0‑L |
238305
|
Infundibulo-neurohypophysitis
|
ORPHAnet |
| 0‑L |
238329
|
Severe X-linked mitochondrial encephalomyopathy
|
ORPHAnet |
| 0‑L |
238446
|
15q11q13 microduplication syndrome
|
ORPHAnet |
| 0‑L |
238455
|
Infantile dystonia-parkinsonism
|
ORPHAnet |
| 0‑L |
238459
|
SLC35A1-CDG
|
ORPHAnet |
| 0‑L |
238468
|
Hypohidrotic ectodermal dysplasia
|
ORPHAnet |
| 0‑L |
238475
|
Familial hypercholanemia
|
ORPHAnet |
| 0‑L |
238505
|
Combined immunodeficiency due to CD27 deficiency
|
ORPHAnet |
| 0‑L |
238523
|
Atypical hypotonia-cystinuria syndrome
|
ORPHAnet |
| 0‑L |
238557
|
Chuvash erythrocytosis
|
ORPHAnet |
| 0‑L |
238569
|
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome
|
ORPHAnet |
| 0‑L |
238578
|
Familial clubfoot due to 17q23.1q23.2 microduplication
|
ORPHAnet |
| 0‑L |
238583
|
Hyperphenylalaninemia due to tetrahydrobiopterin deficiency
|
ORPHAnet |
| 0‑L |
238593
|
IgG4-related mesenteritis
|
ORPHAnet |
| 0‑L |
238606
|
Primary orthostatic tremor
|
ORPHAnet |
| 0‑L |
238613
|
Beckwith-Wiedemann syndrome due to NSD1 mutation
|
ORPHAnet |
| 0‑L |
238621
|
Ileal pouch anal anastomosis related faecal incontinence
|
ORPHAnet |
| 0‑L |
238624
|
Idiopathic intracranial hypertension
|
ORPHAnet |
| 0‑L |
238637
|
Megacystis-megaureter syndrome
|
ORPHAnet |
| 0‑L |
238642
|
Primary megaureter, adult-onset form
|
ORPHAnet |
| 0‑L |
238646
|
Congenital primary megaureter, obstructed form
|
ORPHAnet |
| 0‑L |
238650
|
Congenital primary megaureter, refluxing form
|
ORPHAnet |
| 0‑L |
238654
|
Congenital primary megaureter, nonrefluxing and unobstructed form
|
ORPHAnet |
| 0‑L |
238666
|
Isolated congenital hypogonadotropic hypogonadism
|
ORPHAnet |
| 0‑L |
238670
|
Isolated thyrotropin-releasing hormone deficiency
|
ORPHAnet |
| 0‑L |
238688
|
Neonatal iodine exposure
|
ORPHAnet |
| 0‑L |
238722
|
Familial congenital mirror movements
|
ORPHAnet |
| 0‑L |
238744
|
Mammary-digital-nail syndrome
|
ORPHAnet |
| 0‑L |
238750
|
4q21 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
238755
|
Autosomal dominant limb-girdle muscular dystrophy type 1H
|
ORPHAnet |
| 0‑L |
238763
|
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea
|
ORPHAnet |
| 0‑L |
238769
|
1q44 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
240071
|
Classic progressive supranuclear palsy syndrome
|
ORPHAnet |
| 0‑L |
240085
|
Progressive supranuclear palsy-parkinsonism syndrome
|
ORPHAnet |
| 0‑L |
240094
|
Progressive supranuclear palsy-pure akinesia with gait freezing syndrome
|
ORPHAnet |
| 0‑L |
240103
|
Progressive supranuclear palsy-corticobasal syndrome
|
ORPHAnet |
| 0‑L |
240112
|
Progressive supranuclear palsy-progressive non-fluent aphasia syndrome
|
ORPHAnet |
| 0‑L |
240760
|
Nijmegen breakage syndrome-like disorder
|
ORPHAnet |
| 0‑L |
243343
|
Dimethylglycine dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
243367
|
Acute fatty liver of pregnancy
|
ORPHAnet |
| 0‑L |
244242
|
HELLP syndrome
|
ORPHAnet |
| 0‑L |
244275
|
De novo thrombotic microangiopathy after kidney transplantation
|
ORPHAnet |
| 0‑L |
244283
|
Biliary atresia with splenic malformation syndrome
|
ORPHAnet |
| 0‑L |
244305
|
Dominant hypophosphatemia with nephrolithiasis or osteoporosis
|
ORPHAnet |
| 0‑L |
244310
|
RFT1-CDG
|
ORPHAnet |
| 0‑L |
247165
|
Infantile mercury poisoning
|
ORPHAnet |
| 0‑L |
247198
|
Progressive cerebello-cerebral atrophy
|
ORPHAnet |
| 0‑L |
247203
|
Collecting duct carcinoma
|
ORPHAnet |
| 0‑L |
247234
|
Sporadic adult-onset ataxia of unknown etiology
|
ORPHAnet |
| 0‑L |
247245
|
Superficial siderosis
|
ORPHAnet |
| 0‑L |
247257
|
Inhalational anthrax
|
ORPHAnet |
| 0‑L |
247262
|
Hyperphosphatasia-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
247353
|
Generalized pustular psoriasis
|
ORPHAnet |
| 0‑L |
247378
|
Autosomal recessive secondary polycythemia not associated with VHL gene
|
ORPHAnet |
| 0‑L |
247511
|
Autosomal dominant secondary polycythemia
|
ORPHAnet |
| 0‑L |
247522
|
Primary ciliary dyskinesia-retinitis pigmentosa syndrome
|
ORPHAnet |
| 0‑L |
247525
|
Citrullinemia type I
|
ORPHAnet |
| 0‑L |
247546
|
Acute neonatal citrullinemia type I
|
ORPHAnet |
| 0‑L |
247573
|
Adult-onset citrullinemia type I
|
ORPHAnet |
| 0‑L |
247585
|
Citrullinemia type II
|
ORPHAnet |
| 0‑L |
247598
|
Neonatal intrahepatic cholestasis due to citrin deficiency
|
ORPHAnet |
| 0‑L |
247604
|
Juvenile primary lateral sclerosis
|
ORPHAnet |
| 0‑L |
247623
|
Perinatal lethal hypophosphatasia
|
ORPHAnet |
| 0‑L |
247638
|
Prenatal benign hypophosphatasia
|
ORPHAnet |
| 0‑L |
247651
|
Infantile hypophosphatasia
|
ORPHAnet |
| 0‑L |
247667
|
Childhood-onset hypophosphatasia
|
ORPHAnet |
| 0‑L |
247676
|
Adult hypophosphatasia
|
ORPHAnet |
| 0‑L |
247685
|
Odontohypophosphatasia
|
ORPHAnet |
| 0‑L |
247691
|
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
|
ORPHAnet |
| 0‑L |
247698
|
Multiple endocrine neoplasia type 2A
|
ORPHAnet |
| 0‑L |
247709
|
Multiple endocrine neoplasia type 2B
|
ORPHAnet |
| 0‑L |
247718
|
Inflammatory myopathy with abundant macrophages
|
ORPHAnet |
| 0‑L |
247724
|
Idiopathic eosinophilic myositis
|
ORPHAnet |
| 0‑L |
247762
|
Lipoblastoma
|
ORPHAnet |
| 0‑L |
247768
|
Müllerian aplasia and hyperandrogenism
|
ORPHAnet |
| 0‑L |
247775
|
Mayer-Rokitansky-Küster-Hauser syndrome type 1
|
ORPHAnet |
| 0‑L |
247790
|
FTH1-related iron overload
|
ORPHAnet |
| 0‑L |
247794
|
Juvenile cataract-microcornea-renal glucosuria syndrome
|
ORPHAnet |
| 0‑L |
247798
|
MUTYH-related attenuated familial adenomatous polyposis
|
ORPHAnet |
| 0‑L |
247806
|
APC-related attenuated familial adenomatous polyposis
|
ORPHAnet |
| 0‑L |
247815
|
Autosomal recessive ataxia due to PEX10 deficiency
|
ORPHAnet |
| 0‑L |
247820
|
Ectodermal dysplasia-syndactyly syndrome
|
ORPHAnet |
| 0‑L |
247827
|
Ectodermal dysplasia-cutaneous syndactyly syndrome
|
ORPHAnet |
| 0‑L |
247834
|
Occult macular dystrophy
|
ORPHAnet |
| 0‑L |
247868
|
NLRP12-associated hereditary periodic fever syndrome
|
ORPHAnet |
| 0‑L |
248111
|
Juvenile Huntington disease
|
ORPHAnet |
| 0‑L |
248340
|
Isolated delta-storage pool disease
|
ORPHAnet |
| 0‑L |
248408
|
Familial hypodysfibrinogenemia
|
ORPHAnet |
| 0‑L |
250831
|
Logopenic progressive aphasia
|
ORPHAnet |
| 0‑L |
250923
|
Isolated aniridia
|
ORPHAnet |
| 0‑L |
250932
|
Autosomal dominant optic atrophy and peripheral neuropathy
|
ORPHAnet |
| 0‑L |
250972
|
Polymicrogyria with optic nerve hypoplasia
|
ORPHAnet |
| 0‑L |
250977
|
AICA-ribosiduria
|
ORPHAnet |
| 0‑L |
250984
|
Autosomal recessive Stickler syndrome
|
ORPHAnet |
| 0‑L |
250989
|
1q21.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
250994
|
1q21.1 microduplication syndrome
|
ORPHAnet |
| 0‑L |
250999
|
1q41q42 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
251004
|
Paternal uniparental disomy of chromosome 1
|
ORPHAnet |
| 0‑L |
251009
|
Maternal uniparental disomy of chromosome 1
|
ORPHAnet |
| 0‑L |
251014
|
2q31.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
251019
|
2q32q33 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
251028
|
SATB2-associated syndrome due to a chromosomal rearrangement
|
ORPHAnet |
| 0‑L |
251038
|
3q29 microduplication syndrome
|
ORPHAnet |
| 0‑L |
251043
|
Ring chromosome 5 syndrome
|
ORPHAnet |
| 0‑L |
251046
|
6p22 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
251056
|
6q25 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
251061
|
7q31 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
251066
|
8p11.2 deletion syndrome
|
ORPHAnet |
| 0‑L |
251071
|
8p23.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
251076
|
8p23.1 duplication syndrome
|
ORPHAnet |
| 0‑L |
251262
|
Familial osteochondritis dissecans
|
ORPHAnet |
| 0‑L |
251274
|
Familial hyperaldosteronism type III
|
ORPHAnet |
| 0‑L |
251279
|
Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome
|
ORPHAnet |
| 0‑L |
251282
|
Autosomal dominant spastic ataxia type 1
|
ORPHAnet |
| 0‑L |
251287
|
Benign concentric annular macular dystrophy
|
ORPHAnet |
| 0‑L |
251290
|
Parietal foramina with clavicular hypoplasia
|
ORPHAnet |
| 0‑L |
251295
|
Pigmented paravenous retinochoroidal atrophy
|
ORPHAnet |
| 0‑L |
251304
|
Infantile onset panniculitis with uveitis and systemic granulomatosis
|
ORPHAnet |
| 0‑L |
251307
|
Idiopathic recurrent pericarditis
|
ORPHAnet |
| 0‑L |
251325
|
Drug-induced vasculitis
|
ORPHAnet |
| 0‑L |
251328
|
Unclassified vasculitis
|
ORPHAnet |
| 0‑L |
251332
|
Unexplained long-lasting fever/inflammatory syndrome
|
ORPHAnet |
| 0‑L |
251347
|
Ataxia-telangiectasia-like disorder
|
ORPHAnet |
| 0‑L |
251359
|
Sickle cell-beta-thalassemia disease syndrome
|
ORPHAnet |
| 0‑L |
251365
|
Sickle cell-hemoglobin C disease syndrome
|
ORPHAnet |
| 0‑L |
251370
|
Sickle cell-hemoglobin D disease syndrome
|
ORPHAnet |
| 0‑L |
251375
|
Sickle cell-hemoglobin E disease syndrome
|
ORPHAnet |
| 0‑L |
251380
|
Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
|
ORPHAnet |
| 0‑L |
251383
|
CK syndrome
|
ORPHAnet |
| 0‑L |
251393
|
Localized junctional epidermolysis bullosa
|
ORPHAnet |
| 0‑L |
251510
|
46,XY partial gonadal dysgenesis
|
ORPHAnet |
| 0‑L |
251515
|
Distal arthrogryposis type 10
|
ORPHAnet |
| 0‑L |
251523
|
Hyperzincemia and hypercalprotectinemia
|
ORPHAnet |
| 0‑L |
251576
|
Gliosarcoma
|
ORPHAnet |
| 0‑L |
251579
|
Giant cell glioblastoma
|
ORPHAnet |
| 0‑L |
251582
|
Gliomatosis cerebri
|
ORPHAnet |
| 0‑L |
251589
|
Anaplastic astrocytoma
|
ORPHAnet |
| 0‑L |
251595
|
Diffuse astrocytoma
|
ORPHAnet |
| 0‑L |
251598
|
Protoplasmic astrocytoma
|
ORPHAnet |
| 0‑L |
251601
|
Fibrillary astrocytoma
|
ORPHAnet |
| 0‑L |
251604
|
Gemistocytic astrocytoma
|
ORPHAnet |
| 0‑L |
251607
|
Pleomorphic xanthoastrocytoma
|
ORPHAnet |
| 0‑L |
251612
|
Pilocytic astrocytoma
|
ORPHAnet |
| 0‑L |
251615
|
Pilomyxoid astrocytoma
|
ORPHAnet |
| 0‑L |
251618
|
Subependymal giant cell astrocytoma
|
ORPHAnet |
| 0‑L |
251623
|
Pituicytoma
|
ORPHAnet |
| 0‑L |
251627
|
Oligodendroglioma
|
ORPHAnet |
| 0‑L |
251630
|
Anaplastic oligodendroglioma
|
ORPHAnet |
| 0‑L |
251636
|
Ependymoma
|
ORPHAnet |
| 0‑L |
251639
|
Subependymoma
|
ORPHAnet |
| 0‑L |
251643
|
Myxopapillary ependymoma
|
ORPHAnet |
| 0‑L |
251646
|
Anaplastic ependymoma
|
ORPHAnet |
| 0‑L |
251656
|
Oligoastrocytoma
|
ORPHAnet |
| 0‑L |
251663
|
Anaplastic oligoastrocytoma
|
ORPHAnet |
| 0‑L |
251671
|
Angiocentric glioma
|
ORPHAnet |
| 0‑L |
251674
|
Chordoid glioma
|
ORPHAnet |
| 0‑L |
251679
|
Astroblastoma
|
ORPHAnet |
| 0‑L |
251855
|
Anaplastic/large cell medulloblastoma
|
ORPHAnet |
| 0‑L |
251858
|
Medulloblastoma with extensive nodularity
|
ORPHAnet |
| 0‑L |
251863
|
Desmoplastic/nodular medulloblastoma
|
ORPHAnet |
| 0‑L |
251867
|
Classic medulloblastoma
|
ORPHAnet |
| 0‑L |
251877
|
Ganglioneuroblastoma
|
ORPHAnet |
| 0‑L |
251880
|
Ependymoblastoma
|
ORPHAnet |
| 0‑L |
251883
|
Medulloepithelioma of the central nervous system
|
ORPHAnet |
| 0‑L |
251899
|
Choroid plexus carcinoma
|
ORPHAnet |
| 0‑L |
251902
|
Atypical papilloma of choroid plexus
|
ORPHAnet |
| 0‑L |
251909
|
Pineoblastoma
|
ORPHAnet |
| 0‑L |
251912
|
Pineocytoma
|
ORPHAnet |
| 0‑L |
251915
|
Papillary tumor of the pineal region
|
ORPHAnet |
| 0‑L |
251919
|
Pineal parenchymal tumor of intermediate differenciation
|
ORPHAnet |
| 0‑L |
251927
|
Extraventricular neurocytoma
|
ORPHAnet |
| 0‑L |
251931
|
Cerebellar liponeurocytoma
|
ORPHAnet |
| 0‑L |
251937
|
Gangliocytoma
|
ORPHAnet |
| 0‑L |
251940
|
Desmoplastic infantile astrocytoma/ganglioglioma
|
ORPHAnet |
| 0‑L |
251946
|
Dysembryoplastic neuroepithelial tumor
|
ORPHAnet |
| 0‑L |
251949
|
Ganglioglioma
|
ORPHAnet |
| 0‑L |
251957
|
Anaplastic ganglioglioma
|
ORPHAnet |
| 0‑L |
251962
|
Papillary glioneuronal tumor
|
ORPHAnet |
| 0‑L |
251975
|
Rosette-forming glioneuronal tumor
|
ORPHAnet |
| 0‑L |
251992
|
Ganglioneuroma
|
ORPHAnet |
| 0‑L |
252006
|
Yolk sac tumor of central nervous system
|
ORPHAnet |
| 0‑L |
252015
|
Choriocarcinoma of the central nervous system
|
ORPHAnet |
| 0‑L |
252018
|
Teratoma of the central nervous system
|
ORPHAnet |
| 0‑L |
252021
|
Mixed germ cell tumor of central nervous system
|
ORPHAnet |
| 0‑L |
252031
|
Diffuse leptomeningeal melanocytosis
|
ORPHAnet |
| 0‑L |
252046
|
Meningeal melanocytoma
|
ORPHAnet |
| 0‑L |
252050
|
Primary melanoma of the central nervous system
|
ORPHAnet |
| 0‑L |
252054
|
Hemangioblastoma
|
ORPHAnet |
| 0‑L |
252128
|
Malignant peripheral nerve sheath tumor with perineurial differentiation
|
ORPHAnet |
| 0‑L |
252164
|
Benign schwannoma
|
ORPHAnet |
| 0‑L |
252175
|
Vestibular schwannoma
|
ORPHAnet |
| 0‑L |
252183
|
Neurofibroma
|
ORPHAnet |
| 0‑L |
252202
|
Constitutional mismatch repair deficiency syndrome
|
ORPHAnet |
| 0‑L |
252206
|
Melanoma and neural system tumor syndrome
|
ORPHAnet |
| 0‑L |
252212
|
Malignant triton tumor
|
ORPHAnet |
| 0‑L |
254334
|
Autosomal recessive intermediate Charcot-Marie-Tooth disease type B
|
ORPHAnet |
| 0‑L |
254343
|
Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome
|
ORPHAnet |
| 0‑L |
254346
|
19p13.12 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
254351
|
Distal 7q11.23 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
254361
|
Plectin-related limb-girdle muscular dystrophy R17
|
ORPHAnet |
| 0‑L |
254379
|
Linear lichen planus
|
ORPHAnet |
| 0‑L |
254395
|
Actinic lichen planus
|
ORPHAnet |
| 0‑L |
254411
|
Annular atrophic lichen planus
|
ORPHAnet |
| 0‑L |
254424
|
Annular lichen planus
|
ORPHAnet |
| 0‑L |
254449
|
Atrophic lichen planus
|
ORPHAnet |
| 0‑L |
254463
|
Lichen planus pigmentosus
|
ORPHAnet |
| 0‑L |
254478
|
Lichen planus pemphigoides
|
ORPHAnet |
| 0‑L |
254492
|
Frontal fibrosing alopecia
|
ORPHAnet |
| 0‑L |
254504
|
Inhalational botulism
|
ORPHAnet |
| 0‑L |
254509
|
Iatrogenic botulism
|
ORPHAnet |
| 0‑L |
254516
|
Temple syndrome
|
ORPHAnet |
| 0‑L |
254519
|
Kagami-Ogata syndrome
|
ORPHAnet |
| 0‑L |
254525
|
Temple syndrome due to paternal 14q32.2 microdeletion
|
ORPHAnet |
| 0‑L |
254528
|
Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion
|
ORPHAnet |
| 0‑L |
254531
|
Temple syndrome due to paternal 14q32.2 hypomethylation
|
ORPHAnet |
| 0‑L |
254534
|
Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation
|
ORPHAnet |
| 0‑L |
254688
|
Complete hydatidiform mole
|
ORPHAnet |
| 0‑L |
254693
|
Partial hydatidiform mole
|
ORPHAnet |
| 0‑L |
254698
|
Epithelioid trophoblastic tumor
|
ORPHAnet |
| 0‑L |
254704
|
Genetic hyperferritinemia without iron overload
|
ORPHAnet |
| 0‑L |
254851
|
Mitochondrial DNA-related dystonia
|
ORPHAnet |
| 0‑L |
254854
|
Pure mitochondrial myopathy
|
ORPHAnet |
| 0‑L |
254857
|
Lethal infantile mitochondrial myopathy
|
ORPHAnet |
| 0‑L |
254864
|
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency
|
ORPHAnet |
| 0‑L |
254875
|
Mitochondrial DNA depletion syndrome, myopathic form
|
ORPHAnet |
| 0‑L |
254881
|
Spinocerebellar ataxia with epilepsy
|
ORPHAnet |
| 0‑L |
254886
|
Autosomal recessive progressive external ophthalmoplegia
|
ORPHAnet |
| 0‑L |
254892
|
Autosomal dominant progressive external ophthalmoplegia
|
ORPHAnet |
| 0‑L |
254898
|
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome
|
ORPHAnet |
| 0‑L |
254902
|
Renal tubulopathy-encephalopathy-liver failure syndrome
|
ORPHAnet |
| 0‑L |
254905
|
Isolated cytochrome C oxidase deficiency
|
ORPHAnet |
| 0‑L |
254913
|
Isolated ATP synthase deficiency
|
ORPHAnet |
| 0‑L |
254920
|
Combined oxidative phosphorylation defect type 2
|
ORPHAnet |
| 0‑L |
254925
|
Combined oxidative phosphorylation defect type 4
|
ORPHAnet |
| 0‑L |
254930
|
Combined oxidative phosphorylation defect type 7
|
ORPHAnet |
| 0‑L |
255132
|
Adult-onset autosomal recessive sideroblastic anemia
|
ORPHAnet |
| 0‑L |
255138
|
Pyruvate dehydrogenase E1-beta deficiency
|
ORPHAnet |
| 0‑L |
255182
|
Pyruvate dehydrogenase E3-binding protein deficiency
|
ORPHAnet |
| 0‑L |
255210
|
Mitochondrial DNA-associated Leigh syndrome
|
ORPHAnet |
| 0‑L |
255229
|
Navajo neurohepatopathy
|
ORPHAnet |
| 0‑L |
255235
|
Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy
|
ORPHAnet |
| 0‑L |
255241
|
Leigh syndrome with leukodystrophy
|
ORPHAnet |
| 0‑L |
255249
|
Leigh syndrome with nephrotic syndrome
|
ORPHAnet |
| 0‑L |
260305
|
Autosomal recessive sideroblastic anemia
|
ORPHAnet |
| 0‑L |
261102
|
Distal 7q11.23 microduplication syndrome
|
ORPHAnet |
| 0‑L |
261112
|
Monosomy 9p
|
ORPHAnet |
| 0‑L |
261120
|
14q11.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261144
|
FOXG1 syndrome due to 14q12 microdeletion
|
ORPHAnet |
| 0‑L |
261183
|
15q11.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261190
|
15q14 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261197
|
Proximal 16p11.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261204
|
16p11.2p12.2 microduplication syndrome
|
ORPHAnet |
| 0‑L |
261211
|
16p11.2p12.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261222
|
Distal 16p11.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261229
|
14q11.2 microduplication syndrome
|
ORPHAnet |
| 0‑L |
261236
|
16p13.11 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261243
|
16p13.11 microduplication syndrome
|
ORPHAnet |
| 0‑L |
261250
|
16q24.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261257
|
Distal 17p13.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261265
|
17q12 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261272
|
17q12 microduplication syndrome
|
ORPHAnet |
| 0‑L |
261279
|
17q23.1q23.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261290
|
Trisomy 17p
|
ORPHAnet |
| 0‑L |
261295
|
20p12.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261304
|
Paternal 20q13.2q13.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261311
|
20q13.33 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261318
|
Trisomy 20p
|
ORPHAnet |
| 0‑L |
261323
|
21q22.11q22.12 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261330
|
Distal 22q11.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261337
|
Distal 22q11.2 microduplication syndrome
|
ORPHAnet |
| 0‑L |
261344
|
Trisomy 1q
|
ORPHAnet |
| 0‑L |
261349
|
2p15p16.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
261476
|
Xp21 deletion syndrome
|
ORPHAnet |
| 0‑L |
261483
|
Xq27.3q28 duplication syndrome
|
ORPHAnet |
| 0‑L |
261494
|
Kleefstra syndrome
|
ORPHAnet |
| 0‑L |
261501
|
Atypical Norrie disease due to Xp11.3 microdeletion
|
ORPHAnet |
| 0‑L |
261519
|
Maternal uniparental disomy of chromosome X
|
ORPHAnet |
| 0‑L |
261524
|
Paternal uniparental disomy of chromosome X
|
ORPHAnet |
| 0‑L |
261529
|
Ring chromosome Y syndrome
|
ORPHAnet |
| 0‑L |
261534
|
49,XXXYY syndrome
|
ORPHAnet |
| 0‑L |
261537
|
Mowat-Wilson syndrome due to monosomy 2q22
|
ORPHAnet |
| 0‑L |
261552
|
Mowat-Wilson syndrome due to a ZEB2 point mutation
|
ORPHAnet |
| 0‑L |
261584
|
Familial adenomatous polyposis due to 5q22.2 microdeletion
|
ORPHAnet |
| 0‑L |
261600
|
Alagille syndrome due to 20p12 microdeletion
|
ORPHAnet |
| 0‑L |
261619
|
Alagille syndrome due to a JAG1 point mutation
|
ORPHAnet |
| 0‑L |
261629
|
Alagille syndrome due to a NOTCH2 point mutation
|
ORPHAnet |
| 0‑L |
261638
|
Okihiro syndrome due to 20q13 microdeletion
|
ORPHAnet |
| 0‑L |
261647
|
Okihiro syndrome due to a point mutation
|
ORPHAnet |
| 0‑L |
261652
|
Kleefstra syndrome due to a point mutation
|
ORPHAnet |
| 0‑L |
263297
|
Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency
|
ORPHAnet |
| 0‑L |
263310
|
Thymoma type A
|
ORPHAnet |
| 0‑L |
263317
|
Thymoma type B
|
ORPHAnet |
| 0‑L |
263324
|
Thymoma type AB
|
ORPHAnet |
| 0‑L |
263331
|
Well-differentiated thymic neuroendocrine carcinoma
|
ORPHAnet |
| 0‑L |
263335
|
Moderately-differentiated thymic neuroendocrine carcinoma
|
ORPHAnet |
| 0‑L |
263339
|
Poorly differentiated thymic neuroendocrine carcinoma
|
ORPHAnet |
| 0‑L |
263347
|
MRCS syndrome
|
ORPHAnet |
| 0‑L |
263352
|
Postcardiotomy right ventricular failure
|
ORPHAnet |
| 0‑L |
263410
|
Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease
syndrome
|
ORPHAnet |
| 0‑L |
263413
|
Angiosarcoma
|
ORPHAnet |
| 0‑L |
263425
|
Nevus of Ota
|
ORPHAnet |
| 0‑L |
263432
|
Nevus of Ito
|
ORPHAnet |
| 0‑L |
263435
|
Congenital smooth muscle hamartoma
|
ORPHAnet |
| 0‑L |
263455
|
Hyperinsulinism due to HNF4A deficiency
|
ORPHAnet |
| 0‑L |
263458
|
Hyperinsulinism due to INSR deficiency
|
ORPHAnet |
| 0‑L |
263463
|
CHST3-related skeletal dysplasia
|
ORPHAnet |
| 0‑L |
263479
|
Fuchs heterochromic iridocyclitis
|
ORPHAnet |
| 0‑L |
263482
|
Spondyloepiphyseal dysplasia, Maroteaux type
|
ORPHAnet |
| 0‑L |
263487
|
COG5-CDG
|
ORPHAnet |
| 0‑L |
263494
|
DPM3-CDG
|
ORPHAnet |
| 0‑L |
263501
|
COG4-CDG
|
ORPHAnet |
| 0‑L |
263508
|
COG1-CDG
|
ORPHAnet |
| 0‑L |
263516
|
Progressive myoclonic epilepsy type 3
|
ORPHAnet |
| 0‑L |
263524
|
Acute necrotizing encephalopathy of childhood
|
ORPHAnet |
| 0‑L |
263534
|
Acral peeling skin syndrome
|
ORPHAnet |
| 0‑L |
263543
|
Generalized peeling skin syndrome
|
ORPHAnet |
| 0‑L |
263548
|
Peeling skin syndrome type A
|
ORPHAnet |
| 0‑L |
263553
|
Peeling skin syndrome type B
|
ORPHAnet |
| 0‑L |
263558
|
Peeling skin syndrome type C
|
ORPHAnet |
| 0‑L |
263662
|
Familial multiple meningioma
|
ORPHAnet |
| 0‑L |
263665
|
NK-cell enteropathy
|
ORPHAnet |
| 0‑L |
264200
|
14q22q23 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
264450
|
Trisomy 8p
|
ORPHAnet |
| 0‑L |
264580
|
Glycogen storage disease due to liver phosphorylase kinase deficiency
|
ORPHAnet |
| 0‑L |
264675
|
Hereditary pulmonary alveolar proteinosis
|
ORPHAnet |
| 0‑L |
264688
|
Congenital chylothorax
|
ORPHAnet |
| 0‑L |
264691
|
Isolated pulmonary capillaritis
|
ORPHAnet |
| 0‑L |
264978
|
Drug or radiation exposure-related interstitial lung disease
|
ORPHAnet |
| 0‑L |
268114
|
RAS-associated autoimmune leukoproliferative disease
|
ORPHAnet |
| 0‑L |
268129
|
Spheroid body myopathy
|
ORPHAnet |
| 0‑L |
268139
|
Intraocular medulloepithelioma
|
ORPHAnet |
| 0‑L |
268145
|
Classic maple syrup urine disease
|
ORPHAnet |
| 0‑L |
268162
|
Intermediate maple syrup urine disease
|
ORPHAnet |
| 0‑L |
268173
|
Intermittent maple syrup urine disease
|
ORPHAnet |
| 0‑L |
268184
|
Thiamine-responsive maple syrup urine disease
|
ORPHAnet |
| 0‑L |
268249
|
Mycophenolate mofetil embryopathy
|
ORPHAnet |
| 0‑L |
268261
|
DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion
|
ORPHAnet |
| 0‑L |
268316
|
Complication in hemodialysis
|
ORPHAnet |
| 0‑L |
268322
|
Hereditary thrombocytopenia with normal platelets
|
ORPHAnet |
| 0‑L |
268363
|
Open iniencephaly
|
ORPHAnet |
| 0‑L |
268366
|
Closed iniencephaly
|
ORPHAnet |
| 0‑L |
268369
|
Spina bifida aperta
|
ORPHAnet |
| 0‑L |
268377
|
Total spina bifida aperta
|
ORPHAnet |
| 0‑L |
268384
|
Thoracolumbosacral spina bifida aperta
|
ORPHAnet |
| 0‑L |
268388
|
Lumbosacral spina bifida aperta
|
ORPHAnet |
| 0‑L |
268392
|
Cervical spina bifida aperta
|
ORPHAnet |
| 0‑L |
268397
|
Cervicothoracic spina bifida aperta
|
ORPHAnet |
| 0‑L |
268740
|
Upper thoracic spina bifida aperta
|
ORPHAnet |
| 0‑L |
268748
|
Total spina bifida cystica
|
ORPHAnet |
| 0‑L |
268752
|
Thoracolumbosacral spina bifida cystica
|
ORPHAnet |
| 0‑L |
268758
|
Lumbosacral spina bifida cystica
|
ORPHAnet |
| 0‑L |
268762
|
Cervical spina bifida cystica
|
ORPHAnet |
| 0‑L |
268766
|
Cervicothoracic spina bifida cystica
|
ORPHAnet |
| 0‑L |
268770
|
Upper thoracic spina bifida cystica
|
ORPHAnet |
| 0‑L |
268810
|
Posterior meningocele
|
ORPHAnet |
| 0‑L |
268813
|
Myelocystocele
|
ORPHAnet |
| 0‑L |
268820
|
Cranial meningocele
|
ORPHAnet |
| 0‑L |
268823
|
Occipital encephalocele
|
ORPHAnet |
| 0‑L |
268826
|
Parietal encephalocele
|
ORPHAnet |
| 0‑L |
268829
|
Basal encephalocele
|
ORPHAnet |
| 0‑L |
268835
|
Lipomyelomeningocele
|
ORPHAnet |
| 0‑L |
268838
|
Leptomyelolipoma
|
ORPHAnet |
| 0‑L |
268861
|
Primary tethered cord syndrome
|
ORPHAnet |
| 0‑L |
268865
|
Neurenteric cyst
|
ORPHAnet |
| 0‑L |
268868
|
Isolated amyelia
|
ORPHAnet |
| 0‑L |
268882
|
Arnold-Chiari malformation type I
|
ORPHAnet |
| 0‑L |
268920
|
Isolated megalencephaly
|
ORPHAnet |
| 0‑L |
268936
|
Isolated arhinencephaly
|
ORPHAnet |
| 0‑L |
268940
|
Bilateral polymicrogyria
|
ORPHAnet |
| 0‑L |
268943
|
Unilateral polymicrogyria
|
ORPHAnet |
| 0‑L |
268947
|
Unilateral focal polymicrogyria
|
ORPHAnet |
| 0‑L |
268961
|
Isolated focal cortical dysplasia type I
|
ORPHAnet |
| 0‑L |
268973
|
Isolated focal cortical dysplasia type Ia
|
ORPHAnet |
| 0‑L |
268980
|
Isolated focal cortical dysplasia type Ib
|
ORPHAnet |
| 0‑L |
268987
|
Isolated focal cortical dysplasia type Ic
|
ORPHAnet |
| 0‑L |
268994
|
Isolated focal cortical dysplasia type II
|
ORPHAnet |
| 0‑L |
269001
|
Isolated focal cortical dysplasia type IIa
|
ORPHAnet |
| 0‑L |
269008
|
Isolated focal cortical dysplasia type IIb
|
ORPHAnet |
| 0‑L |
269197
|
Glioependymal/ependymal cyst
|
ORPHAnet |
| 0‑L |
269203
|
Isolated cerebellar vermis agenesis
|
ORPHAnet |
| 0‑L |
269206
|
Isolated total cerebellar vermis agenesis
|
ORPHAnet |
| 0‑L |
269209
|
Isolated partial cerebellar vermis agenesis
|
ORPHAnet |
| 0‑L |
269212
|
Isolated Dandy-Walker malformation with hydrocephalus
|
ORPHAnet |
| 0‑L |
269215
|
Isolated Dandy-Walker malformation without hydrocephalus
|
ORPHAnet |
| 0‑L |
269218
|
Isolated unilateral hemispheric cerebellar hypoplasia
|
ORPHAnet |
| 0‑L |
269221
|
Isolated bilateral hemispheric cerebellar hypoplasia
|
ORPHAnet |
| 0‑L |
269229
|
Pontine tegmental cap dysplasia
|
ORPHAnet |
| 0‑L |
269505
|
Congenital communicating hydrocephalus
|
ORPHAnet |
| 0‑L |
269510
|
Congenital non-communicating hydrocephalus
|
ORPHAnet |
| 0‑L |
275517
|
Autoimmune lymphoproliferative syndrome with recurrent viral infections
|
ORPHAnet |
| 0‑L |
275523
|
Dianzani autoimmune lymphoproliferative disease
|
ORPHAnet |
| 0‑L |
275534
|
Myostatin-related muscle hypertrophy
|
ORPHAnet |
| 0‑L |
275543
|
L1 syndrome
|
ORPHAnet |
| 0‑L |
275555
|
Preeclampsia
|
ORPHAnet |
| 0‑L |
275761
|
Lysosomal acid lipase deficiency
|
ORPHAnet |
| 0‑L |
275766
|
Idiopathic pulmonary arterial hypertension
|
ORPHAnet |
| 0‑L |
275777
|
Heritable pulmonary arterial hypertension
|
ORPHAnet |
| 0‑L |
275864
|
Behavioral variant of frontotemporal dementia
|
ORPHAnet |
| 0‑L |
275872
|
Frontotemporal dementia with motor neuron disease
|
ORPHAnet |
| 0‑L |
275944
|
Hemolytic disease of the newborn with Kell alloimmunization
|
ORPHAnet |
| 0‑L |
276066
|
Bile acid CoA ligase deficiency and defective amidation
|
ORPHAnet |
| 0‑L |
276145
|
Malignant epithelial tumor of salivary glands
|
ORPHAnet |
| 0‑L |
276148
|
Benign epithelial tumor of salivary glands
|
ORPHAnet |
| 0‑L |
276152
|
Multiple endocrine neoplasia type 4
|
ORPHAnet |
| 0‑L |
276174
|
Idiopathic recurrent stupor
|
ORPHAnet |
| 0‑L |
276183
|
Spinocerebellar ataxia type 32
|
ORPHAnet |
| 0‑L |
276193
|
Spinocerebellar ataxia type 35
|
ORPHAnet |
| 0‑L |
276198
|
Spinocerebellar ataxia type 36
|
ORPHAnet |
| 0‑L |
276212
|
Mucopolysaccharidosis type 6, rapidly progressing
|
ORPHAnet |
| 0‑L |
276223
|
Mucopolysaccharidosis type 6, slowly progressing
|
ORPHAnet |
| 0‑L |
276234
|
Non-syndromic male infertility due to sperm motility disorder
|
ORPHAnet |
| 0‑L |
276238
|
Machado-Joseph disease type 1
|
ORPHAnet |
| 0‑L |
276241
|
Machado-Joseph disease type 2
|
ORPHAnet |
| 0‑L |
276244
|
Machado-Joseph disease type 3
|
ORPHAnet |
| 0‑L |
276280
|
Hemihyperplasia-multiple lipomatosis syndrome
|
ORPHAnet |
| 0‑L |
276399
|
Familial multinodular goiter
|
ORPHAnet |
| 0‑L |
276405
|
Hyperbiliverdinemia
|
ORPHAnet |
| 0‑L |
276413
|
10q22.3q23.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
276422
|
10q22.3q23.3 microduplication syndrome
|
ORPHAnet |
| 0‑L |
276429
|
Hypnic headache
|
ORPHAnet |
| 0‑L |
276432
|
Ogden syndrome
|
ORPHAnet |
| 0‑L |
276435
|
Lower motor neuron syndrome with late-adult onset
|
ORPHAnet |
| 0‑L |
276556
|
Hyperinsulinism due to UCP2 deficiency
|
ORPHAnet |
| 0‑L |
276575
|
Autosomal dominant hyperinsulinism due to SUR1 deficiency
|
ORPHAnet |
| 0‑L |
276580
|
Autosomal dominant hyperinsulinism due to Kir6.2 deficiency
|
ORPHAnet |
| 0‑L |
276598
|
Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency
|
ORPHAnet |
| 0‑L |
276603
|
Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency
|
ORPHAnet |
| 0‑L |
276608
|
Non-insulinoma pancreatogenous hypoglycemia syndrome
|
ORPHAnet |
| 0‑L |
276621
|
Sporadic pheochromocytoma/secreting paraganglioma
|
ORPHAnet |
| 0‑L |
276630
|
Symptomatic form of Coffin-Lowry syndrome in female carriers
|
ORPHAnet |
| 0‑L |
279882
|
Spasmus nutans
|
ORPHAnet |
| 0‑L |
279888
|
Acute endophthalmitis
|
ORPHAnet |
| 0‑L |
279891
|
Chronic endophthalmitis
|
ORPHAnet |
| 0‑L |
279894
|
Toxic maculopathy due to antimalarial drugs
|
ORPHAnet |
| 0‑L |
279897
|
Primary oculocerebral lymphoma
|
ORPHAnet |
| 0‑L |
279904
|
Primary intraocular lymphoma
|
ORPHAnet |
| 0‑L |
279914
|
Intermediate uveitis
|
ORPHAnet |
| 0‑L |
279919
|
Infectious posterior uveitis
|
ORPHAnet |
| 0‑L |
279922
|
Infectious anterior uveitis
|
ORPHAnet |
| 0‑L |
279925
|
Infectious panuveitis
|
ORPHAnet |
| 0‑L |
279928
|
Paraneoplastic uveitis
|
ORPHAnet |
| 0‑L |
279934
|
Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency
|
ORPHAnet |
| 0‑L |
279943
|
Hereditary neutrophilia
|
ORPHAnet |
| 0‑L |
279947
|
Postorgasmic illness syndrome
|
ORPHAnet |
| 0‑L |
280062
|
Calciphylaxis
|
ORPHAnet |
| 0‑L |
280065
|
Calciphylaxis cutis
|
ORPHAnet |
| 0‑L |
280068
|
Visceral calciphylaxis
|
ORPHAnet |
| 0‑L |
280071
|
ALG11-CDG
|
ORPHAnet |
| 0‑L |
280133
|
Complement component 3 deficiency
|
ORPHAnet |
| 0‑L |
280142
|
Severe combined immunodeficiency due to LCK deficiency
|
ORPHAnet |
| 0‑L |
280183
|
Methylmalonic aciduria due to transcobalamin receptor defect
|
ORPHAnet |
| 0‑L |
280195
|
Septopreoptic holoprosencephaly
|
ORPHAnet |
| 0‑L |
280200
|
Microform holoprosencephaly
|
ORPHAnet |
| 0‑L |
280205
|
Laryngotracheoesophageal cleft type 0
|
ORPHAnet |
| 0‑L |
280210
|
Pelizaeus-Merzbacher disease, connatal form
|
ORPHAnet |
| 0‑L |
280219
|
Pelizaeus-Merzbacher disease, classic form
|
ORPHAnet |
| 0‑L |
280224
|
Pelizaeus-Merzbacher disease, transitional form
|
ORPHAnet |
| 0‑L |
280229
|
Pelizaeus-Merzbacher disease in female carriers
|
ORPHAnet |
| 0‑L |
280234
|
Null syndrome
|
ORPHAnet |
| 0‑L |
280270
|
Pelizaeus-Merzbacher-like disease
|
ORPHAnet |
| 0‑L |
280282
|
Pelizaeus-Merzbacher-like disease due to GJC2 mutation
|
ORPHAnet |
| 0‑L |
280288
|
Pelizaeus-Merzbacher-like disease due to HSPD1 mutation
|
ORPHAnet |
| 0‑L |
280293
|
Pelizaeus-Merzbacher-like disease due to AIMP1 mutation
|
ORPHAnet |
| 0‑L |
280302
|
Autoimmune pancreatitis type 1
|
ORPHAnet |
| 0‑L |
280315
|
Autoimmune pancreatitis type 2
|
ORPHAnet |
| 0‑L |
280325
|
Distal monosomy 12p
|
ORPHAnet |
| 0‑L |
280333
|
Alpha-dystroglycan-related limb-girdle muscular dystrophy R16
|
ORPHAnet |
| 0‑L |
280356
|
PLIN1-related familial partial lipodystrophy
|
ORPHAnet |
| 0‑L |
280365
|
Autosomal semi-dominant severe lipodystrophic laminopathy
|
ORPHAnet |
| 0‑L |
280379
|
Erythropoietic uroporphyria associated with myeloid malignancy
|
ORPHAnet |
| 0‑L |
280384
|
Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome
|
ORPHAnet |
| 0‑L |
280397
|
Familial Alzheimer-like prion disease
|
ORPHAnet |
| 0‑L |
280403
|
Familial omphalocele syndrome with facial dysmorphism
|
ORPHAnet |
| 0‑L |
280406
|
Familial steroid-resistant nephrotic syndrome with sensorineural deafness
|
ORPHAnet |
| 0‑L |
280553
|
Fatal infantile hypertonic myofibrillar myopathy
|
ORPHAnet |
| 0‑L |
280558
|
Warsaw breakage syndrome
|
ORPHAnet |
| 0‑L |
280576
|
Nestor-Guillermo progeria syndrome
|
ORPHAnet |
| 0‑L |
280586
|
Chondrodysplasia with joint dislocations, gPAPP type
|
ORPHAnet |
| 0‑L |
280598
|
Hereditary sensorimotor neuropathy with hyperelastic skin
|
ORPHAnet |
| 0‑L |
280615
|
Hemoglobinopathy Toms River
|
ORPHAnet |
| 0‑L |
280620
|
Progressive myoclonic epilepsy type 6
|
ORPHAnet |
| 0‑L |
280628
|
Familial progressive hyper- and hypopigmentation
|
ORPHAnet |
| 0‑L |
280633
|
Multiple congenital anomalies-hypotonia-seizures syndrome
|
ORPHAnet |
| 0‑L |
280640
|
Occipital pachygyria and polymicrogyria
|
ORPHAnet |
| 0‑L |
280651
|
Acrodysostosis with multiple hormone resistance
|
ORPHAnet |
| 0‑L |
280654
|
Autosomal recessive nail dysplasia
|
ORPHAnet |
| 0‑L |
280671
|
Megaconial congenital muscular dystrophy
|
ORPHAnet |
| 0‑L |
280679
|
Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism
syndrome
|
ORPHAnet |
| 0‑L |
280763
|
Severe intellectual disability and progressive spastic paraplegia
|
ORPHAnet |
| 0‑L |
280774
|
Generalized essential telangiectasia
|
ORPHAnet |
| 0‑L |
280779
|
Cutaneous collagenous vasculopathy
|
ORPHAnet |
| 0‑L |
280785
|
Bullous diffuse cutaneous mastocytosis
|
ORPHAnet |
| 0‑L |
280794
|
Pseudoxanthomatous diffuse cutaneous mastocytosis
|
ORPHAnet |
| 0‑L |
280802
|
Intralobar congenital pulmonary sequestration
|
ORPHAnet |
| 0‑L |
280811
|
Extralobar congenital pulmonary sequestration
|
ORPHAnet |
| 0‑L |
280821
|
Communicating congenital bronchopulmonary-foregut malformation
|
ORPHAnet |
| 0‑L |
280827
|
Congenital pulmonary airway malformation type 0
|
ORPHAnet |
| 0‑L |
280832
|
Congenital pulmonary airway malformation type 1
|
ORPHAnet |
| 0‑L |
280840
|
Congenital pulmonary airway malformation type 2
|
ORPHAnet |
| 0‑L |
280847
|
Congenital pulmonary airway malformation type 3
|
ORPHAnet |
| 0‑L |
280854
|
Congenital pulmonary airway malformation type 4
|
ORPHAnet |
| 0‑L |
280914
|
Idiopathic anterior uveitis
|
ORPHAnet |
| 0‑L |
280917
|
Idiopathic posterior uveitis
|
ORPHAnet |
| 0‑L |
280921
|
Idiopathic panuveitis
|
ORPHAnet |
| 0‑L |
281090
|
Syndromic recessive X-linked ichthyosis
|
ORPHAnet |
| 0‑L |
281122
|
Self-improving collodion baby
|
ORPHAnet |
| 0‑L |
281127
|
Acral self-healing collodion baby
|
ORPHAnet |
| 0‑L |
281139
|
Annular epidermolytic ichthyosis
|
ORPHAnet |
| 0‑L |
281190
|
Congenital reticular ichthyosiform erythroderma
|
ORPHAnet |
| 0‑L |
281201
|
Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome
|
ORPHAnet |
| 0‑L |
282166
|
Inherited Creutzfeldt-Jakob disease
|
ORPHAnet |
| 0‑L |
284139
|
Larsen-like syndrome, B3GAT3 type
|
ORPHAnet |
| 0‑L |
284149
|
Craniosynostosis-dental anomalies
|
ORPHAnet |
| 0‑L |
284160
|
8q21.11 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
284169
|
Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31
microdeletion
|
ORPHAnet |
| 0‑L |
284180
|
Xp22.13p22.2 duplication syndrome
|
ORPHAnet |
| 0‑L |
284227
|
TEMPI syndrome
|
ORPHAnet |
| 0‑L |
284232
|
Autosomal dominant Charcot-Marie-Tooth disease type 2O
|
ORPHAnet |
| 0‑L |
284247
|
Familial retinal arterial macroaneurysm
|
ORPHAnet |
| 0‑L |
284271
|
Autosomal recessive cerebellar ataxia-psychomotor delay syndrome
|
ORPHAnet |
| 0‑L |
284282
|
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due
to WWOX deficiency
|
ORPHAnet |
| 0‑L |
284289
|
Adult-onset autosomal recessive cerebellar ataxia
|
ORPHAnet |
| 0‑L |
284324
|
Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia
|
ORPHAnet |
| 0‑L |
284332
|
Infantile-onset autosomal recessive nonprogressive cerebellar ataxia
|
ORPHAnet |
| 0‑L |
284339
|
Pontocerebellar hypoplasia type 7
|
ORPHAnet |
| 0‑L |
284343
|
Pleuropulmonary blastoma familial tumor susceptibility syndrome
|
ORPHAnet |
| 0‑L |
284362
|
Fetal lung interstitial tumor
|
ORPHAnet |
| 0‑L |
284388
|
Reversible cerebral vasoconstriction syndrome
|
ORPHAnet |
| 0‑L |
284395
|
Well-differentiated fetal adenocarcinoma of the lung
|
ORPHAnet |
| 0‑L |
284400
|
Small cell carcinoma of the bladder
|
ORPHAnet |
| 0‑L |
284411
|
Glycerol kinase deficiency, juvenile form
|
ORPHAnet |
| 0‑L |
284414
|
Glycerol kinase deficiency, adult form
|
ORPHAnet |
| 0‑L |
284417
|
Phosphoserine aminotransferase deficiency, infantile/juvenile form
|
ORPHAnet |
| 0‑L |
284426
|
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency
|
ORPHAnet |
| 0‑L |
284435
|
Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency
|
ORPHAnet |
| 0‑L |
284448
|
CLIPPERS
|
ORPHAnet |
| 0‑L |
284454
|
Acute zonal occult outer retinopathy
|
ORPHAnet |
| 0‑L |
284460
|
Acute annular outer retinopathy
|
ORPHAnet |
| 0‑L |
284963
|
Marfan syndrome type 1
|
ORPHAnet |
| 0‑L |
284973
|
Marfan syndrome type 2
|
ORPHAnet |
| 0‑L |
284979
|
Neonatal Marfan syndrome
|
ORPHAnet |
| 0‑L |
284984
|
Aneurysm-osteoarthritis syndrome
|
ORPHAnet |
| 0‑L |
289157
|
Hypocalcemic vitamin D-dependent rickets
|
ORPHAnet |
| 0‑L |
289176
|
Autosomal recessive hypophosphatemic rickets
|
ORPHAnet |
| 0‑L |
289266
|
Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
|
ORPHAnet |
| 0‑L |
289290
|
Hypermethioninemia encephalopathy due to adenosine kinase deficiency
|
ORPHAnet |
| 0‑L |
289307
|
Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
289326
|
Tropical spastic paraparesis
|
ORPHAnet |
| 0‑L |
289347
|
Infective dermatitis associated with HTLV-1
|
ORPHAnet |
| 0‑L |
289356
|
Primary non-gestational choriocarcinoma of ovary
|
ORPHAnet |
| 0‑L |
289362
|
Non-central nervous system-localized embryonal carcinoma
|
ORPHAnet |
| 0‑L |
289365
|
Familial vesicoureteral reflux
|
ORPHAnet |
| 0‑L |
289377
|
Early-onset myopathy with fatal cardiomyopathy
|
ORPHAnet |
| 0‑L |
289380
|
Myosclerosis
|
ORPHAnet |
| 0‑L |
289385
|
Malignancy diagnosed during pregnancy
|
ORPHAnet |
| 0‑L |
289390
|
Primary Sjögren syndrome
|
ORPHAnet |
| 0‑L |
289465
|
Isolated congenital adermatoglyphia
|
ORPHAnet |
| 0‑L |
289478
|
Pyoderma gangrenosum-acne-suppurative hidradenitis syndrome
|
ORPHAnet |
| 0‑L |
289483
|
Intellectual disability-alacrima-achalasia syndrome
|
ORPHAnet |
| 0‑L |
289494
|
4H leukodystrophy
|
ORPHAnet |
| 0‑L |
289499
|
Congenital cataract microcornea with corneal opacity
|
ORPHAnet |
| 0‑L |
289504
|
Combined malonic and methylmalonic acidemia
|
ORPHAnet |
| 0‑L |
289513
|
12q15q21.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
289522
|
Microtriplication 11q24.1
|
ORPHAnet |
| 0‑L |
289539
|
BAP1-related tumor predisposition syndrome
|
ORPHAnet |
| 0‑L |
289548
|
Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency
|
ORPHAnet |
| 0‑L |
289553
|
Dysmorphism-conductive hearing loss-heart defect syndrome
|
ORPHAnet |
| 0‑L |
289560
|
Mitochondrial membrane protein-associated neurodegeneration
|
ORPHAnet |
| 0‑L |
289586
|
Exfoliative ichthyosis
|
ORPHAnet |
| 0‑L |
289596
|
Juvenile nasopharyngeal angiofibroma
|
ORPHAnet |
| 0‑L |
289601
|
Hereditary arterial and articular multiple calcification syndrome
|
ORPHAnet |
| 0‑L |
289661
|
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly
|
ORPHAnet |
| 0‑L |
289666
|
Plasmablastic lymphoma
|
ORPHAnet |
| 0‑L |
289682
|
Lymphoepithelial-like carcinoma
|
ORPHAnet |
| 0‑L |
289685
|
Myopericytoma
|
ORPHAnet |
| 0‑L |
289846
|
Glutathione synthetase deficiency with 5-oxoprolinuria
|
ORPHAnet |
| 0‑L |
289849
|
Glutathione synthetase deficiency without 5-oxoprolinuria
|
ORPHAnet |
| 0‑L |
289857
|
Neonatal glycine encephalopathy
|
ORPHAnet |
| 0‑L |
289860
|
Infantile glycine encephalopathy
|
ORPHAnet |
| 0‑L |
289863
|
Atypical glycine encephalopathy
|
ORPHAnet |
| 0‑L |
289877
|
Transient hyperammonemia of the newborn
|
ORPHAnet |
| 0‑L |
289891
|
Hypermethioninemia due to glycine N-methyltransferase deficiency
|
ORPHAnet |
| 0‑L |
289916
|
Vitamin B12-unresponsive methylmalonic acidemia type mut0
|
ORPHAnet |
| 0‑L |
293144
|
Familial clubfoot due to 5q31 microdeletion
|
ORPHAnet |
| 0‑L |
293150
|
Familial clubfoot due to PITX1 point mutation
|
ORPHAnet |
| 0‑L |
293165
|
Skin fragility-woolly hair-palmoplantar keratoderma syndrome
|
ORPHAnet |
| 0‑L |
293168
|
Infantile-onset ascending hereditary spastic paralysis
|
ORPHAnet |
| 0‑L |
293173
|
Acute generalized exanthematous pustulosis
|
ORPHAnet |
| 0‑L |
293181
|
Malignant migrating focal seizures of infancy
|
ORPHAnet |
| 0‑L |
293199
|
Pleomorphic rhabdomyosarcoma
|
ORPHAnet |
| 0‑L |
293202
|
Epithelioid sarcoma
|
ORPHAnet |
| 0‑L |
293208
|
Celiac artery compression syndrome
|
ORPHAnet |
| 0‑L |
293284
|
Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria
|
ORPHAnet |
| 0‑L |
293375
|
Grayson-Wilbrandt corneal dystrophy
|
ORPHAnet |
| 0‑L |
293381
|
Epithelial recurrent erosion dystrophy
|
ORPHAnet |
| 0‑L |
293462
|
Pre-Descemet corneal dystrophy
|
ORPHAnet |
| 0‑L |
293603
|
Congenital hereditary endothelial dystrophy type II
|
ORPHAnet |
| 0‑L |
293621
|
X-linked endothelial corneal dystrophy
|
ORPHAnet |
| 0‑L |
293633
|
PYCR1-related De Barsy syndrome
|
ORPHAnet |
| 0‑L |
293707
|
Blepharophimosis-intellectual disability syndrome, MKB type
|
ORPHAnet |
| 0‑L |
293725
|
Blepharophimosis-intellectual disability syndrome, Verloes type
|
ORPHAnet |
| 0‑L |
293807
|
Ketamine-induced biliary dilatation
|
ORPHAnet |
| 0‑L |
293812
|
Fixed drug eruption
|
ORPHAnet |
| 0‑L |
293822
|
MITF-related melanoma and renal cell carcinoma predisposition syndrome
|
ORPHAnet |
| 0‑L |
293825
|
Congenital dyserythropoietic anemia type IV
|
ORPHAnet |
| 0‑L |
293843
|
3MC syndrome
|
ORPHAnet |
| 0‑L |
293864
|
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome
|
ORPHAnet |
| 0‑L |
293888
|
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form
|
ORPHAnet |
| 0‑L |
293899
|
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form
|
ORPHAnet |
| 0‑L |
293910
|
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
|
ORPHAnet |
| 0‑L |
293925
|
Lethal occipital encephalocele-skeletal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
293936
|
EDICT syndrome
|
ORPHAnet |
| 0‑L |
293939
|
Distal Xq28 microduplication syndrome
|
ORPHAnet |
| 0‑L |
293948
|
1p21.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
293955
|
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency
|
ORPHAnet |
| 0‑L |
293958
|
Hypertelorism-preauricular sinus-punctual pits-deafness syndrome
|
ORPHAnet |
| 0‑L |
293964
|
Hypoinsulinemic hypoglycemia and body hemihypertrophy
|
ORPHAnet |
| 0‑L |
293967
|
Hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism
syndrome
|
ORPHAnet |
| 0‑L |
293978
|
Deficiency in anterior pituitary function-variable immunodeficiency syndrome
|
ORPHAnet |
| 0‑L |
293987
|
Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation
syndrome
|
ORPHAnet |
| 0‑L |
294016
|
Microcephaly-capillary malformation syndrome
|
ORPHAnet |
| 0‑L |
294023
|
Neonatal inflammatory skin and bowel disease
|
ORPHAnet |
| 0‑L |
294026
|
Syndactyly-nystagmus syndrome due to 2q31.1 microduplication
|
ORPHAnet |
| 0‑L |
294415
|
Renal-hepatic-pancreatic dysplasia
|
ORPHAnet |
| 0‑L |
294422
|
Chronic intestinal failure
|
ORPHAnet |
| 0‑L |
294967
|
Amelia of upper limb
|
ORPHAnet |
| 0‑L |
294969
|
Amelia of lower limb
|
ORPHAnet |
| 0‑L |
294971
|
Tetra-amelia
|
ORPHAnet |
| 0‑L |
294973
|
Humeral agenesis/hypoplasia
|
ORPHAnet |
| 0‑L |
294975
|
Congenital absence of upper arm and forearm with hand present
|
ORPHAnet |
| 0‑L |
294977
|
Congenital absence of thigh and lower leg with foot present
|
ORPHAnet |
| 0‑L |
294979
|
Congenital absence of both forearm and hand
|
ORPHAnet |
| 0‑L |
294981
|
Congenital absence of both lower leg and foot
|
ORPHAnet |
| 0‑L |
294983
|
Acheiria
|
ORPHAnet |
| 0‑L |
294986
|
Apodia
|
ORPHAnet |
| 0‑L |
294988
|
Congenital hypoplasia of thumb
|
ORPHAnet |
| 0‑L |
295000
|
Constriction rings syndrome
|
ORPHAnet |
| 0‑L |
295002
|
Hyperphalangy
|
ORPHAnet |
| 0‑L |
295004
|
Central polydactyly
|
ORPHAnet |
| 0‑L |
295012
|
Syndactyly type 6
|
ORPHAnet |
| 0‑L |
295014
|
Familial isolated clinodactyly of fingers
|
ORPHAnet |
| 0‑L |
295016
|
Camptodactyly of fingers
|
ORPHAnet |
| 0‑L |
295018
|
Congenital pseudoarthrosis of the tibia
|
ORPHAnet |
| 0‑L |
295020
|
Congenital pseudoarthrosis of the femur
|
ORPHAnet |
| 0‑L |
295022
|
Congenital pseudoarthrosis of the fibula
|
ORPHAnet |
| 0‑L |
295024
|
Congenital pseudoarthrosis of the radius
|
ORPHAnet |
| 0‑L |
295026
|
Congenital pseudoarthrosis of the ulna
|
ORPHAnet |
| 0‑L |
295028
|
Tibio-fibular synostosis
|
ORPHAnet |
| 0‑L |
295030
|
True congenital shoulder dislocation
|
ORPHAnet |
| 0‑L |
295032
|
Isolated congenital radial head dislocation
|
ORPHAnet |
| 0‑L |
295034
|
Congenital knee dislocation
|
ORPHAnet |
| 0‑L |
295036
|
Congenital patella dislocation
|
ORPHAnet |
| 0‑L |
295044
|
Macrodactyly of fingers
|
ORPHAnet |
| 0‑L |
295047
|
Macrodactyly of toes
|
ORPHAnet |
| 0‑L |
295049
|
Upper limb hypertrophy
|
ORPHAnet |
| 0‑L |
295051
|
Lower limb hypertrophy
|
ORPHAnet |
| 0‑L |
295187
|
Zygodactyly type 1
|
ORPHAnet |
| 0‑L |
295189
|
Zygodactyly type 2
|
ORPHAnet |
| 0‑L |
295191
|
Zygodactyly type 3
|
ORPHAnet |
| 0‑L |
295193
|
Zygodactyly type 4
|
ORPHAnet |
| 0‑L |
295195
|
Synpolydactyly type 1
|
ORPHAnet |
| 0‑L |
295197
|
Synpolydactyly type 2
|
ORPHAnet |
| 0‑L |
295199
|
Synpolydactyly type 3
|
ORPHAnet |
| 0‑L |
295201
|
Congenital vertical talus, unilateral
|
ORPHAnet |
| 0‑L |
295203
|
Congenital vertical talus, bilateral
|
ORPHAnet |
| 0‑L |
295213
|
Humero-ulnar synostosis, unilateral
|
ORPHAnet |
| 0‑L |
295215
|
Humero-ulnar synostosis, bilateral
|
ORPHAnet |
| 0‑L |
295217
|
Radio-ulnar synostosis, unilateral
|
ORPHAnet |
| 0‑L |
295219
|
Radio-ulnar synostosis, bilateral
|
ORPHAnet |
| 0‑L |
295225
|
Congenital elbow dislocation, unilateral
|
ORPHAnet |
| 0‑L |
295227
|
Congenital elbow dislocation, bilateral
|
ORPHAnet |
| 0‑L |
295229
|
Congenital genu recurvatum
|
ORPHAnet |
| 0‑L |
295232
|
Congenital genu flexum
|
ORPHAnet |
| 0‑L |
295239
|
Macrodactyly of fingers, unilateral
|
ORPHAnet |
| 0‑L |
295241
|
Macrodactyly of fingers, bilateral
|
ORPHAnet |
| 0‑L |
295243
|
Macrodactyly of toes, unilateral
|
ORPHAnet |
| 0‑L |
295245
|
Macrodactyly of toes, bilateral
|
ORPHAnet |
| 0‑L |
300179
|
Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency
|
ORPHAnet |
| 0‑L |
300284
|
Connective tissue disorder due to lysyl hydroxylase-3 deficiency
|
ORPHAnet |
| 0‑L |
300293
|
Transient infantile hypertriglyceridemia and hepatosteatosis
|
ORPHAnet |
| 0‑L |
300298
|
Severe congenital hypochromic anemia with ringed sideroblasts
|
ORPHAnet |
| 0‑L |
300305
|
11p15.4 microduplication syndrome
|
ORPHAnet |
| 0‑L |
300313
|
Congenital cataract-hearing loss-severe developmental delay syndrome
|
ORPHAnet |
| 0‑L |
300319
|
Charcot-Marie-Tooth disease type 2P
|
ORPHAnet |
| 0‑L |
300324
|
Persistent polyclonal B-cell lymphocytosis
|
ORPHAnet |
| 0‑L |
300333
|
Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome
|
ORPHAnet |
| 0‑L |
300345
|
Autosomal systemic lupus erythematosus
|
ORPHAnet |
| 0‑L |
300359
|
PLCG2-associated antibody deficiency and immune dysregulation
|
ORPHAnet |
| 0‑L |
300373
|
X-linked acrogigantism
|
ORPHAnet |
| 0‑L |
300382
|
Progeroid and marfanoid aspect-lipodystrophy syndrome
|
ORPHAnet |
| 0‑L |
300385
|
Pituitary carcinoma
|
ORPHAnet |
| 0‑L |
300493
|
Sagliker syndrome
|
ORPHAnet |
| 0‑L |
300496
|
Multiple congenital anomalies-hypotonia-seizures syndrome type 2
|
ORPHAnet |
| 0‑L |
300501
|
Painful orbital and systemic neurofibromas-marfanoid habitus syndrome
|
ORPHAnet |
| 0‑L |
300504
|
Onychocytic matricoma
|
ORPHAnet |
| 0‑L |
300512
|
Onychomatricoma
|
ORPHAnet |
| 0‑L |
300525
|
Pseudohypoaldosteronism type 2D
|
ORPHAnet |
| 0‑L |
300530
|
Pseudohypoaldosteronism type 2E
|
ORPHAnet |
| 0‑L |
300536
|
DDOST-CDG
|
ORPHAnet |
| 0‑L |
300547
|
Autosomal recessive infantile hypercalcemia
|
ORPHAnet |
| 0‑L |
300552
|
Follicular cholangitis and pancreatitis
|
ORPHAnet |
| 0‑L |
300557
|
Carcinoma of the ampulla of Vater
|
ORPHAnet |
| 0‑L |
300564
|
Combined pulmonary fibrosis-emphysema syndrome
|
ORPHAnet |
| 0‑L |
300570
|
Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation
|
ORPHAnet |
| 0‑L |
300573
|
Polymicrogyria due to TUBB2B mutation
|
ORPHAnet |
| 0‑L |
300576
|
Oligodontia-cancer predisposition syndrome
|
ORPHAnet |
| 0‑L |
300605
|
Juvenile amyotrophic lateral sclerosis
|
ORPHAnet |
| 0‑L |
300751
|
Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
|
ORPHAnet |
| 0‑L |
300849
|
Diffuse large B-cell lymphoma of the central nervous system
|
ORPHAnet |
| 0‑L |
300857
|
T-cell/histiocyte rich large B cell lymphoma
|
ORPHAnet |
| 0‑L |
300865
|
Primary cutaneous anaplastic large cell lymphoma
|
ORPHAnet |
| 0‑L |
300869
|
Splenic diffuse red pulp small B-cell lymphoma
|
ORPHAnet |
| 0‑L |
300878
|
Hairy cell leukemia variant
|
ORPHAnet |
| 0‑L |
300888
|
Diffuse large B-cell lymphoma with chronic inflammation
|
ORPHAnet |
| 0‑L |
300895
|
ALK-positive anaplastic large cell lymphoma
|
ORPHAnet |
| 0‑L |
300903
|
ALK-negative anaplastic large cell lymphoma
|
ORPHAnet |
| 0‑L |
306431
|
Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies
|
ORPHAnet |
| 0‑L |
306504
|
Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome
|
ORPHAnet |
| 0‑L |
306511
|
Autosomal recessive spastic paraplegia type 48
|
ORPHAnet |
| 0‑L |
306516
|
Primary hypomagnesemia with hypercalciuria and nephrocalcinosis
|
ORPHAnet |
| 0‑L |
306527
|
Isolated hereditary congenital facial paralysis
|
ORPHAnet |
| 0‑L |
306530
|
Congenital hereditary facial paralysis-variable hearing loss syndrome
|
ORPHAnet |
| 0‑L |
306542
|
Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome
|
ORPHAnet |
| 0‑L |
306547
|
Porencephaly-microcephaly-bilateral congenital cataract syndrome
|
ORPHAnet |
| 0‑L |
306550
|
FADD-related immunodeficiency
|
ORPHAnet |
| 0‑L |
306553
|
Myospherulosis
|
ORPHAnet |
| 0‑L |
306558
|
Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome
|
ORPHAnet |
| 0‑L |
306577
|
Sodium channelopathy-related small fiber neuropathy
|
ORPHAnet |
| 0‑L |
306617
|
X-linked complicated spastic paraplegia type 1
|
ORPHAnet |
| 0‑L |
306644
|
Complication after organ transplantation
|
ORPHAnet |
| 0‑L |
306658
|
Familial normophosphatemic tumoral calcinosis
|
ORPHAnet |
| 0‑L |
306661
|
Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome
|
ORPHAnet |
| 0‑L |
306669
|
Hemiparkinsonism-hemiatrophy syndrome
|
ORPHAnet |
| 0‑L |
306674
|
Kufor-Rakeb syndrome
|
ORPHAnet |
| 0‑L |
306682
|
Manganese poisoning
|
ORPHAnet |
| 0‑L |
306686
|
Delayed encephalopathy due to carbon monoxide poisoning
|
ORPHAnet |
| 0‑L |
306692
|
Cyanide-induced parkinsonism-dystonia
|
ORPHAnet |
| 0‑L |
306731
|
Sydenham chorea
|
ORPHAnet |
| 0‑L |
306734
|
Primary dystonia, DYT21 type
|
ORPHAnet |
| 0‑L |
306741
|
Hemidystonia-hemiatrophy syndrome
|
ORPHAnet |
| 0‑L |
306776
|
Sporadic hyperekplexia
|
ORPHAnet |
| 0‑L |
307766
|
Curly hair-acral keratoderma-caries syndrome
|
ORPHAnet |
| 0‑L |
307936
|
Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome
|
ORPHAnet |
| 0‑L |
308013
|
Focal acral hyperkeratosis
|
ORPHAnet |
| 0‑L |
308380
|
Methylcobalamin deficiency type cblDv1
|
ORPHAnet |
| 0‑L |
308386
|
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A
|
ORPHAnet |
| 0‑L |
308393
|
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B
|
ORPHAnet |
| 0‑L |
308400
|
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
|
ORPHAnet |
| 0‑L |
308410
|
Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency
|
ORPHAnet |
| 0‑L |
308425
|
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency
|
ORPHAnet |
| 0‑L |
308442
|
Vitamin B12-responsive methylmalonic acidemia, type cblDv2
|
ORPHAnet |
| 0‑L |
308473
|
Erythrocyte galactose epimerase deficiency
|
ORPHAnet |
| 0‑L |
308487
|
Generalized galactose epimerase deficiency
|
ORPHAnet |
| 0‑L |
308552
|
Glycogen storage disease due to acid maltase deficiency, infantile onset
|
ORPHAnet |
| 0‑L |
308621
|
Glycogen storage disease due to glycogen branching enzyme deficiency, progressive
hepatic form
|
ORPHAnet |
| 0‑L |
308638
|
Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive
hepatic form
|
ORPHAnet |
| 0‑L |
308655
|
Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal
neuromuscular form
|
ORPHAnet |
| 0‑L |
308670
|
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular
form
|
ORPHAnet |
| 0‑L |
308684
|
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined
hepatic and myopathic form
|
ORPHAnet |
| 0‑L |
308698
|
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular
form
|
ORPHAnet |
| 0‑L |
308712
|
Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular
form
|
ORPHAnet |
| 0‑L |
309015
|
Familial lipoprotein lipase deficiency
|
ORPHAnet |
| 0‑L |
309020
|
Familial apolipoprotein C-II deficiency
|
ORPHAnet |
| 0‑L |
309025
|
Mevalonate kinase deficiency
|
ORPHAnet |
| 0‑L |
309031
|
Pancreatic triacylglycerol lipase deficiency
|
ORPHAnet |
| 0‑L |
309108
|
Pancreatic colipase deficiency
|
ORPHAnet |
| 0‑L |
309111
|
Combined pancreatic lipase-colipase deficiency
|
ORPHAnet |
| 0‑L |
309147
|
Hyper-beta-alaninemia
|
ORPHAnet |
| 0‑L |
309155
|
Sandhoff disease, infantile form
|
ORPHAnet |
| 0‑L |
309162
|
Sandhoff disease, juvenile form
|
ORPHAnet |
| 0‑L |
309169
|
Sandhoff disease, adult form
|
ORPHAnet |
| 0‑L |
309178
|
Tay-Sachs disease, B variant, infantile form
|
ORPHAnet |
| 0‑L |
309185
|
Tay-Sachs disease, B variant, juvenile form
|
ORPHAnet |
| 0‑L |
309192
|
Tay-Sachs disease, B variant, adult form
|
ORPHAnet |
| 0‑L |
309239
|
Tay-Sachs disease, B1 variant
|
ORPHAnet |
| 0‑L |
309246
|
GM2 gangliosidosis, AB variant
|
ORPHAnet |
| 0‑L |
309252
|
Atypical Gaucher disease due to saposin C deficiency
|
ORPHAnet |
| 0‑L |
309256
|
Metachromatic leukodystrophy, late infantile form
|
ORPHAnet |
| 0‑L |
309263
|
Metachromatic leukodystrophy, juvenile form
|
ORPHAnet |
| 0‑L |
309271
|
Metachromatic leukodystrophy, adult form
|
ORPHAnet |
| 0‑L |
309282
|
Alpha-mannosidosis, infantile form
|
ORPHAnet |
| 0‑L |
309288
|
Alpha-mannosidosis, adult form
|
ORPHAnet |
| 0‑L |
309297
|
Mucopolysaccharidosis type 4A
|
ORPHAnet |
| 0‑L |
309310
|
Mucopolysaccharidosis type 4B
|
ORPHAnet |
| 0‑L |
309324
|
Free sialic acid storage disease, infantile form
|
ORPHAnet |
| 0‑L |
309331
|
Intermediate severe Salla disease
|
ORPHAnet |
| 0‑L |
309334
|
Salla disease
|
ORPHAnet |
| 0‑L |
309789
|
Rhizomelic chondrodysplasia punctata type 1
|
ORPHAnet |
| 0‑L |
309796
|
Rhizomelic chondrodysplasia punctata type 2
|
ORPHAnet |
| 0‑L |
309803
|
Rhizomelic chondrodysplasia punctata type 3
|
ORPHAnet |
| 0‑L |
309854
|
Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome
|
ORPHAnet |
| 0‑L |
313772
|
Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome
|
ORPHAnet |
| 0‑L |
313781
|
20p13 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
313795
|
Jawad syndrome
|
ORPHAnet |
| 0‑L |
313800
|
Retinal dystrophy-optic nerve edema-splenomegaly-anhidrosis-migraine headache syndrome
|
ORPHAnet |
| 0‑L |
313808
|
Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
|
ORPHAnet |
| 0‑L |
313838
|
Coats plus syndrome
|
ORPHAnet |
| 0‑L |
313846
|
Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome
|
ORPHAnet |
| 0‑L |
313850
|
Infantile cerebellar-retinal degeneration
|
ORPHAnet |
| 0‑L |
313855
|
FGFR2-related bent bone dysplasia
|
ORPHAnet |
| 0‑L |
313884
|
12p12.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
313892
|
Developmental and speech delay due to SOX5 deficiency
|
ORPHAnet |
| 0‑L |
313906
|
Congenital pancreatic cyst
|
ORPHAnet |
| 0‑L |
313920
|
Epstein-Barr virus-associated gastric carcinoma
|
ORPHAnet |
| 0‑L |
313936
|
PENS syndrome
|
ORPHAnet |
| 0‑L |
313947
|
2q23.1 microduplication syndrome
|
ORPHAnet |
| 0‑L |
314002
|
Contractures-webbed neck-micrognathia-hypoplastic nipples syndrome
|
ORPHAnet |
| 0‑L |
314017
|
Idiopathic linear interstitial keratitis
|
ORPHAnet |
| 0‑L |
314022
|
Gastric adenocarcinoma and proximal polyposis of the stomach
|
ORPHAnet |
| 0‑L |
314029
|
High bone mass osteogenesis imperfecta
|
ORPHAnet |
| 0‑L |
314034
|
7p22.1 microduplication syndrome
|
ORPHAnet |
| 0‑L |
314041
|
Marfanoid habitus-inguinal hernia-advanced bone age syndrome
|
ORPHAnet |
| 0‑L |
314051
|
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome
|
ORPHAnet |
| 0‑L |
314373
|
Chronic infantile diarrhea due to guanylate cyclase 2C overactivity
|
ORPHAnet |
| 0‑L |
314376
|
Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency
|
ORPHAnet |
| 0‑L |
314381
|
Hereditary sensory and autonomic neuropathy type 6
|
ORPHAnet |
| 0‑L |
314389
|
Xq12-q13.3 duplication syndrome
|
ORPHAnet |
| 0‑L |
314394
|
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome
|
ORPHAnet |
| 0‑L |
314399
|
Autosomal dominant aplasia and myelodysplasia
|
ORPHAnet |
| 0‑L |
314404
|
Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome
|
ORPHAnet |
| 0‑L |
314419
|
Ameloblastoma
|
ORPHAnet |
| 0‑L |
314422
|
Ameloblastic carcinoma
|
ORPHAnet |
| 0‑L |
314432
|
Spigelian hernia-cryptorchidism syndrome
|
ORPHAnet |
| 0‑L |
314451
|
Meigs syndrome
|
ORPHAnet |
| 0‑L |
314459
|
Pseudo-Meigs syndrome
|
ORPHAnet |
| 0‑L |
314466
|
Atypical Meigs syndrome
|
ORPHAnet |
| 0‑L |
314473
|
Ovarian fibroma
|
ORPHAnet |
| 0‑L |
314478
|
Ovarian fibrothecoma
|
ORPHAnet |
| 0‑L |
314485
|
Young adult-onset distal hereditary motor neuropathy
|
ORPHAnet |
| 0‑L |
314555
|
Facial dysmorphism-ocular anomalies-osteopenia-intellectual disability-dental anomalies
syndrome
|
ORPHAnet |
| 0‑L |
314566
|
Primary progressive apraxia of speech
|
ORPHAnet |
| 0‑L |
314572
|
Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome
|
ORPHAnet |
| 0‑L |
314575
|
Intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome
|
ORPHAnet |
| 0‑L |
314585
|
15q overgrowth syndrome
|
ORPHAnet |
| 0‑L |
314588
|
Distal tetrasomy 15q
|
ORPHAnet |
| 0‑L |
314597
|
Chudley-McCullough syndrome
|
ORPHAnet |
| 0‑L |
314603
|
Autosomal recessive spastic ataxia with leukoencephalopathy
|
ORPHAnet |
| 0‑L |
314613
|
Growing teratoma syndrome
|
ORPHAnet |
| 0‑L |
314621
|
Duplication of the pituitary gland
|
ORPHAnet |
| 0‑L |
314629
|
CLN11 disease
|
ORPHAnet |
| 0‑L |
314632
|
ATP13A2-related juvenile neuronal ceroid lipofuscinosis
|
ORPHAnet |
| 0‑L |
314637
|
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency
|
ORPHAnet |
| 0‑L |
314647
|
Non-progressive cerebellar ataxia with intellectual disability
|
ORPHAnet |
| 0‑L |
314652
|
Variant ABeta2M amyloidosis
|
ORPHAnet |
| 0‑L |
314655
|
Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion
|
ORPHAnet |
| 0‑L |
314662
|
Segmental progressive overgrowth syndrome with fibroadipose hyperplasia
|
ORPHAnet |
| 0‑L |
314667
|
TMEM165-CDG
|
ORPHAnet |
| 0‑L |
314679
|
Cerebrofacioarticular syndrome
|
ORPHAnet |
| 0‑L |
314684
|
Primary bone lymphoma
|
ORPHAnet |
| 0‑L |
314689
|
Combined immunodeficiency due to STK4 deficiency
|
ORPHAnet |
| 0‑L |
314697
|
Acquired porencephaly
|
ORPHAnet |
| 0‑L |
314701
|
Primary systemic amyloidosis
|
ORPHAnet |
| 0‑L |
314709
|
Primary localized amyloidosis
|
ORPHAnet |
| 0‑L |
314718
|
Lethal arteriopathy syndrome due to fibulin-4 deficiency
|
ORPHAnet |
| 0‑L |
314721
|
Atypical dentin dysplasia due to SMOC2 deficiency
|
ORPHAnet |
| 0‑L |
314769
|
Somatomammotropinoma
|
ORPHAnet |
| 0‑L |
314777
|
Familial isolated pituitary adenoma
|
ORPHAnet |
| 0‑L |
314786
|
Silent pituitary adenoma
|
ORPHAnet |
| 0‑L |
314790
|
Null pituitary adenoma
|
ORPHAnet |
| 0‑L |
314795
|
SHOX-related short stature
|
ORPHAnet |
| 0‑L |
314802
|
Short stature due to partial GHR deficiency
|
ORPHAnet |
| 0‑L |
314811
|
Short stature due to GHSR deficiency
|
ORPHAnet |
| 0‑L |
314889
|
Autosomal dominant proximal renal tubular acidosis
|
ORPHAnet |
| 0‑L |
314911
|
Severe Canavan disease
|
ORPHAnet |
| 0‑L |
314918
|
Mild Canavan disease
|
ORPHAnet |
| 0‑L |
314950
|
Primary hypereosinophilic syndrome
|
ORPHAnet |
| 0‑L |
314962
|
Secondary hypereosinophilic syndrome
|
ORPHAnet |
| 0‑L |
314970
|
Lymphocytic hypereosinophilic syndrome
|
ORPHAnet |
| 0‑L |
314978
|
X-linked non progressive cerebellar ataxia
|
ORPHAnet |
| 0‑L |
314993
|
Cataract-congenital heart disease-neural tube defect syndrome
|
ORPHAnet |
| 0‑L |
315306
|
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting
form
|
ORPHAnet |
| 0‑L |
315311
|
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing
form
|
ORPHAnet |
| 0‑L |
317425
|
Severe combined immunodeficiency due to DNA-PKcs deficiency
|
ORPHAnet |
| 0‑L |
317428
|
Combined immunodeficiency due to ORAI1 deficiency
|
ORPHAnet |
| 0‑L |
317430
|
Combined immunodeficiency due to STIM1 deficiency
|
ORPHAnet |
| 0‑L |
317473
|
Pancytopenia due to IKZF1 mutations
|
ORPHAnet |
| 0‑L |
317476
|
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and
neoplasia
|
ORPHAnet |
| 0‑L |
319160
|
Congenital myopathy with internal nuclei and atypical cores
|
ORPHAnet |
| 0‑L |
319171
|
Distal 17p13.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
319182
|
Wiedemann-Steiner syndrome
|
ORPHAnet |
| 0‑L |
319189
|
Familial cortical myoclonus
|
ORPHAnet |
| 0‑L |
319192
|
Diencephalic-mesencephalic junction dysplasia
|
ORPHAnet |
| 0‑L |
319195
|
Chondroectodermal dysplasia with night blindness
|
ORPHAnet |
| 0‑L |
319199
|
Autosomal recessive spastic paraplegia type 53
|
ORPHAnet |
| 0‑L |
319205
|
Bilateral massive adrenal hemorrhage
|
ORPHAnet |
| 0‑L |
319213
|
Lujo hemorrhagic fever
|
ORPHAnet |
| 0‑L |
319218
|
Ebola hemorrhagic fever
|
ORPHAnet |
| 0‑L |
319223
|
Argentine hemorrhagic fever
|
ORPHAnet |
| 0‑L |
319229
|
Bolivian hemorrhagic fever
|
ORPHAnet |
| 0‑L |
319234
|
Venezuelan hemorrhagic fever
|
ORPHAnet |
| 0‑L |
319239
|
Brazilian hemorrhagic fever
|
ORPHAnet |
| 0‑L |
319244
|
Chapare hemorrhagic fever
|
ORPHAnet |
| 0‑L |
319247
|
Hantavirus pulmonary syndrome
|
ORPHAnet |
| 0‑L |
319251
|
Rift valley fever
|
ORPHAnet |
| 0‑L |
319254
|
Kyasanur forest disease
|
ORPHAnet |
| 0‑L |
319266
|
Omsk hemorrhagic fever
|
ORPHAnet |
| 0‑L |
319276
|
Clear cell renal carcinoma
|
ORPHAnet |
| 0‑L |
319287
|
Multilocular cystic renal neoplasm of low malignant potential
|
ORPHAnet |
| 0‑L |
319298
|
Papillary renal cell carcinoma
|
ORPHAnet |
| 0‑L |
319303
|
Chromophobe renal cell carcinoma
|
ORPHAnet |
| 0‑L |
319308
|
MiT family translocation renal cell carcinoma
|
ORPHAnet |
| 0‑L |
319319
|
Renal medullary carcinoma
|
ORPHAnet |
| 0‑L |
319322
|
Mucinous tubular and spindle cell renal carcinoma
|
ORPHAnet |
| 0‑L |
319325
|
Tubulocystic renal cell carcinoma
|
ORPHAnet |
| 0‑L |
319332
|
Autosomal recessive myogenic arthrogryposis multiplex congenita
|
ORPHAnet |
| 0‑L |
319340
|
Carney complex-trismus-pseudocamptodactyly syndrome
|
ORPHAnet |
| 0‑L |
319462
|
Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations
|
ORPHAnet |
| 0‑L |
319465
|
Inherited acute myeloid leukemia
|
ORPHAnet |
| 0‑L |
319480
|
Acute myeloid leukemia with CEBPA somatic mutations
|
ORPHAnet |
| 0‑L |
319487
|
Familial papillary or follicular thyroid carcinoma
|
ORPHAnet |
| 0‑L |
319504
|
Combined oxidative phosphorylation defect type 8
|
ORPHAnet |
| 0‑L |
319509
|
Combined oxidative phosphorylation defect type 9
|
ORPHAnet |
| 0‑L |
319514
|
Combined oxidative phosphorylation defect type 13
|
ORPHAnet |
| 0‑L |
319519
|
Combined oxidative phosphorylation defect type 14
|
ORPHAnet |
| 0‑L |
319524
|
Combined oxidative phosphorylation defect type 15
|
ORPHAnet |
| 0‑L |
319547
|
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency
|
ORPHAnet |
| 0‑L |
319552
|
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency
|
ORPHAnet |
| 0‑L |
319558
|
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency
|
ORPHAnet |
| 0‑L |
319563
|
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency
|
ORPHAnet |
| 0‑L |
319569
|
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial
IFNgammaR1 deficiency
|
ORPHAnet |
| 0‑L |
319574
|
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial
IFNgammaR2 deficiency
|
ORPHAnet |
| 0‑L |
319581
|
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial
IFNgammaR1 deficiency
|
ORPHAnet |
| 0‑L |
319589
|
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial
IFNgammaR2 deficiency
|
ORPHAnet |
| 0‑L |
319595
|
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
|
ORPHAnet |
| 0‑L |
319600
|
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency
|
ORPHAnet |
| 0‑L |
319605
|
X-linked mendelian susceptibility to mycobacterial diseases
|
ORPHAnet |
| 0‑L |
319612
|
X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency
|
ORPHAnet |
| 0‑L |
319623
|
X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency
|
ORPHAnet |
| 0‑L |
319635
|
Amyloidosis cutis dyschromia
|
ORPHAnet |
| 0‑L |
319640
|
Retinal macular dystrophy type 2
|
ORPHAnet |
| 0‑L |
319646
|
PGM1-CDG
|
ORPHAnet |
| 0‑L |
319651
|
Constitutional megaloblastic anemia with severe neurologic disease
|
ORPHAnet |
| 0‑L |
319667
|
Primary lymphoma of the conjunctiva
|
ORPHAnet |
| 0‑L |
319671
|
Alazami syndrome
|
ORPHAnet |
| 0‑L |
319675
|
Microcephalic primordial dwarfism, Dauber type
|
ORPHAnet |
| 0‑L |
319678
|
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome
|
ORPHAnet |
| 0‑L |
320355
|
Autosomal dominant spastic paraplegia type 41
|
ORPHAnet |
| 0‑L |
320360
|
MT-ATP6-related mitochondrial spastic paraplegia
|
ORPHAnet |
| 0‑L |
320365
|
Autosomal dominant spastic paraplegia type 36
|
ORPHAnet |
| 0‑L |
320370
|
Autosomal recessive spastic paraplegia type 43
|
ORPHAnet |
| 0‑L |
320375
|
Autosomal recessive spastic paraplegia type 55
|
ORPHAnet |
| 0‑L |
320380
|
Autosomal recessive spastic paraplegia type 54
|
ORPHAnet |
| 0‑L |
320385
|
Hereditary sensory and autonomic neuropathy due to TECPR2 mutation
|
ORPHAnet |
| 0‑L |
320391
|
Autosomal recessive spastic paraplegia type 46
|
ORPHAnet |
| 0‑L |
320396
|
Autosomal recessive spastic paraplegia type 45
|
ORPHAnet |
| 0‑L |
320401
|
Autosomal recessive spastic paraplegia type 44
|
ORPHAnet |
| 0‑L |
320406
|
Spastic paraplegia-optic atrophy-neuropathy syndrome
|
ORPHAnet |
| 0‑L |
320411
|
Autosomal recessive spastic paraplegia type 56
|
ORPHAnet |
| 0‑L |
324262
|
Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency
|
ORPHAnet |
| 0‑L |
324290
|
Early-onset Lafora body disease
|
ORPHAnet |
| 0‑L |
324294
|
T-cell immunodeficiency with epidermodysplasia verruciformis
|
ORPHAnet |
| 0‑L |
324299
|
Multiple paragangliomas associated with polycythemia
|
ORPHAnet |
| 0‑L |
324307
|
Severe lateral tibial bowing with short stature
|
ORPHAnet |
| 0‑L |
324313
|
9p13 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
324321
|
Sinoatrial node dysfunction and deafness
|
ORPHAnet |
| 0‑L |
324353
|
Congenital achiasma
|
ORPHAnet |
| 0‑L |
324364
|
Mixed sclerosing bone dystrophy with extra-skeletal manifestations
|
ORPHAnet |
| 0‑L |
324381
|
Hereditary inclusion body myopathy type 4
|
ORPHAnet |
| 0‑L |
324410
|
X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome
|
ORPHAnet |
| 0‑L |
324416
|
Muscular hypertrophy-hepatomegaly-polyhydramnios syndrome
|
ORPHAnet |
| 0‑L |
324422
|
ALG13-CDG
|
ORPHAnet |
| 0‑L |
324442
|
Autosomal recessive axonal neuropathy with neuromyotonia
|
ORPHAnet |
| 0‑L |
324525
|
Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation
|
ORPHAnet |
| 0‑L |
324530
|
Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation
|
ORPHAnet |
| 0‑L |
324535
|
Combined oxidative phosphorylation defect type 11
|
ORPHAnet |
| 0‑L |
324540
|
Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
324561
|
Hypopigmentation-punctate palmoplantar keratoderma syndrome
|
ORPHAnet |
| 0‑L |
324569
|
Pontocerebellar hypoplasia type 8
|
ORPHAnet |
| 0‑L |
324575
|
Hyperinsulinism due to HNF1A deficiency
|
ORPHAnet |
| 0‑L |
324581
|
Benign Samaritan congenital myopathy
|
ORPHAnet |
| 0‑L |
324585
|
Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain
|
ORPHAnet |
| 0‑L |
324588
|
Familial dyskinesia and facial myokymia
|
ORPHAnet |
| 0‑L |
324601
|
X-linked cleft palate and ankyloglossia
|
ORPHAnet |
| 0‑L |
324604
|
Classic multiminicore myopathy
|
ORPHAnet |
| 0‑L |
324611
|
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation
|
ORPHAnet |
| 0‑L |
324625
|
Chikungunya
|
ORPHAnet |
| 0‑L |
324632
|
Hendra virus infection
|
ORPHAnet |
| 0‑L |
324636
|
Autoerythrocyte sensitization syndrome
|
ORPHAnet |
| 0‑L |
324648
|
Invasive non-typhoidal salmonellosis
|
ORPHAnet |
| 0‑L |
324703
|
ABetaL34V amyloidosis
|
ORPHAnet |
| 0‑L |
324708
|
ABeta amyloidosis, Iowa type
|
ORPHAnet |
| 0‑L |
324713
|
ABeta amyloidosis, Italian type
|
ORPHAnet |
| 0‑L |
324718
|
ABetaA21G amyloidosis
|
ORPHAnet |
| 0‑L |
324723
|
ABeta amyloidosis, Arctic type
|
ORPHAnet |
| 0‑L |
324737
|
SRD5A3-CDG
|
ORPHAnet |
| 0‑L |
324964
|
Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis
|
ORPHAnet |
| 0‑L |
324972
|
MAGIC syndrome
|
ORPHAnet |
| 0‑L |
324977
|
Proteasome-associated autoinflammatory syndrome
|
ORPHAnet |
| 0‑L |
325124
|
Testicular agenesis
|
ORPHAnet |
| 0‑L |
325345
|
46,XY ovotesticular disorder of sex development
|
ORPHAnet |
| 0‑L |
325448
|
Leydig cell hypoplasia due to LHB deficiency
|
ORPHAnet |
| 0‑L |
325524
|
Classic congenital lipoid adrenal hyperplasia due to STAR deficency
|
ORPHAnet |
| 0‑L |
325529
|
Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency
|
ORPHAnet |
| 0‑L |
329173
|
Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis
|
ORPHAnet |
| 0‑L |
329178
|
Congenital muscular dystrophy with intellectual disability and severe epilepsy
|
ORPHAnet |
| 0‑L |
329191
|
Tall stature-long halluces-multiple extra-epiphyses syndrome
|
ORPHAnet |
| 0‑L |
329195
|
Developmental delay with autism spectrum disorder and gait instability
|
ORPHAnet |
| 0‑L |
329211
|
Autosomal dominant neovascular inflammatory vitreoretinopathy
|
ORPHAnet |
| 0‑L |
329217
|
Cerebral sinovenous thrombosis
|
ORPHAnet |
| 0‑L |
329224
|
Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
|
ORPHAnet |
| 0‑L |
329228
|
Microcephalic primordial dwarfism due to ZNF335 deficiency
|
ORPHAnet |
| 0‑L |
329235
|
X-linked central congenital hypothyroidism with late-onset testicular enlargement
|
ORPHAnet |
| 0‑L |
329242
|
Congenital chronic diarrhea with protein-losing enteropathy
|
ORPHAnet |
| 0‑L |
329249
|
Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency
|
ORPHAnet |
| 0‑L |
329258
|
Autosomal dominant Charcot-Marie-Tooth disease type 2Q
|
ORPHAnet |
| 0‑L |
329284
|
Beta-propeller protein-associated neurodegeneration
|
ORPHAnet |
| 0‑L |
329308
|
Fatty acid hydroxylase-associated neurodegeneration
|
ORPHAnet |
| 0‑L |
329314
|
Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency
|
ORPHAnet |
| 0‑L |
329319
|
Thrombocythemia with distal limb defects
|
ORPHAnet |
| 0‑L |
329324
|
Inverse Klippel-Trénaunay syndrome
|
ORPHAnet |
| 0‑L |
329329
|
Autosomal recessive frontotemporal pachygyria
|
ORPHAnet |
| 0‑L |
329332
|
Microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome
|
ORPHAnet |
| 0‑L |
329336
|
Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy
|
ORPHAnet |
| 0‑L |
329457
|
Distal arthrogryposis type 5D
|
ORPHAnet |
| 0‑L |
329466
|
Autosomal dominant focal dystonia, DYT25 type
|
ORPHAnet |
| 0‑L |
329469
|
Acute megakaryoblastic leukemia without Down syndrome
|
ORPHAnet |
| 0‑L |
329475
|
Spastic paraplegia-Paget disease of bone syndrome
|
ORPHAnet |
| 0‑L |
329478
|
Adult-onset distal myopathy due to VCP mutation
|
ORPHAnet |
| 0‑L |
329481
|
Lipoprotein glomerulopathy
|
ORPHAnet |
| 0‑L |
329802
|
5p13 microduplication syndrome
|
ORPHAnet |
| 0‑L |
329813
|
Mosaic genome-wide paternal uniparental disomy
|
ORPHAnet |
| 0‑L |
329874
|
Idiopathic giant cell myocarditis
|
ORPHAnet |
| 0‑L |
329883
|
Non-hypoproteinemic hypertrophic gastropathy
|
ORPHAnet |
| 0‑L |
329894
|
Juvenile overlap myositis
|
ORPHAnet |
| 0‑L |
329903
|
Immunoglobulin-mediated membranoproliferative glomerulonephritis
|
ORPHAnet |
| 0‑L |
329918
|
C3 glomerulopathy
|
ORPHAnet |
| 0‑L |
329931
|
C3 glomerulonephritis
|
ORPHAnet |
| 0‑L |
329942
|
Transient neonatal multiple acyl-CoA dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
329967
|
Intermittent hydrarthrosis
|
ORPHAnet |
| 0‑L |
329971
|
Generalized juvenile polyposis/juvenile polyposis coli
|
ORPHAnet |
| 0‑L |
329977
|
Classic neuroendocrine tumor of appendix
|
ORPHAnet |
| 0‑L |
329984
|
Goblet cell carcinoma
|
ORPHAnet |
| 0‑L |
330001
|
Wild type ATTR amyloidosis
|
ORPHAnet |
| 0‑L |
330012
|
High altitude pulmonary edema
|
ORPHAnet |
| 0‑L |
330015
|
Lead poisoning
|
ORPHAnet |
| 0‑L |
330021
|
Mercury poisoning
|
ORPHAnet |
| 0‑L |
330029
|
Hypotrichosis-deafness syndrome
|
ORPHAnet |
| 0‑L |
330032
|
Hemoglobin Lepore-beta-thalassemia syndrome
|
ORPHAnet |
| 0‑L |
330041
|
Hemoglobin M disease
|
ORPHAnet |
| 0‑L |
330050
|
DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect
|
ORPHAnet |
| 0‑L |
330054
|
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay
syndrome
|
ORPHAnet |
| 0‑L |
330058
|
Hydroa vacciniforme
|
ORPHAnet |
| 0‑L |
330061
|
Actinic prurigo
|
ORPHAnet |
| 0‑L |
330064
|
Chronic actinic dermatitis
|
ORPHAnet |
| 0‑L |
331176
|
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency
|
ORPHAnet |
| 0‑L |
331187
|
Immunodeficiency due to MASP-2 deficiency
|
ORPHAnet |
| 0‑L |
331190
|
Immunodeficiency due to ficolin3 deficiency
|
ORPHAnet |
| 0‑L |
331206
|
Severe combined immunodeficiency due to complete RAG1/2 deficiency
|
ORPHAnet |
| 0‑L |
331226
|
Susceptibility to infection due to TYK2 deficiency
|
ORPHAnet |
| 0‑L |
331235
|
Selective IgM deficiency
|
ORPHAnet |
| 0‑L |
352328
|
MEGDEL syndrome
|
ORPHAnet |
| 0‑L |
352333
|
Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome
|
ORPHAnet |
| 0‑L |
352403
|
Spectrin-associated autosomal recessive cerebellar ataxia
|
ORPHAnet |
| 0‑L |
352447
|
Progressive external ophthalmoplegia-myopathy-emaciation syndrome
|
ORPHAnet |
| 0‑L |
352470
|
DNA2-related mitochondrial DNA deletion syndrome
|
ORPHAnet |
| 0‑L |
352479
|
ISPD-related limb-girdle muscular dystrophy R20
|
ORPHAnet |
| 0‑L |
352490
|
Autism spectrum disorder due to AUTS2 deficiency
|
ORPHAnet |
| 0‑L |
352530
|
Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
352540
|
Oncogenic osteomalacia
|
ORPHAnet |
| 0‑L |
352563
|
Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency
|
ORPHAnet |
| 0‑L |
352577
|
Bainbridge-Ropers syndrome
|
ORPHAnet |
| 0‑L |
352582
|
Familial infantile myoclonic epilepsy
|
ORPHAnet |
| 0‑L |
352587
|
Focal epilepsy-intellectual disability-cerebro-cerebellar malformation
|
ORPHAnet |
| 0‑L |
352596
|
Progressive myoclonic epilepsy with dystonia
|
ORPHAnet |
| 0‑L |
352629
|
16q24.1 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
352636
|
Phalangeal microgeodic syndrome
|
ORPHAnet |
| 0‑L |
352641
|
Autosomal recessive cerebellar ataxia with late-onset spasticity
|
ORPHAnet |
| 0‑L |
352649
|
Brain dopamine-serotonin vesicular transport disease
|
ORPHAnet |
| 0‑L |
352654
|
Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome
|
ORPHAnet |
| 0‑L |
352657
|
Hereditary benign intraepithelial dyskeratosis
|
ORPHAnet |
| 0‑L |
352662
|
Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis
syndrome
|
ORPHAnet |
| 0‑L |
352665
|
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies
syndrome due to 9q21.3 microdeletion
|
ORPHAnet |
| 0‑L |
352670
|
Autosomal dominant intermediate Charcot-Marie-Tooth disease type F
|
ORPHAnet |
| 0‑L |
352675
|
X-linked Charcot-Marie-Tooth disease type 6
|
ORPHAnet |
| 0‑L |
352682
|
Cobblestone lissencephaly without muscular or ocular involvement
|
ORPHAnet |
| 0‑L |
352709
|
CLN13 disease
|
ORPHAnet |
| 0‑L |
352712
|
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome
|
ORPHAnet |
| 0‑L |
352718
|
Progressive retinal dystrophy due to retinol transport defect
|
ORPHAnet |
| 0‑L |
352723
|
Attenuated Chédiak-Higashi syndrome
|
ORPHAnet |
| 0‑L |
352731
|
Oculocutaneous albinism type 1
|
ORPHAnet |
| 0‑L |
352734
|
Minimal pigment oculocutaneous albinism type 1
|
ORPHAnet |
| 0‑L |
352737
|
Temperature-sensitive oculocutaneous albinism type 1
|
ORPHAnet |
| 0‑L |
352745
|
Oculocutaneous albinism type 7
|
ORPHAnet |
| 0‑L |
352763
|
Scleredema
|
ORPHAnet |
| 0‑L |
353217
|
Epileptic encephalopathy with global cerebral demyelination
|
ORPHAnet |
| 0‑L |
353220
|
Familial primary localized cutaneous amyloidosis
|
ORPHAnet |
| 0‑L |
353253
|
Burning mouth syndrome
|
ORPHAnet |
| 0‑L |
353277
|
Rubinstein-Taybi syndrome due to CREBBP mutations
|
ORPHAnet |
| 0‑L |
353281
|
Rubinstein-Taybi syndrome due to 16p13.3 microdeletion
|
ORPHAnet |
| 0‑L |
353284
|
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
|
ORPHAnet |
| 0‑L |
353298
|
Roifman syndrome
|
ORPHAnet |
| 0‑L |
353308
|
Pyruvate carboxylase deficiency, infantile type
|
ORPHAnet |
| 0‑L |
353314
|
Pyruvate carboxylase deficiency, severe neonatal type
|
ORPHAnet |
| 0‑L |
353320
|
Pyruvate carboxylase deficiency, benign type
|
ORPHAnet |
| 0‑L |
353327
|
Congenital myasthenic syndromes with glycosylation defect
|
ORPHAnet |
| 0‑L |
353334
|
Congenital retinal arteriovenous communication
|
ORPHAnet |
| 0‑L |
353344
|
Idiopathic macular telangiectasia type 1
|
ORPHAnet |
| 0‑L |
353351
|
Idiopathic macular telangiectasia type 3
|
ORPHAnet |
| 0‑L |
353356
|
Vasoproliferative tumor of the retina
|
ORPHAnet |
| 0‑L |
356947
|
3q26q27 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
356961
|
SLC35A2-CDG
|
ORPHAnet |
| 0‑L |
356978
|
D,L-2-hydroxyglutaric aciduria
|
ORPHAnet |
| 0‑L |
356996
|
ANK3-related intellectual disability-sleep disturbance syndrome
|
ORPHAnet |
| 0‑L |
357001
|
19p13.13 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
357008
|
Hemolytic uremic syndrome with DGKE deficiency
|
ORPHAnet |
| 0‑L |
357027
|
Hereditary retinoblastoma
|
ORPHAnet |
| 0‑L |
357034
|
Non-hereditary retinoblastoma
|
ORPHAnet |
| 0‑L |
357043
|
Amyotrophic lateral sclerosis type 4
|
ORPHAnet |
| 0‑L |
357058
|
Autosomal recessive cutis laxa type 2A
|
ORPHAnet |
| 0‑L |
357064
|
Autosomal recessive cutis laxa type 2B
|
ORPHAnet |
| 0‑L |
357074
|
Autosomal recessive cutis laxa type 2, classic type
|
ORPHAnet |
| 0‑L |
357107
|
Arterial thoracic outlet syndrome
|
ORPHAnet |
| 0‑L |
357131
|
Venous thoracic outlet syndrome
|
ORPHAnet |
| 0‑L |
357154
|
Oral submucous fibrosis
|
ORPHAnet |
| 0‑L |
357158
|
Mandibulofacial dysostosis-macroblepharon-macrostomia syndrome
|
ORPHAnet |
| 0‑L |
357175
|
Short ulna-dysmorphism-hypotonia-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
357220
|
Primary essential cutis verticis gyrata
|
ORPHAnet |
| 0‑L |
357225
|
Primary non-essential cutis verticis gyrata
|
ORPHAnet |
| 0‑L |
357237
|
Severe combined immunodeficiency due to CARD11 deficiency
|
ORPHAnet |
| 0‑L |
357329
|
Combined immunodeficiency due to IL21R deficiency
|
ORPHAnet |
| 0‑L |
357332
|
Syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome
|
ORPHAnet |
| 0‑L |
363396
|
High myopia-sensorineural deafness syndrome
|
ORPHAnet |
| 0‑L |
363400
|
Severe neurodegenerative syndrome with lipodystrophy
|
ORPHAnet |
| 0‑L |
363409
|
Fetal akinesia-cerebral and retinal hemorrhage syndrome
|
ORPHAnet |
| 0‑L |
363412
|
Hypomyelination with brain stem and spinal cord involvement and leg spasticity
|
ORPHAnet |
| 0‑L |
363417
|
Temtamy preaxial brachydactyly syndrome
|
ORPHAnet |
| 0‑L |
363424
|
Multiple mitochondrial dysfunctions syndrome type 3
|
ORPHAnet |
| 0‑L |
363429
|
Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia
syndrome
|
ORPHAnet |
| 0‑L |
363432
|
Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency
|
ORPHAnet |
| 0‑L |
363444
|
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
363447
|
Autosomal dominant childhood-onset proximal spinal muscular atrophy
|
ORPHAnet |
| 0‑L |
363454
|
BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy
|
ORPHAnet |
| 0‑L |
363478
|
Paratesticular adenocarcinoma
|
ORPHAnet |
| 0‑L |
363483
|
Testicular teratoma
|
ORPHAnet |
| 0‑L |
363489
|
Sex cord-stromal tumor of testis
|
ORPHAnet |
| 0‑L |
363494
|
Non-seminomatous germ cell tumor of testis
|
ORPHAnet |
| 0‑L |
363523
|
Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
363528
|
Intellectual disability-strabismus syndrome
|
ORPHAnet |
| 0‑L |
363534
|
Mitochondrial DNA depletion syndrome, hepatocerebrorenal form
|
ORPHAnet |
| 0‑L |
363540
|
Leukoencephalopathy with mild cerebellar ataxia and white matter edema
|
ORPHAnet |
| 0‑L |
363549
|
Acute encephalopathy with biphasic seizures and late reduced diffusion
|
ORPHAnet |
| 0‑L |
363558
|
New-onset refractory status epilepticus
|
ORPHAnet |
| 0‑L |
363611
|
CTCF-related neurodevelopmental disorder
|
ORPHAnet |
| 0‑L |
363618
|
LMNA-related cardiocutaneous progeria syndrome
|
ORPHAnet |
| 0‑L |
363623
|
GMPPB-related limb-girdle muscular dystrophy R19
|
ORPHAnet |
| 0‑L |
363649
|
Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome
|
ORPHAnet |
| 0‑L |
363654
|
X-linked parkinsonism-spasticity syndrome
|
ORPHAnet |
| 0‑L |
363659
|
20q11.2 microduplication syndrome
|
ORPHAnet |
| 0‑L |
363665
|
Acroosteolysis-keloid-like lesions-premature aging syndrome
|
ORPHAnet |
| 0‑L |
363677
|
Childhood-onset autosomal recessive myopathy with external ophthalmoplegia
|
ORPHAnet |
| 0‑L |
363680
|
2p13.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
363686
|
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers
syndrome
|
ORPHAnet |
| 0‑L |
363694
|
Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome
|
ORPHAnet |
| 0‑L |
363700
|
Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion
|
ORPHAnet |
| 0‑L |
363705
|
Craniofaciofrontodigital syndrome
|
ORPHAnet |
| 0‑L |
363710
|
Spinocerebellar ataxia type 37
|
ORPHAnet |
| 0‑L |
363717
|
Alexander disease type I
|
ORPHAnet |
| 0‑L |
363722
|
Alexander disease type II
|
ORPHAnet |
| 0‑L |
363727
|
X-linked dyserythropoietic anemia with abnormal platelets and neutropenia
|
ORPHAnet |
| 0‑L |
363741
|
Colobomatous microphthalmia-obesity-hypogenitalism-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
363746
|
Balint syndrome
|
ORPHAnet |
| 0‑L |
363958
|
17q21.31 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
363965
|
Koolen-De Vries syndrome due to a point mutation
|
ORPHAnet |
| 0‑L |
363969
|
Autosomal recessive cerebral atrophy
|
ORPHAnet |
| 0‑L |
363972
|
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia
|
ORPHAnet |
| 0‑L |
363976
|
Giant cell tumor of bone
|
ORPHAnet |
| 0‑L |
363981
|
Charcot-Marie-Tooth disease type 4B3
|
ORPHAnet |
| 0‑L |
363989
|
Familial benign flecked retina
|
ORPHAnet |
| 0‑L |
363992
|
Ichthyosis-short stature-brachydactyly-microspherophakia syndrome
|
ORPHAnet |
| 0‑L |
363999
|
Non-immune hydrops fetalis
|
ORPHAnet |
| 0‑L |
364013
|
Immune hydrops fetalis
|
ORPHAnet |
| 0‑L |
364028
|
X-linked intellectual disability due to GRIA3 mutations
|
ORPHAnet |
| 0‑L |
364033
|
Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood
|
ORPHAnet |
| 0‑L |
364039
|
Hydroa vacciniforme-like lymphoma
|
ORPHAnet |
| 0‑L |
364043
|
ALK-positive large B-cell lymphoma
|
ORPHAnet |
| 0‑L |
364055
|
Severe early-childhood-onset retinal dystrophy
|
ORPHAnet |
| 0‑L |
364063
|
Infantile epileptic-dyskinetic encephalopathy
|
ORPHAnet |
| 0‑L |
364198
|
Bipartite talus
|
ORPHAnet |
| 0‑L |
364577
|
Intellectual disability-brachydactyly-Pierre Robin syndrome
|
ORPHAnet |
| 0‑L |
369837
|
Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome
|
ORPHAnet |
| 0‑L |
369840
|
TRAPPC11-related limb-girdle muscular dystrophy R18
|
ORPHAnet |
| 0‑L |
369847
|
Intellectual disability-hyperkinetic movement-truncal ataxia syndrome
|
ORPHAnet |
| 0‑L |
369852
|
Congenital neutropenia-myelofibrosis-nephromegaly syndrome
|
ORPHAnet |
| 0‑L |
369861
|
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental
delay syndrome
|
ORPHAnet |
| 0‑L |
369867
|
Autosomal recessive intermediate Charcot-Marie-Tooth disease type C
|
ORPHAnet |
| 0‑L |
369873
|
Obesity due to SIM1 deficiency
|
ORPHAnet |
| 0‑L |
369881
|
2p21 microdeletion syndrome without cystinuria
|
ORPHAnet |
| 0‑L |
369891
|
Developmental delay-facial dysmorphism syndrome due to MED13L deficiency
|
ORPHAnet |
| 0‑L |
369897
|
Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial
anomalies
|
ORPHAnet |
| 0‑L |
369913
|
Combined oxidative phosphorylation defect type 17
|
ORPHAnet |
| 0‑L |
369920
|
Pontocerebellar hypoplasia type 9
|
ORPHAnet |
| 0‑L |
369929
|
Primary hyperaldosteronism-seizures-neurological abnormalities syndrome
|
ORPHAnet |
| 0‑L |
369939
|
Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome
|
ORPHAnet |
| 0‑L |
369942
|
CADDS
|
ORPHAnet |
| 0‑L |
369950
|
Intellectual disability-seizures-macrocephaly-obesity syndrome
|
ORPHAnet |
| 0‑L |
369955
|
Methylmalonic acidemia with homocystinuria, type cblJ
|
ORPHAnet |
| 0‑L |
369962
|
Methylmalonic acidemia with homocystinuria, type cblX
|
ORPHAnet |
| 0‑L |
369970
|
Microcornea-myopic chorioretinal atrophy-telecanthus syndrome
|
ORPHAnet |
| 0‑L |
369979
|
Finger hyperphalangy-toe anomalies-severe pectus excavatum syndrome
|
ORPHAnet |
| 0‑L |
369992
|
Severe dermatitis-multiple allergies-metabolic wasting syndrome
|
ORPHAnet |
| 0‑L |
369999
|
Diffuse palmoplantar keratoderma with painful fissures
|
ORPHAnet |
| 0‑L |
370002
|
Focal palmoplantar keratoderma with joint keratoses
|
ORPHAnet |
| 0‑L |
370010
|
Intellectual disability-facial dysmorphism-hand anomalies syndrome
|
ORPHAnet |
| 0‑L |
370015
|
Spondyloepimetaphyseal dysplasia, Isidor type
|
ORPHAnet |
| 0‑L |
370019
|
Spondylometaphyseal dysplasia, Czarny-Ratajczak type
|
ORPHAnet |
| 0‑L |
370022
|
Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome
|
ORPHAnet |
| 0‑L |
370026
|
Acute myeloid leukemia with t(8;16)(p11;p13) translocation
|
ORPHAnet |
| 0‑L |
370034
|
Familial syringomyelia
|
ORPHAnet |
| 0‑L |
370039
|
Angora hair nevus
|
ORPHAnet |
| 0‑L |
370046
|
Didymosis aplasticosebacea
|
ORPHAnet |
| 0‑L |
370052
|
SCALP syndrome
|
ORPHAnet |
| 0‑L |
370059
|
NEVADA syndrome
|
ORPHAnet |
| 0‑L |
370076
|
Fetal carbamazepine syndrome
|
ORPHAnet |
| 0‑L |
370079
|
Proximal 16p11.2 microduplication syndrome
|
ORPHAnet |
| 0‑L |
370088
|
Acute infantile liver failure-multisystemic involvement syndrome
|
ORPHAnet |
| 0‑L |
370091
|
Oculocutaneous albinism type 5
|
ORPHAnet |
| 0‑L |
370097
|
Oculocutaneous albinism type 6
|
ORPHAnet |
| 0‑L |
370103
|
Primary dystonia, DYT17 type
|
ORPHAnet |
| 0‑L |
370109
|
Ataxia-telangiectasia variant
|
ORPHAnet |
| 0‑L |
370127
|
Medich giant platelet syndrome
|
ORPHAnet |
| 0‑L |
370131
|
White platelet syndrome
|
ORPHAnet |
| 0‑L |
370334
|
Extraskeletal Ewing sarcoma
|
ORPHAnet |
| 0‑L |
370348
|
Peripheral primitive neuroectodermal tumor
|
ORPHAnet |
| 0‑L |
370396
|
Small cell carcinoma of the ovary
|
ORPHAnet |
| 0‑L |
370921
|
STT3A-CDG
|
ORPHAnet |
| 0‑L |
370924
|
STT3B-CDG
|
ORPHAnet |
| 0‑L |
370927
|
SSR4-CDG
|
ORPHAnet |
| 0‑L |
370930
|
XYLT1-CDG
|
ORPHAnet |
| 0‑L |
370933
|
GM3 synthase deficiency
|
ORPHAnet |
| 0‑L |
370943
|
Autism spectrum disorder-epilepsy-arthrogryposis syndrome
|
ORPHAnet |
| 0‑L |
370959
|
Congenital muscular dystrophy with cerebellar involvement
|
ORPHAnet |
| 0‑L |
370968
|
Congenital muscular dystrophy with intellectual disability
|
ORPHAnet |
| 0‑L |
370980
|
Congenital muscular dystrophy without intellectual disability
|
ORPHAnet |
| 0‑L |
370997
|
Muscle-eye-brain disease with bilateral multicystic leucodystrophy
|
ORPHAnet |
| 0‑L |
371007
|
Congenital muscular dystrophy with hyperlaxity
|
ORPHAnet |
| 0‑L |
371364
|
Hypotonia-speech impairment-severe cognitive delay syndrome
|
ORPHAnet |
| 0‑L |
371428
|
Multicentric osteolysis-nodulosis-arthropathy spectrum
|
ORPHAnet |
| 0‑L |
391307
|
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism
syndrome
|
ORPHAnet |
| 0‑L |
391311
|
Susceptibility to viral and mycobacterial infections due to STAT1 deficiency
|
ORPHAnet |
| 0‑L |
391316
|
Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression
|
ORPHAnet |
| 0‑L |
391320
|
East Texas bleeding disorder
|
ORPHAnet |
| 0‑L |
391327
|
X-linked calvarial hyperostosis
|
ORPHAnet |
| 0‑L |
391330
|
X-linked osteoporosis with fractures
|
ORPHAnet |
| 0‑L |
391343
|
Fatal post-viral neurodegenerative disorder
|
ORPHAnet |
| 0‑L |
391348
|
Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome
|
ORPHAnet |
| 0‑L |
391351
|
SURF1-related Charcot-Marie-Tooth disease type 4
|
ORPHAnet |
| 0‑L |
391366
|
Growth retardation-mild developmental delay-chronic hepatitis syndrome
|
ORPHAnet |
| 0‑L |
391372
|
Intellectual disability-severe speech delay-mild dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
391376
|
Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome
|
ORPHAnet |
| 0‑L |
391384
|
Familial episodic pain syndrome
|
ORPHAnet |
| 0‑L |
391389
|
Familial episodic pain syndrome with predominantly upper body involvement
|
ORPHAnet |
| 0‑L |
391392
|
Familial episodic pain syndrome with predominantly lower limb involvement
|
ORPHAnet |
| 0‑L |
391397
|
Hereditary sensory and autonomic neuropathy type 7
|
ORPHAnet |
| 0‑L |
391408
|
Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome
|
ORPHAnet |
| 0‑L |
391411
|
Atypical juvenile parkinsonism
|
ORPHAnet |
| 0‑L |
391417
|
HSD10 disease
|
ORPHAnet |
| 0‑L |
391428
|
HSD10 disease, infantile type
|
ORPHAnet |
| 0‑L |
391457
|
HSD10 disease, neonatal type
|
ORPHAnet |
| 0‑L |
391474
|
Frontorhiny
|
ORPHAnet |
| 0‑L |
391487
|
Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome
|
ORPHAnet |
| 0‑L |
391490
|
Adult-onset myasthenia gravis
|
ORPHAnet |
| 0‑L |
391497
|
Juvenile myasthenia gravis
|
ORPHAnet |
| 0‑L |
391504
|
Transient neonatal myasthenia gravis
|
ORPHAnet |
| 0‑L |
391641
|
Feingold syndrome type 1
|
ORPHAnet |
| 0‑L |
391646
|
Feingold syndrome type 2
|
ORPHAnet |
| 0‑L |
391651
|
Glomus tumor
|
ORPHAnet |
| 0‑L |
391655
|
Off-periods in Parkinson disease not responding to oral treatment
|
ORPHAnet |
| 0‑L |
391665
|
Homozygous familial hypercholesterolemia
|
ORPHAnet |
| 0‑L |
391673
|
Necrotizing enterocolitis
|
ORPHAnet |
| 0‑L |
391677
|
Short stature-optic atrophy-Pelger-Huët anomaly syndrome
|
ORPHAnet |
| 0‑L |
391723
|
Mucinous adenocarcinoma of the appendix
|
ORPHAnet |
| 0‑L |
394529
|
Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type
|
ORPHAnet |
| 0‑L |
394532
|
Multiple acyl-CoA dehydrogenase deficiency, mild type
|
ORPHAnet |
| 0‑L |
397587
|
Deep dermatophytosis
|
ORPHAnet |
| 0‑L |
397590
|
Silver-Russell syndrome due to a point mutation
|
ORPHAnet |
| 0‑L |
397593
|
Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency
|
ORPHAnet |
| 0‑L |
397596
|
Activated PI3K-delta syndrome
|
ORPHAnet |
| 0‑L |
397606
|
PrP systemic amyloidosis
|
ORPHAnet |
| 0‑L |
397612
|
Macrocephaly-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
397615
|
Obesity due to CEP19 deficiency
|
ORPHAnet |
| 0‑L |
397618
|
Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome
|
ORPHAnet |
| 0‑L |
397623
|
Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome
|
ORPHAnet |
| 0‑L |
397685
|
Familial hyperprolactinemia
|
ORPHAnet |
| 0‑L |
397692
|
Hereditary isolated aplastic anemia
|
ORPHAnet |
| 0‑L |
397695
|
3q27.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
397709
|
Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome
|
ORPHAnet |
| 0‑L |
397715
|
Joubert syndrome with Jeune asphyxiating thoracic dystrophy
|
ORPHAnet |
| 0‑L |
397725
|
COASY protein-associated neurodegeneration
|
ORPHAnet |
| 0‑L |
397735
|
Autosomal dominant Charcot-Marie-Tooth disease type 2U
|
ORPHAnet |
| 0‑L |
397744
|
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
|
ORPHAnet |
| 0‑L |
397750
|
Periodic paralysis with later-onset distal motor neuropathy
|
ORPHAnet |
| 0‑L |
397755
|
Periodic paralysis with transient compartment-like syndrome
|
ORPHAnet |
| 0‑L |
397758
|
Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
|
ORPHAnet |
| 0‑L |
397787
|
Severe combined immunodeficiency due to IKK2 deficiency
|
ORPHAnet |
| 0‑L |
397922
|
Ferro-cerebro-cutaneous syndrome
|
ORPHAnet |
| 0‑L |
397927
|
Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal
canal syndrome
|
ORPHAnet |
| 0‑L |
397933
|
Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic
hand movements syndrome
|
ORPHAnet |
| 0‑L |
397937
|
Polyglucosan body myopathy type 1
|
ORPHAnet |
| 0‑L |
397941
|
MAN1B1-CDG
|
ORPHAnet |
| 0‑L |
397946
|
Autosomal spastic paraplegia type 58
|
ORPHAnet |
| 0‑L |
397951
|
Microcephaly-thin corpus callosum-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
397959
|
TCR-alpha-beta-positive T-cell deficiency
|
ORPHAnet |
| 0‑L |
397964
|
Combined immunodeficiency due to MALT1 deficiency
|
ORPHAnet |
| 0‑L |
397968
|
Charcot-Marie-Tooth disease type 2R
|
ORPHAnet |
| 0‑L |
397973
|
Intellectual disability-obesity-prognathism-eye and skin anomalies syndrome
|
ORPHAnet |
| 0‑L |
398053
|
Adenocarcinoma of the penis
|
ORPHAnet |
| 0‑L |
398058
|
Squamous cell carcinoma of the penis
|
ORPHAnet |
| 0‑L |
398063
|
Refractory celiac disease
|
ORPHAnet |
| 0‑L |
398069
|
MAGEL2-related Prader-Willi-like syndrome
|
ORPHAnet |
| 0‑L |
398079
|
SIM1-related Prader-Willi-like syndrome
|
ORPHAnet |
| 0‑L |
398088
|
Hereditary cryohydrocytosis with normal stomatin
|
ORPHAnet |
| 0‑L |
398097
|
Neonatal antiphospholipid syndrome
|
ORPHAnet |
| 0‑L |
398109
|
Neonatal autoimmune hemolytic anemia
|
ORPHAnet |
| 0‑L |
398117
|
Neonatal dermatomyositis
|
ORPHAnet |
| 0‑L |
398124
|
Neonatal lupus erythematosus
|
ORPHAnet |
| 0‑L |
398127
|
Neonatal scleroderma
|
ORPHAnet |
| 0‑L |
398147
|
Persistent idiopathic facial pain
|
ORPHAnet |
| 0‑L |
398156
|
Oculoauriculofrontonasal syndrome
|
ORPHAnet |
| 0‑L |
398166
|
Focal facial dermal dysplasia
|
ORPHAnet |
| 0‑L |
398173
|
Focal facial dermal dysplasia type II
|
ORPHAnet |
| 0‑L |
398189
|
Focal facial dermal dysplasia type IV
|
ORPHAnet |
| 0‑L |
398961
|
Mucinous adenocarcinoma of ovary
|
ORPHAnet |
| 0‑L |
398971
|
Clear cell adenocarcinoma of the ovary
|
ORPHAnet |
| 0‑L |
398980
|
Primary peritoneal serous/papillary carcinoma
|
ORPHAnet |
| 0‑L |
398987
|
Malignant teratoma of ovary
|
ORPHAnet |
| 0‑L |
399058
|
Alpha-B crystallin-related late-onset myopathy
|
ORPHAnet |
| 0‑L |
399081
|
KLHL9-related early-onset distal myopathy
|
ORPHAnet |
| 0‑L |
399086
|
Finnish upper limb-onset distal myopathy
|
ORPHAnet |
| 0‑L |
399096
|
Distal anoctaminopathy
|
ORPHAnet |
| 0‑L |
399103
|
Distal nebulin myopathy
|
ORPHAnet |
| 0‑L |
399175
|
Traumatic avascular necrosis
|
ORPHAnet |
| 0‑L |
399180
|
Secondary non-traumatic avascular necrosis
|
ORPHAnet |
| 0‑L |
399293
|
Osteonecrosis of the jaw
|
ORPHAnet |
| 0‑L |
399307
|
Idiopathic avascular necrosis
|
ORPHAnet |
| 0‑L |
399329
|
Epiphysiolysis of the hip
|
ORPHAnet |
| 0‑L |
399805
|
Male infertility with azoospermia or oligozoospermia due to single gene mutation
|
ORPHAnet |
| 0‑L |
399808
|
Male infertility with teratozoospermia due to single gene mutation
|
ORPHAnet |
| 0‑L |
401764
|
Pancytopenia-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
401768
|
Proximal myopathy with extrapyramidal signs
|
ORPHAnet |
| 0‑L |
401777
|
Optic atrophy-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
401780
|
Autosomal recessive spastic paraplegia type 61
|
ORPHAnet |
| 0‑L |
401785
|
Autosomal recessive spastic paraplegia type 62
|
ORPHAnet |
| 0‑L |
401795
|
Autosomal recessive spastic paraplegia type 59
|
ORPHAnet |
| 0‑L |
401800
|
Autosomal recessive spastic paraplegia type 60
|
ORPHAnet |
| 0‑L |
401805
|
Autosomal recessive spastic paraplegia type 63
|
ORPHAnet |
| 0‑L |
401810
|
Autosomal recessive spastic paraplegia type 64
|
ORPHAnet |
| 0‑L |
401815
|
Autosomal recessive spastic paraplegia type 66
|
ORPHAnet |
| 0‑L |
401820
|
Autosomal recessive spastic paraplegia type 67
|
ORPHAnet |
| 0‑L |
401830
|
Autosomal recessive spastic paraplegia type 69
|
ORPHAnet |
| 0‑L |
401835
|
Autosomal recessive spastic paraplegia type 70
|
ORPHAnet |
| 0‑L |
401840
|
Autosomal recessive spastic paraplegia type 71
|
ORPHAnet |
| 0‑L |
401849
|
Autosomal spastic paraplegia type 72
|
ORPHAnet |
| 0‑L |
401859
|
Lipoic acid synthetase deficiency
|
ORPHAnet |
| 0‑L |
401862
|
Lipoyl transferase 1 deficiency
|
ORPHAnet |
| 0‑L |
401866
|
Childhood-onset spasticity with hyperglycinemia
|
ORPHAnet |
| 0‑L |
401869
|
Multiple mitochondrial dysfunctions syndrome type 1
|
ORPHAnet |
| 0‑L |
401874
|
Multiple mitochondrial dysfunctions syndrome type 2
|
ORPHAnet |
| 0‑L |
401901
|
Huntington disease-like syndrome due to C9ORF72 expansions
|
ORPHAnet |
| 0‑L |
401911
|
AXIN2-related attenuated familial adenomatous polyposis
|
ORPHAnet |
| 0‑L |
401920
|
Fibrolamellar hepatocellular carcinoma
|
ORPHAnet |
| 0‑L |
401923
|
9q31.1q31.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
401935
|
14q24.1q24.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
401942
|
Familial median cleft of the upper and lower lips
|
ORPHAnet |
| 0‑L |
401945
|
Moyamoya disease with early-onset achalasia
|
ORPHAnet |
| 0‑L |
401948
|
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency
|
ORPHAnet |
| 0‑L |
401953
|
Episodic ataxia with slurred speech
|
ORPHAnet |
| 0‑L |
401959
|
Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa
cysts syndrome
|
ORPHAnet |
| 0‑L |
401964
|
Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons
|
ORPHAnet |
| 0‑L |
401973
|
MEND syndrome
|
ORPHAnet |
| 0‑L |
401979
|
Autosomal recessive spondylometaphyseal dysplasia, Mégarbané type
|
ORPHAnet |
| 0‑L |
401986
|
1p31p32 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
401996
|
Karyomegalic interstitial nephritis
|
ORPHAnet |
| 0‑L |
402003
|
Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering
|
ORPHAnet |
| 0‑L |
402014
|
Acute myeloid leukemia with t(6;9)(p23;q34)
|
ORPHAnet |
| 0‑L |
402017
|
Acute myeloid leukemia with t(9;11)(p22;q23)
|
ORPHAnet |
| 0‑L |
402020
|
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
|
ORPHAnet |
| 0‑L |
402023
|
Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
|
ORPHAnet |
| 0‑L |
402026
|
Acute myeloid leukemia with NPM1 somatic mutations
|
ORPHAnet |
| 0‑L |
402035
|
Eosinophilic colitis
|
ORPHAnet |
| 0‑L |
402041
|
Autosomal recessive distal renal tubular acidosis
|
ORPHAnet |
| 0‑L |
402075
|
Familial bicuspid aortic valve
|
ORPHAnet |
| 0‑L |
402082
|
Progressive myoclonic epilepsy type 5
|
ORPHAnet |
| 0‑L |
402364
|
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly
|
ORPHAnet |
| 0‑L |
402823
|
Hepatitis delta
|
ORPHAnet |
| 0‑L |
404437
|
Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly
syndrome
|
ORPHAnet |
| 0‑L |
404440
|
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency
|
ORPHAnet |
| 0‑L |
404443
|
Tatton-Brown-Rahman syndrome
|
ORPHAnet |
| 0‑L |
404448
|
ADNP syndrome
|
ORPHAnet |
| 0‑L |
404451
|
FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome
|
ORPHAnet |
| 0‑L |
404454
|
Alacrimia-choreoathetosis-liver dysfunction syndrome
|
ORPHAnet |
| 0‑L |
404463
|
Multisystemic smooth muscle dysfunction syndrome
|
ORPHAnet |
| 0‑L |
404466
|
Female infertility due to zona pellucida defect
|
ORPHAnet |
| 0‑L |
404473
|
Severe intellectual disability-progressive spastic diplegia syndrome
|
ORPHAnet |
| 0‑L |
404476
|
Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome
|
ORPHAnet |
| 0‑L |
404493
|
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due
to TUD deficiency
|
ORPHAnet |
| 0‑L |
404499
|
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due
to RUBCN deficiency
|
ORPHAnet |
| 0‑L |
404507
|
Chondromyxoid fibroma
|
ORPHAnet |
| 0‑L |
404511
|
Clear cell papillary renal cell carcinoma
|
ORPHAnet |
| 0‑L |
404514
|
Acquired cystic disease-associated renal cell carcinoma
|
ORPHAnet |
| 0‑L |
404521
|
Spinal muscular atrophy with respiratory distress type 2
|
ORPHAnet |
| 0‑L |
404546
|
DITRA
|
ORPHAnet |
| 0‑L |
404553
|
Vasculitis due to ADA2 deficiency
|
ORPHAnet |
| 0‑L |
404560
|
Familial atypical multiple mole melanoma syndrome
|
ORPHAnet |
| 0‑L |
411493
|
Pontocerebellar hypoplasia type 10
|
ORPHAnet |
| 0‑L |
411501
|
Williams-Campbell syndrome
|
ORPHAnet |
| 0‑L |
411511
|
Angelman syndrome due to a point mutation
|
ORPHAnet |
| 0‑L |
411515
|
Angelman syndrome due to imprinting defect in 15q11-q13
|
ORPHAnet |
| 0‑L |
411527
|
Central retinal vein occlusion
|
ORPHAnet |
| 0‑L |
411536
|
Mild phosphoribosylpyrophosphate synthetase superactivity
|
ORPHAnet |
| 0‑L |
411543
|
Severe phosphoribosylpyrophosphate synthetase superactivity
|
ORPHAnet |
| 0‑L |
411590
|
Wolfram-like syndrome
|
ORPHAnet |
| 0‑L |
411593
|
Insulin autoimmune syndrome
|
ORPHAnet |
| 0‑L |
411602
|
Hereditary late-onset Parkinson disease
|
ORPHAnet |
| 0‑L |
411629
|
Infantile nephropathic cystinosis
|
ORPHAnet |
| 0‑L |
411634
|
Juvenile nephropathic cystinosis
|
ORPHAnet |
| 0‑L |
411641
|
Ocular cystinosis
|
ORPHAnet |
| 0‑L |
411696
|
Proton-pump inhibitor-responsive esophageal eosinophilia
|
ORPHAnet |
| 0‑L |
411703
|
Pulmonary non-tuberculous mycobacterial infection
|
ORPHAnet |
| 0‑L |
411709
|
Renal agenesis
|
ORPHAnet |
| 0‑L |
411712
|
Maternal riboflavin deficiency
|
ORPHAnet |
| 0‑L |
411777
|
Generalized eruptive keratoacanthoma
|
ORPHAnet |
| 0‑L |
411788
|
Familial isolated trichomegaly
|
ORPHAnet |
| 0‑L |
411986
|
Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial
dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
412022
|
Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering
blebs syndrome
|
ORPHAnet |
| 0‑L |
412035
|
13q12.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
412057
|
Autosomal recessive cerebellar ataxia due to STUB1 deficiency
|
ORPHAnet |
| 0‑L |
412066
|
PRKAR1B-related neurodegenerative dementia with intermediate filaments
|
ORPHAnet |
| 0‑L |
412069
|
AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
412181
|
Epidermolysis bullosa simplex due to BP230 deficiency
|
ORPHAnet |
| 0‑L |
412189
|
Epidermolysis bullosa simplex due to exophilin 5 deficiency
|
ORPHAnet |
| 0‑L |
412206
|
Primary failure of tooth eruption
|
ORPHAnet |
| 0‑L |
412217
|
Dystonia-aphonia syndrome
|
ORPHAnet |
| 0‑L |
418945
|
Carcinoma of esophagus, salivary gland type
|
ORPHAnet |
| 0‑L |
418951
|
Undifferentiated carcinoma of esophagus
|
ORPHAnet |
| 0‑L |
418959
|
Squamous cell carcinoma of the stomach
|
ORPHAnet |
| 0‑L |
420179
|
Malan overgrowth syndrome
|
ORPHAnet |
| 0‑L |
420259
|
Secondary pulmonary alveolar proteinosis
|
ORPHAnet |
| 0‑L |
420402
|
Semicircular canal dehiscence syndrome
|
ORPHAnet |
| 0‑L |
420429
|
Glycogen storage disease due to acid maltase deficiency, late-onset
|
ORPHAnet |
| 0‑L |
420485
|
Cranio-cervical dystonia with laryngeal and upper-limb involvement
|
ORPHAnet |
| 0‑L |
420492
|
Adult-onset cervical dystonia, DYT23 type
|
ORPHAnet |
| 0‑L |
420556
|
Visual snow syndrome
|
ORPHAnet |
| 0‑L |
420561
|
Temple-Baraitser syndrome
|
ORPHAnet |
| 0‑L |
420566
|
Bleeding disorder due to CalDAG-GEFI deficiency
|
ORPHAnet |
| 0‑L |
420573
|
Severe combined immunodeficiency due to CTPS1 deficiency
|
ORPHAnet |
| 0‑L |
420584
|
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
420611
|
Transient myeloproliferative syndrome
|
ORPHAnet |
| 0‑L |
420686
|
Woolly hair-palmoplantar keratoderma syndrome
|
ORPHAnet |
| 0‑L |
420699
|
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency
|
ORPHAnet |
| 0‑L |
420702
|
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency
|
ORPHAnet |
| 0‑L |
420728
|
Combined oxidative phosphorylation defect type 20
|
ORPHAnet |
| 0‑L |
420733
|
Combined oxidative phosphorylation defect type 21
|
ORPHAnet |
| 0‑L |
420741
|
RIDDLE syndrome
|
ORPHAnet |
| 0‑L |
420789
|
Autoimmune encephalopathy with parasomnia and obstructive sleep apnea
|
ORPHAnet |
| 0‑L |
420794
|
Cono-spondylar dysplasia
|
ORPHAnet |
| 0‑L |
422526
|
Hereditary clear cell renal cell carcinoma
|
ORPHAnet |
| 0‑L |
423275
|
Spinocerebellar ataxia type 40
|
ORPHAnet |
| 0‑L |
423296
|
Spinocerebellar ataxia type 38
|
ORPHAnet |
| 0‑L |
423306
|
Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
423384
|
Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency
|
ORPHAnet |
| 0‑L |
423454
|
Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation
syndrome
|
ORPHAnet |
| 0‑L |
423461
|
Mucolipidosis type III alpha/beta
|
ORPHAnet |
| 0‑L |
423470
|
Mucolipidosis type III gamma
|
ORPHAnet |
| 0‑L |
423479
|
X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus
syndrome
|
ORPHAnet |
| 0‑L |
423693
|
Double outlet right ventricle with subaortic or doubly committed ventricular septal
defect
|
ORPHAnet |
| 0‑L |
423712
|
Double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis,
heterotaxy
|
ORPHAnet |
| 0‑L |
423717
|
Cutaneous larva migrans
|
ORPHAnet |
| 0‑L |
423786
|
Undifferentiated carcinoma of stomach
|
ORPHAnet |
| 0‑L |
423894
|
Microcephaly-complex motor and sensory axonal neuropathy syndrome
|
ORPHAnet |
| 0‑L |
423968
|
Squamous cell carcinoma of the small intestine
|
ORPHAnet |
| 0‑L |
423994
|
Squamous cell carcinoma of the colon
|
ORPHAnet |
| 0‑L |
424002
|
Squamous cell carcinoma of the rectum
|
ORPHAnet |
| 0‑L |
424016
|
Adenocarcinoma of the anal canal
|
ORPHAnet |
| 0‑L |
424019
|
Squamous cell carcinoma of the anal canal
|
ORPHAnet |
| 0‑L |
424027
|
Progressive myoclonic epilepsy type 8
|
ORPHAnet |
| 0‑L |
424039
|
Squamous cell carcinoma of pancreas
|
ORPHAnet |
| 0‑L |
424046
|
Acinar cell carcinoma of pancreas
|
ORPHAnet |
| 0‑L |
424053
|
Mucinous cystadenocarcinoma of the pancreas
|
ORPHAnet |
| 0‑L |
424058
|
Intraductal papillary mucinous carcinoma of pancreas
|
ORPHAnet |
| 0‑L |
424065
|
Solid pseudopapillary carcinoma of pancreas
|
ORPHAnet |
| 0‑L |
424073
|
Serous cystadenocarcinoma of pancreas
|
ORPHAnet |
| 0‑L |
424080
|
Osteoclastic giant cell tumor of pancreas
|
ORPHAnet |
| 0‑L |
424099
|
Colobomatous microphthalmia-rhizomelic dysplasia syndrome
|
ORPHAnet |
| 0‑L |
424107
|
Congenital myopathy with myasthenic-like onset
|
ORPHAnet |
| 0‑L |
424261
|
TOR1AIP1-related limb-girdle muscular dystrophy
|
ORPHAnet |
| 0‑L |
424943
|
Adenocarcinoma of the liver and intrahepatic biliary tract
|
ORPHAnet |
| 0‑L |
424970
|
Undifferentiated carcinoma of liver and intrahepatic biliary tract
|
ORPHAnet |
| 0‑L |
424975
|
Squamous cell carcinoma of liver and intrahepatic biliary tract
|
ORPHAnet |
| 0‑L |
424982
|
Biliary cystadenocarcinoma
|
ORPHAnet |
| 0‑L |
424991
|
Adenocarcinoma of the gallbladder and extrahepatic biliary tract
|
ORPHAnet |
| 0‑L |
424996
|
Squamous cell carcinoma of gallbladder and extrahepatic biliary tract
|
ORPHAnet |
| 0‑L |
425120
|
STING-associated vasculopathy with onset in infancy
|
ORPHAnet |
| 0‑L |
431140
|
X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature
syndrome
|
ORPHAnet |
| 0‑L |
431149
|
Combined immunodeficiency due to OX40 deficiency
|
ORPHAnet |
| 0‑L |
431166
|
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection
|
ORPHAnet |
| 0‑L |
431255
|
Scapuloperoneal spinal muscular atrophy
|
ORPHAnet |
| 0‑L |
431272
|
X-linked scapuloperoneal muscular dystrophy
|
ORPHAnet |
| 0‑L |
431329
|
Autosomal recessive spastic paraplegia type 57
|
ORPHAnet |
| 0‑L |
431341
|
Patent urachus
|
ORPHAnet |
| 0‑L |
431344
|
Urachal sinus
|
ORPHAnet |
| 0‑L |
431347
|
Urachal diverticulum
|
ORPHAnet |
| 0‑L |
431361
|
Progressive encephalopathy with leukodystrophy due to DECR deficiency
|
ORPHAnet |
| 0‑L |
434179
|
Orofaciodigital syndrome type 14
|
ORPHAnet |
| 0‑L |
435329
|
Familial ossifying fibroma
|
ORPHAnet |
| 0‑L |
435372
|
Anterior urethral valve
|
ORPHAnet |
| 0‑L |
435387
|
Autosomal dominant Charcot-Marie-Tooth disease type 2Y
|
ORPHAnet |
| 0‑L |
435438
|
Progressive myoclonic epilepsy type 7
|
ORPHAnet |
| 0‑L |
435628
|
Keppen-Lubinsky syndrome
|
ORPHAnet |
| 0‑L |
435638
|
3p25.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
435651
|
CIDEC-related familial partial lipodystrophy
|
ORPHAnet |
| 0‑L |
435660
|
LIPE-related familial partial lipodystrophy
|
ORPHAnet |
| 0‑L |
435804
|
Short stature-advanced bone age-early-onset osteoarthritis syndrome
|
ORPHAnet |
| 0‑L |
435819
|
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation
|
ORPHAnet |
| 0‑L |
435845
|
Lethal neonatal spasticity-epileptic encephalopathy syndrome
|
ORPHAnet |
| 0‑L |
435930
|
Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome
|
ORPHAnet |
| 0‑L |
435934
|
COG2-CDG
|
ORPHAnet |
| 0‑L |
435938
|
X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome
|
ORPHAnet |
| 0‑L |
435953
|
Progeroid features-hepatocellular carcinoma predisposition syndrome
|
ORPHAnet |
| 0‑L |
435988
|
Chronic atrial and intestinal dysrhythmia syndrome
|
ORPHAnet |
| 0‑L |
435998
|
Autosomal recessive intermediate Charcot-Marie-Tooth disease type D
|
ORPHAnet |
| 0‑L |
436003
|
Contractures-developmental delay-Pierre Robin syndrome
|
ORPHAnet |
| 0‑L |
436141
|
Severe intellectual disability-hypotonia-strabismus-coarse face-planovalgus syndrome
|
ORPHAnet |
| 0‑L |
436144
|
Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome
|
ORPHAnet |
| 0‑L |
436151
|
Intellectual disability-expressive aphasia-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
436159
|
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency
|
ORPHAnet |
| 0‑L |
436166
|
Periodic fever-infantile enterocolitis-autoinflammatory syndrome
|
ORPHAnet |
| 0‑L |
436169
|
Thrombomodulin-related bleeding disorder
|
ORPHAnet |
| 0‑L |
436174
|
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal
dysplasia syndrome
|
ORPHAnet |
| 0‑L |
436182
|
Microcephalic primordial dwarfism-insulin resistance syndrome
|
ORPHAnet |
| 0‑L |
436242
|
Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease
|
ORPHAnet |
| 0‑L |
436245
|
Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
436252
|
Combined immunodeficiency-enteropathy spectrum
|
ORPHAnet |
| 0‑L |
436271
|
Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral
neuropathy
|
ORPHAnet |
| 0‑L |
436274
|
Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa
|
ORPHAnet |
| 0‑L |
437552
|
Autosomal recessive primary immunodeficiency with defective spontaneous natural killer
cell cytotoxicity
|
ORPHAnet |
| 0‑L |
437572
|
MYH7-related late-onset scapuloperoneal muscular dystrophy
|
ORPHAnet |
| 0‑L |
438075
|
Ketoacidosis due to monocarboxylate transporter-1 deficiency
|
ORPHAnet |
| 0‑L |
438114
|
RARS-related autosomal recessive hypomyelinating leukodystrophy
|
ORPHAnet |
| 0‑L |
438117
|
Steel syndrome
|
ORPHAnet |
| 0‑L |
438134
|
PCNA-related progressive neurodegenerative photosensitivity syndrome
|
ORPHAnet |
| 0‑L |
438159
|
STAT3-related early-onset multisystem autoimmune disease
|
ORPHAnet |
| 0‑L |
438178
|
Fatty acyl-CoA reductase 1 deficiency
|
ORPHAnet |
| 0‑L |
438207
|
Severe autosomal recessive macrothrombocytopenia
|
ORPHAnet |
| 0‑L |
438213
|
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome
|
ORPHAnet |
| 0‑L |
438216
|
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point
mutation
|
ORPHAnet |
| 0‑L |
438266
|
Progressive encephalomyelitis with rigidity and myoclonus
|
ORPHAnet |
| 0‑L |
438274
|
GCGR-related hyperglucagonemia
|
ORPHAnet |
| 0‑L |
438279
|
Human infection by orthopoxvirus
|
ORPHAnet |
| 0‑L |
439167
|
Placental insufficiency
|
ORPHAnet |
| 0‑L |
439175
|
Pediatric arterial ischemic stroke
|
ORPHAnet |
| 0‑L |
439196
|
Zinc-responsive necrolytic acral erythema
|
ORPHAnet |
| 0‑L |
439202
|
Non-recovering obstetric brachial plexus lesion
|
ORPHAnet |
| 0‑L |
439212
|
Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome
|
ORPHAnet |
| 0‑L |
439218
|
KCNQ2-related epileptic encephalopathy
|
ORPHAnet |
| 0‑L |
439224
|
ALECT2 amyloidosis
|
ORPHAnet |
| 0‑L |
439232
|
AApoAIV amyloidosis
|
ORPHAnet |
| 0‑L |
439254
|
ITM2B amyloidosis
|
ORPHAnet |
| 0‑L |
439729
|
Cutaneous polyarteritis nodosa
|
ORPHAnet |
| 0‑L |
439737
|
Primary polyarteritis nodosa
|
ORPHAnet |
| 0‑L |
439746
|
Secondary polyarteritis nodosa
|
ORPHAnet |
| 0‑L |
439755
|
Single-organ polyarteritis nodosa
|
ORPHAnet |
| 0‑L |
439762
|
Systemic polyarteritis nodosa
|
ORPHAnet |
| 0‑L |
439822
|
PDE4D haploinsufficiency syndrome
|
ORPHAnet |
| 0‑L |
439854
|
Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease
|
ORPHAnet |
| 0‑L |
439881
|
Plastic bronchitis
|
ORPHAnet |
| 0‑L |
439897
|
Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome
|
ORPHAnet |
| 0‑L |
440221
|
Congenital oculomotor nerve palsy
|
ORPHAnet |
| 0‑L |
440233
|
Congenital abducens nerve palsy
|
ORPHAnet |
| 0‑L |
440354
|
Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic
dysplasia syndrome
|
ORPHAnet |
| 0‑L |
440368
|
Necrotizing soft tissue infection
|
ORPHAnet |
| 0‑L |
440392
|
Interstitial lung disease due to SP-C deficiency
|
ORPHAnet |
| 0‑L |
440402
|
Interstitial lung disease due to ABCA3 deficiency
|
ORPHAnet |
| 0‑L |
440427
|
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency
|
ORPHAnet |
| 0‑L |
440437
|
Familial colorectal cancer Type X
|
ORPHAnet |
| 0‑L |
440706
|
Ribose-5-P isomerase deficiency
|
ORPHAnet |
| 0‑L |
440713
|
Isolated sedoheptulokinase deficiency
|
ORPHAnet |
| 0‑L |
440724
|
Extensive peripapillary myelinated nerve fibers
|
ORPHAnet |
| 0‑L |
440727
|
Combined hamartoma of the retina and retinal pigment epithelium
|
ORPHAnet |
| 0‑L |
440731
|
L-ferritin deficiency
|
ORPHAnet |
| 0‑L |
440987
|
Isolated agenesis of gallbladder
|
ORPHAnet |
| 0‑L |
441447
|
Early-onset posterior subcapsular cataract
|
ORPHAnet |
| 0‑L |
441452
|
Early-onset lamellar cataract
|
ORPHAnet |
| 0‑L |
442582
|
AH amyloidosis
|
ORPHAnet |
| 0‑L |
442835
|
Non-specific early-onset epileptic encephalopathy
|
ORPHAnet |
| 0‑L |
443057
|
Sporadic porphyria cutanea tarda
|
ORPHAnet |
| 0‑L |
443062
|
Familial porphyria cutanea tarda
|
ORPHAnet |
| 0‑L |
443070
|
Hemicrania continua
|
ORPHAnet |
| 0‑L |
443073
|
Charcot-Marie-Tooth disease type 2S
|
ORPHAnet |
| 0‑L |
443079
|
Central serous chorioretinopathy
|
ORPHAnet |
| 0‑L |
443084
|
Baroreflex failure
|
ORPHAnet |
| 0‑L |
443087
|
46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
|
ORPHAnet |
| 0‑L |
443098
|
Hyperostosis cranialis interna
|
ORPHAnet |
| 0‑L |
443101
|
Hypothalamic adipsic hypernatraemia syndrome
|
ORPHAnet |
| 0‑L |
443159
|
Lymphoplasmacytic lymphoma without IgM production
|
ORPHAnet |
| 0‑L |
443162
|
NDE1-related microhydranencephaly
|
ORPHAnet |
| 0‑L |
443167
|
NUT midline carcinoma
|
ORPHAnet |
| 0‑L |
443173
|
Postpartum psychosis
|
ORPHAnet |
| 0‑L |
443180
|
Spontaneous intracranial hypotension
|
ORPHAnet |
| 0‑L |
443192
|
Classic stiff person syndrome
|
ORPHAnet |
| 0‑L |
443197
|
X-linked erythropoietic protoporphyria
|
ORPHAnet |
| 0‑L |
443227
|
Paratyphoid fever
|
ORPHAnet |
| 0‑L |
443236
|
Postural orthostatic tachycardia syndrome due to NET deficiency
|
ORPHAnet |
| 0‑L |
443291
|
HIV-associated cancer
|
ORPHAnet |
| 0‑L |
443804
|
Focal stiff limb syndrome
|
ORPHAnet |
| 0‑L |
443811
|
PGM3-CDG
|
ORPHAnet |
| 0‑L |
443950
|
DNAJB2-related Charcot-Marie-Tooth disease type 2
|
ORPHAnet |
| 0‑L |
443988
|
Ventriculomegaly-cystic kidney disease
|
ORPHAnet |
| 0‑L |
443995
|
Mandibulofacial dysostosis with alopecia
|
ORPHAnet |
| 0‑L |
444002
|
11q22.2q22.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
444013
|
Combined oxidative phosphorylation defect type 23
|
ORPHAnet |
| 0‑L |
444048
|
46,XX ovarian dysgenesis-short stature syndrome
|
ORPHAnet |
| 0‑L |
444051
|
20q11.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
444069
|
Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome
|
ORPHAnet |
| 0‑L |
444072
|
Cerebellar-facial-dental syndrome
|
ORPHAnet |
| 0‑L |
444077
|
Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short
stature-skeletal dysplasia syndrome
|
ORPHAnet |
| 0‑L |
444092
|
Autoimmune interstitial lung disease-arthritis syndrome
|
ORPHAnet |
| 0‑L |
444099
|
Autosomal dominant spastic paraplegia type 73
|
ORPHAnet |
| 0‑L |
444138
|
Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome
|
ORPHAnet |
| 0‑L |
444316
|
Idiopathic phalangeal acro-osteolysis
|
ORPHAnet |
| 0‑L |
444458
|
Combined oxidative phosphorylation defect type 24
|
ORPHAnet |
| 0‑L |
444463
|
Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome
|
ORPHAnet |
| 0‑L |
444490
|
Familial chylomicronemia syndrome
|
ORPHAnet |
| 0‑L |
445018
|
Combined immunodeficiency due to LRBA deficiency
|
ORPHAnet |
| 0‑L |
445038
|
3-methylglutaconic aciduria type 7
|
ORPHAnet |
| 0‑L |
445062
|
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome
|
ORPHAnet |
| 0‑L |
445110
|
Limb-girdle muscular dystrophy due to POMK deficiency
|
ORPHAnet |
| 0‑L |
447731
|
NIK deficiency
|
ORPHAnet |
| 0‑L |
447737
|
DOCK2 deficiency
|
ORPHAnet |
| 0‑L |
447740
|
Susceptibility to localized juvenile periodontitis
|
ORPHAnet |
| 0‑L |
447753
|
Autosomal dominant spastic paraplegia type 9A
|
ORPHAnet |
| 0‑L |
447757
|
Autosomal dominant spastic paraplegia type 9B
|
ORPHAnet |
| 0‑L |
447760
|
Autosomal recessive spastic paraplegia type 9B
|
ORPHAnet |
| 0‑L |
447764
|
IgG4-related sclerosing cholangitis
|
ORPHAnet |
| 0‑L |
447774
|
Secondary sclerosing cholangitis
|
ORPHAnet |
| 0‑L |
447777
|
Keratocystic odontogenic tumor
|
ORPHAnet |
| 0‑L |
447784
|
Mitochondrial pyruvate carrier deficiency
|
ORPHAnet |
| 0‑L |
447788
|
Cerebral visual impairment
|
ORPHAnet |
| 0‑L |
447795
|
Lipoyl transferase 2 deficiency
|
ORPHAnet |
| 0‑L |
447877
|
Polymerase proofreading-related adenomatous polyposis
|
ORPHAnet |
| 0‑L |
447881
|
Idiopathic dropped head syndrome
|
ORPHAnet |
| 0‑L |
447893
|
Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome
|
ORPHAnet |
| 0‑L |
447896
|
Tremor-ataxia-central hypomyelination syndrome
|
ORPHAnet |
| 0‑L |
447954
|
Combined oxidative phosphorylation defect type 25
|
ORPHAnet |
| 0‑L |
447961
|
Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome
|
ORPHAnet |
| 0‑L |
447964
|
Autosomal dominant Charcot-Marie-Tooth disease type 2V
|
ORPHAnet |
| 0‑L |
447974
|
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
447977
|
Progressive scapulohumeroperoneal distal myopathy
|
ORPHAnet |
| 0‑L |
447980
|
19p13.3 microduplication syndrome
|
ORPHAnet |
| 0‑L |
447997
|
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome
|
ORPHAnet |
| 0‑L |
448010
|
CAD-CDG
|
ORPHAnet |
| 0‑L |
448237
|
Zika virus disease
|
ORPHAnet |
| 0‑L |
448242
|
Autosomal recessive brachyolmia
|
ORPHAnet |
| 0‑L |
448251
|
Progressive autosomal recessive ataxia-deafness syndrome
|
ORPHAnet |
| 0‑L |
448264
|
Isolated focal non-epidermolytic palmoplantar keratoderma
|
ORPHAnet |
| 0‑L |
448267
|
Regressive spondylometaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
448270
|
Ectopia cordis
|
ORPHAnet |
| 0‑L |
449266
|
Pleural empyema
|
ORPHAnet |
| 0‑L |
449280
|
Scedosporiosis
|
ORPHAnet |
| 0‑L |
449285
|
Snakebite envenomation
|
ORPHAnet |
| 0‑L |
449291
|
Symptomatic form of fragile X syndrome in female carriers
|
ORPHAnet |
| 0‑L |
449395
|
IgG4-related kidney disease
|
ORPHAnet |
| 0‑L |
449400
|
IgG4-related aortitis
|
ORPHAnet |
| 0‑L |
449427
|
IgG4-related pachymeningitis
|
ORPHAnet |
| 0‑L |
449432
|
IgG4-related submandibular gland disease
|
ORPHAnet |
| 0‑L |
449563
|
IgG4-related ophthalmic disease
|
ORPHAnet |
| 0‑L |
449566
|
Eosinophilic angiocentric fibrosis
|
ORPHAnet |
| 0‑L |
450322
|
Polyclonal hyperviscosity syndrome
|
ORPHAnet |
| 0‑L |
451602
|
Primary cutaneous plasmacytosis
|
ORPHAnet |
| 0‑L |
451607
|
Cutaneous pseudolymphoma
|
ORPHAnet |
| 0‑L |
451612
|
Familial congenital nasolacrimal duct obstruction
|
ORPHAnet |
| 0‑L |
453499
|
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies
syndrome
|
ORPHAnet |
| 0‑L |
453504
|
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies
syndrome due to a point mutation
|
ORPHAnet |
| 0‑L |
453510
|
Congenital insensitivity to pain with severe intellectual disability
|
ORPHAnet |
| 0‑L |
453521
|
Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency
|
ORPHAnet |
| 0‑L |
453533
|
Polyendocrine-polyneuropathy syndrome
|
ORPHAnet |
| 0‑L |
454706
|
Progressive muscular atrophy
|
ORPHAnet |
| 0‑L |
454710
|
Anti-p200 pemphigoid
|
ORPHAnet |
| 0‑L |
454714
|
Plasma cell leukemia
|
ORPHAnet |
| 0‑L |
454718
|
Holmes-Adie syndrome
|
ORPHAnet |
| 0‑L |
454723
|
Endometrioid carcinoma of ovary
|
ORPHAnet |
| 0‑L |
454742
|
Variably protease-sensitive prionopathy
|
ORPHAnet |
| 0‑L |
454745
|
Kuru
|
ORPHAnet |
| 0‑L |
454750
|
Isolated tracheoesophageal fistula
|
ORPHAnet |
| 0‑L |
454821
|
Pleomorphic salivary gland adenoma
|
ORPHAnet |
| 0‑L |
454831
|
Acute radiation syndrome
|
ORPHAnet |
| 0‑L |
454836
|
Avian influenza
|
ORPHAnet |
| 0‑L |
454840
|
NTHL1-related attenuated familial adenomatous polyposis
|
ORPHAnet |
| 0‑L |
454887
|
Corticobasal syndrome
|
ORPHAnet |
| 0‑L |
456298
|
1p35.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
456312
|
Infantile multisystem neurologic-endocrine-pancreatic disease
|
ORPHAnet |
| 0‑L |
456318
|
Hereditary sensory neuropathy-deafness-dementia syndrome
|
ORPHAnet |
| 0‑L |
456328
|
X-linked myotubular myopathy-abnormal genitalia syndrome
|
ORPHAnet |
| 0‑L |
456333
|
Hereditary neuroendocrine tumor of small intestine
|
ORPHAnet |
| 0‑L |
456369
|
Polyglucosan body myopathy type 2
|
ORPHAnet |
| 0‑L |
457050
|
Autosomal dominant mitochondrial myopathy with exercise intolerance
|
ORPHAnet |
| 0‑L |
457077
|
TAFRO syndrome
|
ORPHAnet |
| 0‑L |
457083
|
Isolated splenogonadal fusion
|
ORPHAnet |
| 0‑L |
457088
|
Predisposition to invasive fungal disease due to CARD9 deficiency
|
ORPHAnet |
| 0‑L |
457095
|
Actinomycosis
|
ORPHAnet |
| 0‑L |
457185
|
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome
|
ORPHAnet |
| 0‑L |
457193
|
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects
syndrome
|
ORPHAnet |
| 0‑L |
457205
|
Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative
syndrome
|
ORPHAnet |
| 0‑L |
457212
|
Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal
behavior syndrome
|
ORPHAnet |
| 0‑L |
457223
|
Syndromic sensorineural deafness due to combined oxidative phosphorylation defect
|
ORPHAnet |
| 0‑L |
457240
|
X-linked intellectual disability-short stature-overweight syndrome
|
ORPHAnet |
| 0‑L |
457246
|
Clear cell sarcoma of kidney
|
ORPHAnet |
| 0‑L |
457260
|
X-linked intellectual disability-hypotonia-movement disorder syndrome
|
ORPHAnet |
| 0‑L |
457265
|
Progressive myoclonic epilepsy type 9
|
ORPHAnet |
| 0‑L |
457279
|
Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome
|
ORPHAnet |
| 0‑L |
457284
|
Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism
syndrome
|
ORPHAnet |
| 0‑L |
457351
|
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal
muscle tone syndrome
|
ORPHAnet |
| 0‑L |
457359
|
Megalencephaly-severe kyphoscoliosis-overgrowth syndrome
|
ORPHAnet |
| 0‑L |
457365
|
Intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
457375
|
ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement
|
ORPHAnet |
| 0‑L |
457378
|
Complex lethal osteochondrodysplasia
|
ORPHAnet |
| 0‑L |
457395
|
Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual
disability syndrome
|
ORPHAnet |
| 0‑L |
457406
|
Multiple mitochondrial dysfunctions syndrome type 4
|
ORPHAnet |
| 0‑L |
457485
|
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome
|
ORPHAnet |
| 0‑L |
458718
|
Idiopathic spontaneous coronary artery dissection
|
ORPHAnet |
| 0‑L |
458758
|
Composite hemangioendothelioma
|
ORPHAnet |
| 0‑L |
458763
|
Retiform hemangioendothelioma
|
ORPHAnet |
| 0‑L |
458768
|
Primary intralymphatic angioendothelioma
|
ORPHAnet |
| 0‑L |
458785
|
Partially involuting congenital hemangioma
|
ORPHAnet |
| 0‑L |
458792
|
Mixed cystic lymphatic malformation
|
ORPHAnet |
| 0‑L |
458798
|
Spinocerebellar ataxia type 41
|
ORPHAnet |
| 0‑L |
458803
|
Spinocerebellar ataxia type 42
|
ORPHAnet |
| 0‑L |
459033
|
Ataxia-oculomotor apraxia type 4
|
ORPHAnet |
| 0‑L |
459051
|
Spondyloepiphyseal dysplasia, Stanescu type
|
ORPHAnet |
| 0‑L |
459056
|
Autosomal recessive spastic paraplegia type 75
|
ORPHAnet |
| 0‑L |
459061
|
Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability
syndrome
|
ORPHAnet |
| 0‑L |
459070
|
X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia
syndrome
|
ORPHAnet |
| 0‑L |
459074
|
Corpus callosum agenesis-macrocephaly-hypertelorism syndrome
|
ORPHAnet |
| 0‑L |
464282
|
Spastic paraplegia-severe developmental delay-epilepsy syndrome
|
ORPHAnet |
| 0‑L |
464288
|
Short stature-brachydactyly-obesity-global developmental delay syndrome
|
ORPHAnet |
| 0‑L |
464306
|
DYRK1A-related intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
464311
|
Intellectual disability syndrome due to a DYRK1A point mutation
|
ORPHAnet |
| 0‑L |
464318
|
Verrucous hemangioma
|
ORPHAnet |
| 0‑L |
464321
|
Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome
|
ORPHAnet |
| 0‑L |
464329
|
Kaposiform lymphangiomatosis
|
ORPHAnet |
| 0‑L |
464336
|
BENTA disease
|
ORPHAnet |
| 0‑L |
464343
|
Catastrophic antiphospholipid syndrome
|
ORPHAnet |
| 0‑L |
464359
|
Benign metanephric tumor
|
ORPHAnet |
| 0‑L |
464366
|
NEK9-related lethal skeletal dysplasia
|
ORPHAnet |
| 0‑L |
464370
|
Neonatal alloimmune neutropenia
|
ORPHAnet |
| 0‑L |
464440
|
Primary dystonia, DYT27 type
|
ORPHAnet |
| 0‑L |
464443
|
COG6-CGD
|
ORPHAnet |
| 0‑L |
464453
|
Acquired methemoglobinemia
|
ORPHAnet |
| 0‑L |
464458
|
Paracetamol poisoning
|
ORPHAnet |
| 0‑L |
464724
|
Fever-associated acute infantile liver failure syndrome
|
ORPHAnet |
| 0‑L |
464738
|
Basel-Vanagaite-Smirin-Yosef syndrome
|
ORPHAnet |
| 0‑L |
464756
|
Familial gastric type 1 neuroendocrine tumor
|
ORPHAnet |
| 0‑L |
464760
|
Familial cavitary optic disc anomaly
|
ORPHAnet |
| 0‑L |
465508
|
Symptomatic form of hemochromatosis type 1
|
ORPHAnet |
| 0‑L |
465824
|
Fetal encasement syndrome
|
ORPHAnet |
| 0‑L |
466026
|
Class I glucose-6-phosphate dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
466650
|
Exercise-induced malignant hyperthermia
|
ORPHAnet |
| 0‑L |
466670
|
Cyanide poisoning
|
ORPHAnet |
| 0‑L |
466677
|
Scorpion envenomation
|
ORPHAnet |
| 0‑L |
466682
|
Euthyroid Graves orbitopathy
|
ORPHAnet |
| 0‑L |
466688
|
Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar
ataxia syndrome
|
ORPHAnet |
| 0‑L |
466695
|
Supratip dysplasia
|
ORPHAnet |
| 0‑L |
466703
|
TMEM199-CDG
|
ORPHAnet |
| 0‑L |
466718
|
Martinique crinkled retinal pigment epitheliopathy
|
ORPHAnet |
| 0‑L |
466722
|
Autosomal recessive spastic paraplegia type 77
|
ORPHAnet |
| 0‑L |
466729
|
Familial patent arterial duct
|
ORPHAnet |
| 0‑L |
466768
|
Autosomal dominant Charcot-Marie-Tooth disease type 2Z
|
ORPHAnet |
| 0‑L |
466775
|
Autosomal recessive Charcot-Marie-Tooth disease type 2X
|
ORPHAnet |
| 0‑L |
466784
|
Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect
|
ORPHAnet |
| 0‑L |
466791
|
Macrocephaly-intellectual disability-left ventricular non compaction syndrome
|
ORPHAnet |
| 0‑L |
466794
|
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy
syndrome
|
ORPHAnet |
| 0‑L |
466801
|
LIMS2-related limb-girdle muscular dystrophy
|
ORPHAnet |
| 0‑L |
466806
|
Autosomal dominant thrombocytopenia with platelet secretion defect
|
ORPHAnet |
| 0‑L |
466921
|
Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome
|
ORPHAnet |
| 0‑L |
466926
|
Seizures-scoliosis-macrocephaly syndrome
|
ORPHAnet |
| 0‑L |
466934
|
VPS11-related autosomal recessive hypomyelinating leukodystrophy
|
ORPHAnet |
| 0‑L |
466943
|
WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome
|
ORPHAnet |
| 0‑L |
466950
|
Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC
point mutation
|
ORPHAnet |
| 0‑L |
466962
|
SMARCA4-deficient sarcoma of thorax
|
ORPHAnet |
| 0‑L |
467166
|
Tubulinopathy-associated dysgyria
|
ORPHAnet |
| 0‑L |
467176
|
Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect
syndrome
|
ORPHAnet |
| 0‑L |
468620
|
Intellectual disability-epilepsy-extrapyramidal syndrome
|
ORPHAnet |
| 0‑L |
468631
|
Microcephalic cortical malformations-short stature due to RTTN deficiency
|
ORPHAnet |
| 0‑L |
468635
|
Cryptogenic multifocal ulcerous stenosing enteritis
|
ORPHAnet |
| 0‑L |
468641
|
Chronic enteropathy associated with SLCO2A1 gene
|
ORPHAnet |
| 0‑L |
468661
|
Autosomal recessive spastic paraplegia type 74
|
ORPHAnet |
| 0‑L |
468666
|
Isolated generalized anhidrosis with normal sweat glands
|
ORPHAnet |
| 0‑L |
468672
|
Colobomatous macrophthalmia-microcornea syndrome
|
ORPHAnet |
| 0‑L |
468678
|
White-Sutton syndrome
|
ORPHAnet |
| 0‑L |
468684
|
CCDC115-CDG
|
ORPHAnet |
| 0‑L |
468699
|
SLC39A8-CDG
|
ORPHAnet |
| 0‑L |
468717
|
Rhizomelic chondrodysplasia punctata type 5
|
ORPHAnet |
| 0‑L |
468726
|
Severe primary trimethylaminuria
|
ORPHAnet |
| 0‑L |
476084
|
BVES-related limb-girdle muscular dystrophy
|
ORPHAnet |
| 0‑L |
476093
|
Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome
|
ORPHAnet |
| 0‑L |
476096
|
Erythrokeratodermia-cardiomyopathy syndrome
|
ORPHAnet |
| 0‑L |
476102
|
Hereditary pediatric Behçet-like disease
|
ORPHAnet |
| 0‑L |
476113
|
Combined immunodeficiency due to TFRC deficiency
|
ORPHAnet |
| 0‑L |
476119
|
Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome
|
ORPHAnet |
| 0‑L |
476126
|
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability
syndrome
|
ORPHAnet |
| 0‑L |
476394
|
PMP2-related Charcot-Marie-Tooth disease type 1
|
ORPHAnet |
| 0‑L |
476406
|
Congenital generalized hypercontractile muscle stiffness syndrome
|
ORPHAnet |
| 0‑L |
477650
|
Fibroblastic rheumatism
|
ORPHAnet |
| 0‑L |
477661
|
IL21-related infantile inflammatory bowel disease
|
ORPHAnet |
| 0‑L |
477673
|
Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual
disability syndrome
|
ORPHAnet |
| 0‑L |
477684
|
Combined oxidative phosphorylation defect type 26
|
ORPHAnet |
| 0‑L |
477738
|
Pediatric multiple sclerosis
|
ORPHAnet |
| 0‑L |
477742
|
Nodular fasciitis
|
ORPHAnet |
| 0‑L |
477749
|
Pontine autosomal dominant microangiopathy with leukoencephalopathy
|
ORPHAnet |
| 0‑L |
477774
|
Combined oxidative phosphorylation defect type 27
|
ORPHAnet |
| 0‑L |
477781
|
Primary condylar hyperplasia
|
ORPHAnet |
| 0‑L |
477787
|
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder
|
ORPHAnet |
| 0‑L |
477814
|
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
477817
|
PMP22-RAI1 contiguous gene duplication syndrome
|
ORPHAnet |
| 0‑L |
477831
|
Kosaki overgrowth syndrome
|
ORPHAnet |
| 0‑L |
477857
|
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete
RORgamma receptor deficiency
|
ORPHAnet |
| 0‑L |
477993
|
Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
478029
|
Combined oxidative phosphorylation defect type 29
|
ORPHAnet |
| 0‑L |
478042
|
Combined oxidative phosphorylation defect type 30
|
ORPHAnet |
| 0‑L |
478049
|
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay
syndrome
|
ORPHAnet |
| 0‑L |
478664
|
Hereditary sensory and autonomic neuropathy type 8
|
ORPHAnet |
| 0‑L |
480476
|
Progressive familial intrahepatic cholestasis type 5
|
ORPHAnet |
| 0‑L |
480483
|
Progressive familial intrahepatic cholestasis type 4
|
ORPHAnet |
| 0‑L |
480491
|
MYO5B-related progressive familial intrahepatic cholestasis
|
ORPHAnet |
| 0‑L |
480501
|
Choledochal cyst
|
ORPHAnet |
| 0‑L |
480506
|
Primary intrahepatic lithiasis
|
ORPHAnet |
| 0‑L |
480512
|
Idiopathic ductopenia
|
ORPHAnet |
| 0‑L |
480520
|
Caroli syndrome
|
ORPHAnet |
| 0‑L |
480524
|
Idiopathic peliosis hepatis
|
ORPHAnet |
| 0‑L |
480528
|
Lethal hydranencephaly-diaphragmatic hernia syndrome
|
ORPHAnet |
| 0‑L |
480531
|
Congenital portosystemic shunt
|
ORPHAnet |
| 0‑L |
480536
|
MSH3-related attenuated familial adenomatous polyposis
|
ORPHAnet |
| 0‑L |
480541
|
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement
|
ORPHAnet |
| 0‑L |
480553
|
Aneurysmal bone cyst
|
ORPHAnet |
| 0‑L |
480556
|
Isolated neonatal sclerosing cholangitis
|
ORPHAnet |
| 0‑L |
480682
|
POGLUT1-related limb-girdle muscular dystrophy R21
|
ORPHAnet |
| 0‑L |
480701
|
Facial diplegia with paresthesias
|
ORPHAnet |
| 0‑L |
480851
|
Hereditary thrombocytopenia with early-onset myelofibrosis
|
ORPHAnet |
| 0‑L |
480864
|
Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual
disability syndrome
|
ORPHAnet |
| 0‑L |
480880
|
X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual
disability
|
ORPHAnet |
| 0‑L |
480898
|
Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal
hypotonia syndrome
|
ORPHAnet |
| 0‑L |
480907
|
X-linked intellectual disability-global development delay-facial dysmorphism-sacral
caudal remnant syndrome
|
ORPHAnet |
| 0‑L |
481152
|
PYCR2-related microcephaly-progressive leukoencephalopathy
|
ORPHAnet |
| 0‑L |
481662
|
Familial Chilblain lupus
|
ORPHAnet |
| 0‑L |
481665
|
USP18 deficiency
|
ORPHAnet |
| 0‑L |
481986
|
Familial schizencephaly
|
ORPHAnet |
| 0‑L |
482077
|
HTRA1-related autosomal dominant cerebral small vessel disease
|
ORPHAnet |
| 0‑L |
482601
|
Adenylosuccinate synthetase-like 1-related distal myopathy
|
ORPHAnet |
| 0‑L |
482606
|
X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio
syndrome
|
ORPHAnet |
| 0‑L |
485275
|
Acquired schizencephaly
|
ORPHAnet |
| 0‑L |
485350
|
CLCN4-related X-linked intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
485358
|
Propylthiouracil embryofetopathy
|
ORPHAnet |
| 0‑L |
485405
|
16p12.1p12.3 triplication syndrome
|
ORPHAnet |
| 0‑L |
485418
|
EMILIN-1-related connective tissue disease
|
ORPHAnet |
| 0‑L |
485421
|
MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect
|
ORPHAnet |
| 0‑L |
485426
|
Isolated congenital hepatic fibrosis
|
ORPHAnet |
| 0‑L |
486811
|
Prenatal-onset spinal muscular atrophy with congenital bone fractures
|
ORPHAnet |
| 0‑L |
486815
|
Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity
syndrome
|
ORPHAnet |
| 0‑L |
487796
|
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly
syndrome
|
ORPHAnet |
| 0‑L |
487809
|
Pediatric collagenous gastritis
|
ORPHAnet |
| 0‑L |
487814
|
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation
|
ORPHAnet |
| 0‑L |
487825
|
Pierpont syndrome
|
ORPHAnet |
| 0‑L |
488168
|
Microcephaly-congenital cataract-psoriasiform dermatitis syndrome
|
ORPHAnet |
| 0‑L |
488191
|
Female infertility due to oocyte meiotic arrest
|
ORPHAnet |
| 0‑L |
488197
|
Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome
|
ORPHAnet |
| 0‑L |
488232
|
Split-foot malformation-mesoaxial polydactyly syndrome
|
ORPHAnet |
| 0‑L |
488239
|
Acute macular neuroretinopathy
|
ORPHAnet |
| 0‑L |
488265
|
Osteofibrous dysplasia
|
ORPHAnet |
| 0‑L |
488280
|
14q32 duplication syndrome
|
ORPHAnet |
| 0‑L |
488333
|
Autosomal dominant Charcot-Marie-Tooth disease type 2W
|
ORPHAnet |
| 0‑L |
488434
|
Camptodactyly syndrome, Guadalajara type 3
|
ORPHAnet |
| 0‑L |
488437
|
SIX2-related frontonasal dysplasia
|
ORPHAnet |
| 0‑L |
488586
|
Congenital amyoplasia
|
ORPHAnet |
| 0‑L |
488594
|
Autosomal recessive spastic paraplegia type 76
|
ORPHAnet |
| 0‑L |
488613
|
Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual
disability syndrome
|
ORPHAnet |
| 0‑L |
488618
|
Transketolase deficiency
|
ORPHAnet |
| 0‑L |
488627
|
Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability
syndrome
|
ORPHAnet |
| 0‑L |
488632
|
TBCK-related intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
488635
|
Early-onset epilepsy-intellectual disability-brain anomalies syndrome
|
ORPHAnet |
| 0‑L |
488642
|
TELO2-related intellectual disability-neurodevelopmental disorder
|
ORPHAnet |
| 0‑L |
488647
|
DDX41-related hematologic malignancy predisposition syndrome
|
ORPHAnet |
| 0‑L |
488650
|
Distal myopathy, Tateyama type
|
ORPHAnet |
| 0‑L |
493342
|
Vibratory urticaria
|
ORPHAnet |
| 0‑L |
493348
|
Vibratory angioedema
|
ORPHAnet |
| 0‑L |
494344
|
RERE-related neurodevelopmental syndrome
|
ORPHAnet |
| 0‑L |
494418
|
Vulvar carcinoma
|
ORPHAnet |
| 0‑L |
494421
|
Sacrococcygeal teratoma
|
ORPHAnet |
| 0‑L |
494424
|
Extracranial carotid artery aneurysm
|
ORPHAnet |
| 0‑L |
494428
|
Idiopathic pleuroparenchymal fibroelastosis
|
ORPHAnet |
| 0‑L |
494433
|
MIRAGE syndrome
|
ORPHAnet |
| 0‑L |
494439
|
Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism
syndrome
|
ORPHAnet |
| 0‑L |
494444
|
DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
|
ORPHAnet |
| 0‑L |
494448
|
Vulvar squamous cell carcinoma
|
ORPHAnet |
| 0‑L |
494451
|
Vulvar basal cell carcinoma
|
ORPHAnet |
| 0‑L |
494454
|
Vulvar adenocarcinoma
|
ORPHAnet |
| 0‑L |
494526
|
Infantile-onset generalized dyskinesia with orofacial involvement
|
ORPHAnet |
| 0‑L |
494541
|
Childhood-onset benign chorea with striatal involvement
|
ORPHAnet |
| 0‑L |
494547
|
Squamous cell carcinoma of the hypopharynx
|
ORPHAnet |
| 0‑L |
494550
|
Squamous cell carcinoma of the larynx
|
ORPHAnet |
| 0‑L |
495274
|
Charcot-Marie-Tooth disease type 2T
|
ORPHAnet |
| 0‑L |
495818
|
9q33.3q34.11 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
495844
|
C11ORF73-related autosomal recessive hypomyelinating leukodystrophy
|
ORPHAnet |
| 0‑L |
495875
|
Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial
dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
495879
|
Congenital agenesis of the scrotum
|
ORPHAnet |
| 0‑L |
495930
|
Familial monosomy 7 syndrome
|
ORPHAnet |
| 0‑L |
496641
|
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy
syndrome
|
ORPHAnet |
| 0‑L |
496686
|
Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome
|
ORPHAnet |
| 0‑L |
496689
|
Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome
|
ORPHAnet |
| 0‑L |
496693
|
Omphalocele-diaphragmatic hernia-cardiovascular anomalies-radial ray defect syndrome
|
ORPHAnet |
| 0‑L |
496751
|
EVEN-plus syndrome
|
ORPHAnet |
| 0‑L |
496756
|
Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy
syndrome
|
ORPHAnet |
| 0‑L |
496790
|
Ocular anomalies-axonal neuropathy-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
497188
|
Diffuse intrinsic pontine glioma
|
ORPHAnet |
| 0‑L |
497737
|
Epidermolytic nevus
|
ORPHAnet |
| 0‑L |
497757
|
MME-related autosomal dominant Charcot Marie Tooth disease type 2
|
ORPHAnet |
| 0‑L |
497764
|
Spinocerebellar ataxia type 43
|
ORPHAnet |
| 0‑L |
497906
|
Childhood-onset basal ganglia degeneration syndrome
|
ORPHAnet |
| 0‑L |
498228
|
Phyllodes tumor of the prostate
|
ORPHAnet |
| 0‑L |
498251
|
Menstrual cycle-dependent periodic fever
|
ORPHAnet |
| 0‑L |
498359
|
Aquagenic palmoplantar keratoderma
|
ORPHAnet |
| 0‑L |
498474
|
Hyaline fibromatosis syndrome
|
ORPHAnet |
| 0‑L |
498481
|
LRP5-related primary osteoporosis
|
ORPHAnet |
| 0‑L |
498485
|
Overgrowth-metaphyseal undermodeling-spondylar dysplasia syndrome
|
ORPHAnet |
| 0‑L |
498488
|
Overgrowth syndrome with 2q37 translocation
|
ORPHAnet |
| 0‑L |
498494
|
Mirror-image polydactyly
|
ORPHAnet |
| 0‑L |
498497
|
Short rib-polydactyly syndrome type 5
|
ORPHAnet |
| 0‑L |
498602
|
Sugarman brachydactyly
|
ORPHAnet |
| 0‑L |
498693
|
MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome
|
ORPHAnet |
| 0‑L |
499004
|
Tuberculous meningitis
|
ORPHAnet |
| 0‑L |
499009
|
Congenital syphilis
|
ORPHAnet |
| 0‑L |
499085
|
Chronic relapsing inflammatory optic neuropathy
|
ORPHAnet |
| 0‑L |
499096
|
Isolated optic neuritis
|
ORPHAnet |
| 0‑L |
499103
|
Recurrent idiopathic neuroretinitis
|
ORPHAnet |
| 0‑L |
499107
|
Idiopathic optic perineuritis
|
ORPHAnet |
| 0‑L |
499182
|
Pilomatrix carcinoma
|
ORPHAnet |
| 0‑L |
500055
|
16p13.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
500062
|
Infantile-onset periodic fever-panniculitis-dermatosis syndrome
|
ORPHAnet |
| 0‑L |
500095
|
Tall stature-intellectual disability-renal anomalies syndrome
|
ORPHAnet |
| 0‑L |
500135
|
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly
syndrome
|
ORPHAnet |
| 0‑L |
500144
|
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy
syndrome
|
ORPHAnet |
| 0‑L |
500150
|
Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual
disability syndrome
|
ORPHAnet |
| 0‑L |
500159
|
Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual
disability syndrom
|
ORPHAnet |
| 0‑L |
500163
|
Witteveen-Kolk syndrome
|
ORPHAnet |
| 0‑L |
500166
|
SIN3A-related intellectual disability syndrome due to a point mutation
|
ORPHAnet |
| 0‑L |
500180
|
Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement
disorder
|
ORPHAnet |
| 0‑L |
500188
|
X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism
syndrome
|
ORPHAnet |
| 0‑L |
500464
|
Squamous cell carcinoma of the nasal cavity and paranasal sinuses
|
ORPHAnet |
| 0‑L |
500478
|
Squamous cell carcinoma of the oropharynx
|
ORPHAnet |
| 0‑L |
500481
|
Squamous cell carcinoma of salivary glands
|
ORPHAnet |
| 0‑L |
500533
|
Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome
|
ORPHAnet |
| 0‑L |
500545
|
Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral
cataract
|
ORPHAnet |
| 0‑L |
500548
|
Osteosclerotic metaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
502305
|
Cochleovestibular malformation
|
ORPHAnet |
| 0‑L |
502318
|
Cochlear nerve deficiency
|
ORPHAnet |
| 0‑L |
502363
|
Squamous cell carcinoma of the oral cavity
|
ORPHAnet |
| 0‑L |
502366
|
Squamous cell carcinoma of the lip
|
ORPHAnet |
| 0‑L |
502423
|
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
|
ORPHAnet |
| 0‑L |
502430
|
Metopic ridging-ptosis-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
502434
|
STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome
|
ORPHAnet |
| 0‑L |
502437
|
4q25 proximal deletion syndrome
|
ORPHAnet |
| 0‑L |
502444
|
Alkaline ceramidase 3 deficiency
|
ORPHAnet |
| 0‑L |
502499
|
Erythema multiforme major
|
ORPHAnet |
| 0‑L |
504476
|
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
|
ORPHAnet |
| 0‑L |
504523
|
Severe combined immunodeficiency due to LAT deficiency
|
ORPHAnet |
| 0‑L |
504530
|
Combined immunodeficiency due to Moesin deficiency
|
ORPHAnet |
| 0‑L |
505208
|
3-methylglutaconic aciduria type 8
|
ORPHAnet |
| 0‑L |
505216
|
3-methylglutaconic aciduria type 9
|
ORPHAnet |
| 0‑L |
505227
|
Combined immunodeficiency due to GINS1 deficiency
|
ORPHAnet |
| 0‑L |
505237
|
Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental
delay syndrome
|
ORPHAnet |
| 0‑L |
505242
|
Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome
|
ORPHAnet |
| 0‑L |
505248
|
Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic
disorders
|
ORPHAnet |
| 0‑L |
505395
|
Ventilator-induced diaphragmatic dysfunction
|
ORPHAnet |
| 0‑L |
505652
|
CDKL5-deficiency disorder
|
ORPHAnet |
| 0‑L |
506075
|
Non-functioning neuroendocrine tumor of pancreas
|
ORPHAnet |
| 0‑L |
506090
|
Serotonin-producing neuroendocrine tumor of pancreas
|
ORPHAnet |
| 0‑L |
506098
|
Neuroendocrine carcinoma of pancreas
|
ORPHAnet |
| 0‑L |
506112
|
Mixed neuroendocrine and non-neuroendocrine neoplasm of pancreas
|
ORPHAnet |
| 0‑L |
506136
|
Neuroendocrine neoplasm of esophagus
|
ORPHAnet |
| 0‑L |
506307
|
Stromme syndrome
|
ORPHAnet |
| 0‑L |
506334
|
Familial steroid-resistant nephrotic syndrome with adrenal insufficiency
|
ORPHAnet |
| 0‑L |
506353
|
Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction
|
ORPHAnet |
| 0‑L |
506358
|
Gabriele-de Vries syndrome
|
ORPHAnet |
| 0‑L |
506784
|
Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome
|
ORPHAnet |
| 0‑L |
508093
|
MEPAN syndrome
|
ORPHAnet |
| 0‑L |
508410
|
Familial intestinal malrotation
|
ORPHAnet |
| 0‑L |
508476
|
Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss
syndrome
|
ORPHAnet |
| 0‑L |
508488
|
8q24.3 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
508498
|
Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome
|
ORPHAnet |
| 0‑L |
508501
|
Oral-facial-digital syndrome with short stature and brachymesophalangy
|
ORPHAnet |
| 0‑L |
508512
|
Intrauterine growth restriction-congenital multiple café-au-lait macules-increased
sister chromatid exchange syndrome
|
ORPHAnet |
| 0‑L |
508523
|
Hyperphenylalaninemia due to DNAJC12 deficiency
|
ORPHAnet |
| 0‑L |
508529
|
Intermediate epidermolysis bullosa simplex with cardiomyopathy
|
ORPHAnet |
| 0‑L |
508533
|
Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
508542
|
Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia
syndrome
|
ORPHAnet |
| 0‑L |
512017
|
Chronic lymphoproliferative disorder of natural killer cells
|
ORPHAnet |
| 0‑L |
512103
|
Autosomal recessive epidermolytic ichthyosis
|
ORPHAnet |
| 0‑L |
512260
|
Congenital cerebellar ataxia due to RNU12 mutation
|
ORPHAnet |
| 0‑L |
513436
|
Autosomal recessive spastic paraplegia type 78
|
ORPHAnet |
| 0‑L |
513456
|
Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
514352
|
Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome
|
ORPHAnet |
| 0‑L |
519384
|
Congenital cystic eye
|
ORPHAnet |
| 0‑L |
519386
|
Isolated congenital entropion
|
ORPHAnet |
| 0‑L |
519388
|
Autosomal recessive anterior segment dysgenesis
|
ORPHAnet |
| 0‑L |
519390
|
Isolated blepharochalasis
|
ORPHAnet |
| 0‑L |
519392
|
Isolated iridoschisis
|
ORPHAnet |
| 0‑L |
519396
|
Isolated microspherophakia
|
ORPHAnet |
| 0‑L |
519398
|
Isolated foveal hypoplasia
|
ORPHAnet |
| 0‑L |
519400
|
Peripapillary staphyloma
|
ORPHAnet |
| 0‑L |
519402
|
Isolated megalopapilla
|
ORPHAnet |
| 0‑L |
519404
|
Optic disc pit
|
ORPHAnet |
| 0‑L |
519406
|
Thygeson superficial punctate keratitis
|
ORPHAnet |
| 0‑L |
519408
|
Mooren ulcer
|
ORPHAnet |
| 0‑L |
519410
|
Terrien marginal degeneration
|
ORPHAnet |
| 0‑L |
519930
|
Fungal keratitis
|
ORPHAnet |
| 0‑L |
521123
|
Radiation-induced plexopathy
|
ORPHAnet |
| 0‑L |
521127
|
Osteoradionecrosis of the mandible
|
ORPHAnet |
| 0‑L |
521219
|
Mirizzi syndrome
|
ORPHAnet |
| 0‑L |
521258
|
Xq25 microduplication syndrome
|
ORPHAnet |
| 0‑L |
521305
|
Proximal myopathy with focal depletion of mitochondria
|
ORPHAnet |
| 0‑L |
521308
|
Frontonasal dysplasia-bifid nose-upper limb anomalies syndrome
|
ORPHAnet |
| 0‑L |
521390
|
Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome
|
ORPHAnet |
| 0‑L |
521406
|
Dystonia-parkinsonism-hypermanganesemia syndrome
|
ORPHAnet |
| 0‑L |
521411
|
Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect
|
ORPHAnet |
| 0‑L |
521414
|
Autosomal dominant Charcot-Marie-Tooth disease type 2DD
|
ORPHAnet |
| 0‑L |
521426
|
PLAA-associated neurodevelopmental disorder
|
ORPHAnet |
| 0‑L |
521432
|
Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome
|
ORPHAnet |
| 0‑L |
521438
|
Congenital vertebral-cardiac-renal anomalies syndrome
|
ORPHAnet |
| 0‑L |
521445
|
Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome
|
ORPHAnet |
| 0‑L |
521450
|
LAMA5-related multisystemic syndrome
|
ORPHAnet |
| 0‑L |
522037
|
Primary autoimmune enteropathy
|
ORPHAnet |
| 0‑L |
522077
|
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay
syndrome
|
ORPHAnet |
| 0‑L |
525731
|
Pediatric-onset Graves disease
|
ORPHAnet |
| 0‑L |
525738
|
Prepubertal anorexia nervosa
|
ORPHAnet |
| 0‑L |
527276
|
Encephalopathy due to mitochondrial and peroxisomal fission defect
|
ORPHAnet |
| 0‑L |
527450
|
Severe myopia-generalized joint laxity-short stature syndrome
|
ORPHAnet |
| 0‑L |
527468
|
Diaphragmatic hernia-short bowel-asplenia syndrome
|
ORPHAnet |
| 0‑L |
527497
|
NKX6-2-related autosomal recessive hypomyelinating leukodystrophy
|
ORPHAnet |
| 0‑L |
528084
|
Non-specific syndromic intellectual disability
|
ORPHAnet |
| 0‑L |
528091
|
Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome
|
ORPHAnet |
| 0‑L |
528105
|
Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia
syndrome
|
ORPHAnet |
| 0‑L |
528623
|
Hereditary angioedema with C1Inh deficiency
|
ORPHAnet |
| 0‑L |
528647
|
Hereditary angioedema with normal C1Inh
|
ORPHAnet |
| 0‑L |
528663
|
Acquired angioedema with C1Inh deficiency
|
ORPHAnet |
| 0‑L |
529468
|
Monoclonal mast cell activation syndrome
|
ORPHAnet |
| 0‑L |
529574
|
Duane retraction syndrome with congenital deafness
|
ORPHAnet |
| 0‑L |
529665
|
Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy
syndrome
|
ORPHAnet |
| 0‑L |
529799
|
Acute bilirubin encephalopathy
|
ORPHAnet |
| 0‑L |
529808
|
Chronic bilirubin encephalopathy
|
ORPHAnet |
| 0‑L |
529831
|
Letrozole toxicity
|
ORPHAnet |
| 0‑L |
529852
|
Combined hepatocellular carcinoma and cholangiocarcinoma
|
ORPHAnet |
| 0‑L |
529864
|
Secondary erythromelalgia
|
ORPHAnet |
| 0‑L |
529962
|
17q24.2 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
529965
|
Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
529970
|
Male infertility due to acephalic spermatozoa
|
ORPHAnet |
| 0‑L |
529977
|
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia
syndrome
|
ORPHAnet |
| 0‑L |
529980
|
Inflammatory bowel disease-recurrent sinopulmonary infections syndrome
|
ORPHAnet |
| 0‑L |
530033
|
Dermoid or epidermoid cyst of the central nervous system
|
ORPHAnet |
| 0‑L |
530298
|
Progressive myoclonic epilepsy with neuroserpin inclusion bodies
|
ORPHAnet |
| 0‑L |
530303
|
Progressive dementia with neuroserpin inclusion bodies
|
ORPHAnet |
| 0‑L |
530792
|
RELA fusion-positive ependymoma
|
ORPHAnet |
| 0‑L |
530838
|
KRT1-related diffuse nonepidermolytic keratoderma
|
ORPHAnet |
| 0‑L |
530849
|
Familial apolipoprotein A5 deficiency
|
ORPHAnet |
| 0‑L |
530983
|
Lamb-Shaffer syndrome
|
ORPHAnet |
| 0‑L |
530995
|
Mixed phenotype acute leukemia
|
ORPHAnet |
| 0‑L |
531151
|
9q21.13 microdeletion syndrome
|
ORPHAnet |
| 0‑L |
535453
|
Familial lipase maturation factor 1 deficiency
|
ORPHAnet |
| 0‑L |
535458
|
Familial GPIHBP1 deficiency
|
ORPHAnet |
| 0‑L |
536467
|
B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
536471
|
Spondylodysplastic Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
536516
|
Myopathic Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
536532
|
Classical-like Ehlers-Danlos syndrome type 2
|
ORPHAnet |
| 0‑L |
536545
|
Kyphoscoliotic Ehlers-Danlos syndrome
|
ORPHAnet |
| 0‑L |
537072
|
PLG-related hereditary angioedema with normal C1Inh
|
ORPHAnet |
| 0‑L |
538096
|
Autosomal recessive lethal neonatal axonal sensorimotor polyneuropathy
|
ORPHAnet |
| 0‑L |
538101
|
Congenital axonal neuropathy with encephalopathy
|
ORPHAnet |
| 0‑L |
538574
|
Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome
|
ORPHAnet |
| 0‑L |
538756
|
Familial multiple discoid fibromas
|
ORPHAnet |
| 0‑L |
538863
|
Classic pyoderma gangrenosum
|
ORPHAnet |
| 0‑L |
538866
|
Pustular pyoderma gangrenosum
|
ORPHAnet |
| 0‑L |
538869
|
Bullous pyoderma gangrenosum
|
ORPHAnet |
| 0‑L |
538872
|
Vegetative pyoderma gangrenosum
|
ORPHAnet |
| 0‑L |
538931
|
X-linked lymphoproliferative disease due to SH2D1A deficiency
|
ORPHAnet |
| 0‑L |
538934
|
X-linked lymphoproliferative disease due to XIAP deficiency
|
ORPHAnet |
| 0‑L |
538958
|
Combined immunodeficiency due to CD70 deficiency
|
ORPHAnet |
| 0‑L |
538963
|
Combined immunodeficiency due to ITK deficiency
|
ORPHAnet |
| 0‑L |
541423
|
Growth delay-intellectual disability-hepatopathy syndrome
|
ORPHAnet |
| 0‑L |
541443
|
Anomalous aortic origin of the left coronary artery
|
ORPHAnet |
| 0‑L |
541454
|
Anomalous aortic origin of the right coronary artery
|
ORPHAnet |
| 0‑L |
541507
|
Anomalous origin of coronary artery from the pulmonary artery
|
ORPHAnet |
| 0‑L |
542301
|
Combined immunodeficiency due to CARMIL2 deficiency
|
ORPHAnet |
| 0‑L |
542306
|
GNB5-related intellectual disability-cardiac arrhythmia syndrome
|
ORPHAnet |
| 0‑L |
542310
|
Leukoencephalopathy with calcifications and cysts
|
ORPHAnet |
| 0‑L |
542323
|
CAR T cell therapy-associated cytokine release syndrome
|
ORPHAnet |
| 0‑L |
542568
|
Quadricuspid aortic valve
|
ORPHAnet |
| 0‑L |
542585
|
Auditory neuropathy-optic atrophy syndrome
|
ORPHAnet |
| 0‑L |
542592
|
Necrobiosis lipoidica
|
ORPHAnet |
| 0‑L |
542643
|
Livedoid vasculopathy
|
ORPHAnet |
| 0‑L |
542657
|
Isolated hyperchlorhidrosis
|
ORPHAnet |
| 0‑L |
543470
|
Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome
|
ORPHAnet |
| 0‑L |
544254
|
SYNGAP1-related developmental and epileptic encephalopathy
|
ORPHAnet |
| 0‑L |
544469
|
PRUNE1-related neurological syndrome
|
ORPHAnet |
| 0‑L |
544472
|
Atypical hemolytic uremic syndrome with complement gene abnormality
|
ORPHAnet |
| 0‑L |
544482
|
Infection-related hemolytic uremic syndrome
|
ORPHAnet |
| 0‑L |
544488
|
Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain
anomalies syndrome
|
ORPHAnet |
| 0‑L |
544493
|
Streptococcus pneumoniae-associated hemolytic uremic syndrome
|
ORPHAnet |
| 0‑L |
544503
|
RNF13-related severe early-onset epileptic encephalopathy
|
ORPHAnet |
| 0‑L |
544578
|
Congenital primary megaureter, refluxing and obstructed form
|
ORPHAnet |
| 0‑L |
544602
|
Congenital myopathy with reduced type 2 muscle fibers
|
ORPHAnet |
| 0‑L |
544628
|
Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome
|
ORPHAnet |
| 0‑L |
555402
|
NAD(P)HX dehydratase deficiency
|
ORPHAnet |
| 0‑L |
555407
|
NAD(P)HX epimerase deficiency
|
ORPHAnet |
| 0‑L |
555434
|
Fibrohistiocytic inflammatory pseudotumor of the liver
|
ORPHAnet |
| 0‑L |
555437
|
Lymphoplasmacytic inflammatory pseudotumor of the liver
|
ORPHAnet |
| 0‑L |
555874
|
Congenital tricuspid valve dysplasia
|
ORPHAnet |
| 0‑L |
555877
|
FLNA-related X-linked myxomatous valvular dysplasia
|
ORPHAnet |
| 0‑L |
555905
|
IgA pemphigus
|
ORPHAnet |
| 0‑L |
556030
|
Early-onset familial hypoaldosteronism
|
ORPHAnet |
| 0‑L |
556037
|
Late-onset familial hypoaldosteronism
|
ORPHAnet |
| 0‑L |
556955
|
Pancreatic agenesis-holoprosencephaly syndrome
|
ORPHAnet |
| 0‑L |
556985
|
Early-onset calcifying leukoencephalopathy-skeletal dysplasia
|
ORPHAnet |
| 0‑L |
557003
|
Oculocerebrodental syndrome
|
ORPHAnet |
| 0‑L |
557056
|
Spastic ataxia-dysarthria due to glutaminase deficiency
|
ORPHAnet |
| 0‑L |
557064
|
Neonatal epileptic encephalopathy due to glutaminase deficiency
|
ORPHAnet |
| 0‑L |
558411
|
Idiopathic gastroparesis
|
ORPHAnet |
| 0‑L |
561854
|
FOXG1 syndrome
|
ORPHAnet |
| 0‑L |
562509
|
Heme oxygenase-1 deficiency
|
ORPHAnet |
| 0‑L |
562528
|
Congenital limbs-face contractures-hypotonia-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
562538
|
Autosomal recessive extra-oral halitosis
|
ORPHAnet |
| 0‑L |
562559
|
Anterior maxillary protrusion-strabismus-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
562569
|
TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome
|
ORPHAnet |
| 0‑L |
562639
|
Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis
overlap syndrome
|
ORPHAnet |
| 0‑L |
563576
|
Autoimmune hepatitis type 1
|
ORPHAnet |
| 0‑L |
563581
|
Autoimmune hepatitis type 2
|
ORPHAnet |
| 0‑L |
563589
|
Seronegative autoimmune hepatitis
|
ORPHAnet |
| 0‑L |
563609
|
Isolated anencephaly
|
ORPHAnet |
| 0‑L |
563612
|
Isolated exencephaly
|
ORPHAnet |
| 0‑L |
563666
|
Serous cystadenoma of childhood
|
ORPHAnet |
| 0‑L |
563671
|
Mucinous cystadenoma of childhood
|
ORPHAnet |
| 0‑L |
563676
|
Seromucinous cystadenoma of childhood
|
ORPHAnet |
| 0‑L |
563684
|
Furuncular myiasis due to Dermatobia hominis
|
ORPHAnet |
| 0‑L |
563687
|
Furuncular myiasis due to Cordylobia anthropophaga
|
ORPHAnet |
| 0‑L |
563690
|
Furuncular myiasis due to Cordylobia rodhaini
|
ORPHAnet |
| 0‑L |
563708
|
Syndromic congenital sodium diarrhea
|
ORPHAnet |
| 0‑L |
563951
|
Isolated congenital aglossia
|
ORPHAnet |
| 0‑L |
563954
|
Isolated congenital hypoglossia
|
ORPHAnet |
| 0‑L |
563991
|
Osteochondrosis of the tarsal bone
|
ORPHAnet |
| 0‑L |
564003
|
Osteochondrosis of the metatarsal bone
|
ORPHAnet |
| 0‑L |
564178
|
Primary hypomagnesemia-refractory seizures-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
565612
|
Triglyceride deposit cardiomyovasculopathy
|
ORPHAnet |
| 0‑L |
565624
|
Combined oxidative phosphorylation defect type 39
|
ORPHAnet |
| 0‑L |
565641
|
Primary desmosis coli
|
ORPHAnet |
| 0‑L |
565782
|
Methotrexate toxicity
|
ORPHAnet |
| 0‑L |
565788
|
Infantile inflammatory bowel disease with neurological involvement
|
ORPHAnet |
| 0‑L |
565837
|
Laminin subunit alpha 2-related limb-girdle muscular dystrophy R23
|
ORPHAnet |
| 0‑L |
565858
|
Craniosynostosis-microretrognathia-severe intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
565899
|
POMGNT2-related limb-girdle muscular dystrophy R24
|
ORPHAnet |
| 0‑L |
565909
|
Calpain-3-related limb-girdle muscular dystrophy D4
|
ORPHAnet |
| 0‑L |
566067
|
CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome
|
ORPHAnet |
| 0‑L |
566175
|
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome
|
ORPHAnet |
| 0‑L |
566192
|
Congenital autosomal recessive small-platelet thrombocytopenia
|
ORPHAnet |
| 0‑L |
566231
|
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha
|
ORPHAnet |
| 0‑L |
566243
|
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta
|
ORPHAnet |
| 0‑L |
566393
|
Acute mast cell leukemia
|
ORPHAnet |
| 0‑L |
566396
|
Chronic mast cell leukemia
|
ORPHAnet |
| 0‑L |
566841
|
Liver adenomatosis
|
ORPHAnet |
| 0‑L |
566847
|
Aprosencephaly/atelencephaly spectrum
|
ORPHAnet |
| 0‑L |
566852
|
Atelencephaly
|
ORPHAnet |
| 0‑L |
566857
|
Aprosencephaly
|
ORPHAnet |
| 0‑L |
566862
|
Left sided atrial isomerism
|
ORPHAnet |
| 0‑L |
566943
|
Mueller-Weiss syndrome
|
ORPHAnet |
| 0‑L |
567502
|
B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome
|
ORPHAnet |
| 0‑L |
567544
|
Idiopathic non-lupus full-house nephropathy
|
ORPHAnet |
| 0‑L |
567546
|
Idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance
|
ORPHAnet |
| 0‑L |
567548
|
Idiopathic steroid-resistant nephrotic syndrome
|
ORPHAnet |
| 0‑L |
567550
|
Idiopathic multidrug-resistant nephrotic syndrome
|
ORPHAnet |
| 0‑L |
567552
|
Idiopathic steroid-resistant nephrotic syndrome with sensitivity to second-line immunosuppressive
therapy
|
ORPHAnet |
| 0‑L |
567983
|
Parenteral nutrition-associated cholestasis
|
ORPHAnet |
| 0‑L |
568051
|
GJC2-related late-onset primary lymphedema
|
ORPHAnet |
| 0‑L |
568056
|
Warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome
|
ORPHAnet |
| 0‑L |
568062
|
PIEZO1-related generalized lymphatic dysplasia with non-immune hydrops fetalis
|
ORPHAnet |
| 0‑L |
568065
|
EPHB4-related lymphatic-related hydrops fetalis
|
ORPHAnet |
| 0‑L |
569164
|
Angiomatoid fibrous histiocytoma
|
ORPHAnet |
| 0‑L |
569248
|
Microcystic stromal tumor
|
ORPHAnet |
| 0‑L |
569274
|
Multiple mitochondrial dysfunctions syndrome type 5
|
ORPHAnet |
| 0‑L |
569290
|
Multiple mitochondrial dysfunctions syndrome type 6
|
ORPHAnet |
| 0‑L |
569816
|
CELSR1-related late-onset primary lymphedema
|
ORPHAnet |
| 0‑L |
569821
|
Congenital primary lymphedema of Gordon
|
ORPHAnet |
| 0‑L |
570371
|
Bartter syndrome type 5
|
ORPHAnet |
| 0‑L |
570422
|
Galactose mutarotase deficiency
|
ORPHAnet |
| 0‑L |
570431
|
Idiopathic multicentric Castleman disease
|
ORPHAnet |
| 0‑L |
570438
|
HHV-8-associated multicentric Castleman disease
|
ORPHAnet |
| 0‑L |
570470
|
Ricin poisoning
|
ORPHAnet |
| 0‑L |
570491
|
QRSL1-related combined oxidative phosphorylation defect
|
ORPHAnet |
| 0‑L |
570762
|
Infective endocarditis
|
ORPHAnet |
| 0‑L |
572013
|
Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects
syndrome
|
ORPHAnet |
| 0‑L |
572333
|
Blepharophimosis-ptosis-epicanthus inversus syndrome plus
|
ORPHAnet |
| 0‑L |
572354
|
Blepharophimosis-ptosis-epicanthus inversus syndrome type 1
|
ORPHAnet |
| 0‑L |
572361
|
Blepharophimosis-ptosis-epicanthus inversus syndrome type 2
|
ORPHAnet |
| 0‑L |
572385
|
Brachydactyly type B1
|
ORPHAnet |
| 0‑L |
572428
|
Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia
|
ORPHAnet |
| 0‑L |
572543
|
RFVT2-related riboflavin transporter deficiency
|
ORPHAnet |
| 0‑L |
572550
|
RFVT3-related riboflavin transporter deficiency
|
ORPHAnet |
| 0‑L |
572761
|
DONSON-related microcephaly-short stature-limb abnormalities spectrum
|
ORPHAnet |
| 0‑L |
572768
|
Microcephaly-micromelia syndrome
|
ORPHAnet |
| 0‑L |
572773
|
Microcephaly-short stature-limb abnormalities syndrome
|
ORPHAnet |
| 0‑L |
572798
|
WARS2-related combined oxidative phosphorylation defect
|
ORPHAnet |
| 0‑L |
573253
|
Split cord malformation type II
|
ORPHAnet |
| 0‑L |
573278
|
Split cord malformation
|
ORPHAnet |
| 0‑L |
574918
|
Predisposition to severe viral infection due to IRF7 deficiency
|
ORPHAnet |
| 0‑L |
574957
|
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial
JAK1 deficiency
|
ORPHAnet |
| 0‑L |
575553
|
Cathepsin A-related arteriopathy-strokes-leukoencephalopathy
|
ORPHAnet |
| 0‑L |
576074
|
Middle East respiratory syndrome
|
ORPHAnet |
| 0‑L |
576227
|
Complete atrioventricular septal defect without ventricular hypoplasia
|
ORPHAnet |
| 0‑L |
576232
|
Partial atrioventricular septal defect with ventricular hypoplasia
|
ORPHAnet |
| 0‑L |
576235
|
Partial atrioventricular septal defect without ventricular hypoplasia
|
ORPHAnet |
| 0‑L |
576242
|
Intermediate atrioventricular septal defect
|
ORPHAnet |
| 0‑L |
576278
|
SATB2-associated syndrome
|
ORPHAnet |
| 0‑L |
576283
|
SATB2-associated syndrome due to a pathogenic variant
|
ORPHAnet |
| 0‑L |
576349
|
NLRC4-related familial cold autoinflammatory syndrome
|
ORPHAnet |
| 0‑L |
576370
|
Variant Creutzfeldt-Jakob disease
|
ORPHAnet |
| 0‑L |
576379
|
Iatrogenic Creutzfeldt-Jakob disease
|
ORPHAnet |
| 0‑L |
580572
|
Intraductal tubulopapillary neoplasm of pancreas
|
ORPHAnet |
| 0‑L |
580933
|
Lethal brain and heart developmental defects
|
ORPHAnet |
| 0‑L |
580940
|
QRICH1-related intellectual disability-chondrodysplasia syndrome
|
ORPHAnet |
| 0‑L |
580951
|
Punctate inner choroidopathy
|
ORPHAnet |
| 0‑L |
581271
|
Cramp-fasciculation syndrome
|
ORPHAnet |
| 0‑L |
583097
|
Congenital infiltrating lipomatosis of the face
|
ORPHAnet |
| 0‑L |
583595
|
Serine biosynthesis pathway deficiency, infantile/juvenile form
|
ORPHAnet |
| 0‑L |
583602
|
Neu-laxova syndrome due to phosphoserine aminotransferase deficiency
|
ORPHAnet |
| 0‑L |
583607
|
Neu-laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency
|
ORPHAnet |
| 0‑L |
583612
|
Neu-laxova syndrome due to 3-phosphoserine phosphatase deficiency
|
ORPHAnet |
| 0‑L |
583856
|
Isolated splenic vein thrombosis
|
ORPHAnet |
| 0‑L |
583861
|
Isolated mesenteric vein thrombosis
|
ORPHAnet |
| 0‑L |
585867
|
Acute myeloid leukemia with t(9;22)(q34.1;q11.2)
|
ORPHAnet |
| 0‑L |
585877
|
B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality
|
ORPHAnet |
| 0‑L |
585909
|
B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
|
ORPHAnet |
| 0‑L |
585918
|
B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
|
ORPHAnet |
| 0‑L |
585929
|
B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
|
ORPHAnet |
| 0‑L |
585936
|
B-lymphoblastic leukemia/lymphoma with hyperdiploidy
|
ORPHAnet |
| 0‑L |
585942
|
B-lymphoblastic leukemia/lymphoma with hypodiploidy
|
ORPHAnet |
| 0‑L |
585948
|
B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3)
|
ORPHAnet |
| 0‑L |
585956
|
B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
|
ORPHAnet |
| 0‑L |
586130
|
Sporadic fatal insomnia
|
ORPHAnet |
| 0‑L |
589435
|
Spondylometaphyseal dysplasia-corneal dystrophy syndrome
|
ORPHAnet |
| 0‑L |
589442
|
Short stature-skeletal dysplasia-retinal degeneration-intellectual disability-sensorineural
hearing loss syndrome
|
ORPHAnet |
| 0‑L |
589515
|
PUM1-associated developmental disability-ataxia-seizure syndrome
|
ORPHAnet |
| 0‑L |
589522
|
Spinocerebellar ataxia type 46
|
ORPHAnet |
| 0‑L |
589527
|
Spinocerebellar ataxia type 45
|
ORPHAnet |
| 0‑L |
589534
|
Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
|
ORPHAnet |
| 0‑L |
589542
|
Myeloid/lymphoid neoplasm associated with JAK2 rearrangement
|
ORPHAnet |
| 0‑L |
589547
|
GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder
|
ORPHAnet |
| 0‑L |
589595
|
Mixed phenotype acute leukemia with t(v;11q23.3)
|
ORPHAnet |
| 0‑L |
589608
|
Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies
|
ORPHAnet |
| 0‑L |
589618
|
Dystonia 28
|
ORPHAnet |
| 0‑L |
589821
|
Congenital-onset Steinert myotonic dystrophy
|
ORPHAnet |
| 0‑L |
589824
|
Childhood-onset Steinert myotonic dystrophy
|
ORPHAnet |
| 0‑L |
589827
|
Juvenile-onset Steinert myotonic dystrophy
|
ORPHAnet |
| 0‑L |
589830
|
Adult-onset Steinert myotonic dystrophy
|
ORPHAnet |
| 0‑L |
589833
|
Late-onset Steinert myotonic dystrophy
|
ORPHAnet |
| 0‑L |
589856
|
Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
|
ORPHAnet |
| 0‑L |
589905
|
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features
syndrome
|
ORPHAnet |
| 0‑L |
590539
|
Isolated melanotic schwannoma
|
ORPHAnet |
| 0‑L |
592564
|
GNAO1-related developmental delay-seizures-movement disorder spectrum
|
ORPHAnet |
| 0‑L |
592570
|
TRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech
delay syndrome
|
ORPHAnet |
| 0‑L |
592574
|
Menke-Hennekam syndrome
|
ORPHAnet |
| 0‑L |
592850
|
Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies
|
ORPHAnet |
| 0‑L |
592856
|
Neuromyelitis optica spectrum disorder with anti-MOG antibodies
|
ORPHAnet |
| 0‑L |
592869
|
Neuromyelitis optica spectrum disorder without anti-MOG and without anti-AQP4 antibodies
|
ORPHAnet |
| 0‑L |
592873
|
Acute transverse myelitis with anti-MOG antibodies
|
ORPHAnet |
| 0‑L |
592885
|
Isolated optic neuritis without anti-MOG antibodies
|
ORPHAnet |
| 0‑L |
592888
|
Isolated optic neuritis with anti-MOG antibodies
|
ORPHAnet |
| 0‑L |
592894
|
Acute disseminated encephalomyelitis with anti-MOG antibodies
|
ORPHAnet |
| 0‑L |
592900
|
Acute disseminated encephalomyelitis without anti-MOG antibodies
|
ORPHAnet |
| 0‑L |
595098
|
Timothy syndrome type 1
|
ORPHAnet |
| 0‑L |
595105
|
Timothy syndrome type 2
|
ORPHAnet |
| 0‑L |
595109
|
Atypical Timothy syndrome
|
ORPHAnet |
| 0‑L |
595133
|
Perivascular epithelioid cell neoplasm
|
ORPHAnet |
| 0‑L |
595356
|
Localized dystrophic epidermolysis bullosa
|
ORPHAnet |
| 0‑L |
596008
|
Antley-Bixler syndrome without genital anomaly or disorder of steroidogenesis
|
ORPHAnet |
| 0‑L |
596448
|
IgG4-related systemic disease
|
ORPHAnet |
| 0‑L |
596753
|
VEXAS syndrome
|
ORPHAnet |
| 0‑L |
596759
|
Combined immunodeficiency due to RELA haploinsufficiency
|
ORPHAnet |
| 0‑L |
596937
|
Portosinusoidal vascular disease
|
ORPHAnet |
| 0‑L |
596941
|
Incomplete septal cirrhosis
|
ORPHAnet |
| 0‑L |
597201
|
TRIM22-related inflammatory bowel disease
|
ORPHAnet |
| 0‑L |
597623
|
IRF2BPL-related regressive neurodevelopmental disorder-dystonia-seizures syndrome
|
ORPHAnet |
| 0‑L |
597733
|
Oculocutaneous albinism type 8
|
ORPHAnet |
| 0‑L |
597738
|
Luscan-Lumish syndrome
|
ORPHAnet |
| 0‑L |
597743
|
SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies
syndrome
|
ORPHAnet |
| 0‑L |
597746
|
Blepharophimosis-intellectual disability syndrome/genitopatellar overlap syndrome
|
ORPHAnet |
| 0‑L |
597874
|
MTHFS-related developmental delay-microcephaly-short stature-epilepsy syndrome
|
ORPHAnet |
| 0‑L |
597887
|
ALPI-related inflammatory bowel disease
|
ORPHAnet |
| 0‑L |
597939
|
Euthyroid dysprealbuminemic hyperthyroxinemia
|
ORPHAnet |
| 0‑L |
598164
|
FOXG1 syndrome due to intragenic alteration
|
ORPHAnet |
| 0‑L |
598216
|
Upper tract urothelial carcinoma
|
ORPHAnet |
| 0‑L |
598363
|
Multisystem inflammatory syndrome in children and adults
|
ORPHAnet |
| 0‑L |
598603
|
Facial dysmorphism-hypertrichosis-epilepsy-intellectual disability/developmental delay-gingival
overgrowth syndrome
|
ORPHAnet |
| 0‑L |
599082
|
CHD3-related developmental delay-speech delay-intellectual disability-abnormalities
of vision-facial dysmorphism syndrome
|
ORPHAnet |
| 0‑L |
599373
|
STXBP1-related encephalopathy
|
ORPHAnet |
| 0‑L |
599376
|
Hypomyelination of early myelinating structures
|
ORPHAnet |
| 0‑L |
599418
|
Hereditary angioedema with normal C1Inh not related to F12 or PLG variant
|
ORPHAnet |
| 0‑L |
599480
|
Acquired hemophilia A
|
ORPHAnet |
| 0‑L |
599485
|
Acquired hemophilia B
|
ORPHAnet |
| 0‑L |
599490
|
Acquired factor V deficiency
|
ORPHAnet |
| 0‑L |
599495
|
Acquired factor VII deficiency
|
ORPHAnet |
| 0‑L |
599501
|
Acquired factor X deficiency
|
ORPHAnet |
| 0‑L |
599507
|
Acquired factor XI deficiency
|
ORPHAnet |
| 0‑L |
599513
|
Acquired factor XIII deficiency
|
ORPHAnet |
| 0‑L |
599519
|
Factor V short isoforms-related bleeding disorder
|
ORPHAnet |
| 0‑L |
599579
|
Factor V Amsterdam bleeding disorder
|
ORPHAnet |
| 0‑L |
600194
|
Factor V Atlanta bleeding disorder
|
ORPHAnet |
| 0‑L |
600663
|
NRXN1-related severe neurodevelopmental disorder-motor stereotypies-chronic constipation-sleep-wake
cycle disturbance
|
ORPHAnet |
| 0‑L |
600668
|
CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism
syndrome
|
ORPHAnet |
| 0‑L |
600691
|
Combined deficiency of factor VII and factor X
|
ORPHAnet |
| 0‑L |
600731
|
Clark-Baraitser syndrome
|
ORPHAnet |
| 0‑L |
600952
|
Non-syndromic anorectal malformation with perineal fistula
|
ORPHAnet |
| 0‑L |
600961
|
Non-syndromic anorectal malformation with rectourethral fistula
|
ORPHAnet |
| 0‑L |
600966
|
Non-syndromic anorectal malformation with rectourethral fistula, bulbar type
|
ORPHAnet |
| 0‑L |
600975
|
Non-syndromic anorectal malformation with rectourethral fistula, prostatic type
|
ORPHAnet |
| 0‑L |
600984
|
Non-syndromic anorectal malformation with rectovesical fistula
|
ORPHAnet |
| 0‑L |
600993
|
Non-syndromic anorectal malformation with vestibular fistula
|
ORPHAnet |
| 0‑L |
600998
|
Non-syndromic cloacal malformation
|
ORPHAnet |
| 0‑L |
601002
|
Non-syndromic anorectal malformation without fistula
|
ORPHAnet |
| 0‑L |
601008
|
Non-syndromic anorectal malformation with anal stenosis
|
ORPHAnet |
| 0‑L |
601013
|
Non-syndromic anorectal malformation with pouch colon
|
ORPHAnet |
| 0‑L |
601018
|
Non-syndromic anorectal malformation with rectal atresia
|
ORPHAnet |
| 0‑L |
601023
|
Non-syndromic anorectal malformation with rectal stenosis
|
ORPHAnet |
| 0‑L |
601028
|
Non-syndromic anorectal malformation with rectovaginal fistula
|
ORPHAnet |
| 0‑L |
601033
|
Non-syndromic anorectal malformation with H-type fistula
|
ORPHAnet |
| 0‑L |
603448
|
Cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth
retardation syndrome
|
ORPHAnet |
| 0‑L |
603494
|
Coloboma-osteopetrosis-microphthalmia-macrocephaly-albinism-deafness syndrome
|
ORPHAnet |
| 0‑L |
603515
|
Isolated female hypospadias
|
ORPHAnet |
| 0‑L |
603684
|
KLHL7-related Bohring-Opitz-like/Cold-induced sweating-like overlap syndrome
|
ORPHAnet |
| 0‑L |
603689
|
KLHL7-related Bohring-Opitz-like syndrome
|
ORPHAnet |
| 0‑L |
603694
|
KLHL7-related cold-induced sweating-like syndrome
|
ORPHAnet |
| 0‑L |
604680
|
Symptomatic form of X-linked centronuclear myopathy in female carriers
|
ORPHAnet |
| 0‑L |
610569
|
KIAA1109-related early lethal congenital brain malformations-arthrogryposis syndrome
|
ORPHAnet |
| 0‑L |
610573
|
CLCN6-related childhood-onset progressive neurodegeneration-peripheral neuropathy
syndrome
|
ORPHAnet |
| 0‑L |
611201
|
Oculogastrointestinal-neurodevelopmental syndrome
|
ORPHAnet |
| 0‑L |
611207
|
Spondyloepiphyseal dysplasia-sensorineural hearing loss-intellectual disability-Leber
congenital amaurosis syndrome
|
ORPHAnet |
| 0‑L |
611216
|
Aplastic anemia-intellectual disability-dwarfism syndrome
|
ORPHAnet |
| 0‑L |
611223
|
EN1-related dorsoventral syndrome
|
ORPHAnet |
| 0‑L |
611237
|
Parkinsonism with polyneuropathy
|
ORPHAnet |
| 0‑L |
611247
|
Pontocerebellar hypoplasia type 11
|
ORPHAnet |
| 0‑L |
611256
|
Pontocerebellar hypoplasia type 12
|
ORPHAnet |
| 0‑L |
613267
|
Pontocerebellar hypoplasia type 13
|
ORPHAnet |
| 0‑L |
613274
|
Pontocerebellar hypoplasia type 14
|
ORPHAnet |
| 0‑L |
615938
|
Spastic paraparesis-cataracts-speech delay syndrome
|
ORPHAnet |
| 0‑L |
615943
|
Granuloma faciale
|
ORPHAnet |
| 0‑L |
615954
|
Lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome
|
ORPHAnet |
| 0‑L |
615964
|
Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate
|
ORPHAnet |
| 0‑L |
615970
|
Chronic intervillositis of unknown etiology
|
ORPHAnet |
| 0‑L |
615983
|
Lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome due
to a point mutation
|
ORPHAnet |
| 0‑L |
615986
|
Lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome due
to biallelic deletions in the ATAD3 gene cluster
|
ORPHAnet |
| 0‑L |
616874
|
Rare disorder without a determined diagnosis after full investigation
|
ORPHAnet |
| 0‑L |
617294
|
Twin anemia-polycythemia sequence
|
ORPHAnet |
| 0‑L |
617297
|
Twin-reversed arterial perfusion sequence
|
ORPHAnet |
| 0‑L |
617301
|
Selective intrauterine growth restriction
|
ORPHAnet |
| 0‑L |
617304
|
Amniotic fluid embolism
|
ORPHAnet |
| 0‑L |
617408
|
Classic eosinophilic pustular folliculitis
|
ORPHAnet |
| 0‑L |
617440
|
Painful legs and moving toes syndrome
|
ORPHAnet |
| 0‑L |
617449
|
Congenital aphakia-iris hypoplasia-microphthalmia-microcornea syndrome
|
ORPHAnet |
| 0‑L |
617910
|
Conjunctival malignant melanoma
|
ORPHAnet |
| 0‑L |
617916
|
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
|
ORPHAnet |
| 0‑L |
617919
|
F12-associated cold autoinflammatory syndrome
|
ORPHAnet |
| 0‑L |
617930
|
Hemophilia B Leyden
|
ORPHAnet |
| 0‑L |
618891
|
Chronic neurovisceral acid sphingomyelinase deficiency
|
ORPHAnet |
| 0‑L |
619233
|
Hereditary persistence of fetal hemoglobin-intellectual disability syndrome
|
ORPHAnet |
| 0‑L |
619363
|
Neonatal-onset severe multisystemic autoinflammatory disease with increased IL18
|
ORPHAnet |
| 0‑L |
619367
|
SAMD9L-associated autoinflammatory syndrome
|
ORPHAnet |
| 0‑L |
619941
|
Immune deficiency due to impaired neutrophil phagocytosis and migration
|
ORPHAnet |
| 0‑L |
619948
|
Early-onset autoimmunity-autoinflammation-immunodeficiency syndrome
|
ORPHAnet |
| 0‑L |
619953
|
Familial hyperinflammatory lymphoproliferative immunodeficiency
|
ORPHAnet |
| 0‑L |
619972
|
CADINS disease
|
ORPHAnet |
| 0‑L |
619979
|
Developmental delay-immunodeficiency-leukoencephalopathy-hypohomocysteinemia syndrome
|
ORPHAnet |
| 0‑L |
620102
|
Non-syndromic unicoronal craniosynostosis
|
ORPHAnet |
| 0‑L |
620113
|
Non-syndromic unilambdoid craniosynostosis
|
ORPHAnet |
| 0‑L |
620139
|
Non-syndromic unifrontosphenoidal craniosynostosis
|
ORPHAnet |
| 0‑L |
620146
|
Non-syndromic unisquamosal craniosynostosis
|
ORPHAnet |
| 0‑L |
620158
|
Non-syndromic non-specific multisutural craniosynostosis
|
ORPHAnet |
| 0‑L |
620178
|
Non-syndromic bilambdoid craniosynostosis
|
ORPHAnet |
| 0‑L |
620186
|
Non-syndromic unicoronal and sagittal craniosynostosis
|
ORPHAnet |
| 0‑L |
620192
|
Non-syndromic metopic and sagittal craniosynostosis
|
ORPHAnet |
| 0‑L |
620198
|
Non-syndromic bicoronal and metopic craniosynostosis
|
ORPHAnet |
| 0‑L |
620205
|
Non-syndromic bicoronal and sagittal craniosynostosis
|
ORPHAnet |
| 0‑L |
620212
|
Non-syndromic pansynostosis
|
ORPHAnet |
| 0‑L |
620217
|
Bartter syndrome type 1
|
ORPHAnet |
| 0‑L |
620220
|
Bartter syndrome type 2
|
ORPHAnet |
| 0‑L |
620363
|
Primary hypomagnesemia-generalized seizures-intellectual disability-obesity syndrome
|
ORPHAnet |
| 0‑L |
620368
|
EGF-related primary hypomagnesemia with intellectual disability
|
ORPHAnet |
| 0‑L |
620371
|
Gitelman-like kidney tubulopathy due to mitochondrial DNA mutation
|
ORPHAnet |
| 0‑L |
621758
|
Fibrosis-neurodegeneration-cerebral angiomatosis syndrome
|
ORPHAnet |
| 0‑L |
622099
|
Superior mesenteric artery syndrome
|
ORPHAnet |
| 0‑L |
622925
|
X-linked severe syndromic thoracic aortic aneurysm and dissection
|
ORPHAnet |
| 0‑L |
622934
|
SBDS-related severe neonatal spondylometaphyseal dysplasia
|
ORPHAnet |
| 0‑L |
623615
|
Autoimmune limbic encephalitis
|
ORPHAnet |
| 0‑L |
623626
|
Paraneoplastic cerebellar degeneration
|
ORPHAnet |
| 0‑L |
623695
|
MIR140-related spondyloepiphyseal dysplasia
|
ORPHAnet |
| 0‑L |
623789
|
Body integrity dysphoria
|
ORPHAnet |
| 0‑L |
623801
|
Acute flaccid myelitis
|
ORPHAnet |
| 0‑L |
624166
|
Non-specific autoimmune supratentorial encephalitis with characteristic antibodies
|
ORPHAnet |
| 0‑L |
624178
|
Non-specific autoimmune supratentorial encephalitis without characteristic antibodies
|
ORPHAnet |
| 0‑L |
624190
|
Paraneoplastic isolated brainstem encephalitis
|
ORPHAnet |
| 0‑L |
624199
|
Non-specific autoimmune brainstem encephalitis with characteristic antibodies
|
ORPHAnet |
| 0‑L |
624216
|
Non-specific autoimmune brainstem encephalitis without characteristic antibodies
|
ORPHAnet |
| 0‑L |
624244
|
Postinfectious cerebellitis
|
ORPHAnet |
| 0‑L |
624259
|
Non-specific autoimmune cerebellar ataxia with characteristic antibodies
|
ORPHAnet |
| 0‑L |
624268
|
Non-specific autoimmune cerebellar ataxia without characteristic antibodies
|
ORPHAnet |
| This value set has 7241 codes in it. In order to keep the publication size manageable,
only a selection (500 codes) of the whole set of codes is shown.
|
|